Kelly K. Hunt, MD, FACS, FSSO

Peer-Reviewed Articles

1. So, A, Yi, M, Simons, JM, Kuerer, HM, Caudle, A, DeSnyder, SM, Bedrosian, I, Nead, KT, Chavez-MacGregor, M, Teshome, M, Hunt, KK. Significance of Residual Nodal Disease in Clinically Node-Negative Breast Cancer After Neoadjuvant Chemotherapy. Annals of surgical oncology 32(2):922-930, 2025. PMID: 39441324.
2. Moore, AM, Caudle, AS, Sun, SX, Yi, M, Smith, B, Valero, V, Yang, W, Kuerer, HM, Hunt, KK, Teshome, M. ASO Visual Abstract. Annals of surgical oncology 32(1):123-124, 2025. PMID: 39443343.
3. Tomczak, K, Patel, MS, Bhalla, A, Peterson, CB, Landers, S, Callahan, SC, Zhang, D, Wong, J, Landry, JP, Lazar, A, Livingston, JA, Guadagnolo, BA, Lyu, H, Lillemoe, HA, Roland, CL, Keung, EZ, Scally, CP, Hunt, KK, McCutcheon, IE, Slopis, JM, Gu, J, Scheet, PA, Wang, L, Rai, K, Torres, KE. Plasma DNA Methylation-Based Biomarkers for MPNST Detection in Patients With Neurofibromatosis Type 1. Molecular Carcinogenesis 64(1):44-56, 2025. PMID: 39600120.
4. Moore, AM, Caudle, A, Sun, SX, Yi, M, Smith, BD, Valero, V, Yang, W, Kuerer, HM, Hunt, KK, Teshome, M. Impact of Clipped Node as a Sentinel Lymph Node on Axillary Staging Following Neoadjuvant Chemotherapy in Clinically Node-Positive Breast Cancer. Annals of surgical oncology 32(1):84-91, 2025. PMID: 39419889.
5. Horowitz, M, Sample, J, Rudasill, S, Zaveri, S, Francescatti, A, Teshome, M, Villano, AM, Hieken, TJ, Katz, MH, Hunt, KK. Setting the Standard for the Future of Cancer Surgery. Journal of Surgical Education 82(1), 2025. PMID: 39581164.
6. Horowitz, Michelle, Sample, Jack, Rudasill, Sarah, Zaveri, Shruti, Francescatti, Amanda, Teshome, Mediget, Villano, Anthony, Hieken, Tina, Katz, Matthew, Hunt, Kelly. Setting the Standard for the Future of Cancer Surgery. JSURG 82(1):None, 2025. PMID: None.
7. Kiefer J, Paidisetty P, Elmorsi RAI, Nguyen CHM, Yu JZ, Hunt KK, Lillemoe HA, Mericli AF, Olenczak JB. Contemporary Trends in Reconstruction for Patients With Sarcoma of the Breast. J Surg Oncol None(None):None, 2024. PMID: 39665744.
8. Neven, P, Stahl, N, Vidal, M, Martin, M, Kaufman, PA, Harbeck, N, Hunt, KK, Carter, SA, Bidard, FC, Fasching, PA, Aftimos, P, Wheatley, D, Hamilton, E, Aft, R, Kulkarni, S, Schmid, P, Bhave, M, Ismail-Khan, R, Karacsonyi, C, Estrem, ST, Nguyen, B, Özbek, U, Yuen, ES, Rodrik-Outmezguine, V, Ciruelos, E. A Preoperative Window-of-Opportunity Study of Oral SERD, Imlunestrant, in Newly Diagnosed ER-Positive, HER2-Negative Early Breast Cancer. Clinical Cancer Research 30(23):5304-5313, 2024. PMID: 39377773.
9. Muppidi, N, Adesoye, T, Hunt, KK, Teshome, M. ASO Author Reflections. Annals of surgical oncology 31(13):8908-8909, 2024. PMID: 39251515.
10. Lyu, H, Witt, RG, Rajkot, N, Keung, EZ, Torres, KE, Hunt, KK, Somaiah, N, Lazar, A, Roland, CL, Scally, CP. Patterns of Care and Outcomes of Patients with Small Gastrointestinal Stromal Tumors at a High-Volume Sarcoma Center. Annals of surgical oncology 31(13):9258-9264, 2024. PMID: 39230849.
11. Ohannesian, N, Mallick, MS, He, J, Qiao, Y, Li, N, Shaitelman, SF, Tang, C, Shinn, EH, Hofstetter, WL, Goltsov, A, Hassan, MM, Hunt, KK, Lin, SH, Shih, WC. Plasmonic nano-aperture label-free imaging of single small extracellular vesicles for cancer detection. Communications Medicine 4(1), 2024. PMID: None.
12. Musall BC, Rauch DE, Mohamed RMM, Panthi B, Boge M, Candelaria RP, Chen H, Guirguis MS, Hunt KK, Huo L, Hwang KP, Korkut A, Litton JK, Moseley TW, Pashapoor S, Patel MM, Reed BJ, Scoggins ME, Son JB, Tripathy D, Valero V, Wei P, White JB, Whitman GJ, Xu Z, Yang WT, Yam C, Adrada BE, Ma J. Diffusion Tensor Imaging for Characterizing Changes in Triple-Negative Breast Cancer During Neoadjuvant Systemic Therapy. J Magn Reson Imaging 60(4):1367-1376, 2024. e-Pub 2024. PMID: 38294179.
13. Lyu HG, Witt RG, Rajkot N, Keung EZ, Torres KE, Hunt KK, Somaiah N, Lazar AJ, Roland CL, Scally CP. Patterns of Care and Outcomes of Patients with Small Gastrointestinal Stromal Tumors at a High-Volume Sarcoma Center. Ann Surg Oncol None(None):None, 2024. PMID: 39230849.
14. Clemens MW, Myckatyn TM, Di Napoli A, Feldman AL, Jaffe ES, Haymaker CL, Horwitz SM, Hunt KK, Kadin ME, McCarthy CM, Miranda RN, Prince HM, Santanelli di Pompeo F, Holmes SD, Phillips LG. American Association of Plastic Surgeons Consensus on Breast Implant-Associated Anaplastic Large-Cell Lymphoma. Plast Reconstr Surg 154(3):473-483, 2024. PMID: 38412359.
15. Muppidi N, Adesoye T, Yi M, Sun SX, Chavez-MacGregor M, Singh P, Karuturi M, Tamirisa N, Hunt KK, Teshome M. Clinical Outcomes in Patients with Early Stage Node-Negative HER2-Positive Breast Cancer Receiving Upfront Surgery or Neoadjuvant Systemic Therapy. Ann Surg Oncol 31(13):8795-8801, 2024. PMID: 39192013.
16. Bishop AJ, Mitra D, Farooqi A, Swanson DM, Hempel C, Willis T, Pearlnath C, Wang WL, Ratan R, Somaiah N, Benjamin RS, Torres KE, Hunt KK, Scally CP, Keung EZ, Satcher RL, Bird JE, Lin PP, Moon BS, Lewis VO, Roland CL, Guadagnolo BA. Moderately hypofractionated, preoperative radiotherapy in patients with soft tissue sarcomas (HYPORT-STS): Updated local control, late toxicities, and patient-reported outcomes. Cancer 131(1), 2024. PMID: 39192597.
17. Li M, Lulla AR, Wang Y, Tsavachidis S, Wang F, Karakas C, Nguyen TDT, Bui TN, Pina MA, Chen MK, Mastoraki S, Multani AS, Fowlkes NW, Sahin A, Marshall CG, Hunt KK, Keyomarsi K. Low Molecular Weight Cyclin E Confers a Vulnerability to PKMYT1 Inhibition in Triple-Negative Breast Cancer. Cancer Res 84(22):3864-3880, 2024. PMID: 39186665.
18. Del Calvo H, Wu Y, Lin HY, Nassif EF, Zarzour MA, Guadagnolo BA, Hunt KK, Bedrosian I, Lillemoe HA. ASO Visual Abstract: Margin Width and Local Recurrence in Patients with Phyllodes Tumors of the Breast. Ann Surg Oncol None(None):None, 2024. PMID: 39179861.
19. Gingrich A, Wangsiricharoen S, Torres MB, Ravi V, Ratan R, Keung EZ, Scally CP, Lazar AJ, Wang WL, Roland CL, Hunt KK, Yu W, Torres KE. ASO Visual Abstract: Clinical Variables Influencing Outcomes in Patients with Atypical Intradermal Smooth Muscle Neoplasms (Formerly Cutaneous Leiomyosarcomas)-Single-Institution Study of 95 Surgical Patients. Ann Surg Oncol None(None):None, 2024. PMID: 39158635.
20. Gingrich A, Wangsiricharoen S, Torres MB, Ravi V, Ratan R, Keung EZ, Scally CP, Lazar AJ, Wang WL, Roland CL, Hunt KK, Yu W, Torres KE. Clinical Variables Influencing Outcomes in Patients with Atypical Intradermal Smooth Muscle Neoplasms (Formerly Cutaneous Leiomyosarcomas): Single-Institution Study of 95 Surgical Patients. Ann Surg Oncol 31(12):7950-7956, 2024. PMID: 39150618.
21. Glencer AC, Wanis KN, Brown S, Lucci A, Sun SX, Adesoye T, DeSnyder SM, Layman R, Woodward WA, Hunt KK, Teshome M. ASO Visual Abstract: Self-Reported Management of Inflammatory Breast Cancer Among the American Society of Breast Surgeons Membership-Consensus and Opportunities. Ann Surg Oncol None(None):None, 2024. PMID: 39126436.
22. Wanis KN, Goetz L, So A, Glencer AC, Sun SX, Teshome M, Resetkova E, Hwang RF, Hunt KK, Candelaria RP, Huo L, Singh P. ASO Visual Abstract: The Prevalence of Sentinel Lymph Node Positivity and Implications for the Utility of Frozen Section Diagnosis Following Neoadjuvant Systemic Therapy in Patients with Clinically Node-Negative HER2-Positive or Triple-Negative Breast Cancer. Ann Surg Oncol None(None):None, 2024. PMID: 39107599.
23. Huang ML, Lane DL, Chang Sen LQ, Candelaria RP, Kuerer HM, Hunt KK, Akay C, Lim B, Shaitelman S, Hwang RF, Chen H, Katta R, Santiago L. Defining Breast Cryoablation Treatment Success: A Guide for the Curative and Palliative Treatment of Breast Cancer. Acad Radiol 31(12):4759-4771, 2024. PMID: 39107186.
24. Zaveri S, Teshome M, Reyna C, Francescatti AB, Yi M, Katz MHG, Hunt KK, Vreeland T. Assessing Surgeon Familiarity with the Commission on Cancer Operative Standards for Cancer Surgery. Ann Surg Oncol 31(10):6378-6386, 2024. PMID: 39090487.
25. Zaveri S, Teshome M, Katz MHG, Hunt KK, Vreeland T. ASO Author Reflections: The Path to Standardizing Surgical Cancer Care in the USA. Ann Surg Oncol 31(10):6406-6407, 2024. PMID: 39090490.
26. Moore AM, Caudle AS, Sun SX, Yi M, Smith BD, Valero V, Yang W, Kuerer HM, Hunt KK, Teshome M. ASO Visual Abstract: Residual Nodal Burden After Neoadjuvant Chemotherapy in cN1 Breast Cancer Patients with Positive Nodes on Targeted Axillary Dissection. Ann Surg Oncol None(None):None, 2024. PMID: 39090492.
27. Zaveri S, Teshome M, Reyna C, Francescatti AB, Yi M, Katz MHG, Hunt KK, Vreeland T. ASO Visual Abstract: Assessing Surgeon Familiarity with the Commission on Cancer Operative Standards for Cancer Surgery. Ann Surg Oncol None(None):None, 2024. PMID: 39090493.
28. Del Calvo H, Wu Y, Lin HY, Nassif EF, Zarzour MA, Guadagnolo BA, Hunt KK, Bedrosian I, Lillemoe HA. Margin Width and Local Recurrence in Patients with Phyllodes Tumors of the Breast. Ann Surg Oncol 31(12):8048-8056, 2024. PMID: 39085546.
29. Wanis KN, Goetz L, So A, Glencer AC, Sun SX, Teshome M, Resetkova E, Hwang RF, Hunt KK, Candelaria RP, Huo L, Singh P. The Prevalence of Sentinel Lymph Node Positivity and Implications for the Utility of Frozen Section Diagnosis Following Neoadjuvant Systemic Therapy in Patients with Clinically Node-Negative HER2-Positive or Triple-Negative Breast Cancer. Ann Surg Oncol 31(11):7339-7346, 2024. PMID: 39048903.
30. Moore AM, Caudle AS, Sun SX, Yi M, Smith BD, Valero V, Yang W, Kuerer HM, Hunt KK, Teshome M. Residual Nodal Burden After Neoadjuvant Chemotherapy in cN1 Breast Cancer Patients with Positive Nodes at Targeted Axillary Dissection. Ann Surg Oncol 31(11):7264-7270, 2024. PMID: 39044106.
31. Glencer AC, Wanis KN, Brown S, Lucci A, Sun SX, Adesoye T, DeSnyder SM, Layman R, Woodward WA, Hunt KK, Teshome M. Self-Reported Management of Inflammatory Breast Cancer Among the American Society of Breast Surgeons Membership: Consensus and Opportunities. Ann Surg Oncol 31(11):7326-7334, 2024. PMID: 39034365.
32. Glencer AC, Hunt KK, Teshome M. ASO Author Reflections: Management of Inflammatory Breast Cancer: No Role for Surgical De-escalation Yet. Ann Surg Oncol 31(11):7335-7336, 2024. PMID: 39020114.
33. Mohamed RM, Panthi B, Adrada BE, Boge M, Candelaria RP, Chen H, Guirguis MS, Hunt KK, Huo L, Hwang KP, Korkut A, Litton JK, Moseley TW, Pashapoor S, Patel MM, Reed B, Scoggins ME, Son JB, Thompson A, Tripathy D, Valero V, Wei P, White J, Whitman GJ, Xu Z, Yang W, Yam C, Ma J, Rauch GM. Multiparametric MRI-based radiomic models for early prediction of response to neoadjuvant systemic therapy in triple-negative breast cancer. Sci Rep 14(1):16073, 2024. PMID: 38992094.
34. Wanis, KN, Kuerer, HM, Sun, SX, Hunt, KK, Glencer, AC, Teshome, M, Lucci, A, Weiser, R, Johnson, HM, Smith, B, Gutierrez, AM, Shaitelman, SF, Arun, BK. Clinical Outcomes for BRCA Pathogenic Variant Carriers with Breast Cancer Undergoing Breast Conservation. JAMA Network Open:e2418486, 2024. PMID: 38916888.
35. Traweek, R, Lyu, H, Witt, RG, Snyder, RA, Nassif, EF, Krijgh, DD, Smith, JM, Tilney, G, Feng, C, Chiang, YJ, Torres, KE, Roubaud, MJ, Scally, CP, Hunt, KK, Keung, EZ, Mericli, AF, Roland, CL. High Community-Level Social Vulnerability is Associated with Worse Recurrence-Free Survival (RFS) After Resection of Extremity and Truncal Soft Tissue Sarcoma. Annals of surgical oncology 31(6):4138-4147, 2024. PMID: 38396039.
36. Traweek, R, Lyu, H, Witt, RG, Snyder, RA, Nassif, EF, Krijgh, DD, Smith, JM, Tilney, G, Feng, C, Chiang, YJ, Torres, KE, Roubaud, MS, Scally, CP, Hunt, KK, Keung, EZ, Mericli, AF, Roland, CL. ASO Visual Abstract. Annals of surgical oncology 31(6):4150-4151, 2024. PMID: 38546800.
37. Ohannesian N, Mallick MS, He J, Qiao Y, Li N, Shaitelman SF, Tang C, Shinn EH, Hofstetter WL, Goltsov A, Hassan MM, Hunt KK, Lin SH, Shih WC. Plasmonic nano-aperture label-free imaging of single small extracellular vesicles for cancer detection. Commun Med (Lond) 4(1):100, 2024. PMID: 38796532.
38. Lulla, A, Akli, S, Karakas, C, Caruso, JA, Warma, LD, Fowlkes, NW, Rao, X, Wang, J, Hunt, KK, Watowich, SS, Keyomarsi, K. Neutrophil Elastase Remodels Mammary Tumors to Facilitate Lung Metastasis. Molecular cancer therapeutics 23(4):492-506, 2024. PMID: 37796181.
39. Roland CL, Nassif Haddad EF, Keung EZ, Wang WL, Lazar AJ, Lin H, Chelvanambi M, Parra ER, Wani K, Guadagnolo BA, Bishop AJ, Burton EM, Hunt KK, Torres KE, Feig BW, Scally CP, Lewis VO, Bird JE, Ratan R, Araujo D, Zarzour MA, Patel S, Benjamin R, Conley AP, Livingston JA, Ravi V, Tawbi HA, Lin PP, Moon BS, Satcher RL, Mujtaba B, Witt RG, Traweek RS, Cope B, Lazcano R, Wu CC, Zhou X, Mohammad MM, Chu RA, Zhang J, Damania A, Sahasrabhojane P, Tate T, Callahan K, Nguyen S, Ingram D, Morey R, Crosby S, Mathew G, Duncan S, Lima CF, Blay JY, Fridman WH, Shaw K, Wistuba I, Futreal A, Ajami N, Wargo JA, Somaiah N. A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma. Nat Cancer 5(4):625-641, 2024. PMID: 38351182.
40. Ma CX, Suman VJ, Sanati S, Vij K, Anurag M, Leitch AM, Unzeitig GW, Hoog J, Fernandez-Martinez A, Fan C, Gibbs RA, Watson MA, Dockter TJ, Hahn O, Guenther JM, Caudle A, Crouch E, Tiersten A, Mita M, Razaq W, Hieken TJ, Wang Y, Rimawi MF, Weiss A, Winer EP, Hunt KK, Perou CM, Ellis MJ, Partridge AH, Carey LA. Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination: A Phase 3 Randomized Clinical Trial. JAMA Oncol 10(3):362-371, 2024. e-Pub 2024. PMID: 38236590.
41. Novick, KL, Chadha, M, Daroui, P, Freedman, GM, Gao, W, Hunt, KK, Park, CC, Rewari, A, Suh, WW, Walker, EM, Wong, J, Harris, EE. American Radium Society Appropriate Use Criteria Postmastectomy Radiation Therapy. International Journal of Radiation Oncology Biology Physics 118(2):458-465, 2024. PMID: 37478956.
42. Woodfin, AA, Yam, C, Teshome, M, Kuerer, HM, Hunt, KK, Meric-Bernstam, F, Schaverien, MV, Barcenas, CH, Sun, SX. Axillary Nodal Metastases Conversion and Perioperative Complications with Neoadjuvant Pembrolizumab Therapy in Triple-Negative Breast Cancer. Annals of surgical oncology 31(2):974-980, 2024. PMID: 37973647.
43. Thomas, KK, Francescatti, A, Vreeland, TJ, Teshome, M, Morris, AM, Hunt, KK, Katz, MH, Villano, AM. ASO Visual Abstract. Annals of surgical oncology 31(1):72-73, 2024. PMID: 37914924.
44. Gunther, J, Iyer, SP, Hunt, KK, Fang, H, Wang, S, Clemens, MW, Pinnix, CC. Beyond surgery. Case Reports in Plastic Surgery and Hand Surgery 11(1), 2024. PMID: None.
45. Farley, CR, Bassett Jr, R, Meric-Bernstam, F, Bedrosian, I, Caudle, AS, DeSnyder, SM, Hunt, KK, Kuerer, HM, Singh, P, Sun, SX, Tamirisa, N, Teshome, M, Hwang, RF. To Dissect or Not to Dissect. Annals of surgical oncology 30(13):8327-8334, 2023. PMID: 37670121.
46. Zaveri S, Everidge S, FitzSullivan E, Hwang R, Smith BD, Lin H, Shen Y, Lucci A, Teshome M, Sun SX, Hunt KK, Kuerer HM. Extremely Low Incidence of Local-Regional Recurrences Observed Among T1-2 N1 (1 or 2 Positive SLNs) Breast Cancer Patients Receiving Upfront Mastectomy Without Completion Axillary Node Dissection. Ann Surg Oncol 30(12):7015-7025, 2023. e-Pub 2023. PMID: 37458948.
47. Xu, Z, Rauch, DE, Mohamed, RM, Pashapoor, S, Zhou, Z, Panthi, B, Son, JB, Hwang, K, Musall, BC, Adrada, BE, Candelaria, RP, Leung, J, Le-Petross, H, Lane, DL, Perez, F, White, JB, Clayborn, A, Reed, BJ, Chen, H, Sun, J, Wei, P, Thompson, A, Korkut, A, Huo, L, Hunt, KK, Litton, J, Valero, V, Tripathy, D, Yang, W, Yam, C, Ma, J. Deep Learning for Fully Automatic Tumor Segmentation on Serially Acquired Dynamic Contrast-Enhanced MRI Images of Triple-Negative Breast Cancer. Cancers 15(19), 2023. PMID: 37835523.
48. Navarro-Yepes J, Kettner NM, Rao X, Bishop CS, Bui TN, Wingate HF, Singareeka Raghavendra A, Wang Y, Wang J, Sahin AA, Meric-Bernstam F, Hunt KK, Damodaran S, Tripathy D, Keyomarsi K. Abemaciclib is effective in palbociclib-resistant hormone receptor-positive metastatic breast cancers. Cancer Res 83(19):3264-3283, 2023. e-Pub 2023. PMID: 37384539.
49. Zhou, Z, Adrada, BE, Candelaria, RP, Elshafeey, N, Boge, M, Mohamed, RM, Pashapoor, S, Sun, J, Xu, Z, Panthi, B, Son, JB, Guirguis, MS, Patel, MM, Whitman, GJ, Moseley, T, Scoggins, ME, White, JB, Litton, J, Valero, V, Hunt, KK, Tripathy, D, Yang, W, Wei, P, Yam, C, Pagel, MD, Rauch, GM, Ma, J. Predicting pathological complete response to neoadjuvant systemic therapy for triple-negative breast cancers using deep learning on multiparametric MRIs. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2023:1-4, 2023. PMID: 38083160.
50. Smith BL, Hunt KK, Carr D, Blumencranz PW, Hwang ES, Gadd MA, Stone K, Dyess DL, Dodge D, Valente S, Dekhne N, Clark P, Lee MC, Samiian L, Lesnikoski BA, Clark L, Smith KP, Chang M, Harris DK, Schlossberg B, Ferrer J, Wapnir IL. Intraoperative Fluorescence Guidance for Breast Cancer Lumpectomy Surgery. NEJM Evid 2(7):EVIDoa2200333, 2023. PMID: 38320161.
51. Boughey JC, Rosenkranz KM, Ballman KV, McCall L, Haffty BG, Cuttino LW, Kubicky CD, Le-Petross HT, Giuliano AE, Van Zee KJ, Hunt KK, Hahn OM, Carey LA, Partridge AH. Local Recurrence After Breast-Conserving Therapy in Patients With Multiple Ipsilateral Breast Cancer: Results From ACOSOG Z11102 (Alliance). J Clin Oncol 41(17):JCO2202553, 2023. e-Pub 2023. PMID: 36977292.
52. Witt RG, Voss RK, Chiang YJ, Nguyen S, Scally CP, Lin PP, Torres KE, Moon BS, Satcher RL, Hunt KK, Bird JE, Feig BW, Lewis VO, Roland CL, Keung EZ. Practice Pattern Variability in the Management of Regional Lymph Node Metastasis in Extremity and Trunk Soft Tissue Sarcoma: A Survey of the Society of Surgical Oncology and Musculoskeletal Tumor Society Membership. Ann Surg Oncol 30(6):3668-3676, 2023. e-Pub 2023. PMID: 36723723.
53. Smith BL, Hunt KK, Carr D, Blumencranz PW, Hwang ES, Gadd MA, Stone K, Dyess DL, Dodge D, Valente S, Dekhne N, Clark P, Lee MC, Samiian L, Lesnikoski BA, Clark L, Smith KP, Chang M, Harris DK, Schlossberg B, Ferrer J, Wapnir IL. Intraoperative Fluorescence Guidance for Breast Cancer Lumpectomy Surgery. NEJM Evidence, 2023. PMID: None.
54. Hunt KK, Suman VJ, Wingate HF, Leitch AM, Unzeitig G, Boughey JC, Meric-Bernstam F, Ellis MJ, Olson J. Local-Regional Recurrence After Neoadjuvant Endocrine Therapy: Data from ACOSOG Z1031 (Alliance), a Randomized Phase 2 Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clinical Stage 2 or 3 Breast Cancer. Ann Surg Oncol 30(4):2111-2118, 2023. e-Pub 2023. PMID: 36653664.
55. Nguyen TDT, Wang Y, Bui TN, Lazcano R, Ingram DR, Yi M, Vakulabharanam V, Luo L, Pina MA, Karakas C, Li M, Kettner NM, Somaiah N, Hougton PJ, Mawlawi O, Lazar AJ, Hunt KK, Keyomarsi K. Sequential targeting of retinoblastoma and DNA synthesis pathways is a therapeutic strategy for sarcomas that can be monitored in real-time. Cancer Res 83(6):939-955, 2023. e-Pub 2023. PMID: 36603130.
56. Smith-Graziani DJ, Parker PA, Peterson SK, Bedrosian I, Shen Y, Black DM, DeSnyder SM, Hunt KK, Dong W, Brewster AM. Prospective Study of Pain Outcomes Associated with Breast Surgery in Women with Nonhereditary Breast Cancer. Ann Surg 277(3):e617-e623, 2023. e-Pub 2021. PMID: 33938495.
57. Murphy BL, Yi M, Gutierrez Barrera AM, Tripathy D, Hunt KK, Arun BK. Other Primary Malignancies in Patients with Breast Cancer Who Undergo Germline Panel Testing. Ann Surg Oncol 30(3):1663-1668, 2023. e-Pub 2022. PMID: 36094691.
58. Panthi B, Adrada BE, Candelaria RP, Guirguis MS, Yam C, Boge M, Chen H, Hunt KK, Huo L, Hwang KP, Korkut A, Lane DL, Le-Petross HC, Leung JWT, Litton JK, Mohamed RM, Musall BC, Pashapoor S, Patel MM, Perez F, Son JB, Thompson A, Valero V, Wei P, White J, Xu Z, Pinsky L, Tripathy D, Yang W, Ma J, Rauch GM. Assessment of Response to Neoadjuvant Systemic Treatment in Triple-Negative Breast Cancer Using Functional Tumor Volumes from Longitudinal Dynamic Contrast-Enhanced MRI. Cancers (Basel) 15(4), 2023. e-Pub 2023. PMID: 36831368.
59. Erstad DJ, Chiang YJ, Witt RG, Cope B, Nassif EF, Scally CP, Torres KE, Feig BW, Hunt KK, Bishop AJ, Guadagnolo BA, Roland CL, Keung EZ. Clinical Impact of External Beam Radiotherapy for Surgically Resected Primary Retroperitoneal Liposarcoma. Ann Surg Oncol 30(2):926-940, 2023. e-Pub 2022. PMID: 36115928.
60. Zhou Z, Adrada BE, Candelaria RP, Elshafeey NA, Boge M, Mohamed RM, Pashapoor S, Sun J, Xu Z, Panthi B, Son JB, Guirguis MS, Patel MM, Whitman GJ, Moseley TW, Scoggins ME, White JB, Litton JK, Valero V, Hunt KK, Tripathy D, Yang W, Wei P, Yam C, Pagel MD, Rauch GM, Ma J. Prediction of pathologic complete response to neoadjuvant systemic therapy in triple negative breast cancer using deep learning on multiparametric MRI. Sci Rep 13(1):1171, 2023. e-Pub 2023. PMID: 36670144.
61. Panthi, B, Mohamed, RM, Adrada, BE, Boge, M, Candelaria, RP, Chen, H, Hunt, KK, Huo, L, Hwang, K, Korkut, A, Lane, DL, Le-Petross, H, Leung, J, Litton, J, Pashapoor, S, Perez, F, Son, JB, Sun, J, Thompson, A, Tripathy, D, Valero, V, Wei, P, White, JB, Xu, Z, Yang, W, Zhou, Z, Yam, C, Rauch, GM, Ma, J. Longitudinal dynamic contrast-enhanced MRI radiomic models for early prediction of response to neoadjuvant systemic therapy in triple-negative breast cancer. Frontiers in Oncology 13, 2023. PMID: 37941561.
62. Carlson, KA, Checka, CM, Hunt, KK, Jung, J, Bridges, CA, Singh, P, Correa Refinetti, AP, Moseley, T, Perez, F, Mayo, C, Tamirisa, N. Evaluation of a Surgical Navigation System for Localization and Excision of Nonpalpable Lesions in Breast and Axillary Surgery. Breast Journal 2023, 2023. PMID: 38162957.
63. Traweek RS, Martin AN, Rajkot NF, Guadagnolo BA, Bishop AJ, Lazar AJ, Keung EZ, Torres KE, Hunt KK, Feig BW, Roland CL, Scally CP. Re-excision After Unplanned Excision of Soft Tissue Sarcoma is Associated with High Morbidity and Limited Pathologic Identification of Residual Disease. Ann Surg Oncol 30(1):480-489, 2023. e-Pub 2022. PMID: 36085392.
64. Kuerer, HM, Smith, B, Krishnamurthy, S, Yang, WT, Valero, V, Shen, Y, Lin, Y, Lucci, A, Boughey, JC, White, RL, Diego, EJ, Rauch, GM, Moseley, T, van la Parra, RF, Adrada, BE, Leung, J, Sun, SX, Teshome, M, Miggins, MV, Hunt, KK, DeSnyder, SM, Ehlers II, RA, Hwang, RF, Colen, JS, Arribas, E, Samiian, L, Lesnikoski, BA, Piotrowski, MJ, Bedrosian, I, Chong, CD, Correa Refinetti, AP, Huang, ML, Candelaria, RP, Loveland-Jones, C, Mitchell, MP, Shaitelman, SF. Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy. The lancet oncology 23(12):1517-1524, 2022. PMID: 36306810.
65. Guadagnolo BA, Bassett RL, Mitra D, Farooqi A, Hempel C, Dorber C, Willis T, Wang WL, Ratan R, Somaiah N, Benjamin RS, Torres KE, Hunt KK, Scally CP, Keung EZ, Satcher RL, Bird JE, Lin PP, Moon BS, Lewis VO, Roland CL, Bishop AJ. Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial. Lancet Oncol 23(12):1547-1557, 2022. e-Pub 2022. PMID: 36343656.
66. Li M, Tsavachidis S, Wang F, Bui T, Nguyen TDT, Luo L, Multani AS, Bondy ML, Hunt KK, Keyomarsi K. Low-molecular-weight cyclin E deregulates DNA replication and damage repair to promote genomic instability in breast cancer. Oncogene 41(50):5331-5346, 2022. e-Pub 2022. PMID: 36344674.
67. Witt RG, Cope B, Erstad DJ, Chiang YJ, Nassif EF, Scally CP, Torres KE, Hunt KK, Feig BW, Roland CL, Keung EZ. Sentinel Lymph Node Biopsy and Formal Lymphadenectomy for Soft Tissue Sarcoma: A Single Center Experience of 86 Consecutive Cases. Ann Surg Oncol 29(11):7092-7100, 2022. e-Pub 2022. PMID: 35501583.
68. Suman VJ, Du L, Hoskin T, Anurag M, Ma C, Bedrosian I, Hunt KK, Ellis MJ, Symmans WF. Evaluation of Sensitivity to Endocrine Therapy Index (SET2,3) for Response to Neoadjuvant Endocrine Therapy and Longer-Term Breast Cancer Patient Outcomes (Alliance Z1031). Clin Cancer Res 28(15):3287-3295, 2022. PMID: 35653124.
69. Hwang ES, Beitsch P, Blumencranz P, Carr D, Chagpar A, Clark L, Dekhne N, Dodge D, Dyess DL, Gold L, Grobmyer S, Hunt K, Karp S, Lesnikoski BA, Wapnir I, Smith BL, team IS. Clinical Impact of Intraoperative Margin Assessment in Breast-Conserving Surgery With a Novel Pegulicianine Fluorescence-Guided System: A Nonrandomized Controlled Trial. JAMA Surg 157(7):573-580, 2022. e-Pub 2022. PMID: 35544130.
70. DiPeri, TP, Newhook, TE, Day, RW, Chiang, YJ, Dewhurst, WL, Arvide, EM, Bruno, M, Scally, CP, Roland, CL, Katz, MH, Vauthey, JN, Chang, GJ, Badgwell, BD, Perrier, ND, Grubbs, EG, Lee, JE, Tzeng, CD, Bednarski, BK, Chen, IB, Comeaux, RJ, Cox, DM, Feig, BW, Fisher, SB, Fournier, KF, Ghebremichael, SJ, Gibson, H, Gourmelon, NC, Graham, PH, Hancher-Hodges, S, Hunt, KK, Ikoma, N, Ivey MPAS, SL, Keung, EZ, Ledet, CR, Limmer, AR, Mansfield, PF, Mayon, L, Messick, C, Popat, KU, Rajkot MPAS, NF, Rodriguez-Bigas, MA, Santos, DA, Skibber, JM, Speer, BB, Soliz, J, Tillman, MM, Torres, KE, Van Meter, A, Williams, UU, You, YN. A prospective feasibility study evaluating the 5x-multiplier to standardize discharge prescriptions in cancer surgery patients. Surgery Open Science 9:51-57, 2022. PMID: 35663797.
71. Ha MJ, Singareeka Raghavendra A, Kettner NM, Qiao W, Damodaran S, Layman RM, Hunt KK, Shen Y, Tripathy D, Keyomarsi K. Palbociclib plus endocrine therapy significantly enhances overall survival of HR+/HER2- metastatic breast cancer patients compared to endocrine therapy alone in the second-line setting-a large institutional study. Int J Cancer 150(12):2025-2037, 2022. e-Pub 2022. PMID: 35133007.
72. Nassif EF, Cope B, Traweek R, Witt RG, Erstad DJ, Scally CP, Thirasastr P, Zarzour MA, Ludwig J, Benjamin R, Bishop AJ, Guadagnolo BA, Ingram D, Wani K, Wang WL, Lazar AJ, Torres KE, Hunt KK, Feig BW, Roland CL, Somaiah N, Keung EZ. Real-world use of palbociclib monotherapy in retroperitoneal liposarcomas at a large volume sarcoma center. Int J Cancer 150(12):2012-2024, 2022. e-Pub 2022. PMID: 35128664.
73. Liang DH, Black D, Yi M, Luo CK, Singh P, Sahin A, Scoggins ME, Moseley TW, Hunt KK. Clinical Outcomes Using Magnetic Seeds as a Non-wire, Non-radioactive Alternative for Localization of Non-palpable Breast Lesions. Ann Surg Oncol 29(6):3822-3828, 2022. e-Pub 2022. PMID: 35233742.
74. Douglas SR, Lizarraga IM, Boughey JC, Weiss A, Hunt KK, Dickson-Witmer D, Subhedar PD, Park KU, Zhao B, Blair SL. National Cancer Database trends in surgical resection of the breast primary for stage IV breast cancer. Surg Oncol 42:101778, 2022. e-Pub 2022. PMID: 35609361.
75. Cuttino LW, McCall L, Kubicky C, Ballman KV, Le-Petross H, Hunt KK, Haffty B, Rosenkranz KM, Boughey JC. The Feasibility of Radiation Therapy after Breast-Conserving Surgery for Multiple Ipsilateral Breast Cancer: An Initial Report from ACOSOG Z11102 (Alliance) Trial. Int J Radiat Oncol Biol Phys 112(3):636-642, 2022. e-Pub 2021. PMID: 34634438.
76. Voss RK, Callegaro D, Chiang YJ, Fiore M, Miceli R, Keung EZ, Feig BW, Torres KE, Scally CP, Hunt KK, Gronchi A, Roland CL. Sarculator is a Good Model to Predict Survival in Resected Extremity and Trunk Sarcomas in US Patients. Ann Surg Oncol. e-Pub 2022. PMID: 35224688.
77. Tevis SE, Hunt KK, Miranda RN, Lange C, Pinnix CC, Iyer S, Butler CE, Clemens MW. Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Prospective Series of 52 Patients. Ann Surg 275(1):e245-e249, 2022. e-Pub 2020. PMID: 32568749.
78. Medeiros LJ, Marques-Piubelli ML, Sangiorgio VFI, Ruiz-Cordero R, Vega F, Feldman AL, Chapman JR, Clemens MW, Hunt KK, Evans MG, Khoo C, Lade S, Silberman M, Morkowski J, Pina EM, Mills DC, Bates CM, Magno WB, Sohani AR, Sieling BA, O'Donoghue JM, Bacon CM, Patani N, Televantou D, Turner SD, Johnson L, MacNeill F, Wotherspoon AC, Iyer SP, Malpica LE, Patel KP, Xu J, Miranda RN. Epstein-Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationship. Mod Pathol 34(12):2154-2167, 2021. e-Pub 2021. PMID: 34226673.
79. Evans MG, Medeiros LJ, Marques-Piubelli ML, Wang HY, Ortiz-Hidalgo C, Pina-Oviedo S, Morine A, Clemens MW, Hunt KK, Iyer S, Hu Q, Recavarren C, Demichelis R, Romero M, Sohani AR, Misialek M, Amin MB, Bueso-Ramos CE, Carballo-Zarate AA, Lee HJ, Ok CY, Xu J, Miranda RN. Breast implant-associated anaplastic large cell lymphoma: clinical follow-up and analysis of sequential pathologic specimens of untreated patients shows persistent or progressive disease. Mod Pathol 34(12):2148-2153, 2021. e-Pub 2021. PMID: 34155351.
80. Kilgore LJ, Murphy BL, Postlewait LM, Liang DH, Bedrosian I, Lucci A, Kuerer HM, Hunt KK, Teshome M. Impact of the early COVID-19 pandemic on Breast Surgical Oncology fellow education. J Surg Oncol 124(7):989-994, 2021. e-Pub 2021. PMID: 34328640.
81. Weng JK, Lei X, Schlembach P, Bloom ES, Shaitelman SF, Arzu IY, Chronowski G, Dvorak T, Grade E, Hoffman K, Perkins G, Reed VK, Shah SJ, Stauder MC, Strom EA, Tereffe W, Woodward WA, Hortobagyi GN, Hunt KK, Buchholz TA, Smith BD. Five-Year Longitudinal Analysis of Patient-Reported Outcomes and Cosmesis in a Randomized Trial of Conventionally Fractionated Versus Hypofractionated Whole-Breast Irradiation. Int J Radiat Oncol Biol Phys 111(2):360-370, 2021. e-Pub 2021. PMID: 33992718.
82. Adesoye T, Babayemi O, Postlewait LM, DeSnyder SM, Sun SX, Woodward WA, Ueno NT, Hunt KK, Lucci A, Teshome M. Inflammatory Breast Cancer at the Extremes of Age. Ann Surg Oncol 28(10):5626-5634, 2021. e-Pub 2021. PMID: 34292426.
83. Elmore LC, Kuerer HM, Barcenas CH, Smith BD, Miggins MV, Lucci A, Caudle AS, Meric-Bernstam F, Hunt KK, Teshome M. Clinical Course of Breast Cancer Patients with Local-Regional Progression During Neoadjuvant Systemic Therapy. Ann Surg Oncol 28(10):5477-5485, 2021. e-Pub 2021. PMID: 34247335.
84. Kantor O, Chang C, Yao K, Boughey J, Roland C, Francescatti AB, Blair S, Dickson Witmer D, Hunt KK, Nelson H, Weiss A, Oseni T. Uptake of Breast Cancer Clinical Trials at Minority Serving Cancer Centers. Ann Surg Oncol 28(9):4995-5004, 2021. e-Pub 2021. PMID: 33423122.
85. Kochat V, Raman AT, Landers SM, Tang M, Schulz J, Terranova C, Landry JP, Bhalla AD, Beird HC, Wu CC, Jiang Y, Mao X, Lazcano R, Gite S, Ingram DR, Yi M, Zhang J, Keung EZ, Scally CP, Roland CL, Hunt KK, Feig BW, Futreal PA, Hwu P, Wang WL, Lazar AJ, Slopis JM, Wilson-Robles H, Wiener DJ, McCutcheon IE, Wustefeld-Janssens B, Rai K, Torres KE. Enhancer reprogramming in PRC2-deficient malignant peripheral nerve sheath tumors induces a targetable de-differentiated state. Acta Neuropathol 142(3):565-590, 2021. e-Pub 2021. PMID: 34283254.
86. Simons JM, Scoggins ME, Kuerer HM, Krishnamurthy S, Yang WT, Sahin AA, Shen Y, Lin H, Bedrosian I, Mittendorf EA, Thompson A, Lane DL, Hunt KK, Caudle AS. Prospective Registry Trial Assessing the Use of Magnetic Seeds to Locate Clipped Nodes After Neoadjuvant Chemotherapy for Breast Cancer Patients. Ann Surg Oncol 28(8):4277-4283, 2021. e-Pub 2021. PMID: 33417121.
87. Karakas C, Francis AM, Ha MJ, Wingate HF, Meena RA, Yi M, Rasaputra KS, Barrera AMG, Arun B, Do KA, Sahin A, Keyomarsi K, Hunt KK. Cytoplasmic Cyclin E Expression Predicts for Response to Neoadjuvant Chemotherapy in Breast Cancer. Ann Surg 274(2):e150-e159, 2021. e-Pub 2019. PMID: 31436549.
88. Weiss A, Cooley V, Al-Hilli Z, Ballman K, Poorvu N, Haffty B, Hunt KK, Nelson H, Blair SL, Boughey J. Extrapolation of ACOSOG Z0011 trial results-A survey of breast cancer providers. Breast J 27(6):537-542, 2021. e-Pub 2021. PMID: 33720478.
89. Lulla AR, Akli S, Karakas C, Ha MJ, Fowlkes NW, Mitani Y, Bui T, Wang J, Rao X, Hunt KK, Meijer L, El-Naggar AK, Keyomarsi K. LMW cyclin E and its novel catalytic partner CDK5 are therapeutic targets and prognostic biomarkers in salivary gland cancers. Oncogenesis 10(5):40, 2021. e-Pub 2021. PMID: 33990543.
90. Chen X, Yang D, Carey JPW, Karakas C, Albarracin C, Sahin AA, Arun BK, Guray Durak M, Li M, Kohansal M, Bui TN, Ha MJ, Hunt KK, Keyomarsi K. Targeting Replicative Stress and DNA Repair by Combining PARP and Wee1 Kinase Inhibitors is Synergistic in Triple Negative Breast Cancers with Cyclin E or BRCA1 Alteration. Cancers (Basel) 13(7), 2021. e-Pub 2021. PMID: 33916118.
91. Landry JP, Schertz KL, Chiang YJ, Bhalla AD, Yi M, Keung EZ, Scally CP, Feig BW, Hunt KK, Roland CL, Guadagnolo A, Bishop AJ, Lazar AJ, Slopis JM, McCutcheon IE, Torres KE. Comparison of Cancer Prevalence in Patients With Neurofibromatosis Type 1 at an Academic Cancer Center vs in the General Population From 1985 to 2020. JAMA Netw Open 4(3):e210945, 2021. e-Pub 2021. PMID: 33734413.
92. Keung EZ, Rajkot N, Torres KE, Somaiah N, Hunt KK, Feig BW, Scally CP, Ikoma N, Roland CL. Evaluating the Impact of Surveillance Follow-Up Intervals in Patients Following Resection of Primary Well-Differentiated Liposarcoma of the Retroperitoneum. Ann Surg Oncol 28(1):570-575, 2021. e-Pub 2020. PMID: 32409969.
93. Singh P, Scoggins ME, Sahin AA, Hwang RF, Kuerer HM, Caudle AS, Mittendorf EA, Thompson AM, Bedrosian I, Teshome M, DeSnyder SM, Meric-Bernstam F, Hunt KK. Effectiveness and Safety of Magseed Localization for Excision of Breast Lesions. Ann Surg 1(2), 2020. PMID: None.
94. Singh P, Scoggins ME, Sahin AA, Hwang RF, Kuerer HM, Caudle AS, Mittendorf EA, Thompson AM, Bedrosian I, Teshome M, DeSnyder SM, Meric-Bernstam F, Hunt KK. Effectiveness and Safety of Magseed-localization for Excision of Breast Lesions: A Prospective, Phase IV Trial. Ann Surg Open 1(2):e008, 2020. PMID: 34017965.
95. Rosenkranz KM, Ballman K, McCall L, McCarthy C, Kubicky CD, Cuttino L, Hunt KK, Giuliano A, Van Zee KJ, Haffty B, Boughey JC. Cosmetic outcomes following breast conservation surgery and radiation for multiple ipsilateral breast cancer: Data from the Alliance Z11102 Study. Ann Surg Oncol 27(12):4650-4661, 2020. e-Pub 2020. PMID: 32699926.
96. Chapman BV, Lei X, Patil P, Tripathi S, Nicklaus KM, Grossberg AJ, Shaitelman SF, Thompson AM, Hunt KK, Buchholz TA, Merchant F, Markey MK, Smith BD, Reddy JP. Quantitative 3-Dimensional Photographic Assessment of Breast Cosmesis After Whole Breast Irradiation for Early Stage Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial. Adv Radiat Oncol 5(5):824-833, 2020. e-Pub 2020. PMID: 33083644.
97. Roland CL, Grubbs EG, Katz MHG, Teshome M, Hunt KK, Tzeng CW. Clinical Trials - Designing, Implementing, and Collaborating. J Surg Oncol 122(1):25-28, 2020. e-Pub 2020. PMID: 32149390.
98. Kantor O, Niu J, Zhao H, Giordano SH, Hunt KK, King TA, Mittendorf EA, Chavez-MacGregor M. Comparative Analysis of Proposed Strategies for Incorporating Biologic Factors into Breast Cancer Staging. Ann Surg Oncol 27(7):2229-2237, 2020. e-Pub 2020. PMID: 31916091.
99. Keung EZ, Asare EA, Chiang YJ, Prakash LR, Rajkot N, Torres KE, Hunt KK, Feig BW, Cormier JN, Roland CL, Katz MHG, Lee JE, Tzeng CD. Postoperative pancreatic fistula after distal pancreatectomy for non-pancreas retroperitoneal tumor resection. Am J Surg 220(1):140-146, 2020. e-Pub 2019. PMID: 31843190.
100. Johnston SJ, Syed BM, Parks RM, Monteiro CJ, Caruso JA, Green AR, Ellis IO, Hunt KK, Karakas C, Keyomarsi K, Cheung KL. Cytoplasmic Cyclin E Is an Independent Marker of Aggressive Tumor Biology and Breast Cancer-Specific Mortality in Women over 70 Years of Age. Cancers (Basel) 12(3), 2020. e-Pub 2020. PMID: 32197318.
101. Asare EA, Davis CH, Chiang YJ, Sabir S, Rajkot NF, Phillips PR, Roland CL, Torres KE, Hunt KK, Feig BW. Management and outcomes of ruptured, perforated or fistulized tumors of mesenchymal origin. J Surg Oncol 121(3):474-479, 2020. e-Pub 2019. PMID: 31846095.
102. Park KU, Kyrish K, Yi M, Bedrosian I, Caudle AS, Kuerer HM, Hunt KK, Miggins MV, DeSnyder SM. Opioid Use after Breast-Conserving Surgery: Prospective Evaluation of Risk Factors for High Opioid Use. Ann Surg Oncol 27(3):730-735, 2020. e-Pub 2019. PMID: 31820211.
103. Yi M, Lin H, Bedrosian I, Shen Y, Hunt KK, Chavez-MacGregor M, King TA, Mittendorf EA. Staging for Breast Cancer Patients Receiving Neoadjuvant Chemotherapy: Utility of Incorporating Biologic Factors. Ann Surg Oncol 27(2):359-366, 2020. e-Pub 2019. PMID: 31667721.
104. Mull BB, Livingston JA, Patel N, Bui T, Hunt KK, Keyomarsi K. Specific, reversible G1 arrest by UCN-01 in vivo provides cytostatic protection of normal cells against cytotoxic chemotherapy in breast cancer. Br J Cancer. e-Pub 2020. PMID: 31942030.
105. Smith BD, Lei X, Diao K, Xu Y, Shen Y, Smith GL, Giordano SH, DeSnyder SM, Hunt KK, Teshome M, Jagsi R, Shaitelman SF, Peterson SK, Swanick CW. Effect of Surgeon Factors on Long-Term Patient-Reported Outcomes After Breast Conserving Therapy in Older Breast Cancer Survivors. Ann Surg Oncol. e-Pub 2020. PMID: 31916092.
106. Weiss A, Lopez NE, Ward EP, Lee KC, Caudle AS, Dickson-Witmer D, Chang C, Kelly K, Martin LW, Jacobs LK, Hunt KK, Yao K, Blair SL. Challenges in Clinical Trial Implementation: Results from a Survey of the National Accreditation Program of Breast Centers (NAPBC). Ann Surg Oncol 26(13):4364-4371, 2019. PMID: 31625045.
107. Al-Refaie WB, Decker PA, Ballman KV, Pisters PWT, Posner MC, Hunt KK, Meyers B, Weinberg AD, Nelson H, Newman L, Tan A, Le-Rademacher JG, Hurria A, Jatoi A. Comparative Age-Based Prospective Multi-Institutional Observations of 12,367 Patients Enrolled to the American College of Surgeons Oncology Group (ACOSOG) Z901101 Trials (Alliance). Ann Surg Oncol 26(13):4213-4221, 2019. e-Pub 2019. PMID: 31605327.
108. Simons JM, MLMA VP, AWKS M, Straver ME, Zeillemaker AM, Pereira Arias-Bouda LM, van Nijnatten TJA, Koppert LB, Hunt KK, Smidt ML, Luiten EJT, van der Pol CC. Excision of both pretreatment marked positive nodes and sentinel nodes improves axillary staging after neoadjuvant systemic therapy in breast cancer. Br J Surg 106(12):1632-1639, 2019. e-Pub 2019. PMID: 31593294.
109. Haffty BG, McCall LM, Ballman KV, Buchholz TA, Hunt KK, Boughey JC. Impact of Radiation on Locoregional Control in Women with Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy and Axillary Lymph Node Dissection: Results from ACOSOG Z1071 Clinical Trial. Int J Radiat Oncol Biol Phys 105(1):174-182, 2019. e-Pub 2019. PMID: 31085287.
110. Lyapichev KA, Piña-Oviedo S, Medeiros LJ, Evans MG, Liu H, Miranda AR, Hunt KK, Clemens MW, Stewart JM, Amin MB, Quesada AE, Chai SM, Di Napoli A, Yoga A, Dave SK, Wistuba II, Wu Y, Bueso-Ramos CE, Schlette EJ, Ferrufino-Schmidt MC, Loghavi S, Khoury JD, Young KH, Miranda RN. A proposal for pathologic processing of breast implant capsules in patients with suspected breast implant anaplastic large cell lymphoma. Mod Pathol. e-Pub 2019. PMID: 31383966.
111. Zhao B, Tsai C, Hunt KK, Blair SL. Adherence to Surgical and Oncologic Standards Improves Survival in Breast Cancer Patients. J Surg Oncol 120(2):148-159, 2019. e-Pub 2019. PMID: 31172534.
112. Armer JM, Ballman KV, McCall L, Ostby PL, Zagar E, Kuerer HM, Hunt KK, Boughey JC. Factors Associated With Lymphedema in Women With Node-Positive Breast Cancer Treated With Neoadjuvant Chemotherapy and Axillary Dissection. JAMA Surg. e-Pub 2019. PMID: 31314062.
113. Alvarado MD, Mittendorf EA, Teshome M, Thompson AM, Bold RJ, Gittleman MA, Beitsch PD, Blair SL, Kivilaid K, Harmer QJ, Hunt KK. SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer. Ann Surg Oncol. e-Pub 2019. PMID: 31297674.
114. Kettner NM, Vijayaraghavan S, Durak MG, Bui T, Kohansal M, Ha MJ, Liu B, Rao X, Wang J, Yi M, Carey JPW, Chen X, Eckols TK, Raghavendra AS, Ibrahim NK, Karuturi MS, Watowich SS, Sahin A, Tweardy DJ, Hunt KK, Tripathy D, Keyomarsi K. Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer. Clin Cancer Res 25(13):3996-4013, 2019. e-Pub 2019. PMID: 30867218.
115. Weiss A, Lin H, Babiera GV, Bedrosian I, Shaitelman SF, Shen Y, Kuerer HM, Mittendorf EA, Caudle AS, Hunt KK, Hwang RF. Evolution in practice patterns of axillary management following mastectomy in patients with 1-2 positive sentinel nodes. Breast Cancer Res Treat 176(2):435-444, 2019. e-Pub 2019. PMID: 31025270.
116. Advani PG, Lei X, Swanick CW, Xu Y, Shen Y, Goodwin NA, Smith GL, Giordano SH, Hunt KK, Jagsi R, Smith BD. Local Therapy Decisional Regret in Older Women With Breast Cancer: A Population-Based study. Int J Radiat Oncol Biol Phys 104(2):383-391, 2019. e-Pub 2019. PMID: 30716524.
117. Park KU, Kyrish K, Terrell J, Yi M, Caudle AS, Hunt KK, Kuerer HM, Bedrosian I, Thompson A, DeSnyder SM, Study Group OMODOBSO. Surgeon perception versus reality: Opioid use after breast cancer surgery. J Surg Oncol 119(7):909-915, 2019. e-Pub 2019. PMID: 30737785.
118. Lamaris GA, Butler CE, Deva AK, Miranda RN, Hunt KK, Connell T, Lipa JE, Clemens MW. Breast Reconstruction Following Breast Implant-Associated Anaplastic Large Cell Lymphoma. Plast Reconstr Surg 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell L):51S-58S, 2019. PMID: 30817556.
119. Tevis SE, Bassett R, Bedrosian I, Barcenas CH, Black DM, Caudle AS, DeSnyder SM, Fitzsullivan E, Hunt KK, Kuerer HM, Lucci A, Meric-Bernstam F, Mittendorf EA, Park K, Teshome M, Thompson AM, Hwang RF. OncotypeDX Recurrence Score Does Not Predict Nodal Burden in Clinically Node Negative Breast Cancer Patients. Ann Surg Oncol 26(3):815-820, 2019. e-Pub 2018. PMID: 30556120.
120. Tevis SE, Hunt KK, Clemens MW. Stepwise En Bloc Resection of Breast Implant-Associated Anaplastic Large Cell Lymphoma with Oncologic Considerations. Aesthet Surg J Open Forum 1(1):ojz005, 2019. PMID: 33791601.
121. Tevis SE, Hunt KK, Clemens MW. Stepwise En Bloc Resection of Breast Implant-Associated Anaplastic Large Cell Lymphoma with Oncologic Considerations. Aesthetic Surgery Journal Open Forum 1(1), 2019. PMID: None.
122. Tevis SE, Hunt KK, Miranda RN, Lange C, Butler CE, Clemens MW. Differences in Human Leukocyte Antigen Expression Between Breast Implant-Associated ALCL Patients and the General Population. Aesthet Surg J. e-Pub 2019. PMID: 30715139.
123. Caudle AS, Kuerer HM, Krishnamurthy S, Shin K, Hobbs BP, Ma J, Mittendorf EA, Washington AC, DeSnyder SM, Black DM, Hunt KK, Yang WT. Feasibility of fine-needle aspiration for assessing responses to chemotherapy in metastatic nodes marked with clips in breast cancer: A prospective registry study. Cancer 125(3):365-373, 2019. e-Pub 2018. PMID: 30359480.
124. Fisher SB, Chiang YJ, Feig BW, Cormier JN, Hunt KK, Torres KE, Roland CL. An Evaluation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) Staging System for Retroperitoneal Sarcomas Using the National Cancer Data Base (NCDB): Does Size Matter?. Am J Clin Oncol 42(2):160-165, 2019. PMID: 30394881.
125. Armer JM, Ballman KV, McCall L, Armer NC, Sun Y, Udmuangpia T, Hunt KK, Mittendorf EA, Byrd DR, Julian TB, Boughey JC. Lymphedema symptoms and limb measurement changes in breast cancer survivors treated with neoadjuvant chemotherapy and axillary dissection: results of American College of Surgeons Oncology Group (ACOSOG) Z1071 (Alliance) substudy. Support Care Cancer 27(2):495-503, 2019. e-Pub 2018. PMID: 29980907.
126. Buzdar AU, Suman VJ, Meric-Bernstam F, Leitch AM, Ellis MJ, Boughey JC, Unzeitig GW, Royce ME, Hunt KK. Disease-Free and Overall Survival Among Patients With Operable HER2-Positive Breast Cancer Treated With Sequential vs Concurrent Chemotherapy: The ACOSOG Z1041 (Alliance) Randomized Clinical Trial. JAMA Oncol 5(1):45-50, 2019. e-Pub 2018. PMID: 30193295.
127. Tadros AB, Smith BD, Shen Y, Lin H, Krishnamurthy S, Lucci A, Barcenas CH, Hwang RF, Rauch G, Santiago L, Strom EA, DeSnyder SM, Yang WT, Black DM, Albarracin CT, Chavez-MacGregor M, Hunt KK, Kuerer HM. Ductal Carcinoma In Situ and Margins <2mm: Contemporary Outcomes With Breast Conservation. Ann Surg 269(1):150-157, 2019. e-Pub 2017. PMID: 28742682.
128. Chen X, Low KH, Alexander A, Jiang Y, Karakas C, Hess KR, Carey JPW, Bui TN, Vijayaraghavan S, Evans KW, Yi M, Ellis DC, Cheung KL, Ellis IO, Fu S, Meric-Bernstam F, Hunt KK, Keyomarsi K. Cyclin E Overexpression Sensitizes Triple-Negative Breast Cancer to Wee1 Kinase Inhibition. Clin Cancer Res 24(24):6594-6610, 2018. e-Pub 2018. PMID: 30181387.
129. Bhardwaj A, Singh H, Trinidad CM, Albarracin CT, Hunt KK, Bedrosian I. The isomiR-140-3p-regulated mevalonic acid pathway as a potential target for prevention of triple negative breast cancer. Breast Cancer Res 20(150):150, 2018. e-Pub 2018. PMID: 30537987.
130. Keung EZ, Chiang YJ, Cormier JN, Torres KE, Hunt KK, Feig BW, Roland CL. Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma. Cancer 124(23):4495-4503, 2018. e-Pub 2018. PMID: 30317543.
131. Shaitelman SF, Lei X, Thompson A, Schlembach P, Bloom ES, Arzu IY, Buchholz D, Chronowski G, Dvorak T, Grade E, Hoffman K, Perkins G, Reed VK, Shah SJ, Stauder MC, Strom EA, Tereffe W, Woodward WA, Amaya DN, Shen Y, Hortobagyi GN, Hunt KK, Buchholz TA, Smith BD. Three-Year Outcomes With Hypofractionated Versus Conventionally Fractionated Whole-Breast Irradiation: Results of a Randomized, Noninferiority Clinical Trial. J Clin Oncol 36(35):3495-3503. e-Pub 2018. PMID: 30379626.
132. Tevis SE, Neuman HB, Mittendorf EA, Kuerer HM, Bedrosian I, DeSnyder SM, Thompson AM, Black DM, Scoggins ME, Sahin AA, Hunt KK, Caudle AS. Multidisciplinary Intraoperative Assessment of Breast Specimens Reduces Number of Positive Margins. Ann Surg Oncol 25(10):2932-2938, 2018. e-Pub 2018. PMID: 29947001.
133. DeSnyder SM, Hunt KK, Dong W, Smith BD, Moran MS, Chavez-MacGregor M, Shen Y, Kuerer HM, Lucci A. American Society of Breast Surgeons' Practice Patterns After Publication of the SSO-ASTRO-ASCO DCIS Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation. Ann Surg Oncol 25(10):2965-2974, 2018. e-Pub 2018. PMID: 29987598.
134. Rosenkranz KM, Ballman K, McCall L, Kubicky C, Cuttino L, Le-Petross H, Hunt KK, Giuliano A, Van Zee KJ, Haffty B, Boughey JC. The Feasibility of Breast-Conserving Surgery for Multiple Ipsilateral Breast Cancer: An Initial Report from ACOSOG Z11102 (Alliance) Trial. Ann Surg Oncol 25(10):2858-2866, 2018. e-Pub 2018. PMID: 29987605.
135. Keung EZ, Lazar AJ, Torres KE, Wang WL, Cormier JN, Ashleigh Guadagnolo B, Bishop AJ, Lin H, Hunt KK, Bird J, Lewis VO, Patel SR, Wargo JA, Somaiah N, Roland CL. Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma. BMC Cancer 18(1):913, 2018. e-Pub 2018. PMID: 30249211.
136. Parker PA, Peterson SK, Shen Y, Bedrosian I, Black DM, Thompson AM, Nelson JC, DeSnyder SM, Cook RL, Hunt KK, Volk RJ, Cantor SB, Dong W, Brewster AM. Prospective Study of Psychosocial Outcomes of Having Contralateral Prophylactic Mastectomy Among Women With Nonhereditary Breast Cancer. J Clin Oncol 36(25):2630-2638, 2018. e-Pub 2018. PMID: 30044695.
137. Lei JT, Shao J, Zhang J, Iglesia M, Chan DW, Cao J, Anurag M, Singh P, He X, Kosaka Y, Matsunuma R, Crowder R, Hoog J, Phommaly C, Goncalves R, Ramalho S, Peres RMR, Punturi N, Schmidt C, Bartram A, Jou E, Devarakonda V, Holloway KR, Lai WV, Hampton O, Rogers A, Tobias E, Parikh PA, Davies SR, Li S, Ma CX, Suman VJ, Hunt KK, Watson MA, Hoadley KA, Thompson EA, Chen X, Kavuri SM, Creighton CJ, Maher CA, Perou CM, Haricharan S, Ellis MJ. Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast Cancer. Cell Rep 24(6):1434-1444.e7, 2018. PMID: 30089255.
138. Weiss A, Mittendorf EA, DeSnyder SM, Hwang RF, Bea V, Bedrosian I, Hoffman K, Adrade B, Sahin AA, Kuerer HM, Hunt KK, Caudle AS. Expanding Implementation of ACOSOG Z0011 in Surgeon Practice. Clin Breast Cancer 18(4):276-281, 2018. e-Pub 2017. PMID: 29100726.
139. Ikoma N, Roland CL, Torres KE, Chiang YJ, Wang WL, Somaiah N, Mann GN, Hunt KK, Cormier JN, Feig BW. Salvage Surgery for Recurrent Retroperitoneal Well-Differentiated Liposarcoma: Early Reoperation may not Provide Benefit. Ann Surg Oncol 25(8):2193-2200, 2018. e-Pub 2018. PMID: 29520652.
140. Valachis A, Mamounas EP, Mittendorf EA, Hayashi N, Ishitobi M, Natoli C, Fitzal F, Rubio IT, Tiezzi DG, Shin HC, Anderson SJ, Hunt KK, Matsuda N, Ohsumi S, Totomi A, Nilsson C. Risk factors for locoregional disease recurrence after breast-conserving therapy in patients with breast cancer treated with neoadjuvant chemotherapy: An international collaboration and individual patient meta-analysis. Cancer 124(14):2923-2930, 2018. e-Pub 2018. PMID: 29723396.
141. Loghavi S, Medeiros LJ, Javadi S, Lin P, Khoury JD, Nastoupil L, Hunt KK, Clemens MW, Miranda RN. Breast Implant-Associated Anaplastic Large Cell Lymphoma With Bone Marrow Involvement. Aesthet Surg J 38(7), 2018. PMID: 29635424.
142. Ikoma N, Roland CL, Torres KE, Chiang YJ, Wang WL, Somaiah N, Mann GN, Hunt KK, Cormier JN, Feig BW. Concomitant organ resection does not improve outcomes in primary retroperitoneal well-differentiated liposarcoma: A retrospective cohort study at a major sarcoma center. J Surg Oncol 117(6):1188-1194, 2018. e-Pub 2017. PMID: 29228466.
143. Kuerer HM, Rauch GM, Krishnamurthy S, Adrada BE, Caudle AS, DeSnyder SM, Black DM, Santiago L, Hobbs BP, Lucci A, Gilcrease M, Hwang RF, Candelaria RP, Chavez-MacGregor M, Smith BD, Arribas E, Moseley T, Teshome M, Miggins MV, Valero V, Hunt KK, Yang WT. A Clinical Feasibility Trial for Identification of Exceptional Responders in Whom Breast Cancer Surgery Can Be Eliminated Following Neoadjuvant Systemic Therapy. Ann Surg 267(5):946-951, 2018. e-Pub 2017. PMID: 28549010.
144. Fisher SB, Chiang YJ, Feig BW, Cormier JN, Hunt KK, Torres KE, Roland CL. Comparative Performance of the 7th and 8th Editions of the American Joint Committee on Cancer Staging Systems for Soft Tissue Sarcoma of the Trunk and Extremities. Ann Surg Oncol 25(5):1126-1132, 2018. e-Pub 2018. PMID: 29468609.
145. Ikoma N, Roland CL, Cormier JN, Chiang YJ, Torres KE, Hunt KK, You YN, Feig BW. Nongastrointestinal Stromal Tumor Spindle Cell Sarcomas of the Colon or Rectum. Am Surg 84(4):570-575, 2018. PMID: 29712608.
146. Roland CL, Bednarski BK, Watson K, Torres KE, Cormier JN, Wang WL, Lazar AJ, Somaiah N, Hunt KK, Feig BW. Identification of preoperative factors associated with outcomes following surgical management of intra-abdominal recurrent or metastatic GIST following neoadjuvant tyrosine kinase inhibitor therapy. J Surg Oncol 117(5):879-885, 2018. e-Pub 2018. PMID: 29448300.
147. Swanick CW, Lei X, Xu Y, Shen Y, Goodwin NA, Smith GL, Giordano SH, Hunt KK, Jagsi R, Shaitelman SF, Peterson SK, Smith BD. Long-term Patient-Reported Outcomes in Older Breast Cancer Survivors: A Population-Based Survey Study. Int J Radiat Oncol Biol Phys 100(4):882-890, 2018. e-Pub 2017. PMID: 29485067.
148. Ferrufino-Schmidt MC, Medeiros LJ, Liu H, Clemens MW, Hunt KK, Laurent C, Lofts J, Amin MB, Ming Chai S, Morine A, Di Napoli A, Dogan A, Parkash V, Bhagat G, Tritz D, Quesada AE, Pina-Oviedo S, Hu Q, Garcia-Gomez FJ, Jose Borrero J, Horna P, Thakral B, Narbaitz M, Hughes RC, Yang LJ, Fromm JR, Wu D, Zhang D, Sohani AR, Hunt J, Vadlamani IU, Morgan EA, Ferry JA, Szigeti R, C Tardio J, Granados R, Dertinger S, Offner FA, Pircher A, Hosry J, Young KH, Miranda RN. Clinicopathologic Features and Prognostic Impact of Lymph Node Involvement in Patients With Breast Implant-associated Anaplastic Large Cell Lymphoma. Am J Surg Pathol 42(3):293-305, 2018. PMID: 29194092.
149. Le-Petross HT, McCall LM, Hunt KK, Mittendorf EA, Ahrendt GM, Wilke LG, Ballman KV, Boughey JC. Axillary Ultrasound Identifies Residual Nodal Disease After Chemotherapy: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance). AJR Am J Roentgenol 210(3):1-8, 2018. e-Pub 2018. PMID: 29381381.
150. Weiss A, Chavez-MacGregor M, Lichtensztajn DY, Yi M, Tadros A, Hortobagyi GN, Giordano SH, Hunt KK, Mittendorf EA. Validation Study of the American Joint Committee on Cancer Eighth Edition Prognostic Stage Compared With the Anatomic Stage in Breast Cancer. JAMA Oncol 4(2):203-209, 2018. PMID: 29222540.
151. Carey JPW, Karakas C, Bui T, Chen X, Vijayaraghavan S, Zhao Y, Wang J, Mikule K, Litton JK, Hunt KK, Keyomarsi K. Synthetic lethality of PARP inhibitors in combination with MYC blockade is independent of BRCA status in triple negative breast cancer. Cancer Res 78(3):742-757, 2018. e-Pub 2017. PMID: 29180466.
152. Keung EZ, Chiang YJ, Voss RK, Cormier JN, Torres KE, Hunt KK, Feig BW, Roland CL. Defining the incidence and clinical significance of lymph node metastasis in soft tissue sarcoma. Eur J Surg Oncol 44(1):170-177, 2018. e-Pub 2017. PMID: 29208319.
153. Akay CL, Albarracin C, Torstenson T, Bassett R, Mittendorf EA, Yi M, Kuerer HM, Babiera GV, Bedrosian I, Hunt KK, Hwang RF. Factors impacting the accuracy of intra-operative evaluation of sentinel lymph nodes in breast cancer. Breast J 24(1):28-34, 2018. e-Pub 2017. PMID: 28608612.
154. Keung EZ, Tsai JW, Ali AM, Cormier JN, Bishop AJ, Guadagnolo BA, Torres KE, Somaiah N, Hunt KK, Wargo JA, Lazar AJ, Wang WL, Roland CL. Analysis of the immune infiltrate in undifferentiated pleomorphic sarcoma of the extremity and trunk in response to radiotherapy: Rationale for combination neoadjuvant immune checkpoint inhibition and radiotherapy. Oncoimmunology 7(2):e1385689, 2018. e-Pub 2017. PMID: 29308306.
155. Doostan I, Karakas C, Kohansal M, Low KH, Ellis MJ, Olson JA, Suman VJ, Hunt KK, Moulder SL, Keyomarsi K. Cytoplasmic Cyclin E Mediates Resistance to Aromatase Inhibitors in Breast Cancer. Clin Cancer Res 23(23):7288-7300, 2017. e-Pub 2017. PMID: 28947566.
156. Mittendorf EA, Chavez-MacGregor M, Vila J, Yi M, Lichtensztajn DY, Clarke CA, Giordano SH, Hunt KK. Bioscore: A Staging System for Breast Cancer Patients that Reflects the Prognostic Significance of Underlying Tumor Biology. Ann Surg Oncol 24(12):3502-3509, 2017. e-Pub 2017. PMID: 28726077.
157. Chavez-MacGregor M, Mittendorf EA, Clarke CA, Lichtensztajn DY, Hunt KK, Giordano SH. Incorporating Tumor Characteristics to the American Joint Committee on Cancer Breast Cancer Staging System. Oncologist 22(11):1292-1300, 2017. e-Pub 2017. PMID: 28592619.
158. Fujii T, Kogawa T, Dong W, Sahin AA, Moulder S, Litton JK, Tripathy D, Iwamoto T, Hunt KK, Pusztai L, Lim B, Shen Y, Ueno NT. Revisiting the definition of estrogen receptor positivity in HER2-negative primary breast cancer. Ann Oncol 28(10):2420-2428, 2017. PMID: 28961844.
159. Haricharan S, Punturi N, Singh P, Holloway KR, Anurag M, Schmelz J, Schmidt C, Lei JT, Suman V, Hunt K, Olson JA, Hoog J, Li S, Huang S, Edwards DP, Kavuri SM, Bainbridge MN, Ma CX, Ellis MJ. Loss of MutL Disrupts CHK2-Dependent Cell-Cycle Control through CDK4/6 to Promote Intrinsic Endocrine Therapy Resistance in Primary Breast Cancer. Cancer Discov 7(10):1168-1183, 2017. e-Pub 2017. PMID: 28801307.
160. Caudle AS, Bedrosian I, Milton DR, DeSnyder SM, Kuerer HM, Hunt KK, Mittendorf EA. Use of Sentinel Lymph Node Dissection After Neoadjuvant Chemotherapy in Patients with Node-Positive Breast Cancer at Diagnosis: Practice Patterns of American Society of Breast Surgeons Members. Ann Surg Oncol 24(10):2925-2934, 2017. e-Pub 2017. PMID: 28766207.
161. Boughey JC, Ballman KV, McCall LM, Mittendorf EA, Symmans WF, Julian TB, Byrd D, Hunt KK. Tumor Biology and Response to Chemotherapy Impact Breast Cancer-specific Survival in Node-positive Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: Long-term Follow-up From ACOSOG Z1071 (Alliance). Ann Surg 266(4):667-676, 2017. PMID: 28657941.
162. Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, Kelemen PR, Ollila DW, Hansen NM, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Morrow M. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial. JAMA 318(10):918-926, 2017. PMID: 28898379.
163. Francis AM, Alexander A, Liu Y, Vijayaraghavan S, Low KH, Yang D, Bui T, Somaiah N, Ravi V, Keyomarsi K, Hunt KK. CDK4/6 Inhibitors Sensitize Rb-positive Sarcoma Cells to Wee1 Kinase Inhibition through Reversible Cell-Cycle Arrest. Mol Cancer Ther 16(9):1751-1764, 2017. e-Pub 2017. PMID: 28619757.
164. Ikoma N, Torres KE, Lin HY, Ravi V, Roland CL, Mann GN, Hunt KK, Cormier JN, Feig BW. Recurrence patterns of retroperitoneal leiomyosarcoma and impact of salvage surgery. J Surg Oncol 116(3):313-319, 2017. e-Pub 2017. PMID: 28557016.
165. Moran MS, Zhao Y, Ma S, Kirova Y, Fourquet A, Chen P, Hoffman K, Hunt K, Wong J, Halasz LM, Freedman G, Prosnitz R, Yassa M, Nguyen DHA, Hijal T, Haffty BG, Wai ES, Truong PT. Association of Radiotherapy Boost for Ductal Carcinoma In Situ With Local Control After Whole-Breast Radiotherapy. JAMA Oncol 3(8):1060-1068, 2017. PMID: 28358936.
166. Tadros AB, Yang WT, Krishnamurthy S, Rauch GM, Smith BD, Valero V, Black DM, Lucci A, Caudle AS, DeSnyder SM, Teshome M, Barcenas CH, Miggins M, Adrada BE, Moseley T, Hwang RF, Hunt KK, Kuerer HM. Identification of Patients With Documented Pathologic Complete Response in the Breast After Neoadjuvant Chemotherapy for Omission of Axillary Surgery. JAMA Surg 152(7):665-670, 2017. e-Pub 2017. PMID: 28423171.
167. Vijayaraghavan S, Karakas C, Doostan I, Chen X, Bui T, Yi M, Raghavendra AS, Zhao Y, Bashour SI, Ibrahim NK, Karuturi M, Wang J, Winkler JD, Amaravadi RK, Hunt KK, Tripathy D, Keyomarsi K. CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancers. Nat Commun 8:15916, 2017. e-Pub 2017. PMID: 28653662.
168. Hunt KK, Karakas C, Ha MJ, Biernacka A, Yi M, Sahin AA, Adjapong O, Hortobagyi GN, Bondy M, Thompson P, Cheung KL, Ellis IO, Bacus S, Symmans WF, Do KA, Keyomarsi K. Cytoplasmic cyclin e predicts recurrence in patients with breast cancer. Clin Cancer Res 23(12):2991-3002, 2017. e-Pub 2016. PMID: 27881578.
169. Lesurf R, Griffith OL, Griffith M, Hundal J, Trani L, Watson MA, Aft R, Ellis MJ, Ota D, Suman VJ, Meric-Bernstam F, Leitch AM, Boughey JC, Unzeitig G, Buzdar AU, Hunt KK, Mardis ER. Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy-results from the ACOSOG Z1041 (Alliance) trial. Ann Oncol 28(5):1070-1077, 2017. PMID: 28453704.
170. Reddy JP, Lei X, Huang SC, Nicklaus KM, Fingeret MC, Shaitelman SF, Hunt KK, Buchholz TA, Merchant F, Markey MK, Smith BD. Quantitative Assessment of Breast Cosmetic Outcome After Whole-Breast Irradiation. Int J Radiat Oncol Biol Phys 97(5):894-902, 2017. e-Pub 2016. PMID: 28333010.
171. Symmans WF, Wei C, Gould R, Yu X, Zhang Y, Liu M, Walls A, Bousamra A, Ramineni M, Sinn B, Hunt K, Buchholz TA, Valero V, Buzdar AU, Yang W, Brewster AM, Moulder S, Pusztai L, Hatzis C, Hortobagyi GN. Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype. J Clin Oncol 35(10):1049-1060, 2017. e-Pub 2017. PMID: 28135148.
172. Ellis MJ, Suman VJ, Hoog J, Goncalves R, Sanati S, Creighton CJ, DeSchryver K, Crouch E, Brink A, Watson M, Luo J, Tao Y, Barnes M, Dowsett M, Budd GT, Winer E, Silverman P, Esserman L, Carey L, Ma CX, Unzeitig G, Pluard T, Whitworth P, Babiera G, Guenther JM, Dayao Z, Ota D, Leitch M, Olson JA, Allred DC, Hunt K. Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance). J Clin Oncol 35(10):1061-1069, 2017. e-Pub 2017. PMID: 28045625.
173. Vila J, Teshome M, Tucker SL, Woodward WA, Chavez-MacGregor M, Hunt KK, Mittendorf EA. Combining clinical and pathologic staging variables has prognostic value in predicting local-regional recurrence following neoadjuvant chemotherapy for breast cancer. Ann Surg 265(3):574-580, 2017. PMID: 27735826.
174. FitzSullivan E, Bassett RL, Kuerer HM, Mittendorf EA, Yi M, Hunt KK, Babiera GV, Caudle AS, Black DM, Bedrosian I, Reyna C, Teshome M, Meric-Bernstam F, Hwang R. Outcomes of Sentinel Lymph Node-Positive Breast Cancer Patients Treated with Mastectomy Without Axillary Therapy. Ann Surg Oncol 24(3):652-659, 2017. e-Pub 2016. PMID: 27822630.
175. Alexander A, Karakas C, Chen X, Carey JP, Yi M, Bondy M, Thompson P, Cheung KL, Ellis IO, Gong Y, Krishnamurthy S, Alvarez RH, Ueno NT, Hunt KK, Keyomarsi K. Cyclin E overexpression as a biomarker for combination treatment strategies in inflammatory breast cancer. Oncotarget 8(9):14897-14911, 2017. PMID: 28107181.
176. Chiba A, Hoskin TL, Heins CN, Hunt KK, Habermann EB, Boughey JC. Trends in neoadjuvant endocrine therapy use and impact on rates of breast conservation in hormone receptor-positive breast cancer: a national cancer data base study. Ann Surg Oncol 24(2):418-424, 2017. e-Pub 2016. PMID: 27663568.
177. Hunt KK, Euhus DM, Boughey JC, Chagpar AB, Feldman SM, Hansen NM, Kulkarni SA, McCready DR, Mamounas EP, Wilke LG, Van Zee KJ, Morrow M. Society of Surgical Oncology Breast Disease Working Group Statement on Prophylactic (Risk-Reducing) Mastectomy. Ann Surg Oncol 24(2):375-397, 2017. e-Pub 2016. PMID: 27933411.
178. Candelaria RP, Huang ML, Adrada BE, Bassett R, Hunt KK, Kuerer HM, Smith BD, Chavez-MacGregor M, Yang WT. Incremental cancer detection of locoregional restaging with diagnostic mammography combined with whole-breast and regional nodal ultrasound in women with newly diagnosed breast cancer. Acad Radiol 24(2):191-199, 2017. e-Pub 2016. PMID: 27955877.
179. Balaji K, Vijayaraghavan S, Diao L, Tong P, Fan Y, Carey JP, Bui TN, Warner S, Heymach JV, Hunt KK, Wang J, Byers LA, Keyomarsi K. AXL inhibition suppresses the dna damage response and sensitizes cells to parp inhibition in multiple cancers. Mol Cancer Res 15(1):45-58, 2017. e-Pub 2016. PMID: 27671334.
180. Smith BD, Jiang J, Shih YC, Giordano SH, Huo J, Jagsi R, Momoh AO, Caudle AS, Hunt KK, Shaitelman SF, Buchholz TA, Shirvani SM. Cost and Complications of Local Therapies for Early-Stage Breast Cancer. J Natl Cancer Inst 109(1), 2017. e-Pub 2016. PMID: 27678203.
181. Watson KL, Al Sannaa GA, Kivlin CM, Ingram DR, Landers SM, Roland CL, Cormier JN, Hunt KK, Feig BW, Ashleigh Guadagnolo B, Bishop AJ, Wang WL, Slopis JM, McCutcheon IE, Lazar AJ, Torres KE. Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors. J Neurosurg 126(1):1-11, 2017. e-Pub 2016. PMID: 27035165.
182. Stauder MC, Caudle AS, Allen PK, Shaitelman SF, Smith BD, Hoffman KE, Buchholz TA, Chavez-Macgregor M, Hunt KK, Meric-Bernstam F, Woodward WA. Outcomes of Post Mastectomy Radiation Therapy in Patients Receiving Axillary Lymph Node Dissection After Positive Sentinel Lymph Node Biopsy. Int J Radiat Oncol Biol Phys 96(3):637-44, 2016. e-Pub 2016. PMID: 27681760.
183. Carter SA, Lyons GR, Kuerer HM, Bassett RL, Oates S, Thompson A, Caudle AS, Mittendorf EA, Bedrosian I, Lucci A, DeSnyder SM, Babiera G, Yi M, Baumann DP, Clemens MW, Garvey PB, Hunt KK, Hwang RF. Operative and Oncologic Outcomes in 9861 Patients with Operable Breast Cancer: Single-Institution Analysis of Breast Conservation with Oncoplastic Reconstruction. Ann Surg Oncol 23(10):3190-8, 2016. e-Pub 2016. PMID: 27406093.
184. Vila J, Mittendorf EA, Farante G, Bassett RL, Veronesi P, Galimberti V, Peradze N, Stauder MC, Chavez-MacGregor M, Litton JF, Huo L, Kuerer HM, Hunt KK, Caudle AS. Nomograms for predicting axillary response to neoadjuvant chemotherapy in clinically node-positive patients with breast cancer. Ann Surg Oncol 23(11):3501-3509, 2016. e-Pub 2016. PMID: 27216742.
185. Giuliano AE, Ballman K, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, Saha S, Morrow M, Hunt KK. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: long-term follow-up from the american college of surgeons oncology group (alliance) ACOSOG Z0011 randomized trial. Ann Surg 264(3):413-20, 2016. PMID: 27513155.
186. Miller CA, Gindin Y, Lu C, Griffith OL, Griffith M, Shen D, Hoog J, Li T, Larson DE, Watson M, Davies SR, Hunt K, Suman VJ, Snider J, Walsh T, Colditz GA, DeSchryver K, Wilson RK, Mardis ER, Ellis MJ. Aromatase inhibition remodels the clonal architecture of estrogen-receptor-positive breast cancers. Nat Commun 7:12498, 2016. e-Pub 2016. PMID: 27502118.
187. Chagpar AB, Hughes T, Hunt K, Aguirre J, Babiera G. Variation in Follow-up of Asymptomatic Breast Cancer Patients: Can We Choose More Wisely?. Am Surg 82(8):e188-90, 2016. PMID: 27657562.
188. Simmons RM, Ballman KV, Cox C, Carp N, Sabol J, Hwang RF, Attai D, Sabel M, Nathanson D, Kenler A, Gold L, Kaufman C, Han L, Bleznak A, Stanley Smith J, Holmes D, Fornage B, Le-Petross C, Hoda S, McCall L, Hunt KK, investigators A. A phase II trial exploring the success of cryoablation therapy in the treatment of invasive breast carcinoma: results from ACOSOG (alliance) Z1072. Ann Surg Oncol 23(8):2438-45, 2016. e-Pub 2016. PMID: 27221361.
189. Fayanju OM, Mayo TL, Spinks TE, Lee S, Barcenas CH, Smith BD, Giordano SH, Hwang RF, Ehlers RA, Selber JC, Walters R, Tripathy D, Hunt KK, Buchholz TA, Feeley TW, Kuerer HM. Value-based breast cancer care: a multidisciplinary approach for defining patient-centered outcomes. Ann Surg Oncol 23(8):2385-90, 2016. e-Pub 2016. PMID: 26979306.
190. Mittendorf EA, Vila J, Tucker SL, Chavez-MacGregor M, Smith BD, Symmans WF, Sahin AA, Hortobagyi GN, Hunt KK. The neo-bioscore update for staging breast cancer treated with neoadjuvant chemotherapy: incorporation of prognostic biologic factors into staging after treatment. JAMA Oncol 2(7):929-36, 2016. e-Pub 2016. PMID: 26986538.
191. Roland CL, May CD, Watson KL, Al Sannaa GA, Dineen SP, Feig R, Landers S, Ingram DR, Wang WL, Guadagnolo BA, Feig B, Hunt KK, Cormier JN, Lazar AJ, Torres KE. Analysis of clinical and molecular factors impacting oncologic outcomes in undifferentiated pleomorphic sarcoma. Ann Surg Oncol 23(7):2220-8, 2016. e-Pub 2016. PMID: 26847678.
192. Karakas C, Biernacka A, Bui T, Sahin AA, Yi M, Akli S, Schafer J, Alexander A, Adjapong O, Hunt KK, Keyomarsi K. Cytoplasmic cyclin e and phospho-cyclin-dependent kinase 2 are biomarkers of aggressive breast cancer. Am J Pathol 186(7):1900-12, 2016. e-Pub 2016. PMID: 27182644.
193. JavanMoghadam S, Weihua Z, Hunt KK, Keyomarsi K. Estrogen receptor alpha is cell cycle-regulated and regulates the cell cycle in a ligand-dependent fashion. Cell Cycle 15(12):1-12, 2016. e-Pub 2016. PMID: 27049344.
194. Nanos-Webb A, Bui T, Karakas C, Zhang D, Carey JP, Mills GB, Hunt KK, Keyomarsi K. PKCiota promotes ovarian tumor progression through deregulation of cyclin E. Oncogene 35(19):2428-40, 2016. e-Pub 2015. PMID: 26279297.
195. Teshome M, Wei C, Hunt KK, Thompson A, Rodriguez K, Mittendorf EA. Use of a magnetic tracer for sentinel lymph node detection in early-stage breast cancer patients: a meta-analysis. Ann Surg Oncol 23(5):1508-14, 2016. e-Pub 2016. PMID: 26893221.
196. Dryden MJ, Dogan BE, Fox P, Wang C, Black DM, Hunt K, Yang WT. Imaging Factors That Influence Surgical Margins After Preoperative I125 Radioactive Seed Localization of Breast Lesions: Comparison With Wire Localization. AJR Am J Roentgenol 206(5):1112-8, 2016. e-Pub 2016. PMID: 27007608.
197. Lucenay KS, Doostan I, Karakas C, Bui T, Ding Z, Mills GB, Hunt KK, Keyomarsi K. Cyclin e associates with the lipogenic enzyme atp-citrate lyase to enable malignant growth of breast cancer cells. Cancer Res 76(8):2406-18, 2016. e-Pub 2016. PMID: 26928812.
198. Caudle AS, Yang WT, Krishnamurthy S, Mittendorf EA, Black DM, Gilcrease MZ, Bedrosian I, Hobbs BP, DeSnyder SM, Hwang RF, Adrada BE, Shaitelman SF, Chavez-MacGregor M, Smith BD, Candelaria RP, Babiera GV, Dogan BE, Santiago L, Hunt KK, Kuerer HM. Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection. J Clin Oncol 34(10):1072-8, 2016. e-Pub 2016. PMID: 26811528.
199. Boughey JC, Ballman KV, Le-Petross HT, McCall LM, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, Feliberti EC, Hunt KK. Identification and resection of clipped node decreases the false-negative rate of sentinel lymph node surgery in patients presenting with node-positive breast cancer (T0-T4, N1-N2) who receive neoadjuvant chemotherapy: results from ACOSOG Z1071 (alliance). Ann Surg 263(4):802-7, 2016. e-Pub 2015. PMID: 26649589.
200. Mougalian SS, Hernandez M, Lei X, Lynch S, Kuerer HM, Symmans WF, Theriault RL, Fornage BD, Hsu L, Buchholz TA, Sahin AA, Hunt KK, Yang WT, Hortobagyi GN, Valero V. Ten-year outcomes of patients with breast cancer with cytologically confirmed axillary lymph node metastases and pathologic complete response after primary systemic chemotherapy. JAMA Oncol 2(4):508-16, 2016. PMID: 26720612.
201. Jabbour-Leung NA, Chen X, Bui T, Jiang Y, Yang D, Vijayaraghavan S, McArthur MJ, Hunt KK, Keyomarsi K. Sequential Combination Therapy of CDK Inhibition and Doxorubicin Is Synthetically Lethal in p53-Mutant Triple-Negative Breast Cancer. Mol Cancer Ther 15(4):593-607, 2016. e-Pub 2016. PMID: 26826118.
202. Roland CL, Boland GM, Demicco EG, Lusby K, Ingram D, May CD, Kivlin CM, Watson K, Al Sannaa GA, Wang WL, Ravi V, Pollock RE, Lev D, Cormier JN, Hunt KK, Feig BW, Lazar AJ, Torres KE. Clinical observations and molecular variables of primary vascular leiomyosarcoma. JAMA Surg 151(4):347-54, 2016. PMID: 26629783.
203. Haffty BG, McCall LM, Ballman KV, McLaughlin S, Jagsi R, Ollila DW, Hunt KK, Buchholz TA, Boughey JC. Patterns of local-regional management following neoadjuvant chemotherapy in breast cancer: Results from ACOSOG Z1071 (Alliance). Int J Radiat Oncol Biol Phys 94(3):493-502, 2016. e-Pub 2015. PMID: 26867878.
204. Clemens MW, Medeiros LJ, Butler CE, Hunt KK, Fanale MA, Horwitz S, Weisenburger DD, Liu J, Morgan EA, Kanagal-Shamanna R, Parkash V, Ning J, Sohani AR, Ferry JA, Mehta-Shah N, Dogan A, Liu H, Thormann N, Di Napoli A, DiNapoli A, Lade S, Piccolini J, Reyes R, Williams T, McCarthy CM, Hanson SE, Nastoupil LJ, Gaur R, Oki Y, Young KH, Miranda RN. Complete surgical excision is essential for the management of breast implant-associated anaplastic large cell lymphoma. J Clin Oncol 34(2):160-8, 2016. e-Pub 2015. PMID: 26628470.
205. Hatzis C, Symmans WF, Zhang Y, Gould RE, Moulder SL, Hunt KK, Abu-Khalaf M, Hofstatter EW, Lannin D, Chagpar AB, Pusztai L. Relationship between complete pathologic response to neoadjuvant chemotherapy and survival in triple negative breast cancer. Clin Cancer Res 22(1):26-33, 2016. e-Pub 2015. PMID: 26286912.
206. Bedrosian I, Xing Y, Abdel Rahman S, Allen L, Le-Petross H, Whitman GJ, Meric-Bernstam F, Hunt KK, Babiera GV, Cormier JN. A cost analysis of preoperative breast MRI use for patients with invasive lobular cancer. Ann Surg Oncol 23(1):23-9, 2016. e-Pub 2015. PMID: 26156655.
207. Chagpar AB, Babiera GV, Aguirre J, Hunt KK, Hughes T. Variation in practice of the diagnostic workup of asymptomatic patients diagnosed with invasive breast cancer. Front Oncol 6:56, 2016. e-Pub 2016. PMID: 27014631.
208. Francis AM, Haugen CE, Grimes LM, Crow JR, Yi M, Mittendorf EA, Bedrosian I, Caudle AS, Babiera GV, Krishnamurthy S, Kuerer HM, Hunt KK. Is sentinel lymph node dissection warranted for patients with a diagnosis of ductal carcinoma in situ?. Ann Surg Oncol 13(13):4270-9, 2015. e-Pub 2015. PMID: 25905585.
209. Dineen SP, Roland CL, Feig R, May C, Zhou S, Demicco E, Sannaa GA, Ingram D, Wang WL, Ravi V, Guadagnolo A, Lev D, Pollock RE, Hunt K, Cormier J, Lazar A, Feig B, Torres KE. Radiation-associated undifferentiated pleomorphic sarcoma is associated with worse clinical outcomes than sporadic lesions. Ann Surg Oncol 22(12):3913-20, 2015. e-Pub 2015. PMID: 25743327.
210. Zhou F, Krishnamurthy J, Wei Y, Li M, Hunt K, Johanning GL, Cooper LJ, Wang-Johanning F. Chimeric antigen receptor T cells targeting HERV-K inhibit breast cancer and its metastasis through downregulation of Ras. Oncoimmunology 4(11):e1047582, 2015. e-Pub 2015. PMID: 26451325.
211. Boughey JC, Ballman KV, Hunt KK, McCall LM, Mittendorf EA, Ahrendt GM, Wilke LG, Le-Petross HT. Axillary ultrasound after neoadjuvant chemotherapy and its impact on sentinel lymph node surgery: results from the american college of surgeons oncology group Z1071 trial (alliance). J Clin Oncol 33(30):3386-3393, 2015. e-Pub 2015. PMID: 25646192.
212. Tseng WW, Zhou S, To CA, Thall PF, Lazar AJ, Pollock RE, Lin PP, Cormier JN, Lewis VO, Feig BW, Hunt KK, Ballo MT, Patel S, Pisters PW. Phase 1 adaptive dose-finding study of neoadjuvant gemcitabine combined with radiation therapy for patients with high-risk extremity and trunk soft tissue sarcoma. Cancer 121(20):3659-67, 2015. e-Pub 2015. PMID: 26177983.
213. DeSnyder SM, Hunt KK, Smith BD, Moran MS, Klimberg S, Lucci A. Assessment of practice patterns following publication of the SSO-ASTRO consensus guideline on margins for breast-conserving therapy in stage I and II invasive breast cancer. Ann Surg Oncol 22(10):3250-6, 2015. e-Pub 2015. PMID: 26202554.
214. Dogan BE, Dryden MJ, Wei W, Fornage BD, Buchholz TA, Smith B, Hunt K, Krishnamurthy S, Yang WT. Sonography and sonographically guided needle biopsy of internal mammary nodes in staging of patients with breast cancer. AJR Am J Roentgenol 205(4):905-911, 2015. PMID: 26397343.
215. Shaitelman SF, Schlembach PJ, Arzu I, Ballo M, Bloom ES, Buchholz D, Chronowski GM, Dvorak T, Grade E, Hoffman KE, Kelly P, Ludwig M, Perkins GH, Reed V, Shah S, Stauder MC, Strom EA, Tereffe W, Woodward WA, Ensor J, Baumann D, Thompson AM, Amaya D, Davis T, Guerra W, Hamblin L, Hortobagyi G, Hunt KK, Buchholz TA, Smith BD. Acute and short-term toxic effects of conventionally fractionated vs hypofractionated whole-breast irradiation: a randomized clinical trial. JAMA Oncol 1(7):931-41, 2015. PMID: 26247543.
216. Bishop AJ, Zagars GK, Torres KE, Hunt KK, Cormier JN, Feig BW, Guadagnolo BA. Combined modality management of retroperitoneal sarcomas: a single-institution series of 121 patients. Int J Radiat Oncol Biol Phys 93(1):158-65, 2015. e-Pub 2015. PMID: 26130233.
217. Shaitelman SF, Tereffe W, Dogan BE, Hess KR, Caudle AS, Valero V, Stauder MC, Krishnamurthy S, Candelaria RP, Strom EA, Woodward WA, Hunt KK, Buchholz TA, Whitman GJ. Role of ultrasonography of regional nodal basins in staging triple-negative breast cancer and implications for local-regional treatment. Int J Radiat Oncol Biol Phys 93(1):102-10, 2015. e-Pub 2015. PMID: 26279028.
218. Kim ES, Bernstein D, Hilsenbeck SG, Chung CH, Dicker AP, Ersek JL, Stein S, Khuri FR, Burgess E, Hunt K, Ivy P, Bruinooge SS, Meropol N, Schilsky RL. Modernizing eligibility criteria for molecularly driven trials. J Clin Oncol 33(25):2815-20, 2015. e-Pub 2015. PMID: 26195710.
219. Smith GL, Huo J, Giordano SH, Hunt KK, Buchholz TA, Smith BD. Utilization and outcomes of breast brachytherapy in younger women. Int J Radiat Oncol Biol Phys 93(1):91-101, 2015. e-Pub 2015. PMID: 26279027.
220. Huo L, Gong Y, Guo M, Gilcrease MZ, Wu Y, Zhang H, Zhang J, Resetkova E, Hunt KK, Deavers MT. GATA-binding protein 3 enhances the utility of gross cystic disease fluid protein-15 and mammaglobin A in triple-negative breast cancer by immunohistochemistry. Histopathology 67(2):245-54, 2015. e-Pub 2015. PMID: 25564996.
221. Brudvik KW, Patel SH, Roland CL, Conrad C, Torres KE, Hunt KK, Cormier JN, Feig BW, Aloia TA, Vauthey JN. Survival after resection of gastrointestinal stromal tumor and sarcoma liver metastases in 146 patients. J Gastrointest Surg 19(8):1476-83, 2015. e-Pub 2015. PMID: 26001368.
222. Caruso JA, Akli S, Pageon L, Hunt KK, Keyomarsi K. The serine protease inhibitor elafin maintains normal growth control by opposing the mitogenic effects of neutrophil elastase. Oncogene 34(27):3556-67, 2015. e-Pub 2014. PMID: 25195861.
223. Mittendorf EA, Ballman KV, McCall LM, Yi M, Sahin AA, Bedrosian I, Hansen N, Gabram S, Hurd T, Giuliano AE, Hunt KK. Evaluation of the stage IB designation of the american joint committee on cancer staging system in breast cancer. J Clin Oncol 33(10):1119-27, 2015. e-Pub 2014. PMID: 25488970.
224. Ikoma N, Torres KE, Somaiah N, Hunt KK, Cormier JN, Tseng W, Lev D, Pollock R, Wang WL, Feig B. Accuracy of preoperative percutaneous biopsy for the diagnosis of retroperitoneal liposarcoma subtypes. Ann Surg Oncol 22(4):1068-72, 2015. e-Pub 2014. PMID: 25354575.
225. Boughey JC, Suman VJ, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, Leitch AM, Flippo-Morton TS, Kuerer HM, Bowling M, Hunt KK, in Oncology AFCT. Factors affecting sentinel lymph node identification rate after neoadjuvant chemotherapy for breast cancer patients enrolled in ACOSOG Z1071 (Alliance). Ann Surg 261(3):547-52, 2015. PMID: 25664534.
226. Gonzalez-Angulo AM, Parinyanitikul N, Lei X, Mittendorf EA, Zhang H, Valero V, Hunt KK, Hortobagyi GN, Chavez-MacGregor M. Effect of adjuvant trastuzumab among patients treated with anti-HER2-based neoadjuvant therapy. Br J Cancer 112(4):630-5, 2015. e-Pub 2015. PMID: 25584488.
227. Chang EI, Ito R, Zhang H, Nguyen AT, Skoracki RJ, Hanasono MM, Crosby MA, Ueno NT, Hunt KK. Challenging a traditional paradigm: 12-year experience with autologous free flap breast reconstruction for inflammatory breast cancer. Plast Reconstr Surg 135(2):262e-9e, 2015. PMID: 25626809.
228. Caudle AS, Yang WT, Mittendorf EA, Black DM, Hwang R, Hobbs B, Hunt KK, Krishnamurthy S, Kuerer HM. Selective surgical localization of axillary lymph nodes containing metastases in patients with breast cancer: a prospective feasibility trial. JAMA Surg 150(2):137-43, 2015. e-Pub 2014. PMID: 25517573.
229. Rueth NM, Black DM, Limmer AR, Gabriel E, Huo L, Fornage BD, Dogan BE, Chavez-MacGregor M, Yi M, Hunt KK, Strom EA. Breast conservation in the setting of contemporary multimodality treatment provides excellent outcomes for patients with occult primary breast cancer. Ann Surg Oncol 22(1):90-5, 2015. e-Pub 2014. PMID: 25249256.
230. Luo S, Su X, Yi M, Hunt KK. Simultaneous inference of a misclassified outcome and competing risks failure time data. J Appl Stat 42(5):1080-1090, 2015. PMID: 25821331.
231. Caudle AS, Kuerer HM, Le-Petross HT, Yang W, Yi M, Bedrosian I, Krishnamurthy S, Fornage BD, Hunt KK, Mittendorf EA. Predicting the extent of nodal disease in early-stage breast cancer. Ann Surg Oncol 21(11):3440-7, 2014. e-Pub 2014. PMID: 24859939.
232. Boughey JC, McCall LM, Ballman KV, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, Leitch AM, Flippo-Morton T, Hunt KK. Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) prospective multicenter clinical trial. Ann Surg 260(4):608-16, 2014. PMID: 25203877.
233. Haynes AB, Bloom ES, Bedrosian I, Kuerer HM, Hwang RF, Munsell MF, Chemaly RF, Graviss LS, Caudle AS, Hunt KK, Tereffe W, Shaitelman SF, Babiera GV. Timing of infectious complications following breast-conserving therapy with catheter-based accelerated partial breast irradiation. Ann Surg Oncol 21(8):2512-6, 2014. e-Pub 2014. PMID: 24736987.
234. Mittendorf EA, Caudle AS, Yang W, Krishnamurthy S, Shaitelman S, Chavez-MacGregor M, Woodward WA, Bedrosian I, Kuerer HM, Hunt KK. Implementation of the american college of surgeons oncology group Z1071 trial data in clinical practice: is there a way forward for sentinel lymph node dissection in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy?. Ann Surg Oncol 21(8):2468-73, 2014. e-Pub 2014. PMID: 24841348.
235. Bednarski BK, Araujo DM, Yi M, Torres KE, Lazar A, Trent JC, Cormier JN, Pisters PW, Lev DC, Pollock RE, Feig BW, Hunt KK. Analysis of prognostic factors impacting oncologic outcomes after neoadjuvant tyrosine kinase inhibitor therapy for gastrointestinal stromal tumors. Ann Surg Oncol 21(8):2499-505, 2014. e-Pub 2014. PMID: 24639192.
236. Eberth JM, Xu Y, Smith GL, Shen Y, Jiang J, Buchholz TA, Hunt KK, Black DM, Giordano SH, Whitman GJ, Yang W, Shen C, Elting L, Smith BD. Surgeon influence on use of needle biopsy in patients with breast cancer: a national Medicare study. J Clin Oncol 32(21):2206-16, 2014. e-Pub 2014. PMID: 24912900.
237. Luo S, Su X, DeSantis SM, Huang X, Yi M, Hunt KK. Joint model for a diagnostic test without a gold standard in the presence of a dependent terminal event. Stat Med 33(15):2554-66, 2014. e-Pub 2014. PMID: 24473943.
238. McBride A, Allen P, Woodward W, Kim M, Kuerer HM, Drinka EK, Sahin A, Strom EA, Buzdar A, Valero V, Hortobagyi GN, Hunt KK, Buchholz TA. Locoregional recurrence risk for patients with T1,2 breast cancer with 1-3 positive lymph nodes treated with mastectomy and systemic treatment. Int J Radiat Oncol Biol Phys 89(2):392-8, 2014. e-Pub 2014. PMID: 24721590.
239. Akay CL, Ueno NT, Chisholm GB, Hortobagyi GN, Woodward WA, Alvarez RH, Bedrosian I, Kuerer HM, Hunt KK, Huo L, Babiera GV. Primary tumor resection as a component of multimodality treatment may improve local control and survival in patients with stage IV inflammatory breast cancer. Cancer 120(9):1319-28, 2014. e-Pub 2014. PMID: 24510381.
240. Yi M, Huo L, Koenig KB, Mittendorf EA, Meric-Bernstam F, Kuerer HM, Bedrosian I, Buzdar AU, Symmans WF, Crow JR, Bender M, Shah RR, Hortobagyi GN, Hunt KK. Which threshold for ER positivity? a retrospective study based on 9639 patients. Ann Oncol 25(5):1004-11, 2014. e-Pub 2014. PMID: 24562447.
241. MacDermed DM, Houtman KM, Thang SH, Allen PK, Caudle AS, Gainer SM, Hunt KK, Perkins GH, Shaitelman SF, Smith BD, Strom EA, Tereffe W, Woodward WA, Buchholz TA, Hoffman KE. Therapeutic radiation dose delivered to the low axilla during whole breast radiation therapy in the prone position: Implications for targeting the undissected axilla. Pract Radiat Oncol 4(2):116-22, 2014. e-Pub 2013. PMID: 24890352.
242. Smith GL, Jiang J, Buchholz TA, Xu Y, Hoffman KE, Giordano SH, Hunt KK, Smith BD. Benefit of adjuvant brachytherapy versus external beam radiation for early breast cancer: impact of patient stratification on breast preservation. Int J Radiat Oncol Biol Phys 88(2):274-84, 2014. e-Pub 2013. PMID: 24268788.
243. Yang J, Du X, Wang G, Sun Y, Chen K, Zhu X, Lazar AJ, Hunt KK, Pollock RE, Zhang W. Mesenchymal to epithelial transition in sarcomas. Eur J Cancer 50(3):593-601, 2014. e-Pub 2013. PMID: 24291235.
244. Caudle AS, Yi M, Hoffman KE, Mittendorf EA, Babiera GV, Hwang RF, Meric-Bernstam F, Sahin AA, Hunt KK. Impact of identification of internal mammary sentinel lymph node metastasis in breast cancer patients. Ann Surg Oncol 21(1):60-5, 2014. e-Pub 2013. PMID: 24046126.
245. Ren Y, Black DM, Mittendorf EA, Liu P, Li X, Du XL, He J, Yang J, Hunt KK, Yi M. Crossover effects of estrogen receptor status on breast cancer-specific hazard rates by age and race. PLoS One 9(10):e110281, 2014. e-Pub 2014. PMID: 25333877.
246. Wang J, Mittendorf EA, Sahin AA, Yi M, Caudle A, Hunt KK, Wu Y. Outcomes of sentinel lymph node dissection alone vs. axillary lymph node dissection in early stage invasive lobular carcinoma: a retrospective study of the surveillance, epidemiology and end results (SEER) database. PLoS One 9(2):e89778, 2014. e-Pub 2014. PMID: 24587029.
247. Caruso JA, Karakas C, Zhang J, Yi M, Albarracin C, Sahin A, Bondy M, Liu J, Hunt KK, Keyomarsi K. Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence. Breast Cancer Res 16(6):3417, 2014. e-Pub 2014. PMID: 25551582.
248. Buzdar AU, Suman VJ, Meric-Bernstam F, Leitch AM, Ellis MJ, Boughey JC, Unzeitig G, Royce M, McCall LM, Ewer MS, Hunt KK, Group investigators ACOSO. Fluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab as neoadjuvant treatment for patients with HER2-positive breast cancer (Z1041): a randomized, controlled, phase 3 trial. Lancet Oncol 14(13):1317-25, 2013. e-Pub 2013. PMID: 24239210.
249. Fitzsullivan E, Lari SA, Smith B, Caudle AS, Krishnamurthy S, Lucci A, Mittendorf EA, Babiera GV, Black DM, Wagner JL, Bedrosian I, Woodward W, Gainer SM, Hwang R, Meric-Bernstam F, Hunt KK, Kuerer HM. Incidence and consequence of close margins in patients with ductal carcinoma in situ treated with mastectomy: is further therapy warranted?. Ann Surg Oncol 20(13):4103-12, 2013. e-Pub 2013. PMID: 23975313.
250. Boughey JC, Suman VJ, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, Leitch AM, Kuerer HM, Bowling M, Flippo-Morton TS, Byrd DR, Ollila DW, Julian TB, McLaughlin SA, McCall L, Symmans WF, Le-Petross HT, Haffty BG, Buchholz TA, Nelson H, Hunt KK, in Oncology AFCT. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA 310(14):1455-61, 2013. PMID: 24101169.
251. Weksberg DC, Allen PK, Hoffman KE, Litton JK, Strom EA, Shah RR, Kuerer HM, Hunt KK, Buchholz TA, Mittendorf EA. Outcomes and predictive factors for salvage therapy after local-regional recurrence following neoadjuvant chemotherapy and breast conserving therapy. Ann Surg Oncol 20(11):3430-7, 2013. e-Pub 2013. PMID: 23720073.
252. Murray MM, Bui T, Smith M, Bagheri-Yarmand R, Wingate H, Hunt KK, Keyomarsi K. Staurosporine is chemoprotective by inducing G1 arrest in a Chk1- and pRb-dependent manner. Carcinogenesis 34(10):2244-52, 2013. e-Pub 2013. PMID: 23722650.
253. Liu P, Li X, Mittendorf EA, Li J, Du XL, He J, Ren Y, Yang J, Hunt KK, Yi M. Comparison of clinicopathologic features and survival in young American women aged 18-39 years in different ethnic groups with breast cancer. Br J Cancer 109(5):1302-9, 2013. e-Pub 2013. PMID: 23907433.
254. Duong MT, Akli S, Macalou S, Biernacka A, Debeb BG, Yi M, Hunt KK, Keyomarsi K. Hbo1 is a cyclin e/cdk2 substrate that enriches breast cancer stem-like cells. Cancer Res 73(17):5556-68, 2013. e-Pub 2013. PMID: 23955388.
255. Gould DJ, Hunt KK, Liu J, Kuerer HM, Crosby MA, Babiera G, Kronowitz SJ. Impact of surgical techniques, biomaterials, and patient variables on rate of nipple necrosis after nipple-sparing mastectomy. Plast Reconstr Surg 132(3):330e-8e, 2013. PMID: 23985644.
256. Kim MM, Allen P, Gonzalez-Angulo AM, Woodward WA, Meric-Bernstam F, Buzdar AU, Hunt KK, Kuerer HM, Litton JK, Hortobagyi GN, Buchholz TA, Mittendorf EA. Pathologic complete response to neoadjuvant chemotherapy with trastuzumab predicts for improved survival in women with HER2-overexpressing breast cancer. Ann Oncol 24(8):1999-2004, 2013. e-Pub 2013. PMID: 23562929.
257. Lusby K, Savannah KB, Demicco EG, Zhang Y, Ghadimi MP, Young ED, Colombo C, Lam R, Dogan TE, Hornick JL, Lazar AJ, Hunt KK, Anderson ML, Creighton CJ, Lev D, Pollock RE. Uterine leiomyosarcoma management, outcome, and associated molecular biomarkers: a single institution's experience. Ann Surg Oncol 20(7):2364-72, 2013. e-Pub 2013. PMID: 23334251.
258. Luo S, Yi M, Huang X, Hunt KK. A Bayesian model for misclassified binary outcomes and correlated survival data with applications to breast cancer. Stat Med 32(13):2320-34, 2013. e-Pub 2012. PMID: 22996169.
259. Lang JE, Tereffe W, Mitchell MP, Rao R, Feng L, Meric-Bernstam F, Bedrosian I, Kuerer HM, Hunt KK, Hortobagyi GN, Babiera GV. Primary tumor extirpation in breast cancer patients who present with stage IV disease is associated with improved survival. Ann Surg Oncol 20(6):1893-9, 2013. e-Pub 2013. PMID: 23306905.
260. Yi M, Cormier JN, Xing Y, Giordano SH, Chai C, Meric-Bernstam F, Vlastos G, Kuerer HM, Mirza NQ, Buchholz TA, Hunt KK. Other Primary Malignancies in Breast Cancer Patients Treated with Breast Conserving Surgery and Radiation Therapy. Ann Surg Oncol 20(5):1514-21, 2013. e-Pub 2012. PMID: 23224829.
261. Yi M, Xu J, Liu P, Chang GJ, Du XL, Hu CY, Song Y, He J, Ren Y, Wei Y, Yang J, Hunt KK, Li X. Comparative analysis of lifestyle factors, screening test use, and clinicopathologic features in association with survival among Asian Americans with colorectal cancer. Br J Cancer 108(7):1508-14, 2013. e-Pub 2013. PMID: 23470470.
262. Torres KE, Ravi V, Kin K, Yi M, Guadagnolo BA, May CD, Arun BK, Hunt KK, Lam R, Lahat G, Hoffman A, Cormier JN, Feig BW, Lazar AJ, Lev D, Pollock RE. Long-term outcomes in patients with radiation-associated angiosarcomas of the breast following surgery and radiotherapy for breast cancer. Ann Surg Oncol 20(4):1267-74, 2013. e-Pub 2012. PMID: 23224828.
263. Mittendorf EA, Buchholz TA, Tucker SL, Meric-Bernstam F, Kuerer HM, Gonzalez-Angulo AM, Bedrosian I, Babiera GV, Hoffman K, Yi M, Ross MI, Hortobagyi GN, Hunt KK. Impact of chemotherapy sequencing on local-regional failure risk in breast cancer patients undergoing breast-conserving therapy. Ann Surg 257(2):173-179, 2013. PMID: 23291658.
264. Hunt KK, Wingate H, Yokota T, Liu Y, Mills GB, Zhang F, Fang B, Su CH, Zhang M, Yi M, Keyomarsi K. Elafin, an inhibitor of elastase, is a prognostic indicator in breast cancer. Breast Cancer Res 15(1):R3, 2013. e-Pub 2013. PMID: 23320734.
265. Yi M, Kuerer HM, Mittendorf EA, Hwang RF, Caudle AS, Bedrosian I, Meric-Bernstam F, Wagner JL, Hunt KK. Impact of the American College of Surgeons Oncology Group Z0011 criteria applied to a contemporary patient population. J Am Coll Surg 216(1):105-13, 2013. e-Pub 2012. PMID: 23122536.
266. Huo L, Zhang J, Gilcrease MZ, Gong Y, Wu Y, Zhang H, Resetkova E, Hunt KK, Deavers MT. Gross cystic disease fluid protein-15 and mammaglobin A expression determined by immunohistochemistry is of limited utility in triple-negative breast cancer. Histopathology 62(2):267-74, 2013. e-Pub 2012. PMID: 22963676.
267. Bayraktar S, Gutierrez Barrera AM, Liu D, Pusztai L, Litton J, Valero V, Hunt K, Hortobagyi GN, Wu Y, Symmans F, Arun B. USP-11 as a predictive and prognostic factor following neoadjuvant therapy in women with breast cancer. Cancer J 19(1):10-7, 2013. PMID: 23337751.
268. Kong AL, Tereffe W, Hunt KK, Yi M, Kang T, Weatherspoon K, Mittendorf EA, Bedrosian I, Hwang RF, Babiera GV, Buchholz TA, Meric-Bernstam F. Impact of internal mammary lymph node drainage identified by preoperative lymphoscintigraphy on outcomes in patients with stage I to III breast cancer. Cancer 118(24):6287-96, 2012. e-Pub 2012. PMID: 22648744.
269. Henteleff HJ, Hunt KK, Quan ML, Surgery Group ERI. Comparative effectiveness of magnetic resonance imaging in breast cancer. J Am Coll Surg 215(6):894-896, 2012. PMID: 23164142.
270. Alvarado R, Lari SA, Roses RE, Smith BD, Yang W, Mittendorf EA, Arun BK, Lucci A, Babiera GV, Wagner JL, Caudle AS, Meric-Bernstam F, Hwang RF, Bedrosian I, Hunt KK, Kuerer HM. Biology, treatment, and outcome in very young and older women with dcis. Ann Surg Oncol 19(12):3777-3784, 2012. e-Pub 2012. PMID: 22622473.
271. Kim MM, Dawood S, Allen P, Sahin AA, Woodward WA, Smith BD, Strom EA, Hunt KK, Meric-Bernstam F, Gonzalez-Angulo AM, Buchholz TA. Hormone receptor status influences the locoregional benefit of trastuzumab in patients with nonmetastatic breast cancer. Cancer 118(20):4936-43, 2012. e-Pub 2012. PMID: 22511276.
272. Caudle AS, Hunt KK, Tucker SL, Hoffman K, Gainer SM, Lucci A, Kuerer HM, Meric-Bernstam F, Shah R, Babiera GV, Sahin AA, Mittendorf EA. American college of surgeons oncology group (ACOSOG) Z0011: impact on surgeon practice patterns. Ann Surg Oncol 19(10):3144-3151, 2012. e-Pub 2012. PMID: 22847123.
273. Gainer SM, Hunt KK, Beitsch P, Caudle AS, Mittendorf EA, Lucci A. Changing behavior in clinical practice in response to the ACOSOG Z0011 trial: a survey of the american society of breast surgeons. Ann Surg Oncol 19(10):3152-3158, 2012. e-Pub 2012. PMID: 22820938.
274. Alvarado R, Yi M, Le-Petross H, Gilcrease M, Mittendorf EA, Bedrosian I, Hwang RF, Caudle AS, Babiera GV, Akins JS, Kuerer HM, Hunt KK. The role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancer. Ann Surg Oncol 19(10):3177-3184, 2012. e-Pub 2012. PMID: 22772869.
275. Yi M, Liu P, Li X, Mittendorf EA, He J, Ren Y, Nayeemuddin K, Hunt KK. Comparative analysis of clinicopathologic features, treatment, and survival of Asian women with a breast cancer diagnosis residing in the United States. Cancer 118(17):4117-25, 2012. e-Pub 2012. PMID: 22460701.
276. Brewer Savannah KJ, Demicco EG, Lusby K, Ghadimi MP, Belousov R, Young E, Zhang Y, Huang KL, Lazar AJ, Hunt KK, Pollock RE, Creighton CJ, Anderson ML, Lev D. Dual targeting of mTOR and Aurora-A kinase for the treatment of uterine leiomyosarcoma. Clin Cancer Res 18(17):4633-45, 2012. e-Pub 2012. PMID: 22821997.
277. Hunt KK, Ballman KV, McCall LM, Boughey JC, Mittendorf EA, Cox CE, Whitworth PW, Beitsch PD, Leitch AM, Buchholz TA, Morrow MA, Giuliano AE. Factors associated with local-regional recurrence after a negative sentinel node dissection: results of the ACOSOG Z0010 trial. Ann Surg 256(3):428-436, 2012. PMID: 22868365.
278. Ellis MJ, Ding L, Shen D, Luo J, Suman VJ, Wallis JW, Van Tine BA, Hoog J, Goiffon RJ, Goldstein TC, Ng S, Lin L, Crowder R, Snider J, Ballman K, Weber J, Chen K, Koboldt DC, Kandoth C, Schierding WS, McMichael JF, Miller CA, Lu C, Harris CC, McLellan MD, Wendl MC, DeSchryver K, Allred DC, Esserman L, Unzeitig G, Margenthaler J, Babiera GV, Marcom PK, Guenther JM, Leitch M, Hunt K, Olson J, Tao Y, Maher CA, Fulton LL, Fulton RS, Harrison M, Oberkfell B, Du F, Demeter R, Vickery TL, Elhammali A, Piwnica-Worms H, McDonald S, Watson M, Dooling DJ, Ota D, Chang LW, Bose R, Ley TJ, Piwnica-Worms D, Stuart JM, Wilson RK, Mardis ER. Whole-genome analysis informs breast cancer response to aromatase inhibition. Nature 486(7403):353-360, 2012. e-Pub 2012. PMID: 22722193.
279. Kuerer HM, Lari SA, Arun BK, Hu CY, Brewster A, Mittendorf EA, Albarracin CT, Babiera GV, Caudle AS, Wagner JL, Litton JK, Bedrosian I, Meric-Bernstam F, Lucci A, Hunt KK. Biologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body mass. Breast Cancer Res Treat 133(3):1131-41, 2012. e-Pub 2012. PMID: 22392043.
280. Dominici LS, Mittendorf EA, Wang X, Liu J, Kuerer HM, Hunt KK, Brewster A, Babiera GV, Buchholz TA, Meric-Bernstam F, Bedrosian I. Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy. Breast Cancer Res 14(3):R82, 2012. e-Pub 2012. PMID: 22621306.
281. Caudle AS, Yu TK, Tucker SL, Bedrosian I, Litton JK, Gonzalez-Angulo AM, Hoffman K, Meric-Bernstam F, Hunt KK, Buchholz TA, Mittendorf EA. Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy. Breast Cancer Res 14(3):R83, 2012. e-Pub 2012. PMID: 22621334.
282. Abbott DE, Brouquet A, Mittendorf EA, Andreou A, Meric-Bernstam F, Valero V, Green MC, Kuerer HM, Curley SA, Abdalla EK, Hunt KK, Vauthey JN. Resection of liver metastases from breast cancer: Estrogen receptor status and response to chemotherapy before metastasectomy define outcome. Surgery 151(5):710-6, 2012. e-Pub 2012. PMID: 22285778.
283. Wagner JL, Fearmonti R, Hunt KK, Hwang RF, Meric-Bernstam F, Kuerer HM, Bedrosian I, Crosby MA, Baumann DP, Ross MI, Feig BW, Krishnamurthy S, Hernandez M, Babiera GV. Prospective evaluation of the nipple-areola complex sparing mastectomy for risk reduction and for early-stage breast cancer. Ann Surg Oncol 19(4):1137-44, 2012. e-Pub 2011. PMID: 21979111.
284. Smith TB, Gilcrease MZ, Santiago L, Hunt KK, Yang WT. Imaging features of primary breast sarcoma. AJR Am J Roentgenol 198(4):W386-93, 2012. PMID: 22451578.
285. Nanos-Webb A, Jabbour NA, Multani AS, Wingate H, Oumata N, Galons H, Joseph B, Meijer L, Hunt KK, Keyomarsi K. Targeting low molecular weight cyclin E (LMW-E) in breast cancer. Breast Cancer Res Treat 132(2):575-88, 2012. e-Pub 2011. PMID: 21695458.
286. Kelly CM, Green MC, Broglio K, Thomas ES, Brewster AM, Valero V, Ibrahim NK, Gonzalez-Angulo AM, Booser DJ, Walters RS, Hunt KK, Hortobagyi GN, Buzdar AU. Phase III trial evaluating weekly paclitaxel versus docetaxel in combination with capecitabine in operable breast cancer. J Clin Oncol 30(9):930-5, 2012. e-Pub 2012. PMID: 22331946.
287. Wu Y, Mittendorf EA, Kelten C, Tucker SL, Wei W, Middleton LP, Broglio K, Buchholz TA, Hunt KK, Sahin AA. Occult axillary lymph node metastasis do not have prognostic significance in early stage breast cancer. Cancer 118(6):1507-14, 2012. e-Pub 2011. PMID: 22009292.
288. Akay CL, Meric-Bernstam F, Hunt KK, Grubbs EG, Bedrosian I, Tucker SL, Kuerer HM, Hoffman KE, Babiera GV, Strom EA, Buchholz TA, Mittendorf EA. Evaluation of the md anderson prognostic index for local-regional recurrence after breast conserving therapy in patients receiving neoadjuvant chemotherapy. Ann Surg Oncol 19(3):901-7, 2012. e-Pub 2011. PMID: 21861223.
289. Yi M, Meric-Bernstam F, Kuerer HM, Mittendorf EA, Bedrosian I, Lucci A, Hwang RF, Crow JR, Luo S, Hunt KK. Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision. J Clin Oncol 30(6):600-7, 2012. e-Pub 2012. PMID: 22253459.
290. Wang-Johanning F, Rycaj K, Plummer JB, Li M, Yin B, Frerich K, Garza JG, Shen J, Lin K, Yan P, Glynn SA, Dorsey TH, Hunt KK, Ambs S, Johanning GL. Immunotherapeutic potential of anti-human endogenous retrovirus-K envelope protein antibodies in targeting breast tumors. J Natl Cancer Inst 104(3):189-210, 2012. e-Pub 2012. PMID: 22247020.
291. Mittendorf EA, Hunt KK, Boughey JC, Bassett R, Degnim AC, Harrell R, Yi M, Meric-Bernstam F, Ross MI, Babiera GV, Kuerer HM, Hwang RF. Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node. Ann Surg 255(1):109-15, 2012. PMID: 22167004.
292. Lester TR, Hunt KK, Nayeemuddin KM, Bassett RL, Gonzalez-Angulo AM, Feig BW, Huo L, Rourke LL, Davis WG, Valero V, Gilcrease MZ. Metaplastic sarcomatoid carcinoma of the breast appears more aggressive than other triple receptor-negative breast cancers. Breast Cancer Res Treat 131(1):41-8, 2012. e-Pub 2011. PMID: 21331622.
293. Bilimoria KY, Wayne JD, Merkow RP, Abbott DE, Cormier JN, Feig BW, Hunt KK, Pisters PW, Pollock R, Bentrem DJ. Incorporation of adjuvant therapy into the multimodality management of gastrointestinal stromal tumors of the stomach in the United States. Ann Surg Oncol 19(1):184-91, 2012. e-Pub 2011. PMID: 21725688.
294. Duong MT, Akli S, Wei C, Wingate HF, Liu W, Lu Y, Yi M, Mills GB, Hunt KK, Keyomarsi K. LMW-E/CDK2 Deregulates Acinar Morphogenesis, Induces Tumorigenesis, and Associates with the Activated b-Raf-ERK1/2-mTOR Pathway in Breast Cancer Patients. PLoS Genet 8(3):e1002538, 2012. e-Pub 2012. PMID: 22479189.
295. Yi M, Mittendorf EA, Cormier JN, Buchholz TA, Bilimoria K, Sahin AA, Hortobagyi GN, Gonzalez-Angulo AM, Luo S, Buzdar AU, Crow JR, Kuerer HM, Hunt KK. Novel staging system for predicting disease-specific survival in patients with breast cancer treated with surgery as the first intervention: time to modify the current american joint committee on cancer staging system. J Clin Oncol 29(35):4654-61, 2011. e-Pub 2011. PMID: 22084362.
296. Nagar H, Mittendorf EA, Strom EA, Perkins GH, Oh JL, Tereffe W, Woodward WA, Gonzalez-Angulo AM, Hunt KK, Buchholz TA, Yu TK. Local-regional recurrence with and without radiation therapy after neoadjuvant chemotherapy and mastectomy for clinically staged T3N0 breast cancer. Int J Radiat Oncol Biol Phys 81(3):782-7, 2011. e-Pub 2011. PMID: 21885207.
297. Euhus D, Bu D, Xie XJ, Sarode V, Ashfaq R, Hunt K, Xia W, O'Shaughnessy J, Grant M, Arun B, Dooley W, Miller A, Flockhart D, Lewis C. Tamoxifen downregulates ets oncogene family members ETV4 and ETV5 in benign breast tissue: implications for durable risk reduction. Cancer Prev Res (Phila) 4(11):1852-62, 2011. e-Pub 2011. PMID: 21778330.
298. Adkins FC, Gonzalez-Angulo AM, Lei X, Hernandez-Aya LF, Mittendorf EA, Litton JK, Wagner J, Hunt KK, Woodward WA, Meric-Bernstam F. Triple-negative breast cancer is not a contraindication for breast conservation. Ann Surg Oncol 18(11):3164-73, 2011. e-Pub 2011. PMID: 21947595.
299. Roses RE, Arun BK, Lari SA, Mittendorf EA, Lucci A, Hunt KK, Kuerer HM. Ductal carcinoma-in-situ of the breast with subsequent distant metastasis and death. Ann Surg Oncol 18(10):2873-8, 2011. e-Pub 2011. PMID: 21476105.
300. Caudle AS, Hunt KK, Kuerer HM, Meric-Bernstam F, Lucci A, Bedrosian I, Babiera GV, Hwang RF, Ross MI, Feig BW, Hoffman K, Litton JK, Sahin AA, Yang W, Hortobagyi GN, Buchholz TA, Mittendorf EA. Multidisciplinary considerations in the implementation of the findings from the american college of surgeons oncology group (ACOSOG) Z0011 study: a practice-changing trial. Ann Surg Oncol 18(9):2407-12, 2011. e-Pub 2011. PMID: 21327455.
301. Van Leeuwen BL, Rosenkranz KM, Feng LL, Bedrosian I, Hartmann K, Hunt KK, Kuerer HM, Ross M, Singletary SE, Babiera GV, Surgical Oncology DO, Center MD. The effect of under-treatment of breast cancer in women 80 years of age and older. Crit Rev Oncol Hematol 79(3):315-20, 2011. e-Pub 2010. PMID: 20655242.
302. Durak MG, Gonzalez-Angulo AM, Hanrahan EO, Broglio KR, Valero V, Hortobagyi GN, Hunt KK, Sahin AA. Age and associated fibrocystic changes are prognostically significant in patients with small node-negative (T1a,bN0) invasive breast cancer. Breast J 17(5):462-9, 2011. e-Pub 2011. PMID: 21726347.
303. Tian Z, Wei B, Tang F, Wei W, Gilcrease MZ, Huo L, Albarracin CT, Resetkova E, Middleton L, Sahin A, Xing Y, Hunt KK, Chen J, Bu H, Rashid A, Abraham SC, Wu Y. Prognostic significance of tumor grading and staging in mammary carcinomas with neuroendocrine differentiation. Hum Pathol 42(8):1169-77, 2011. e-Pub 2011. PMID: 21334720.
304. Giuliano AE, Hawes D, Ballman KV, Whitworth PW, Blumencranz PW, Reintgen DS, Morrow M, Leitch AM, Hunt KK, McCall LM, Abati A, Cote R. Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer. JAMA 306(4):385-393, 2011. PMID: 21791687.
305. Wray CJ, Benjamin RS, Hunt KK, Cormier JN, Ross MI, Feig BW. Isolated limb perfusion for unresectable extremity sarcoma: Results of 2 single-institution phase 2 trials. Cancer 117(14):3235-41, 2011. e-Pub 2011. PMID: 21246524.
306. Albert JM, Buzdar AU, Guzman R, Allen PK, Strom EA, Perkins GH, Woodward WA, Hoffman KE, Tereffe W, Hunt KK, Buchholz TA, Oh JL. Prospective randomized trial of 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus paclitaxel and FAC (TFAC) in patients with operable breast cancer: impact of taxane chemotherapy on locoregional control. Breast Cancer Res Treat 128(2):421-7, 2011. e-Pub 2011. PMID: 21553292.
307. Valero V, Wingate H, Chada S, Liu Y, Palalon F, Mills G, Keyomarsi K, Hunt KK. MDA-7 results in downregulation of AKT concomitant with apoptosis and cell cycle arrest in breast cancer cells. Cancer Gene Ther 18(7):510-9, 2011. e-Pub 2011. PMID: 21546925.
308. Wagner JL, Warneke CL, Mittendorf EA, Bedrosian I, Babiera GV, Kuerer HM, Hunt KK, Yang W, Sahin AA, Meric-Bernstam F. Delays in primary surgical treatment are not associated with significant tumor size progression in breast cancer patients. Ann Surg 254(1):119-24, 2011. PMID: 21494124.
309. Ellis MJ, Suman VJ, Hoog J, Lin L, Snider J, Prat A, Parker JS, Luo J, DeSchryver K, Allred DC, Esserman LJ, Unzeitig GW, Margenthaler J, Babiera GV, Marcom PK, Guenther JM, Watson MA, Leitch M, Hunt K, Olson JA. Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: clinical and biomarker outcomes and predictive value of the baseline pam50-based intrinsic subtype--acosog Z1031. J Clin Oncol 29(17):2342-9, 2011. e-Pub 2011. PMID: 21555689.
310. Langsner RJ, Middleton LP, Sun J, Meric-Bernstam F, Hunt KK, Drezek RA, Yu TK. Wide-field imaging of fluorescent deoxy-glucose in ex vivo malignant and normal breast tissue. Biomed Opt Express 2(6):1514-23, 2011. e-Pub 2011. PMID: 21698015.
311. Kronowitz SJ, Lam C, Terefe W, Hunt KK, Kuerer HM, Valero V, Lance S, Robb GL, Feng L, Buchholz TA. A multidisciplinary protocol for planned skin-preserving delayed breast reconstruction for patients with locally advanced breast cancer requiring postmastectomy radiation therapy: 3-year follow-up. Plast Reconstr Surg 127(6):2154-66, 2011. PMID: 21311392.
312. Mittendorf EA, Jeruss JS, Tucker SL, Kolli A, Newman LA, Gonzalez-Angulo AM, Buchholz TA, Sahin AA, Cormier JN, Buzdar AU, Hortobagyi GN, Hunt KK. Validation of a novel staging system for disease-specific survival in patients with breast cancer treated with neoadjuvant chemotherapy. J Clin Oncol 29(15):1956-62, 2011. e-Pub 2011. PMID: 21482989.
313. Sharma R, Rourke LL, Kronowitz SJ, Oh JL, Lucci A, Litton JK, Robb GL, Babiera GV, Mittendorf EA, Hunt KK, Kuerer HM. Management of local-regional recurrence following immediate breast reconstruction in patients with early breast cancer treated without postmastectomy radiotherapy. Plast Reconstr Surg 127(5):1763-72, 2011. PMID: 21532405.
314. Hatzis C, Pusztai L, Valero V, Booser DJ, Esserman L, Lluch A, Vidaurre T, Holmes F, Souchon E, Wang H, Martin M, Cotrina J, Gomez H, Hubbard R, Chacón JI, Ferrer-Lozano J, Dyer R, Buxton M, Gong Y, Wu Y, Ibrahim N, Andreopoulou E, Ueno NT, Hunt K, Yang W, Nazario A, DeMichele A, O'Shaughnessy J, Hortobagyi GN, Symmans WF. A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. JAMA 305(18):1873-81, 2011. PMID: 21558518.
315. Albert JM, Gonzalez-Angulo AM, Guray M, Sahin A, Tereffe W, Woodward WA, Strom EA, Hunt KK, Tucker SL, Buchholz TA. Patients with only 1 positive hormone receptor have increased locoregional recurrence compared with patients with estrogen receptor-positive progesterone receptor-positive disease in very early stage breast cancer. Cancer 117(8):1595-601, 2011. e-Pub 2010. PMID: 21472707.
316. Caudle AS, Gonzalez-Angulo AM, Hunt KK, Pusztai L, Kuerer HM, Mittendorf EA, Hortobagyi GN, Meric-Bernstam F. Impact of progression during neoadjuvant chemotherapy on surgical management of breast cancer. Ann Surg Oncol 18(4):932-8, 2011. e-Pub 2010. PMID: 21061075.
317. Yi M, Kronowitz SJ, Meric-Bernstam F, Feig BW, Symmans WF, Lucci A, Ross MI, Babiera GV, Kuerer HM, Hunt KK. Local, regional, and systemic recurrence rates in patients undergoing skin-sparing mastectomy compared with conventional mastectomy. Cancer 117(5):916-24, 2011. e-Pub 2010. PMID: 20945319.
318. Yi M, Buchholz TA, Meric-Bernstam F, Bedrosian I, Hwang RF, Ross MI, Kuerer HM, Luo S, Gonzalez-Angulo AM, Buzdar AU, Symmans WF, Feig BW, Lucci A, Huang EH, Hunt KK. Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning. Ann Surg 253(3):572-9, 2011. PMID: 21209588.
319. Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, McCall LM, Morrow M. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305(6):569-75, 2011. PMID: 21304082.
320. Ylipää A, Hunt KK, Yang J, Lazar AJ, Torres KE, Lev DC, Nykter M, Pollock RE, Trent J, Zhang W. Integrative genomic characterization and a genomic staging system for gastrointestinal stromal tumors. Cancer 117(2):380-9, 2011. e-Pub 2010. PMID: 20818650.
321. Kuerer HM, Buzdar AU, Mittendorf EA, Esteva FJ, Lucci A, Vence LM, Radvanyi L, Meric-Bernstam F, Hunt KK, Symmans WF. Biologic and immunologic effects of preoperative trastuzumab for ductal carcinoma in situ of the breast. Cancer 117(1):39-47, 2011. e-Pub 2010. PMID: 20740500.
322. Valero V, Kong AL, Hunt KK, Yi M, Hwang RF, Meric-Bernstam F, Bedrosian I, Ross MI, Babiera GV, Litton JK, Mittendorf EA. Sentinel lymph node dissection is technically feasible in older breast cancer patients. Clin Breast Cancer 10(6):477-82, 2010. PMID: 21147692.
323. Hall C, Krishnamurthy S, Lodhi A, Mosalpuria K, Kuerer HM, Meric-Bernstam F, Bedrosian I, Hunt KK, Lucci A. Disseminated tumor cells in biologic subtypes of stage I-III breast cancer patients. Ann Surg Oncol 17(12):3252-8, 2010. e-Pub 2010. PMID: 20559739.
324. Shinde SS, Forman MR, Kuerer HM, Yan K, Peintinger F, Hunt KK, Hortobagyi GN, Pusztai L, Symmans WF. Higher parity and shorter breastfeeding duration: association with triple-negative phenotype of breast cancer. Cancer 116(21):4933-43, 2010. PMID: 20665494.
325. Sharma R, Bedrosian I, Lucci A, Hwang RF, Rourke LL, Qiao W, Buchholz TA, Kronowitz SJ, Krishnamurthy S, Babiera GV, Gonzalez-Angulo AM, Meric-Bernstam F, Mittendorf EA, Hunt KK, Kuerer HM. Present-day locoregional control in patients with t1 or t2 breast cancer with 0 and 1 to 3 positive lymph nodes after mastectomy without radiotherapy. Ann Surg Oncol 17(11):2899-908, 2010. e-Pub 2010. PMID: 20443145.
326. Yang J, Eddy JA, Pan Y, Hategan A, Tabus I, Wang Y, Cogdell D, Price ND, Pollock RE, Lazar AJ, Hunt KK, Trent JC, Zhang W. Integrated proteomics and genomics analysis reveals a novel mesenchymal to epithelial reverting transition in leiomyosarcoma through regulation of slug. Mol Cell Proteomics 9(11):2405-13, 2010. e-Pub 2010. PMID: 20651304.
327. Wei B, Ding T, Xing Y, Wei W, Tian Z, Tang F, Abraham S, Nayeemuddin K, Hunt K, Wu Y. Invasive neuroendocrine carcinoma of the breast: a distinctive subtype of aggressive mammary carcinoma. Cancer 116(19):4463-4473, 2010. PMID: 20572042.
328. Yi M, Giordano SH, Meric-Bernstam F, Mittendorf EA, Kuerer HM, Hwang RF, Bedrosian I, Rourke L, Hunt KK. Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database. Ann Surg Oncol 17(Suppl 3):343-51, 2010. e-Pub 2010. PMID: 20853057.
329. Kang T, Yi M, Hunt KK, Mittendorf EA, Babiera GV, Kuerer H, Bedrosian I, Hwang RF, Lucci A, Meric-Bernstam F. Does blue dye contribute to success of sentinel node mapping for breast cancer?. Ann Surg Oncol 17:280-5, 2010. e-Pub 2010. PMID: 20853047.
330. Rosbach KJ, Shin D, Muldoon TJ, Quraishi MA, Middleton LP, Hunt KK, Meric-Bernstam F, Yu TK, Richards-Kortum RR, Yang W. High-resolution fiber optic microscopy with fluorescent contrast enhancement for the identification of axillary lymph node metastases in breast cancer: a pilot study. Biomed Opt Express 1(3):911-922, 2010. e-Pub 2010. PMID: 21258518.
331. Caruso JA, Hunt KK, Keyomarsi K. The neutrophil elastase inhibitor elafin triggers rb-mediated growth arrest and caspase-dependent apoptosis in breast cancer. Cancer Res 70(18):7125-36, 2010. e-Pub 2010. PMID: 20823156.
332. Walker GV, Smith GL, Perkins GH, Oh JL, Woodward W, Yu TK, Hunt KK, Hoffman K, Strom EA, Buchholz TA. Population-based analysis of occult primary breast cancer with axillary lymph node metastasis. Cancer 116(17):4000-6, 2010. PMID: 20564117.
333. Giuliano AE, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, Saha S, Hunt KK, Morrow M, Ballman K. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg 252(3):426-32; discussion 432-3, 2010. PMID: 20739842.
334. Albert JM, Gonzalez-Angulo AM, Guray M, Sahin A, Strom EA, Tereffe W, Woodward WA, Tucker SL, Hunt KK, Hortobagyi GN, Buchholz TA. Estrogen/progesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a,bN0 breast cancer. Int J Radiat Oncol Biol Phys 77(5):1296-302, 2010. e-Pub 2010. PMID: 20472353.
335. Wilke LG, Ballman KV, McCall LM, Giuliano AE, Whitworth PW, Blumencranz PW, Reintgen DS, Burak WE, Leitch AM, Hunt KK. Adherence to the national quality forum (NQF) breast cancer measures within cancer clinical trials: a review from acosog Z0010. Ann Surg Oncol 17(8):1989-94, 2010. e-Pub 2010. PMID: 20309640.
336. Yi M, Hunt KK, Arun BK, Bedrosian I, Barrera AG, Do KA, Kuerer HM, Babiera GV, Mittendorf EA, Ready K, Litton J, Meric-Bernstam F. Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy. Cancer Prev Res (Phila) 3(8):1026-34, 2010. e-Pub 2010. PMID: 20647335.
337. Mittendorf EA, Liu Y, Tucker SL, McKenzie T, Qiao N, Akli S, Biernacka A, Liu Y, Meijer L, Keyomarsi K, Hunt KK. A novel interaction between HER2/neu and cyclin E in breast cancer. Oncogene 29(27):1-12, 2010. e-Pub 2010. PMID: 20453888.
338. Brown AS, Hunt KK, Shen J, Huo L, Babiera GV, Ross MI, Meric-Bernstam F, Feig BW, Kuerer HM, Boughey JC, Ching CD, Gilcrease MZ. Histologic changes associated with false-negative sentinel lymph nodes after preoperative chemotherapy in patients with confirmed lymph node-positive breast cancer before treatment. Cancer 116(12):2878-83, 2010. PMID: 20564394.
339. Dominici LS, Negron Gonzalez VM, Buzdar AU, Lucci A, Mittendorf EA, Le-Petross HT, Babiera GV, Meric-Bernstam F, Hunt KK, Kuerer HM. Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer. Cancer 116(12):2884-9, 2010. PMID: 20564395.
340. Bagheri-Yarmand R, Biernacka A, Hunt KK, Keyomarsi K. Low molecular weight cyclin e. overexpression shortens mitosis, leading to chromosome missegregation and centrosome amplification. Cancer Res 70(12):5074-84, 2010. e-Pub 2010. PMID: 20530685.
341. Bedrosian I, Babiera GV, Mittendorf EA, Kuerer HM, Pantoja L, Hunt KK, Krishnamurthy S, Meric-Bernstam F. A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients. Cancer 116(11):2543-8, 2010. PMID: 20336790.
342. Lahat G, Dhuka AR, Hallevi H, Xiao L, Zou C, Smith KD, Phung TL, Pollock RE, Benjamin R, Hunt KK, Lazar AJ, Lev D. Angiosarcoma: clinical and molecular insights. Ann Surg 251(6):1098-106, 2010. PMID: 20485141.
343. Caudle AS, Gonzalez-Angulo AM, Hunt KK, Liu P, Pusztai L, Symmans WF, Kuerer HM, Mittendorf EA, Hortobagyi GN, Meric-Bernstam F. Predictors of tumor progression during neoadjuvant chemotherapy in breast cancer. J Clin Oncol 28(11):1821-8, 2010. e-Pub 2010. PMID: 20231683.
344. Nguyen CV, Falcón-Escobedo R, Hunt KK, Nayeemuddin KM, Lester TR, Harrell RK, Bassett RL, Gilcrease MZ. Pleomorphic ductal carcinoma of the breast: predictors of decreased overall survival. Am J Surg Pathol 34(4):486-93, 2010. e-Pub 2010. PMID: 20154588.
345. Sparano JA, Pisano ED, White JR, Hunt KK, Mamounas EP, Perez EA, Hortobagyi GN, Gralow JR, Comis RL. Recommendations for research priorities in breast cancer by the coalition of cancer cooperative groups scientific leadership council: imaging and local therapy. Breast Cancer Res Treat 120(2):273-84, 2010. e-Pub 2009. PMID: 20024613.
346. Yang D, Ylipaa A, Yang J, Hunt K, Pollock R, Trent J, Yli-Harja O, Shmulevich I, Nykter M, Zhang W. An integrated study of aberrant gene copy number and gene expression in GIST and LMS. Technol Cancer Res Treat 9(2):171-8, 2010. PMID: 20218739.
347. Sun B, Wingate H, Swisher SG, Keyomarsi K, Hunt KK. Absence of pRb facilitates E2F1-induced apoptosis in breast cancer cells. Cell Cycle 9(6):1-9, 2010. e-Pub 2010. PMID: 20237430.
348. Akli S, Bui T, Wingate H, Biernacka A, Moulder S, Tucker SL, Hunt KK, Keyomarsi K. Low-molecular-weight cyclin E can bypass letrozole-induced G1 arrest in human breast cancer cells and tumors. Clin Cancer Res 16(4):1179-90, 2010. e-Pub 2010. PMID: 20145171.
349. Silberfein EJ, Hunt KK, Broglio K, Shen J, Sahin A, Le-Petross H, Oh J, Litton J, Hwang RF, Mittendorf EA. Clinicopathologic factors associated with involved margins after breast-conserving surgery for invasive lobular carcinoma. Clin Breast Cancer 10(1):52-8, 2010. PMID: 20133259.
350. Anaya DA, Lahat G, Wang X, Xiao L, Pisters PW, Cormier JN, Hunt KK, Feig BW, Lev DC, Pollock RE. Postoperative nomogram for survival of patients with retroperitoneal sarcoma treated with curative intent. Ann Oncol 21(2):397-402, 2010. e-Pub 2009. PMID: 19622598.
351. Ellis MJ, Lin L, Crowder R, Tao Y, Hoog J, Snider J, Davies S, DeSchryver K, Evans DB, Steinseifer J, Bandaru R, Liu W, Gardner H, Semiglazov V, Watson M, Hunt K, Olson J, Baselga J. Phosphatidyl-inositol-3-kinase alpha catalytic subunit mutation and response to neoadjuvant endocrine therapy for estrogen receptor positive breast cancer. Breast Cancer Res Treat 119(2):379-90, 2010. PMID: 19844788.
352. Fearmonti RM, Gayed IW, Kim E, Bedrosian I, Hunt KK, Meric-Bernstam F, Feig B, Ghonimi E, Warneke C, Babiera GV. Intra-individual comparison of lymphatic drainage patterns using subareolar and peritumoral isotope injection for breast cancer. Ann Surg Oncol 17(1):220-7, 2010. e-Pub 2009. PMID: 19680729.
353. Mittendorf EA, Wu Y, Scaltriti M, Meric-Bernstam F, Hunt KK, Dawood S, Esteva FJ, Buzdar AU, Chen H, Eksambi S, Hortobagyi GN, Baselga J, Gonzalez-Angulo AM. Loss of HER2 amplification following trastuzumab-based neoadjuvant systemic therapy and survival outcomes. Clin Cancer Res 15(23):7381-8, 2009. e-Pub 2009. PMID: 19920100.
354. Fearmonti RM, Batista LI, Meric-Bernstam F, Bedrosian I, Kuerer HM, Hunt KK, Eva Singletary S, Babiera GV. False negative rate of sentinel lymph node biopsy in multicentric and multifocal breast cancers may be higher in cases with large additive tumor burden. Breast J 15(6):645-8, 2009. e-Pub 2009. PMID: 19735388.
355. Boughey JC, Goravanchi F, Parris RN, Kee SS, Kowalski AM, Frenzel JC, Bedrosian I, Meric-Bernstam F, Hunt KK, Ames FC, Kuerer HM, Lucci A. Prospective randomized trial of paravertebral block for patients undergoing breast cancer surgery. Am J Surg 198(5):720-725, 2009. e-Pub 2009. PMID: 19427625.
356. Wagner M, Roh V, Strehlen M, Laemmle A, Stroka D, Egger B, Trochsler M, Hunt KK, Candinas D, Vorburger SA. Effective Treatment of Advanced Colorectal Cancer by Rapamycin and 5-FU/Oxaliplatin Monitored by TIMP-1. J Gastrointest Surg 13(10):1781-90, 2009. e-Pub 2009. PMID: 19565301.
357. Smith GL, Xu Y, Shih YC, Giordano SH, Smith BD, Hunt KK, Strom EA, Perkins GH, Hortobagyi GN, Buchholz TA. Breast-conserving surgery in older patients with invasive breast cancer: current patterns of treatment across the united states. J Am Coll Surg 209(4):425-433, 2009. e-Pub 2009. PMID: 19801315.
358. Hunt KK, Yi M, Mittendorf EA, Guerrero C, Babiera GV, Bedrosian I, Hwang RF, Kuerer HM, Ross MI, Meric-Bernstam F. Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients. Ann Surg 250(4):558-66, 2009. PMID: 19730235.
359. Boughey JC, Goravanchi F, Parris RN, Kee SS, Frenzel JC, Hunt KK, Ames FC, Kuerer HM, Lucci A. Improved postoperative pain control using thoracic paravertebral block for breast operations. Breast J 15(5):483-8, 2009. e-Pub 2009. PMID: 19624418.
360. Wagner J, Boughey JC, Garrett B, Babiera G, Kuerer H, Meric-Bernstam F, Singletary E, Hunt KK, Middleton LP, Bedrosian I. Margin assessment after neoadjuvant chemotherapy in invasive lobular cancer. Am J Surg 198(3):387-391, 2009. e-Pub 2009. PMID: 19362281.
361. Lahat G, Dhuka AR, Lahat S, Smith KD, Pollock RE, Hunt KK, Ravi V, Lazar AJ, Lev D. Outcome of locally recurrent and metastatic angiosarcoma. Ann Surg Oncol 16(9):2502-2509, 2009. e-Pub 2009. PMID: 19551444.
362. Lahat G, Dhuka AR, Lahat S, Lazar AJ, Lewis VO, Lin PP, Feig B, Cormier JN, Hunt KK, Pisters PW, Pollock RE, Lev D. Complete soft tissue sarcoma resection is a viable treatment option for select elderly patients. Ann Surg Oncol 16(9):2579-2586, 2009. e-Pub 2009. PMID: 19557478.
363. Blazer DG, Lazar AJ, Xing Y, Askew RL, Feig BW, Pisters PW, Pollock RE, Lev D, Hunt KK, Cormier JN. Clinical outcomes of molecularly confirmed clear cell sarcoma from a single institution and in comparison with data from the Surveillance, Epidemiology, and End Results registry. Cancer 115(13):2971-9, 2009. PMID: 19402173.
364. Boughey JC, Wagner J, Garrett BJ, Harker L, Middleton LP, Babiera GV, Meric-Bernstam F, Lucci A, Hunt KK, Bedrosian I. Neoadjuvant chemotherapy in invasive lobular carcinoma may not improve rates of breast conservation. Ann Surg Oncol 16(6):1606-1611, 2009. e-Pub 2009. PMID: 19280264.
365. Shaye A, Sahin A, Hao Q, Hunt K, Keyomarsi K, Bedrosian I. Cyclin E deregulation is an early event in the development of breast cancer. Breast Cancer Res Treat 115(3):651-9, 2009. e-Pub 2008. PMID: 19107593.
366. Sahin AA, Guray M, Hunt KK. Identification and biologic significance of micrometastases in axillary lymph nodes in patients with invasive breast cancer. Arch Pathol Lab Med 133(6):869-78, 2009. PMID: 19492879.
367. Lott ST, Chen N, Chandler DS, Yang Q, Wang L, Rodriguez M, Xie H, Balasenthil S, Buchholz TA, Sahin AA, Chaung K, Zhang B, Olufemi SE, Chen J, Adams H, Band V, El-Naggar AK, Frazier ML, Keyomarsi K, Hunt KK, Sen S, Haffty B, Hewitt SM, Krahe R, Killary AM. DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancer. PLoS Med 6(5):e1000068, 2009. e-Pub 2009. PMID: 19536326.
368. Lahat G, Lazar A, Wang X, Wang WL, Zhu QS, Hunt KK, Pollock RE, Lev D. Increased vascular endothelial growth factor-c expression is insufficient to induce lymphatic metastasis in human soft-tissue sarcomas. Clin Cancer Res 15(8):2637-2646, 2009. e-Pub 2009. PMID: 19351758.
369. Krishnamurthy S, Meric-Bernstam F, Lucci A, Hwang RF, Kuerer HM, Babiera G, Ames FC, Feig BW, Ross MI, Singletary E, Hunt KK, Bedrosian I. A prospective study comparing touch imprint cytology, frozen section analysis, and rapid cytokeratin immunostain for intraoperative evaluation of axillary sentinel lymph nodes in breast cancer. Cancer 115(7):1555-62, 2009. e-Pub 2009. PMID: 19195040.
370. Wingate H, Puskas A, Duong M, Bui T, Richardson D, Liu Y, Tucker SL, Van Pelt C, Meijer L, Hunt K, Keyomarsi K. Low molecular weight cyclin E is specific in breast cancer and is associated with mechanisms of tumor progression. Cell Cycle 8(7):1062-1068, 2009. e-Pub 2009. PMID: 19305161.
371. Delk NA, Hunt KK, Keyomarsi K. Altered subcellular localization of tumor-specific cyclin E isoforms affects cyclin-dependent kinase 2 complex formation and proteasomal regulation. Cancer Res 69(7):2817-2825, 2009. e-Pub 2009. PMID: 19318554.
372. McAuliffe JC, Hunt KK, Lazar AJ, Choi H, Qiao W, Thall P, Pollock RE, Benjamin RS, Trent JC. A randomized, Phase II study of preoperative plus postoperative imatinib in GIST: evidence of rapid radiographic response and temporal induction of tumor cell apoptosis. Ann Surg Oncol 16(4):910-919, 2009. e-Pub 2008. PMID: 18953611.
373. Downs-Kelly E, Nayeemuddin KM, Albarracin C, Wu Y, Hunt KK, Gilcrease MZ. Matrix-producing Carcinoma of the Breast: An Aggressive Subtype of Metaplastic Carcinoma. Am J Surg Pathol 33(4):534-41, 2009. e-Pub 2008. PMID: 19047898.
374. Yang J, Du X, Chen K, Ylipää A, Lazar AJ, Trent J, Lev D, Pollock R, Hao X, Hunt K, Zhang W. Genetic aberrations in soft tissue leiomyosarcoma. Cancer Lett 275(1):1-8, 2009. e-Pub 2008. PMID: 18649996.
375. Yi M, Meric-Bernstam F, Middleton LP, Arun BK, Bedrosian I, Babiera GV, Hwang RF, Kuerer HM, Yang W, Hunt KK. Predictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy. Cancer 115(5):962-971, 2009. PMID: 19172584.
376. Cox JD, Giralt SA, Veazie ML, Ajani JA, Bruner JM, Chan KW, Hittelman WN, Hunt KK, Iyer RB, Karp DD, Kuban DA, Lippman SM, Raad II, Rodriguez-Bigas MA, Zwelling LA, Markman M. Evaluating quality in clinical cancer research: the M.D. Anderson Cancer Center experience. Oncology 77(2):75-81, 2009. e-Pub 2009. PMID: 19571599.
377. Moulder SL, Symmans WF, Booser DJ, Madden TL, Lipsanen C, Yuan L, Brewster AM, Cristofanilli M, Hunt KK, Buchholz TA, Zwiebel J, Valero V, Hortobagyi GN, Esteva FJ. Phase I/II study of G3139 (Bcl-2 antisense oligonucleotide) in combination with doxorubicin and docetaxel in breast cancer. Clin Cancer Res 14(23):7909-16, 2008. PMID: 19047121.
378. Mittendorf EA, Sahin AA, Tucker SL, Meric-Bernstam F, Yi M, Nayeemuddin KM, Babiera GV, Ross MI, Feig BW, Kuerer HM, Hunt KK. Lymphovascular invasion and lobular histology are associated with increased incidence of isolated tumor cells in sentinel lymph nodes from early-stage breast cancer patients. Ann Surg Oncol 15(12):3369-77, 2008. e-Pub 2008. PMID: 18815841.
379. Bristol IJ, Woodward WA, Strom EA, Cristofanilli M, Domain D, Singletary SE, Perkins GH, Oh JL, Yu TK, Terrefe W, Sahin AA, Hunt KK, Hortobagyi GN, Buchholz TA. Locoregional treatment outcomes after multimodality management of inflammatory breast cancer. Int J Radiat Oncol Biol Phys 72(2):474-84, 2008. e-Pub 2008. PMID: 18439768.
380. Lambert LA, Qiao N, Hunt KK, Lambert DH, Mills GB, Meijer L, Keyomarsi K. Autophagy: a novel mechanism of synergistic cytotoxicity between doxorubicin and roscovitine in a sarcoma model. Cancer Res 68(19):7966-74, 2008. PMID: 18829554.
381. Yang J, Du X, Lazar AJ, Pollock R, Hunt K, Chen K, Hao X, Trent J, Zhang W. Genetic aberrations of gastrointestinal stromal tumors. Cancer 113(7):1532-1543, 2008. PMID: 18671247.
382. Roh V, Laemmle A, Von Holzen U, Stroka D, Dufour JF, Hunt KK, Candinas D, Vorburger SA. Dual induction of PKR with E2F-1 and IFN-alpha to enhance gene therapy against hepatocellular carcinoma. Cancer Gene Ther 15(10):636-44, 2008. e-Pub 2008. PMID: 18535617.
383. Bedi DG, Krishnamurthy R, Krishnamurthy S, Edeiken BS, Le-Petross H, Fornage BD, Bassett RL, Hunt KK. Cortical morphologic features of axillary lymph nodes as a predictor of metastasis in breast cancer: in vitro sonographic study. AJR Am J Roentgenol 191(3):646-52, 2008. PMID: 18716089.
384. Jeruss JS, Mittendorf EA, Tucker SL, Gonzalez-Angulo AM, Buchholz TA, Sahin AA, Cormier JN, Buzdar AU, Hortobagyi GN, Hunt KK. Staging of breast cancer in the neoadjuvant setting. Cancer Res 68(16):6477-81, 2008. PMID: 18701468.
385. Pataer A, Hu W, Xiaolin L, Chada S, Roth JA, Hunt KK, Swisher SG. Adenoviral endoplasmic reticulum-targeted mda-7/interleukin-24 vector enhances human cancer cell killing. Mol Cancer Ther 7(8):2528-35, 2008. PMID: 18723497.
386. Olson JA, McCall LM, Beitsch P, Whitworth PW, Reintgen DS, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Giuliano AE, American College of Surgeons Oncology Group Trials Z, Z. Impact of immediate versus delayed axillary node dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: results from American College of Surgeons Oncology Group Trials Z0010 and Z0011. J Clin Oncol 26(21):3530-5, 2008. PMID: 18640934.
387. Wang-Johanning F, Radvanyi L, Rycaj K, Plummer JB, Yan P, Sastry KJ, Piyathilake CJ, Hunt KK, Johanning GL. Human endogenous retrovirus K triggers an antigen-specific immune response in breast cancer patients. Cancer Res 68(14):5869-77, 2008. PMID: 18632641.
388. Buchholz TA, Woodward WA, Duan Z, Fang S, Oh JL, Tereffe W, Strom EA, Perkins GH, Yu TK, Hunt KK, Meric-Bernstam F, Hortobagyi GN, Giordano SH. Radiation use and long-term survival in breast cancer patients with T1, T2 primary tumors and one to three positive axillary lymph nodes. Int J Radiat Oncol Biol Phys 71(4):1022-7, 2008. e-Pub 2008. PMID: 18234447.
389. Yi M, Meric-Bernstam F, Ross MI, Akins JS, Hwang RF, Lucci A, Kuerer HM, Babiera GV, Gilcrease MZ, Hunt KK. How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast cancer?. Cancer 113(1):30-37, 2008. PMID: 18457326.
390. Chen LL, Holden JA, Choi H, Zhu J, Wu EF, Jones KA, Ward JH, Andtbacka RH, Randall RL, Scaife CL, Hunt KK, Prieto VG, Raymond AK, Zhang W, Trent JC, Benjamin RS, Frazier ML. Evolution from heterozygous to homozygous KIT mutation in gastrointestinal stromal tumor correlates with the mechanism of mitotic nondisjunction and significant tumor progression. Mod Pathol 21(7):826-36, 2008. e-Pub 2008. PMID: 18488000.
391. Yi M, Krishnamurthy S, Kuerer HM, Meric-Bernstam F, Bedrosian I, Ross MI, Ames FC, Lucci A, Hwang RF, Hunt KK. Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer. Am J Surg 196(1):81-7, 2008. e-Pub 2008. PMID: 18436181.
392. Lu J, Wei Q, Bondy ML, Brewster AM, Bevers TB, Yu TK, Buchholz TA, Meric-Bernstam F, Hunt KK, Singletary SE, Wang LE. Genetic variants in the H2AFX promoter region are associated with risk of sporadic breast cancer in non-Hispanic white women aged
393. Jeruss JS, Newman LA, Ayers GD, Cristofanilli M, Broglio KR, Meric-Bernstam F, Yi M, Waljee JF, Ross MI, Hunt KK. Factors predicting additional disease in the axilla in patients with positive sentinel lymph nodes after neoadjuvant chemotherapy. Cancer 112(12):2646-54, 2008. PMID: 18442039.
394. Rao R, Feng L, Kuerer HM, Singletary SE, Bedrosian I, Hunt KK, Ross MI, Hortobagyi GN, Feig BW, Ames FC, Babiera GV. Timing of surgical intervention for the intact primary in stage IV breast cancer patients. Ann Surg Oncol 15(6):1696-702, 2008. e-Pub 2008. PMID: 18357493.
395. Badgwell BD, Giordano SH, Duan ZZ, Fang S, Bedrosian I, Kuerer HM, Singletary SE, Hunt KK, Hortobagyi GN, Babiera G. Mammography before diagnosis among women age 80 years and older with breast cancer. J Clin Oncol 26(15):2482-8, 2008. e-Pub 2008. PMID: 18427152.
396. Al-Refaie WB, Andtbacka RH, Ensor J, Pisters PW, Ellis TL, Shrout A, Hunt KK, Cormier JN, Pollock RE, Feig BW. Lymphadenectomy for isolated lymph node metastasis from extremity soft-tissue sarcomas. Cancer 112(8):1821-6, 2008. PMID: 18306370.
397. Jeruss JS, Mittendorf EA, Tucker SL, Gonzalez-Angulo AM, Buchholz TA, Sahin AA, Cormier JN, Buzdar AU, Hortobagyi GN, Hunt KK. Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapy. J Clin Oncol 26(2):246-52, 2008. e-Pub 2007. PMID: 18056680.
398. Lim SJ, Feig BW, Wang H, Hunt KK, Rodriguez-Bigas MA, Skibber JM, Ellis V, Cleary K, Chang GJ. Sentinel lymph node evaluation does not improve staging accuracy in colon cancer. Ann Surg Oncol 15(1):46-51, 2008. e-Pub 2007. PMID: 17985187.
399. Pataer A, Chada S, Roth JA, Hunt KK, Swisher SG. Development of Ad-mda7/IL-24-resistant lung cancer cell lines. Cancer Biol Ther 7(1):103-8, 2008. e-Pub 2007. PMID: 18059175.
400. Yokota T, Bui T, Liu Y, Yi M, Hunt KK, Keyomarsi K. Differential regulation of elafin in normal and tumor-derived mammary epithelial cells is mediated by CCAAT/enhancer binding protein beta. Cancer Res 67(23):11272-83, 2007. PMID: 18056453.
401. Oh JL, Nguyen G, Whitman GJ, Hunt KK, Yu TK, Woodward WA, Tereffe W, Strom EA, Perkins GH, Buchholz TA. Placement of radiopaque clips for tumor localization in patients undergoing neoadjuvant chemotherapy and breast conservation therapy. Cancer 110(11):2420-7, 2007. PMID: 17941034.
402. Boughey JC, Cormier JN, Xing Y, Hunt KK, Meric-Bernstam F, Babiera GV, Ross MI, Kuerer HM, Singletary SE, Bedrosian I. Decision analysis to assess the efficacy of routine sentinel lymphadenectomy in patients undergoing prophylactic mastectomy. Cancer 110(11):2542-50, 2007. PMID: 17932905.
403. Yang WT, Hennessy B, Broglio K, Mills C, Sneige N, Davis WG, Valero V, Hunt KK, Gilcrease MZ. Imaging differences in metaplastic and invasive ductal carcinomas of the breast. AJR Am J Roentgenol 189(6):1288-93, 2007. PMID: 18029860.
404. Kronowitz SJ, Hunt KK, Kuerer HM, Strom EA, Buchholz TA, Ensor JE, Koutz CA, Robb GL. Practical guidelines for repair of partial mastectomy defects using the breast reduction technique in patients undergoing breast conservation therapy. Plast Reconstr Surg 120(7):1755-68, 2007. PMID: 18090737.
405. von Holzen U, Pataer A, Raju U, Bocangel D, Vorburger SA, Liu Y, Lu X, Roth JA, Aggarwal BB, Barber GN, Keyomarsi K, Hunt KK, Swisher SG. The double-stranded RNA-activated protein kinase mediates radiation resistance in mouse embryo fibroblasts through nuclear factor kappaB and Akt activation. Clin Cancer Res 13(20):6032-9, 2007. PMID: 17947465.
406. Pisters PW, Pollock RE, Lewis VO, Yasko AW, Cormier JN, Respondek PM, Feig BW, Hunt KK, Lin PP, Zagars G, Wei C, Ballo MT. Long-term results of prospective trial of surgery alone with selective use of radiation for patients with T1 extremity and trunk soft tissue sarcomas. Ann Surg 246(4):675-81; discussion 681-2, 2007. PMID: 17893504.
407. Vo T, Xing Y, Meric-Bernstam F, Mirza N, Vlastos G, Symmans WF, Perkins GH, Buchholz TA, Babiera GV, Kuerer HM, Bedrosian I, Akins JS, Hunt KK. Long-term outcomes in patients with mucinous, medullary, tubular, and invasive ductal carcinomas after lumpectomy. Am J Surg 194(4):527-31, 2007. PMID: 17826073.
408. Boughey JC, Middleton LP, Harker L, Garrett B, Fornage B, Hunt KK, Babiera GV, Dempsey P, Bedrosian I. Utility of ultrasound and fine-needle aspiration biopsy of the axilla in the assessment of invasive lobular carcinoma of the breast. Am J Surg 194(4):450-5, 2007. PMID: 17826054.
409. Lucci A, McCall LM, Beitsch PD, Whitworth PW, Reintgen DS, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Giuliano AE, Oncology Group ACOS. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol 25(24):3657-63, 2007. e-Pub 2007. PMID: 17485711.
410. Hwang RF, Gonzalez-Angulo AM, Yi M, Buchholz TA, Meric-Bernstam F, Kuerer HM, Babiera GV, Tereffe W, Liu DD, Hunt KK. Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection. Cancer 110(4):723-30, 2007. PMID: 17587208.
411. Williams SA, Ehlers RA, Hunt KK, Yi M, Kuerer HM, Singletary SE, Ross MI, Feig BW, Symmans WF, Meric-Bernstam F. Metastases to the breast from nonbreast solid neoplasms: presentation and determinants of survival. Cancer 110(4):731-7, 2007. PMID: 17582626.
412. Lim SJ, Cormier JN, Feig BW, Mansfield PF, Benjamin RS, Griffin JR, Chase JL, Pisters PW, Pollock RE, Hunt KK. Toxicity and outcomes associated with surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with sarcomatosis. Ann Surg Oncol 14(8):2309-18, 2007. e-Pub 2007. PMID: 17541691.
413. Hayes-Jordan A, Anderson P, Curley S, Herzog C, Lally KP, Green HL, Hunt K, Mansfield P. Continuous hyperthermic peritoneal perfusion for desmoplastic small round cell tumor. J Pediatr Surg 42(8):E29-32, 2007. PMID: 17706484.
414. McGuire SE, Gonzalez-Angulo AM, Huang EH, Tucker SL, Kau SW, Yu TK, Strom EA, Oh JL, Woodward WA, Tereffe W, Hunt KK, Kuerer HM, Sahin AA, Hortobagyi GN, Buchholz TA. Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy. Int J Radiat Oncol Biol Phys 68(4):1004-9, 2007. e-Pub 2007. PMID: 17418973.
415. Sher T, Hennessy BT, Valero V, Broglio K, Woodward WA, Trent J, Hunt KK, Hortobagyi GN, Gonzalez-Angulo AM. Primary angiosarcomas of the breast. Cancer 110(1):173-8, 2007. PMID: 17541936.
416. Shen J, Gilcrease MZ, Babiera GV, Ross MI, Meric-Bernstam F, Feig BW, Kuerer HM, Francis A, Ames FC, Hunt KK. Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases. Cancer 109(7):1255-63, 2007. PMID: 17330229.
417. Cabioglu N, Hunt KK, Sahin AA, Kuerer HM, Babiera GV, Singletary SE, Whitman GJ, Ross MI, Ames FC, Feig BW, Buchholz TA, Meric-Bernstam F. Role for intraoperative margin assessment in patients undergoing breast-conserving surgery. Ann Surg Oncol 14(4):1458-71, 2007. e-Pub 2007. PMID: 17260108.
418. Yang WT, Hennessy BT, Dryden MJ, Valero V, Hunt KK, Krishnamurthy S. Mammary angiosarcomas: imaging findings in 24 patients. Radiology 242(3):725-34, 2007. PMID: 17325063.
419. Price ND, Trent J, El-Naggar AK, Cogdell D, Taylor E, Hunt KK, Pollock RE, Hood L, Shmulevich I, Zhang W. Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas. Proc Natl Acad Sci U S A 104(9):3414-9, 2007. e-Pub 2007. PMID: 17360660.
420. Huang EH, Strom EA, Valero V, Fornage B, Perkins GH, Oh JL, Yu TK, Tereffe W, Woodward WA, Hunt KK, Meric-Bernstam F, Sahin AA, Bedrosian I, Hortobagyi GN, Buchholz TA. Locoregional treatment outcomes for breast cancer patients with ipsilateral supraclavicular metastases at diagnosis. Int J Radiat Oncol Biol Phys 67(2):490-6, 2007. PMID: 17236970.
421. Zheng M, Bocangel D, Doneske B, Mhashilkar A, Ramesh R, Hunt KK, Ekmekcioglu S, Sutton RB, Poindexter N, Grimm EA, Chada S. Human interleukin 24 (MDA-7/IL-24) protein kills breast cancer cells via the IL-20 receptor and is antagonized by IL-10. Cancer Immunol Immunother 56(2):205-15, 2007. e-Pub 2006. PMID: 16710719.
422. Buzdar AU, Valero V, Ibrahim NK, Francis D, Broglio KR, Theriault RL, Pusztai L, Green MC, Singletary SE, Hunt KK, Sahin AA, Esteva F, Symmans WF, Ewer MS, Buchholz TA, Hortobagyi GN. Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: an update of the initial randomized study population and data of additional patients treated with the same regimen. Clin Cancer Res 13(1):228-33, 2007. PMID: 17200359.
423. Ballo MT, Zagars GK, Pollock RE, Benjamin RS, Feig BW, Cormier JN, Hunt KK, Patel SR, Trent JC, Beddar S, Pisters PW. Retroperitoneal soft tissue sarcoma: an analysis of radiation and surgical treatment. Int J Radiat Oncol Biol Phys 67(1):158-63, 2007. e-Pub 2006. PMID: 17084545.
424. Pataer A, Bocangel D, Chada S, Roth JA, Hunt KK, Swisher SG. Enhancement of adenoviral MDA-7-mediated cell killing in human lung cancer cells by geldanamycin and its 17-allyl- amino-17-demethoxy analogue. Cancer Gene Ther 14(1):12-8, 2007. e-Pub 2006. PMID: 17024233.
425. Andtbacka RH, Ng CS, Scaife CL, Cormier JN, Hunt KK, Pisters PW, Pollock RE, Benjamin RS, Burgess MA, Chen LL, Trent J, Patel SR, Raymond K, Feig BW. Surgical resection of gastrointestinal stromal tumors after treatment with imatinib. Ann Surg Oncol 14(1):14-24, 2007. PMID: 17072676.
426. Feng W, Shen L, Wen S, Rosen DG, Jelinek J, Hu X, Huan S, Huang M, Liu J, Sahin AA, Hunt KK, Bast RC, Shen Y, Issa JP, Yu Y. Correlation between CpG methylation profiles and hormone receptor status in breast cancers. Breast Cancer Res 9(4):R57, 2007. PMID: 17764565.
427. Jeruss JS, Hunt KK, Xing Y, Krishnamurthy S, Meric-Bernstam F, Cantor SB, Ross MI, Cormier JN. Is intraoperative touch imprint cytology of sentinel lymph nodes in patients with breast cancer cost effective?. Cancer 107(10):2328-36, 2006. PMID: 17039501.
428. Oh JL, Dryden MJ, Woodward WA, Yu TK, Tereffe W, Strom EA, Perkins GH, Middleton L, Hunt KK, Giordano SH, Oswald MJ, Domain D, Buchholz TA. Locoregional control of clinically diagnosed multifocal or multicentric breast cancer after neoadjuvant chemotherapy and locoregional therapy. J Clin Oncol 24(31):4971-5, 2006. PMID: 17075114.
429. Lu J, Wei Q, Bondy ML, Li D, Brewster A, Shete S, Yu TK, Sahin A, Meric-Bernstam F, Hunt KK, Singletary SE, Ross MI, Wang LE. Polymorphisms and haplotypes of the NBS1 gene are associated with risk of sporadic breast cancer in non-Hispanic white women
430. Peintinger F, Kuerer HM, Anderson K, Boughey JC, Meric-Bernstam F, Singletary SE, Hunt KK, Whitman GJ, Stephens T, Buzdar AU, Green MC, Symmans WF. Accuracy of the combination of mammography and sonography in predicting tumor response in breast cancer patients after neoadjuvant chemotherapy. Ann Surg Oncol 13(11):1443-9, 2006. e-Pub 2006. PMID: 17028770.
431. Huo L, Sneige N, Hunt KK, Albarracin CT, Lopez A, Resetkova E. Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ. Cancer 107(8):1760-8, 2006. PMID: 16977650.
432. Trent JC, Ramdas L, Dupart J, Hunt K, Macapinlac H, Taylor E, Hu L, Salvado A, Abbruzzese JL, Pollock R, Benjamin RS, Zhang W. Early effects of imatinib mesylate on the expression of insulin-like growth factor binding protein-3 and positron emission tomography in patients with gastrointestinal stromal tumor. Cancer 107(8):1898-908, 2006. PMID: 16986125.
433. Rouzier R, Pusztai L, Garbay JR, Delaloge S, Hunt KK, Hortobagyi GN, Berry D, Kuerer HM. Development and validation of nomograms for predicting residual tumor size and the probability of successful conservative surgery with neoadjuvant chemotherapy for breast cancer. Cancer 107(7):1459-66, 2006. PMID: 16948128.
434. Huang EH, Strom EA, Perkins GH, Oh JL, Chen AM, Meric-Bernstam F, Hunt KK, Sahin AA, Hortobagyi GN, Buchholz TA. Comparison of risk of local-regional recurrence after mastectomy or breast conservation therapy for patients treated with neoadjuvant chemotherapy and radiation stratified according to a prognostic index score. Int J Radiat Oncol Biol Phys 66(2):352-7, 2006. e-Pub 2006. PMID: 16887286.
435. Boughey JC, Khakpour N, Meric-Bernstam F, Ross MI, Kuerer HM, Singletary SE, Babiera GV, Arun B, Hunt KK, Bedrosian I. Selective use of sentinel lymph node surgery during prophylactic mastectomy. Cancer 107(7):1440-7, 2006. PMID: 16955504.
436. Bocangel D, Zheng M, Mhashilkar A, Liu Y, Ramesh R, Hunt KK, Chada S. Combinatorial synergy induced by adenoviral-mediated mda-7 and Herceptin in Her-2+ breast cancer cells. Cancer Gene Ther 13(10):958-68, 2006. e-Pub 2006. PMID: 16783343.
437. Vo TN, Meric-Bernstam F, Yi M, Buchholz TA, Ames FC, Kuerer HM, Bedrosian I, Hunt KK. Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma. Am J Surg 192(4):552-5, 2006. PMID: 16978974.
438. Kronowitz SJ, Kuerer HM, Hunt KK, Ross MI, Massey PR, Ensor JE, Robb GL. Impact of sentinel lymph node biopsy on the evolution of breast reconstruction. Plast Reconstr Surg 118(5):1089-99, 2006. PMID: 17016172.
439. Rosenkranz KM, Bedrosian I, Feng L, Hunt KK, Hartman K, Lucci A, Meric-Bernstam F, Kuerer HM, Singletary ES, Hwang R, Feig B, Ross M, Ames F, Babiera GV. Breast cancer in the very elderly: treatment patterns and complications in a tertiary cancer center. Am J Surg 192(4):541-4, 2006. PMID: 16978971.
440. Boughey JC, Bedrosian I, Meric-Bernstam F, Ross MI, Kuerer HM, Akins JS, Giordano SH, Babiera GV, Ames FC, Hunt KK. Comparative analysis of sentinel lymph node operation in male and female breast cancer patients. J Am Coll Surg 203(4):475-80, 2006. e-Pub 2006. PMID: 17000390.
441. Peintinger F, Symmans WF, Gonzalez-Angulo AM, Boughey JC, Buzdar AU, Yu TK, Hunt KK, Singletary SE, Babiera GV, Lucci A, Meric-Bernstam F, Kuerer HM. The safety of breast-conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapy. Cancer 107(6):1248-1254, 2006. PMID: 16862596.
442. Tseng JF, Ballo MT, Langstein HN, Wayne JD, Cormier JN, Hunt KK, Feig BW, Yasko AW, Lewis VO, Lin PP, Cannon CP, Zagars GK, Pollock RE, Pisters PW. The effect of preoperative radiotherapy and reconstructive surgery on wound complications after resection of extremity soft-tissue sarcomas. Ann Surg Oncol 13(9):1209-15, 2006. e-Pub 2006. PMID: 16952046.
443. Boughey JC, Peintinger F, Meric-Bernstam F, Perry AC, Hunt KK, Babiera GV, Singletary SE, Bedrosian I, Lucci A, Buzdar AU, Pusztai L, Kuerer HM. Impact of preoperative versus postoperative chemotherapy on the extent and number of surgical procedures in patients treated in randomized clinical trials for breast cancer. Ann Surg 244(3):464-70, 2006. PMID: 16926572.
444. Boughey JC, Ross MI, Babiera GV, Bedrosian I, Feig BW, Hwang RF, Kuerer HM, Hunt KK. Sentinel lymph node surgery in locally recurrent breast cancer. Clin Breast Cancer 7(3):248-53, 2006. PMID: 16942642.
445. Pataer A, Fanale MA, Roth JA, Swisher SG, Hunt KK. Induction of apoptosis in human lung cancer cells following treatment with amifostine and an adenoviral vector containing wild-type p53. Cancer Gene Ther 13(8):806-14, 2006. e-Pub 2006. PMID: 16628227.
446. Kawase K, Gayed IW, Hunt KK, Kuerer HM, Akins J, Yi M, Grimes L, Babiera GV, Ross MI, Feig BW, Ames FC, Singletary SE, Buchholz TA, Symmans WF, Meric-Bernstam F. Use of lymphoscintigraphy defines lymphatic drainage patterns before sentinel lymph node biopsy for breast cancer. J Am Coll Surg 203(1):64-72, 2006. e-Pub 2006. PMID: 16798488.
447. Babiera GV, Rao R, Feng L, Meric-Bernstam F, Kuerer HM, Singletary SE, Hunt KK, Ross MI, Gwyn KM, Feig BW, Ames FC, Hortobagyi GN. Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor. Ann Surg Oncol 13(6):776-82, 2006. e-Pub 2006. PMID: 16614878.
448. Xing Y, Foy M, Cox DD, Kuerer HM, Hunt KK, Cormier JN. Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer. Br J Surg 93(5):539-46, 2006. PMID: 16329089.
449. Khakpour N, Zager JS, Yen T, Stephens T, Kuerer HM, Singletary ES, Ross MI, Hunt KK, Babiera GV. The role of ultrasound in the surgical management of patients diagnosed with ductal carcinoma in situ of the breast. Breast J 12(3):212-5, 2006. PMID: 16684318.
450. Chada S, Mhashilkar AM, Liu Y, Nishikawa T, Bocangel D, Zheng M, Vorburger SA, Pataer A, Swisher SG, Ramesh R, Kawase K, Meyn RE, Hunt KK. mda-7 gene transfer sensitizes breast carcinoma cells to chemotherapy, biologic therapies and radiotherapy: correlation with expression of bcl-2 family members. Cancer Gene Ther 13(5):490-502, 2006. PMID: 16282987.
451. Pawlik TM, Pisters PW, Mikula L, Feig BW, Hunt KK, Cormier JN, Ballo MT, Catton CN, Jones JJ, O'Sullivan B, Pollock RE, Swallow CJ. Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate- or high-grade retroperitoneal soft tissue sarcoma. Ann Surg Oncol 13(4):508-17, 2006. e-Pub 2006. PMID: 16491338.
452. Wilke LG, McCall LM, Posther KE, Whitworth PW, Reintgen DS, Leitch AM, Gabram SG, Lucci A, Cox CE, Hunt KK, Herndon JE, Giuliano AE. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol 13(4):491-500, 2006. e-Pub 2006. PMID: 16514477.
453. Nykter M, Hunt KK, Pollock RE, El-Naggar AK, Taylor E, Shmulevich I, Yli-Harja O, Zhang W. Unsupervised analysis uncovers changes in histopathologic diagnosis in supervised genomic studies. Technol Cancer Res Treat 5(2):177-82, 2006. PMID: 16551137.
454. Pawlik TM, Hawke DH, Liu Y, Krishnamurthy S, Fritsche H, Hunt KK, Kuerer HM. Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein. BMC Cancer 6:68, 2006. e-Pub 2006. PMID: 16542425.
455. Lambert LA, Ayers GD, Hwang RF, Hunt KK, Ross MI, Kuerer HM, Singletary SE, Babiera GV, Ames FC, Feig B, Lucci A, Krishnamurthy S, Meric-Bernstam F. Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy. Ann Surg Oncol 13(3):310-20, 2006. e-Pub 2006. PMID: 16463073.
456. Chagpar AB, Middleton LP, Sahin AA, Dempsey P, Buzdar AU, Mirza AN, Ames FC, Babiera GV, Feig BW, Hunt KK, Kuerer HM, Meric-Bernstam F, Ross MI, Singletary SE. Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy. Ann Surg 243(2):257-64, 2006. PMID: 16432360.
457. Bedrosian I, Giacco G, Pederson L, Rodriguez-Bigas MA, Feig B, Hunt KK, Ellis L, Curley SA, Vauthey JN, Delclos M, Crane CH, Janjan N, Skibber JM. Outcome after curative resection for locally recurrent rectal cancer. Dis Colon Rectum 49(2):175-82, 2006. PMID: 16392024.
458. Lu Z, Luo RZ, Peng H, Huang M, Nishmoto A, Hunt KK, Helin K, Liao WS, Yu Y. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer. Oncogene 25(2):230-9, 2006. PMID: 16158053.
459. Adepoju LJ, Symmans WF, Babiera GV, Singletary SE, Arun B, Sneige N, Pusztai L, Buchholz TA, Sahin A, Hunt KK, Meric-Bernstam F, Ross MI, Ames FC, Kuerer HM. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy. Cancer 106(1):42-50, 2006. PMID: 16333852.
460. Andtbacka RH, Babiera G, Singletary SE, Hunt KK, Meric-Bernstam F, Feig BW, Ames FC, Ross MI, Dejesus Y, Kuerer HM. Incidence and prevention of venous thromboembolism in patients undergoing breast cancer surgery and treated according to clinical pathways. Ann Surg 243(1):96-101, 2006. PMID: 16371742.
461. Kronowitz SJ, Feledy JA, Hunt KK, Kuerer HM, Youssef A, Koutz CA, Robb GL. Determining the optimal approach to breast reconstruction after partial mastectomy. Plast Reconstr Surg 117(1):1-11; discussion 12-4, 2006. PMID: 16404237.
462. Rivers AK, Griffith KA, Hunt KK, Degnim AC, Sabel MS, Diehl KM, Cimmino VM, Chang AE, Lucas PC, Newman LA. Clinicopathologic features associated with having four or more metastatic axillary nodes in breast cancer patients with a positive sentinel lymph node. Ann Surg Oncol 13(1):36-44, 2006. e-Pub 2006. PMID: 16378156.
463. Vorburger SA, Xing Y, Hunt KK, Lakin GE, Benjamin RS, Feig BW, Pisters PW, Ballo MT, Chen L, Trent J, Burgess M, Patel S, Pollock RE, Cormier JN. Angiosarcoma of the breast. Cancer 104(12):2682-8, 2005. PMID: 16288486.
464. Davis WG, Hennessy B, Babiera G, Hunt K, Valero V, Buchholz TA, Sneige N, Gilcrease MZ. Metaplastic sarcomatoid carcinoma of the breast with absent or minimal overt invasive carcinomatous component: a misnomer. Am J Surg Pathol 29(11):1456-63, 2005. PMID: 16224212.
465. Vorburger SA, Hetrakul N, Xia W, Wilson-Heiner M, Mirza N, Pollock RE, Feig B, Swisher SG, Hunt KK. Gene therapy with E2F-1 up-regulates the protein kinase PKR and inhibits growth of leiomyosarcoma in vivo. Mol Cancer Ther 4(11):1710-6, 2005. PMID: 16275992.
466. Ku G, Fornage BD, Jin X, Xu M, Hunt KK, Wang LV. Thermoacoustic and photoacoustic tomography of thick biological tissues toward breast imaging. Technol Cancer Res Treat 4(5):559-66, 2005. PMID: 16173826.
467. Leitch AM, Beitsch PD, McCall LM, Posther K, Newman LA, Herndon JE, Hunt KK, Giuliano AE. Patterns of participation and successful patient recruitment to American College of Surgeons Oncology Group Z0010, a phase II trial for patients with early-stage breast cancer. Am J Surg 190(4):539-42, 2005. PMID: 16164916.
468. Posther KE, McCall LM, Blumencranz PW, Burak WE, Beitsch PD, Hansen NM, Morrow M, Wilke LG, Herndon JE, Hunt KK, Giuliano AE. Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancer. Ann Surg 242(4):593-9; discussion 599-602, 2005. PMID: 16192820.
469. Schechter NR, Strom EA, Perkins GH, Arzu I, McNeese MD, Langstein HN, Kronowitz SJ, Meric-Bernstam F, Babiera G, Hunt KK, Hortobagyi GN, Buchholz TA. Immediate breast reconstruction can impact postmastectomy irradiation. Am J Clin Oncol 28(5):485-94, 2005. PMID: 16199989.
470. Khakpour N, Hunt KK, Kuerer HM, Yi M, Meric-Bernstam F, Ross MI, Lucci A. Sentinel lymph node dissection provides axillary control equal to complete axillary node dissection in breast cancer patients with lobular histology and a negative sentinel node. Am J Surg 190(4):598-601, 2005. PMID: 16164930.
471. Al-Refaie W, Kuerer HM, Khuwaja A, Perry A, Hunt KK, Feig B, Ames F, Ross M, Singletary SE, Meric-Bernstam F, Babiera GV. Determinants of mastectomy in breast conservation therapy candidates. Am J Surg 190(4):602-5, 2005. PMID: 16164931.
472. Green MC, Buzdar AU, Smith T, Ibrahim NK, Valero V, Rosales MF, Cristofanilli M, Booser DJ, Pusztai L, Rivera E, Theriault RL, Carter C, Frye D, Hunt KK, Symmans WF, Strom EA, Sahin AA, Sikov W, Hortobagyi GN. Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks. J Clin Oncol 23(25):5983-92, 2005. e-Pub 2005. PMID: 16087943.
473. Nguyen KH, Hachem P, Khor LY, Salem N, Hunt KK, Calkins PR, Pollack A. Adenoviral-E2F-1 radiosensitizes p53wild-type and p53null human prostate cancer cells. Int J Radiat Oncol Biol Phys 63(1):238-46, 2005. PMID: 15993550.
474. Suh YJ, Chada S, McKenzie T, Liu Y, Swisher SG, Lucci A, Hunt KK. Synergistic tumoricidal effect between celecoxib and adenoviral-mediated delivery of mda-7 in human breast cancer cells. Surgery 138(3):422-30, 2005. PMID: 16213894.
475. Raut CP, Hunt KK, Akins JS, Daley MD, Ross MI, Singletary SE, Marshall GD, Meric-Bernstam F, Babiera G, Feig BW, Ames FC, Kuerer HM. Incidence of anaphylactoid reactions to isosulfan blue dye during breast carcinoma lymphatic mapping in patients treated with preoperative prophylaxis: results of a surgical prospective clinical practice protocol. Cancer 104(4):692-9, 2005. PMID: 15981283.
476. Shen J, Hunt KK, Mirza NQ, Buchholz TA, Babiera GV, Kuerer HM, Bedrosian I, Ross MI, Ames FC, Feig BW, Singletary SE, Cristofanilli M, Meric-Bernstam F. Predictors of systemic recurrence and disease-specific survival after ipsilateral breast tumor recurrence. Cancer 104(3):479-90, 2005. PMID: 15968686.
477. von Holzen U, Bocangel D, Pataer A, Vorburger SA, Liu Y, Lu X, Hunt KK, Swisher SG. Role for the double-stranded RNA-activated protein kinase PKR in Ad-TNF-alpha gene therapy in esophageal cancer. Surgery 138(2):261-8, 2005. PMID: 16153435.
478. Cabioglu N, Hunt KK, Buchholz TA, Mirza N, Singletary SE, Kuerer HM, Babiera GV, Ames FC, Sahin AA, Meric-Bernstam F. Improving local control with breast-conserving therapy: a 27-year single-institution experience. Cancer 104(1):20-9, 2005. PMID: 15912514.
479. Buzdar AU, Ibrahim NK, Francis D, Booser DJ, Thomas ES, Theriault RL, Pusztai L, Green MC, Arun BK, Giordano SH, Cristofanilli M, Frye DK, Smith TL, Hunt KK, Singletary SE, Sahin AA, Ewer MS, Buchholz TA, Berry D, Hortobagyi GN. Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer. J Clin Oncol 23(16):3676-85, 2005. e-Pub 2005. PMID: 15738535.
480. Huang EH, Tucker SL, Strom EA, McNeese MD, Kuerer HM, Hortobagyi GN, Buzdar AU, Valero V, Perkins GH, Schechter NR, Hunt KK, Sahin AA, Buchholz TA. Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy. Int J Radiat Oncol Biol Phys 62(2):351-7, 2005. PMID: 15890574.
481. Kawase K, Dimaio DJ, Tucker SL, Buchholz TA, Ross MI, Feig BW, Kuerer HM, Meric-Bernstam F, Babiera G, Ames FC, Singletary SE, Hunt KK. Paget's disease of the breast: there is a role for breast-conserving therapy. Ann Surg Oncol 12(5):391-7, 2005. e-Pub 2005. PMID: 15915373.
482. Swisher SG, Hofstetter W, Wu TT, Correa AM, Ajani JA, Komaki RR, Chirieac L, Hunt KK, Liao Z, Phan A, Rice DC, Vaporciyan AA, Walsh GL, Roth JA. Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT). Ann Surg 241(5):810-7; discussion 817-20, 2005. PMID: 15849517.
483. Pataer A, Vorburger SA, Chada S, Balachandran S, Barber GN, Roth JA, Hunt KK, Swisher SG. Melanoma differentiation-associated gene-7 protein physically associates with the double-stranded RNA-activated protein kinase PKR. Mol Ther 11(5):717-23, 2005. PMID: 15851010.
484. Shahar KH, Buchholz TA, Delpassand E, Sahin AA, Ross MI, Ames FC, Kuerer HM, Feig BW, Meric-Bernstam F, Babiera GV, Singletary SE, Akins JS, Mirza NQ, Hunt KK. Lower and central tumor location correlates with lymphoscintigraphy drainage to the internal mammary lymph nodes in breast carcinoma. Cancer 103(7):1323-9, 2005. PMID: 15726547.
485. Yen TW, Hunt KK, Ross MI, Mirza NQ, Babiera GV, Meric-Bernstam F, Singletary SE, Symmans WF, Giordano SH, Feig BW, Ames FC, Kuerer HM. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg 200(4):516-26, 2005. PMID: 15804465.
486. Chen AM, Meric-Bernstam F, Hunt KK, Thames HD, Outlaw ED, Strom EA, McNeese MD, Kuerer HM, Ross MI, Singletary SE, Ames FC, Feig BW, Sahin AA, Perkins GH, Babiera G, Hortobagyi GN, Buchholz TA. Breast conservation after neoadjuvant chemotherapy. Cancer 103(4):689-95, 2005. PMID: 15641036.
487. Babiera GV, Delpassand ES, Breslin TM, Ross MI, Ames FC, Singletary SE, Kuerer HM, Feig BW, Meric-Bernstam F, Hunt KK. Lymphatic drainage patterns on early versus delayed breast lymphoscintigraphy performed after injection of filtered Tc-99m sulfur colloid in breast cancer patients undergoing sentinel lymph node biopsy. Clin Nucl Med 30(1):11-5, 2005. PMID: 15604959.
488. Pawlik TM, Fritsche H, Coombes KR, Xiao L, Krishnamurthy S, Hunt KK, Pusztai L, Chen JN, Clarke CH, Arun B, Hung MC, Kuerer HM. Significant differences in nipple aspirate fluid protein expression between healthy women and those with breast cancer demonstrated by time-of-flight mass spectrometry. Breast Cancer Res Treat 89(2):149-57, 2005. PMID: 15692757.
489. Huang EH, Tucker SL, Strom EA, McNeese MD, Kuerer HM, Buzdar AU, Valero V, Perkins GH, Schechter NR, Hunt KK, Sahin AA, Hortobagyi GN, Buchholz TA. Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy. J Clin Oncol 22(23):4691-9, 2004. PMID: 15570071.
490. Goldflam K, Hunt KK, Gershenwald JE, Singletary SE, Mirza N, Kuerer HM, Babiera GV, Ames FC, Ross MI, Feig BW, Sahin AA, Arun B, Meric-Bernstam F. Contralateral prophylactic mastectomy. Predictors of significant histologic findings. Cancer 101(9):1977-86, 2004. PMID: 15389473.
491. Berman RS, Feig BW, Hunt KK, Mansfield PF, Pollock RE. Platelet kinetics and decreased transfusion requirements after splenectomy for hematologic malignancy. Ann Surg 240(5):852-7, 2004. PMID: 15492568.
492. Kuerer HM, Coombes KR, Chen JN, Xiao L, Clarke C, Fritsche H, Krishnamurthy S, Marcy S, Hung MC, Hunt KK. Association between ductal fluid proteomic expression profiles and the presence of lymph node metastases in women with breast cancer. Surgery 136(5):1061-9, 2004. PMID: 15523402.
493. Krishnamurthy S, Zhao L, Hayes K, Glassman AB, Cristofanilli M, Singletary SE, Hunt KK, Kuerer HM, Sneige N. Feasibility and utility of using chromosomal aneusomy to further define the cytologic categories in nipple aspirate fluid specimens: a preliminary study. Cancer 102(5):322-7, 2004. PMID: 15376199.
494. Tseng JF, Kronowitz SJ, Sun CC, Perry AC, Hunt KK, Babiera GV, Newman LA, Singletary SE, Mirza NQ, Ames FC, Meric-Bernstam F, Ross MI, Feig BW, Robb GL, Kuerer HM. The effect of ethnicity on immediate reconstruction rates after mastectomy for breast cancer. Cancer 101(7):1514-23, 2004. PMID: 15378473.
495. Newman LA, Hurd T, Leitch M, Kuerer HM, Diehl K, Lucci A, Giuliano A, Hunt KK, Putnam W, Wells SA. A report on accrual rates for elderly and minority-ethnicity cancer patients to clinical trials of the American College of Surgeons Oncology Group. J Am Coll Surg 199(4):644-51, 2004. PMID: 15454152.
496. Shen J, Hunt KK, Mirza NQ, Krishnamurthy S, Singletary SE, Kuerer HM, Meric-Bernstam F, Feig B, Ross MI, Ames FC, Babiera GV. Intramammary lymph node metastases are an independent predictor of poor outcome in patients with breast carcinoma. Cancer 101(6):1330-7, 2004. PMID: 15316905.
497. Chen LL, Trent JC, Wu EF, Fuller GN, Ramdas L, Zhang W, Raymond AK, Prieto VG, Oyedeji CO, Hunt KK, Pollock RE, Feig BW, Hayes KJ, Choi H, Macapinlac HA, Hittelman W, Velasco MA, Patel S, Burgess MA, Benjamin RS, Frazier ML. A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors. Cancer Res 64(17):5913-9, 2004. PMID: 15342366.
498. Shen J, Valero V, Buchholz TA, Singletary SE, Ames FC, Ross MI, Cristofanilli M, Babiera GV, Meric-Bernstam F, Feig B, Hunt KK, Kuerer HM. Effective local control and long-term survival in patients with T4 locally advanced breast cancer treated with breast conservation therapy. Ann Surg Oncol 11(9):854-60, 2004. e-Pub 2004. PMID: 15313733.
499. Pisters PW, Patel SR, Prieto VG, Thall PF, Lewis VO, Feig BW, Hunt KK, Yasko AW, Lin PP, Jacobson MG, Burgess MA, Pollock RE, Zagars GK, Benjamin RS, Ballo MT. Phase I trial of preoperative doxorubicin-based concurrent chemoradiation and surgical resection for localized extremity and body wall soft tissue sarcomas. J Clin Oncol 22(16):3375-80, 2004. PMID: 15310783.
500. Cabioglu N, Krishnamurthy S, Kuerer HM, Hunt KK, Singletary SE, Meric-Bernstam F, Ross MI, Feig BW, Ames FC, Babiera GV. Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge. Cancer 101(3):508-17, 2004. PMID: 15274063.
501. Buchholz TA, Huang EH, Berry D, Pusztai L, Strom EA, McNeese MD, Perkins GH, Schechter NR, Kuerer HM, Buzdar AU, Valero V, Hunt KK, Hortobagyi GN, Sahin AA. Her2/neu-positive disease does not increase risk of locoregional recurrence for patients treated with neoadjuvant doxorubicin-based chemotherapy, mastectomy, and radiotherapy. Int J Radiat Oncol Biol Phys 59(5):1337-42, 2004. PMID: 15275718.
502. McKenzie T, Liu Y, Fanale M, Swisher SG, Chada S, Hunt KK. Combination therapy of Ad-mda7 and trastuzumab increases cell death in Her-2/neu-overexpressing breast cancer cells. Surgery 136(2):437-42, 2004. PMID: 15300212.
503. Daley MD, Norman PH, Leak JA, Nguyen DT, Bui TP, Kowalski AM, Srejic U, Popat K, Arens JF, Gershenwald JE, Hunt KK, Kuerer HM. Adverse events associated with the intraoperative injection of isosulfan blue. J Clin Anesth 16(5):332-41, 2004. PMID: 15374553.
504. Shahar KH, Hunt KK, Thames HD, Ross MI, Perkins GH, Kuerer HM, Strom EA, McNeese MD, Meric F, Schechter NR, Sahin AA, Middleton LP, Buchholz TA. Factors predictive of having four or more positive axillary lymph nodes in patients with positive sentinel lymph nodes: implications for selection of radiation fields. Int J Radiat Oncol Biol Phys 59(4):1074-9, 2004. PMID: 15234041.
505. Chen AM, Meric-Bernstam F, Hunt KK, Thames HD, Oswald MJ, Outlaw ED, Strom EA, McNeese MD, Kuerer HM, Ross MI, Singletary SE, Ames FC, Feig BW, Sahin AA, Perkins GH, Schechter NR, Hortobagyi GN, Buchholz TA. Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience. J Clin Oncol 22(12):2303-12, 2004. PMID: 15197191.
506. Chagpar A, Evelegh M, Fritsche HA, Krishnamurthy S, Hunt KK, Kuerer HM. Prospective evaluation of a novel approach for the use of a quantitative galactose oxidase-Schiff reaction in ductal fluid samples from women with breast carcinoma. Cancer 100(12):2549-54, 2004. PMID: 15197795.
507. Ding Y, Wang L, Su LK, Frey JA, Shao R, Hunt KK, Yan DH. Antitumor activity of IFIX, a novel interferon-inducible HIN-200 gene, in breast cancer. Oncogene 23(26):4556-66, 2004. PMID: 15122330.
508. Patten LC, Berger DH, Rodriguez-Bigas M, Mansfield P, Delpassand E, Cleary KR, Fagan SP, Curley SA, Hunt KK, Feig BW. A prospective evaluation of radiocolloid and immunohistochemical staining in colon carcinoma lymphatic mapping. Cancer 100(10):2104-9, 2004. PMID: 15139051.
509. Garg AK, Strom EA, McNeese MD, Buzdar AU, Hortobagyi GN, Kuerer HM, Perkins GH, Singletary SE, Hunt KK, Sahin A, Schechter N, Valero V, Tucker SL, Buchholz TA. T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy. Int J Radiat Oncol Biol Phys 59(1):138-45, 2004. PMID: 15093909.
510. Kronowitz SJ, Hunt KK, Kuerer HM, Babiera G, McNeese MD, Buchholz TA, Strom EA, Robb GL. Delayed-immediate breast reconstruction. Plast Reconstr Surg 113(6):1617-28, 2004. PMID: 15114121.
511. Ballo MT, Zagars GK, Cormier JN, Hunt KK, Feig BW, Patel SR, Pisters PW. Interval between surgery and radiotherapy: effect on local control of soft tissue sarcoma. Int J Radiat Oncol Biol Phys 58(5):1461-7, 2004. PMID: 15050324.
512. Yang WT, Whitman GJ, Johnson MM, Bolanos-Clark M, Kushwaha AC, Hunt KK, Dempsey PJ. Needle localization for excisional biopsy of breast lesions: comparison of effect of use of full-field digital versus screen-film mammographic guidance on procedure time. Radiology 231(1):277-81, 2004. PMID: 15068954.
513. Yen TW, Hunt KK, Mirza NQ, Thomas ES, Singletary SE, Babiera GV, Meric-Bernstam F, Buchholz TA, Feig BW, Ross MI, Ames FC, Theriault RL, Kuerer HM. Physician recommendations regarding tamoxifen and patient utilization of tamoxifen after surgery for ductal carcinoma in situ. Cancer 100(5):942-9, 2004. PMID: 14983489.
514. Pawlik TM, Perry A, Strom EA, Babiera GV, Buchholz TA, Singletary E, Perkins GH, Ross MI, Schecter NR, Meric-Bernstam F, Ames FC, Hunt KK, Kuerer HM. Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma. Cancer 100(3):490-8, 2004. PMID: 14745864.
515. Raut CP, Daley MD, Hunt KK, Akins J, Ross MI, Singletary SE, Marshall GD, Meric-Bernstam F, Babiera G, Feig BW, Ames FC, Kuerer HM. Anaphylactoid reactions to isosulfan blue dye during breast cancer lymphatic mapping in patients given preoperative prophylaxis. J Clin Oncol 22(3):567-8, 2004. PMID: 14752082.
516. Chagpar A, Langstein HN, Kronowitz SJ, Singletary SE, Ross MI, Buchholz TA, Hunt KK, Kuerer HM. Treatment and outcome of patients with chest wall recurrence after mastectomy and breast reconstruction. Am J Surg 187(2):164-9, 2004. PMID: 14769300.
517. Bedrosian I, Rodriguez-Bigas MA, Feig B, Hunt KK, Ellis L, Curley SA, Vauthey JN, Delclos M, Crane C, Janjan N, Skibber JM. Predicting the node-negative mesorectum after preoperative chemoradiation for locally advanced rectal carcinoma. J Gastrointest Surg 8(1):56-62; discussion 62-3, 2004. PMID: 14746836.
518. Poindexter NJ, Sahin A, Hunt KK, Grimm EA. Analysis of dendritic cells in tumor-free and tumor-containing sentinel lymph nodes from patients with breast cancer. Breast Cancer Res 6(4):R408-15, 2004. e-Pub 2004. PMID: 15217509.
519. Scaife CL, Hunt KK, Patel SR, Benjamin RS, Burgess MA, Chen LL, Trent J, Raymond AK, Cormier JN, Pisters PW, Pollock RE, Feig BW. Is there a role for surgery in patients with "unresectable" cKIT+ gastrointestinal stromal tumors treated with imatinib mesylate?. Am J Surg 186(6):665-9, 2003. PMID: 14672776.
520. Bedrosian I, Bedi D, Kuerer HM, Fornage BD, Harker L, Ross MI, Ames FC, Krishnamurthy S, Edeiken-Monroe BS, Meric F, Feig BW, Akins J, Singletary SE, Mirza NQ, Hunt KK. Impact of clinicopathological factors on sensitivity of axillary ultrasonography in the detection of axillary nodal metastases in patients with breast cancer. Ann Surg Oncol 10(9):1025-30, 2003. PMID: 14597440.
521. Woodward WA, Strom EA, Tucker SL, Katz A, McNeese MD, Perkins GH, Buzdar AU, Hortobagyi GN, Hunt KK, Sahin A, Meric F, Sneige N, Buchholz TA. Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy: Implications for breast cancer patients with early-stage disease and predictors for recurrence after postmastectomy radiation. Int J Radiat Oncol Biol Phys 57(2):336-44, 2003. PMID: 12957243.
522. Chagpar A, Yen T, Sahin A, Hunt KK, Whitman GJ, Ames FC, Ross MI, Meric-Bernstam F, Babiera GV, Singletary SE, Kuerer HM. Intraoperative margin assessment reduces reexcision rates in patients with ductal carcinoma in situ treated with breast-conserving surgery. Am J Surg 186(4):371-7, 2003. PMID: 14553853.
523. Woodward WA, Strom EA, Tucker SL, McNeese MD, Perkins GH, Schechter NR, Singletary SE, Theriault RL, Hortobagyi GN, Hunt KK, Buchholz TA. Changes in the 2003 American Joint Committee on Cancer staging for breast cancer dramatically affect stage-specific survival. J Clin Oncol 21(17):3244-8, 2003. PMID: 12947058.
524. Chagpar A, Kuerer HM, Hunt KK, Strom EA, Buchholz TA. Outcome of treatment for breast cancer patients with chest wall recurrence according to initial stage: implications for post-mastectomy radiation therapy. Int J Radiat Oncol Biol Phys 57(1):128-35, 2003. PMID: 12909225.
525. Pisters PW, Ballo MT, Fenstermacher MJ, Feig BW, Hunt KK, Raymond KA, Burgess MA, Zagars GK, Pollock RE, Benjamin RS, Patel SR. Phase I trial of preoperative concurrent doxorubicin and radiation therapy, surgical resection, and intraoperative electron-beam radiation therapy for patients with localized retroperitoneal sarcoma. J Clin Oncol 21(16):3092-7, 2003. PMID: 12915599.
526. Mhashilkar AM, Stewart AL, Sieger K, Yang HY, Khimani AH, Ito I, Saito Y, Hunt KK, Grimm EA, Roth JA, Meyn RE, Ramesh R, Chada S. MDA-7 negatively regulates the beta-catenin and PI3K signaling pathways in breast and lung tumor cells. Mol Ther 8(2):207-19, 2003. PMID: 12907143.
527. Chagpar A, Meric-Bernstam F, Hunt KK, Ross MI, Cristofanilli M, Singletary SE, Buchholz TA, Ames FC, Marcy S, Babiera GV, Feig BW, Hortobagyi GN, Kuerer HM. Chest wall recurrence after mastectomy does not always portend a dismal outcome. Ann Surg Oncol 10(6):628-34, 2003. PMID: 12839847.
528. Pataer A, Chada S, Hunt KK, Roth JA, Swisher SG. Adenoviral melanoma differentiation-associated gene 7 induces apoptosis in lung cancer cells through mitochondrial permeability transition-independent cytochrome c release. J Thorac Cardiovasc Surg 125(6):1328-35, 2003. PMID: 12830052.
529. Krishnamurthy S, Sneige N, Thompson PA, Marcy SM, Singletary SE, Cristofanilli M, Hunt KK, Kuerer HM. Nipple aspirate fluid cytology in breast carcinoma. Cancer 99(2):97-104, 2003. PMID: 12704689.
530. Vorburger SA, Pataer A, Yoshida K, Liu Y, Lu X, Swisher SG, Hunt KK. The mitochondrial apoptosis-inducing factor plays a role in E2F-1-induced apoptosis in human colon cancer cells. Ann Surg Oncol 10(3):314-22, 2003. PMID: 12679318.
531. Hwang RF, Krishnamurthy S, Hunt KK, Mirza N, Ames FC, Feig B, Kuerer HM, Singletary SE, Babiera G, Meric F, Akins JS, Neely J, Ross MI. Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol 10(3):248-54, 2003. PMID: 12679309.
532. Yan DH, Abramian A, Li Z, Ding Y, Wen Y, Liu TJ, Hunt K. P202, an Interferon-inducible protein, inhibits E2F1-mediated apoptosis in prostate cancer cells. Biochem Biophys Res Commun 303(1):219-22, 2003. PMID: 12646190.
533. Diaz LK, Hunt K, Ames F, Meric F, Kuerer H, Babiera G, Ross M, Singletary E, Middleton LP, Symmans WF, Krishnamurthy S, Sahin A, Sneige N, Gilcrease MZ. Histologic localization of sentinel lymph node metastases in breast cancer. Am J Surg Pathol 27(3):385-9, 2003. PMID: 12604895.
534. Cabioglu N, Hunt KK, Singletary SE, Stephens TW, Marcy S, Meric F, Ross MI, Babiera GV, Ames FC, Kuerer HM. Surgical decision making and factors determining a diagnosis of breast carcinoma in women presenting with nipple discharge. J Am Coll Surg 196(3):354-64, 2003. PMID: 12648684.
535. Meric F, Mirza NQ, Vlastos G, Buchholz TA, Kuerer HM, Babiera GV, Singletary SE, Ross MI, Ames FC, Feig BW, Krishnamurthy S, Perkins GH, McNeese MD, Strom EA, Valero V, Hunt KK. Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy. Cancer 97(4):926-33, 2003. PMID: 12569592.
536. Kuerer HM, Thompson PA, Krishnamurthy S, Fritsche HA, Marcy SM, Babiera GV, Singletary SE, Cristofanilli M, Sneige N, Hunt KK. High and differential expression of HER-2/neu extracellular domain in bilateral ductal fluids from women with unilateral invasive breast cancer. Clin Cancer Res 9(2):601-5, 2003. PMID: 12576424.
537. Albo D, Ames FC, Hunt KK, Ross MI, Singletary SE, Kuerer HM. Evaluation of lymph node status in male breast cancer patients: a role for sentinel lymph node biopsy. Breast Cancer Res Treat 77(1):9-14, 2003. PMID: 12602900.
538. Le DT, Deavers M, Hunt K, Malpica A, Verschraegen CF. Cisplatin and irinotecan (CPT-11) for peritoneal mesothelioma. Cancer Invest 21(5):682-9, 2003. PMID: 14628425.
539. Kuerer HM, Goldknopf IL, Fritsche H, Krishnamurthy S, Sheta EA, Hunt KK. Identification of distinct protein expression patterns in bilateral matched pair breast ductal fluid specimens from women with unilateral invasive breast carcinoma. High-throughput biomarker discovery. Cancer 95(11):2276-82, 2002. PMID: 12436432.
540. Huang E, Buchholz TA, Meric F, Krishnamurthy S, Mirza NQ, Ames FC, Feig BW, Kuerer HM, Ross MI, Singletary SE, McNeese MD, Strom EA, Hunt KK. Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences. Cancer 95(10):2059-67, 2002. PMID: 12412158.
541. Lin T, Huang X, Gu J, Zhang L, Roth JA, Xiong M, Curley SA, Yu Y, Hunt KK, Fang B. Long-term tumor-free survival from treatment with the GFP-TRAIL fusion gene expressed from the hTERT promoter in breast cancer cells. Oncogene 21(52):8020-8, 2002. PMID: 12439752.
542. Jhingran A, Kim JS, Buchholz TA, Katz A, Strom EA, Hunt KK, Sneige N, McNeese MD. Age as a predictor of outcome for women with DCIS treated with breast-conserving surgery and radiation: The University of Texas M. D. Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys 54(3):804-9, 2002. PMID: 12377332.
543. Vlastos G, Mirza NQ, Meric F, Hunt KK, Mirza AN, Newman LA, Ames FC, Kuerer HM, Ross MI, Feig B, Babiera G, Buchholz TA, Hortobagyi GN, Singletary SE. Breast-conservation therapy in early-stage breast cancer patients with a positive family history. Ann Surg Oncol 9(9):912-9, 2002. PMID: 12417515.
544. Krishnamurthy S, Sneige N, Ordóñez NG, Hunt KK, Kuerer HM. Characterization of foam cells in nipple aspirate fluid. Diagn Cytopathol 27(5):261-4; discussion 265, 2002. PMID: 12411988.
545. Solorzano CC, Middleton LP, Hunt KK, Mirza N, Meric F, Kuerer HM, Ross MI, Ames FC, Feig BW, Pollock RE, Singletary SE, Babiera G. Treatment and outcome of patients with intracystic papillary carcinoma of the breast. Am J Surg 184(4):364-8, 2002. PMID: 12383904.
546. Vorburger SA, Pataer A, Yoshida K, Barber GN, Xia W, Chiao P, Ellis LM, Hung MC, Swisher SG, Hunt KK. Role for the double-stranded RNA activated protein kinase PKR in E2F-1-induced apoptosis. Oncogene 21(41):6278-88, 2002. PMID: 12214268.
547. Meric F, Hess KR, Varma DG, Hunt KK, Pisters PW, Milas KM, Patel SR, Benjamin RS, Plager C, Papadopoulos NE, Burgess MA, Pollock RE, Feig BW. Radiographic response to neoadjuvant chemotherapy is a predictor of local control and survival in soft tissue sarcomas. Cancer 95(5):1120-6, 2002. PMID: 12209699.
548. Krishnamurthy S, Sneige N, Bedi DG, Edieken BS, Fornage BD, Kuerer HM, Singletary SE, Hunt KK. Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma. Cancer 95(5):982-8, 2002. PMID: 12209680.
549. Lee A, Krishnamurthy S, Sahin A, Symmans WF, Hunt K, Sneige N. Intraoperative touch imprint of sentinel lymph nodes in breast carcinoma patients. Cancer 96(4):225-31, 2002. PMID: 12209664.
550. Huang E, McNeese MD, Strom EA, Perkins GH, Katz A, Hortobagyi GN, Valero V, Kuerer HM, Singletary SE, Hunt KK, Buzdar AU, Buchholz TA. Locoregional treatment outcomes for inoperable anthracycline-resistant breast cancer. Int J Radiat Oncol Biol Phys 53(5):1225-33, 2002. PMID: 12128124.
551. Buchholz TA, Katz A, Strom EA, McNeese MD, Perkins GH, Hortobagyi GN, Thames HD, Kuerer HM, Singletary SE, Sahin AA, Hunt KK, Buzdar AU, Valero V, Sneige N, Tucker SL. Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy. Int J Radiat Oncol Biol Phys 53(4):880-8, 2002. PMID: 12095553.
552. Meric F, Buchholz TA, Mirza NQ, Vlastos G, Ames FC, Ross MI, Pollock RE, Singletary SE, Feig BW, Kuerer HM, Newman LA, Perkins GH, Strom EA, McNeese MD, Hortobagyi GN, Hunt KK. Long-term complications associated with breast-conservation surgery and radiotherapy. Ann Surg Oncol 9(6):543-9, 2002. PMID: 12095969.
553. Bilimoria MM, Holtz DJ, Mirza NQ, Feig BW, Pisters PW, Patel S, Pollock RE, Benjamin RS, Papadopoulos NE, Plager C, Murphy A, Griffin JR, Burgess MA, Hunt KK. Tumor volume as a prognostic factor for sarcomatosis. Cancer 94(9):2441-6, 2002. PMID: 12015769.
554. Kronowitz SJ, Chang DW, Robb GL, Hunt KK, Ames FC, Ross MI, Singletary SE, Symmans WF, Kroll SS, Kuerer HM. Implications of axillary sentinel lymph node biopsy in immediate autologous breast reconstruction. Plast Reconstr Surg 109(6):1888-96, 2002. PMID: 11994589.
555. Kuerer HM, Peoples GE, Sahin AA, Murray JL, Singletary SE, Castilleja A, Hunt KK, Gershenson DM, Ioannides CG. Axillary lymph node cellular immune response to HER-2/neu peptides in patients with carcinoma of the breast. J Interferon Cytokine Res 22(5):583-92, 2002. PMID: 12060497.
556. Buzdar AU, Singletary SE, Valero V, Booser DJ, Ibrahim NK, Rahman Z, Theriault RL, Walters R, Rivera E, Smith TL, Holmes FA, Hoy E, Frye DK, Manuel N, Kau SW, McNeese MD, Strom E, Thomas E, Hunt K, Ames F, Berry D, Hortobagyi GN. Evaluation of paclitaxel in adjuvant chemotherapy for patients with operable breast cancer: preliminary data of a prospective randomized trial. Clin Cancer Res 8(5):1073-9, 2002. PMID: 12006521.
557. Pataer A, Vorburger SA, Barber GN, Chada S, Mhashilkar AM, Zou-Yang H, Stewart AL, Balachandran S, Roth JA, Hunt KK, Swisher SG. Adenoviral transfer of the melanoma differentiation-associated gene 7 (mda7) induces apoptosis of lung cancer cells via up-regulation of the double-stranded RNA-dependent protein kinase (PKR). Cancer Res 62(8):2239-43, 2002. PMID: 11956076.
558. Shmulevich I, Hunt K, El-Naggar A, Taylor E, Ramdas L, Labordé P, Hess KR, Pollock R, Zhang W. Tumor specific gene expression profiles in human leiomyosarcoma: an evaluation of intratumor heterogeneity. Cancer 94(7):2069-75, 2002. PMID: 11932911.
559. Newman LA, Buzdar AU, Singletary SE, Kuerer HM, Buchholz T, Ames FC, Ross MI, Hunt KK. A prospective trial of preoperative chemotherapy in resectable breast cancer: predictors of breast-conservation therapy feasibility. Ann Surg Oncol 9(3):228-34, 2002. PMID: 11923128.
560. Mirza NQ, Vlastos G, Meric F, Buchholz TA, Esnaola N, Singletary SE, Kuerer HM, Newman LA, Ames FC, Ross MI, Feig BW, Pollock RE, McNeese M, Strom E, Hunt KK. Predictors of locoregional recurrence among patients with early-stage breast cancer treated with breast-conserving therapy. Ann Surg Oncol 9(3):256-65, 2002. PMID: 11923132.
561. Meric F, Bernstam EV, Mirza NQ, Hunt KK, Ames FC, Ross MI, Kuerer HM, Pollock RE, Musen MA, Singletary SE. Breast cancer on the World Wide Web: cross sectional survey of quality of information and popularity of websites. BMJ 324(7337):577-81, 2002. PMID: 11884322.
562. Yared MA, Middleton LP, Smith TL, Kim HW, Ross MI, Hunt KK, Sahin AA. Recommendations for sentinel lymph node processing in breast cancer. Am J Surg Pathol 26(3):377-82, 2002. PMID: 11859211.
563. Ahmad SA, Patel SR, Ballo MT, Baker TP, Yasko AW, Wang X, Feig BW, Hunt KK, Lin PP, Weber KL, Chen LL, Zagars GK, Pollock RE, Benjamin RS, Pisters PW. Extraosseous osteosarcoma: response to treatment and long-term outcome. J Clin Oncol 20(2):521-7, 2002. PMID: 11786582.
564. Buchholz TA, Tucker SL, Masullo L, Kuerer HM, Erwin J, Salas J, Frye D, Strom EA, McNeese MD, Perkins G, Katz A, Singletary SE, Hunt KK, Buzdar AU, Hortobagyi GN. Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation. J Clin Oncol 20(1):17-23, 2002. PMID: 11773149.
565. Porter GA, Cantor SB, Ahmad SA, Lenert JT, Ballo MT, Hunt KK, Feig BW, Patel SR, Benjamin RS, Pollock RE, Pisters PW. Cost-effectiveness of staging computed tomography of the chest in patients with T2 soft tissue sarcomas. Cancer 94(1):197-204, 2002. PMID: 11815977.
566. Feig BW, Curley S, Lucci A, Hunt KK, Vauthey JN, Mansfield PF, Cleary K, Hamilton S, Ellis V, Brame M, Berger DH. A caution regarding lymphatic mapping in patients with colon cancer. Am J Surg 182(6):707-12, 2001. PMID: 11839343.
567. Solorzano CC, Ross MI, Delpassand E, Mirza N, Akins JS, Kuerer HM, Meric F, Ames FC, Newman L, Feig B, Singletary SE, Hunt KK. Utility of breast sentinel lymph node biopsy using day-before-surgery injection of high-dose 99mTc-labeled sulfur colloid. Ann Surg Oncol 8(10):821-7, 2001. PMID: 11776497.
568. Kuerer HM, Singletary SE, Buzdar AU, Ames FC, Valero V, Buchholz TA, Ross MI, Pusztai L, Hortobagyi GN, Hunt KK. Surgical conservation planning after neoadjuvant chemotherapy for stage II and operable stage III breast carcinoma. Am J Surg 182(6):601-8, 2001. PMID: 11839324.
569. Schlembach PJ, Buchholz TA, Ross MI, Kirsner SM, Salas GJ, Strom EA, McNeese MD, Perkins GH, Hunt KK. Relationship of sentinel and axillary level I-II lymph nodes to tangential fields used in breast irradiation. Int J Radiat Oncol Biol Phys 51(3):671-8, 2001. PMID: 11597808.
570. Cristofanilli M, Buzdar AU, Sneige N, Smith T, Wasaff B, Ibrahim N, Booser D, Rivera E, Murray JL, Valero V, Ueno N, Singletary ES, Hunt K, Strom E, McNeese M, Stelling C, Hortobagyi GN. Paclitaxel in the multimodality treatment for inflammatory breast carcinoma. Cancer 92(7):1775-82, 2001. PMID: 11745249.
571. Albo D, Wayne JD, Hunt KK, Rahlfs TF, Singletary SE, Ames FC, Feig BW, Ross MI, Kuerer HM. Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer. Am J Surg 182(4):393-8, 2001. PMID: 11720678.
572. Vlastos G, Mirza NQ, Meric F, Hunt KK, Kuerer HM, Ames FC, Ross MI, Buchholz TA, Hortobagyi GN, Singletary SE. Breast conservation therapy as a treatment option for the elderly. The M. D. Anderson experience. Cancer 92(5):1092-100, 2001. PMID: 11571720.
573. Fleming JB, Cantor SB, Varma DG, Holst D, Feig BW, Hunt KK, Patel SR, Benjamin RS, Pollock RE, Pisters PW. Utility of chest computed tomography for staging in patients with T1 extremity soft tissue sarcomas. Cancer 92(4):863-8, 2001. PMID: 11550159.
574. Vlastos G, Jean ME, Mirza AN, Mirza NQ, Kuerer HM, Ames FC, Hunt KK, Ross MI, Buchholz TA, Buzdar AU, Singletary SE. Feasibility of breast preservation in the treatment of occult primary carcinoma presenting with axillary metastases. Ann Surg Oncol 8(5):425-31, 2001. PMID: 11407517.
575. Buchholz TA, Tucker SL, Erwin J, Mathur D, Strom EA, McNeese MD, Hortobagyi GN, Cristofanilli M, Esteva FJ, Newman L, Singletary SE, Buzdar AU, Hunt KK. Impact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breast-conservation therapy. J Clin Oncol 19(8):2240-6, 2001. PMID: 11304777.
576. Newman LA, Kuerer HM, Fornage B, Mirza N, Hunt KK, Ross MI, Ames FC, Buzdar AU, Singletary SE. Adverse prognostic significance of infraclavicular lymph nodes detected by ultrasonography in patients with locally advanced breast cancer. Am J Surg 181(4):313-8, 2001. PMID: 11438265.
577. Newman LA, Kuerer HM, McNeese MD, Hunt KK, Gurtner GC, Vlastos GS, Robb G, Singletary SE. Reduction mammoplasty improves breast conservation therapy in patients with macromastia. Am J Surg 181(3):215-20, 2001. PMID: 11376574.
578. Portera CA, Ho V, Patel SR, Hunt KK, Feig BW, Respondek PM, Yasko AW, Benjamin RS, Pollock RE, Pisters PW. Alveolar soft part sarcoma: clinical course and patterns of metastasis in 70 patients treated at a single institution. Cancer 91(3):585-91, 2001. PMID: 11169942.
579. Freedman LM, Buchholz TA, Thames HD, Strom EA, McNeese MD, Hortobagyi GN, Singletary SE, Heaton KM, Hunt KK. Local-regional control in breast cancer patients with a possible genetic predisposition. Int J Radiat Oncol Biol Phys 48(4):951-7, 2000. PMID: 11072150.
580. Breslin TM, Cohen L, Sahin A, Fleming JB, Kuerer HM, Newman LA, Delpassand ES, House R, Ames FC, Feig BW, Ross MI, Singletary SE, Buzdar AU, Hortobagyi GN, Hunt KK. Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. J Clin Oncol 18(20):3480-6, 2000. PMID: 11032588.
581. Chaney AW, Pollack A, McNeese MD, Zagars GK, Pisters PW, Pollock RE, Hunt KK. Primary treatment of cystosarcoma phyllodes of the breast. Cancer 89(7):1502-11, 2000. PMID: 11013364.
582. Meric F, Milas M, Hunt KK, Hess KR, Pisters PW, Hildebrandt G, Patel SR, Benjamin RS, Plager C, Papadopolous NE, Burgess MA, Pollock RE, Feig BW. Impact of neoadjuvant chemotherapy on postoperative morbidity in soft tissue sarcomas. J Clin Oncol 18(19):3378-83, 2000. PMID: 11013278.
583. Mirza NQ, Vlastos G, Meric F, Sahin AA, Singletary SE, Newman LA, Kuerer HM, Ames FC, Ross MI, Feig BW, Pollock RE, Buchholz TA, McNeese MD, Strom EA, Hortobagyi GN, Hunt KK. Ductal carcinoma-in-situ: long-term results of breast-conserving therapy. Ann Surg Oncol 7(9):656-64, 2000. PMID: 11034242.
584. Newman LA, Hunt KK, Buchholz T, Kuerer HM, Vlastos G, Mirza N, Ames FC, Ross MI, Singletary SE. Presentation, management and outcome of axillary recurrence from breast cancer. Am J Surg 180(4):252-6, 2000. PMID: 11113430.
585. Cohen LF, Breslin TM, Kuerer HM, Ross MI, Hunt KK, Sahin AA. Identification and evaluation of axillary sentinel lymph nodes in patients with breast carcinoma treated with neoadjuvant chemotherapy. Am J Surg Pathol 24(9):1266-72, 2000. PMID: 10976701.
586. Newman LA, Kuerer HM, Hunt KK, Vlastos G, Ames FC, Ross MI, Singletary SE. Prophylactic mastectomy. J Am Coll Surg 191(3):322-30, 2000. PMID: None.
587. Liao Z, Strom EA, Buzdar AU, Singletary SE, Hunt K, Allen PK, McNeese MD. Locoregional irradiation for inflammatory breast cancer: Effectiveness of dose escalation in decreasing recurrence. Int J Radiat Oncol Biol Phys 47(5):1191-1200, 2000. PMID: 10889372.
588. Meric F, Mirza NQ, Buzdar AU, Hunt KK, Ames FC, Ross MI, Pollock RE, Newman LA, Feig BW, Strom EA, Buchholz TA, McNeese MD, Hortobagyi GN, Singletary SE. Prognostic implications of pathological lymph node status after preoperative chemotherapy for operable T3N0M0 breast cancer. Ann Surg Oncol 7(6):435-40, 2000. PMID: 10894139.
589. Newman LA, Kuerer HM, Hunt KK, Ames FC, Ross MI, Feig BW, Hortobagyi GN, Buzdar AU, Singletary SE. Response to induction chemotherapy in black and white patients with locally advanced breast cancer. Breast J 6(4):242-246, 2000. PMID: 11348372.
590. Vlastos G, Fornage BD, Mirza NQ, Bedi D, Lenert JT, Winchester DJ, Tolley SM, Ames FC, Ross MI, Feig BW, Hunt KK, Buzdar AU, Singletary SE. The correlation of axillary ultrasonography with histologic breast cancer downstaging after induction chemotherapy. Am J Surg 179(6):446-52, 2000. PMID: 11004328.
591. Peng H, Xu F, Pershad R, Hunt KK, Frazier ML, Berchuck A, Gray JW, Hogg D, Bast RC, Jr, Yu Y. ARHI is the center of allelic deletion on chromosome 1p31 in ovarian and breast cancers. Int J Cancer 86(5):690-4, 2000. PMID: 10797292.
592. Vlastos G, Mirza NQ, Lenert JT, Hunt KK, Ames FC, Feig BW, Ross MI, Buzdar AU, Singletary SE. The feasibility of minimally invasive surgery for stage IIA, IIB, and IIIA breast carcinoma patients after tumor downstaging with induction chemotherapy. Cancer 88(6):1417-24, 2000. PMID: 10717625.
593. Pataer A, Fang B, Yu R, Kagawa S, Hunt KK, McDonnell TJ, Roth JA, Swisher SG. Adenoviral Bak overexpression mediates caspase-dependent tumor killing. Cancer Res 60(4):788-92, 2000. PMID: 10706081.
594. Lenert JT, Vlastos G, Mirza NQ, Winchester DJ, Binkley SM, Ames FC, Ross MI, Feig BW, Hunt KK, Strom E, Buzdar AU, Hortobagyi GN, Singletary SE. Primary tumor response to induction chemotherapy as a predictor of histological status of axillary nodes in operable breast cancer patients. Ann Surg Oncol 6(8):762-7, 1999. PMID: 10622504.
595. Buzdar AU, Singletary SE, Theriault RL, Booser DJ, Valero V, Ibrahim N, Smith TL, Asmar L, Frye D, Manuel N, Kau SW, McNeese M, Strom E, Hunt K, Ames F, Hortobagyi GN. Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer. J Clin Oncol 17(11):3412-7, 1999. PMID: 10550135.
596. Newman LA, Kuerer HM, Hunt KK, Ames FC, Ross MI, Theriault R, Fry N, Kroll SS, Robb GL, Singletary SE. Feasibility of immediate breast reconstruction for locally advanced breast cancer. Ann Surg Oncol 6(7):671-5, 1999. PMID: 10560853.
597. Fleming JB, Berman RS, Cheng SC, Chen NP, Hunt KK, Feig BW, Respondek PM, Yasko AW, Pollack A, Patel SR, Burgess MA, Papadopoulos NE, Plager C, Zagars G, Benjamin RS, Pollock RE, Pisters PW. Long-term outcome of patients with American Joint Committee on Cancer stage IIB extremity soft tissue sarcomas. J Clin Oncol 17(9):2772-80, 1999. PMID: 10561352.
598. Feig BW, Lu X, Hunt KK, Shan Q, Yu D, Pollock R, Chiao P. Inhibition of the transcription factor nuclear factor-kappa B by adenoviral-mediated expression of I kappa B alpha M results in tumor cell death. Surgery 126(2):399-405, 1999. PMID: 10455913.
599. Kuerer HM, Sahin AA, Hunt KK, Newman LA, Breslin TM, Ames FC, Ross MI, Buzdar AU, Hortobagyi GN, Singletary SE. Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy. Ann Surg 230(1):72-8, 1999. PMID: 10400039.
600. Steck K, Hunt K, Tucker S, Singletary S, El-Naggar AK. Flow cytometric analysis of KI-67 in invasive ductal carcinoma of the breast: correlation with tumor and patient characteristics. Oncol Rep 6(4):835-8, 1999. PMID: 10373666.
601. Chiao PJ, Hunt KK, Grau AM, Abramian A, Fleming J, Zhang W, Breslin T, Abbruzzese JL, Evans DB. Tumor suppressor gene Smad4/DPC4, its downstream target genes, and regulation of cell cycle. Ann N Y Acad Sci 880:31-7, 1999. PMID: 10415848.
602. Buchholz TA, Hunt KK, Amosson CM, Tucker SL, Strom EA, McNeese MD, Buzdar AU, Singletary SE, Hortobagyi GN. Sequencing of chemotherapy and radiation in lymph node-negative breast cancer. Cancer J Sci Am 5(3):159-64, 1999. PMID: 10367172.
603. Newman LA, Kuerer HM, Hunt KK, Singh G, Ames FC, Feig BW, Ross MI, Taylor S, Singletary SE. Local recurrence and survival among black women with early-stage breast cancer treated with breast-conservation therapy or mastectomy. Ann Surg Oncol 6(3):241-8, 1999. PMID: 10340882.
604. Kuerer HM, Newman LA, Smith TL, Ames FC, Hunt KK, Dhingra K, Theriault RL, Singh G, Binkley SM, Sneige N, Buchholz TA, Ross MI, McNeese MD, Buzdar AU, Hortobagyi GN, Singletary SE. Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. J Clin Oncol 17(2):460-9, 1999. PMID: 10080586.
605. Delpassand ES, Singletary E, Ross MI, Ames FC, Hunt KK, Podoloff DA. Non-invasive staging of axilla in patients with breast cancer using Tc99m sestamibi and different nuclear medicine techniques - A pilot project. Clin Nucl Med 24(3), 1999. PMID: None.
606. Heaton KM, Peoples GE, Singletary SE, Feig BW, Ross MI, Ames FC, Buchholz TA, Strom EA, McNeese MD, Hunt KK. Feasibility of breast conservation therapy in metachronous or synchronous bilateral breast cancer. Ann Surg Oncol 6(1):102-8, 1999. PMID: 10030422.
607. Pearlstone DB, Pisters PW, Bold RJ, Feig BW, Hunt KK, Yasko AW, Patel S, Pollack A, Benjamin RS, Pollock RE. Patterns of recurrence in extremity liposarcoma: implications for staging and follow-up. Cancer 85(1):85-92, 1999. PMID: 9921978.
608. Pearlstone DB, Janjan NA, Feig BW, Yasko AW, Hunt KK, Pollock RE, Lawyer A, Horton J, Pisters PW. Re-resection with brachytherapy for locally recurrent soft tissue sarcoma arising in a previously radiated field. Cancer J Sci Am 5(1):26-33, 1999. PMID: 10188058.
609. Hunt KK, Fleming JB, Abramian A, Zhang L, Evans DB, Chiao PJ. Overexpression of the tumor suppressor gene Smad4/DPC4 induces p21waf1 expression and growth inhibition in human carcinoma cells. Cancer Res 58(24):5656-61, 1998. PMID: 9865717.
610. Kuerer HM, Newman LA, Fornage BD, Dhingra K, Hunt KK, Buzdar AU, Ames FC, Ross MI, Feig BW, Hortobagyi GN, Singletary SE. Role of axillary lymph node dissection after tumor downstaging with induction chemotherapy for locally advanced breast cancer. Ann Surg Oncol 5(8):673-80, 1998. PMID: 9869512.
611. Kuerer HM, Newman LA, Buzdar AU, Hunt KK, Dhingra K, Buchholz TA, Binkley SM, Ames FC, Feig BW, Ross MI, Hortobagyi GN, Singletary SE. Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer. Am J Surg 176(6):502-9, 1998. PMID: 9926779.
612. McMasters KM, Giuliano AE, Ross MI, Reintgen DS, Hunt KK, Byrd DR, Klimberg VS, Whitworth PW, Tafra LC, Edwards MJ. Sentinel-lymph-node biopsy for breast cancer--not yet the standard of care. N Engl J Med 339(14):990-5, 1998. PMID: 9753717.
613. Newman LA, Kuerer HM, Hunt KK, Kroll SS, Ames FC, Ross MI, Feig BW, Singletary SE. Presentation, treatment, and outcome of local recurrence after skin-sparing mastectomy and immediate breast reconstruction. Ann Surg Oncol 5(7):620-6, 1998. PMID: 9831111.
614. Gershenwald JE, Hunt KK, Kroll SS, Ross MI, Baldwin BJ, Feig BW, Ames FC, Schusterman MA, Singletary SE. Synchronous elective contralateral mastectomy and immediate bilateral breast reconstruction in women with early-stage breast cancer. Ann Surg Oncol 5(6):529-38, 1998. PMID: 9754762.
615. Kuerer HM, Newman LA, Buzdar AU, Dhingra K, Hunt KK, Buchholz TA, Binkley SM, Strom EA, Ames FC, Ross MI, Feig BW, McNeese MD, Hortobagyi GN, Singletary SE. Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status. Cancer J Sci Am 4(4):230-6, 1998. PMID: 9689981.
616. Bouvet M, Ollila DW, Hunt KK, Babiera GV, Spitz FR, Giuliano AE, Strom EA, Ames FC, Ross MI, Singletary SE. Role of conservation therapy for invasive lobular carcinoma of the breast. Ann Surg Oncol 4(8):650-4, 1997. PMID: 9416413.
617. Ricardo AE, Feig BW, Ellis LM, Hunt KK, Curley SA, MacFadyen BV, Jr, Mansfield PF. Gallbladder cancer and trocar site recurrences. Am J Surg 174(6):619-22; discussion 622-3, 1997. PMID: 9409585.
618. Hunt KK, Deng J, Liu TJ, Wilson-Heiner M, Swisher SG, Clayman G, Hung MC. Adenovirus-mediated overexpression of the transcription factor E2F-1 induces apoptosis in human breast and ovarian carcinoma cell lines and does not require p53. Cancer Res 57(21):4722-6, 1997. PMID: 9354430.
619. Hunt KK, Baldwin BJ, Strom EA, Ames FC, McNeese MD, Kroll SS, Singletary SE. Feasibility of postmastectomy radiation therapy after TRAM flap breast reconstruction. Ann Surg Oncol 4(5):377-84, 1997. PMID: 9259963.
620. Toloza EM, Hunt K, Miller AR, McBride W, Lau R, Swisher S, Rhoades K, Arthur J, Choi J, Chen L, Chang P, Chen A, Glaspy J, Economou JS. Transduction of murine and human tumors using recombinant adenovirus vectors. Ann Surg Oncol 4:70-9, 1997. PMID: None.
621. Swisher SG, Holmes EC, Hunt KK, Doty JE, Zinner MJ, McFadden DW. The role of neoadjuvant therapy in surgically resectable esophageal cancer. Arch Surg 131(8):819-24; discussion 824-5, 1996. PMID: 8712904.
622. Swisher SG, Holmes EC, Hunt KK, Gornbein JA, Zinner MJ, McFadden DW. Perioperative blood transfusions and decreased long-term survival in esophageal cancer. J Thorac Cardiovasc Surg 112(2):341-8, 1996. PMID: 8751501.
623. Toloza EM, Hunt K, Swisher S, McBride W, Lau R, Pang S, Rhoades K, Drake T, Belldegrun A, Glaspy J, Economou JS. In vivo cancer gene therapy with a recombinant interleukin-2 adenovirus vector. Cancer Gene Ther 3:11-7, 1996. PMID: None.
624. Swisher SG, Hunt KK, Holmes EC, Zinner MJ, McFadden DW. Changes in the surgical management of esophageal cancer from 1970 to 1993. Am J Surg 169(6):609-14, 1995. PMID: 7771626.
625. Swisher SG, Schmit PJ, Hunt KK, Hiyama DT, Bennion RS, Swisher EM, Thompson JE. Biliary disease during pregnancy. Am J Surg 168(6):576-9; discussion 580-1, 1994. PMID: 7977999.
626. Badie B, Hunt K, Economou JS, Black KL. Stereotactic delivery of a recombinant adenovirus into a C6 glioma cell line in a rat brain tumor model. Neurosurgery 35(5):910-6, 1994. PMID: 7838341.
627. Swisher SG, Hunt KK, Schmit PJ, Hiyama DT, Bennion RS, Thompson JE. Management of pancreatitis complicating pregnancy. Am Surg 60(10):759-62, 1994. PMID: 7944038.
628. Hunt KK, Shibata M, Gupta RK, Morton DL. Complement-dependent lysis of tumor cells by a baboon IgM antibody to a tumor-associated antigen. Cancer Immunol Immunother 34(6):377-82, 1992. PMID: 1563014.
629. Singh KP, Shau H, Gupta RK, Kopald K, Ray PK. Protein A potentiates lymphokine-activated killer cell induction in normal and melanoma patient lymphocytes. Immunopharmacol Immunotoxicol 14(1-2):73-103, 1992. PMID: 1597662.
630. Layfield LJ, Mohrmann RL, Kopald KH, Giuliano AE. Use of aspiration cytology and frozen section examination for management of benign and malignant thyroid nodules. Cancer 68(1):130-4, 1991. PMID: 2049733.
631. Kopald KH, Hiatt JR, Irving C, Giuliano AE. The pathology of nonpalpable breast cancer. Am Surg 56(12):782-7, 1990. PMID: 2268107.
632. Wong JH, Kopald KH, Morton DL. The impact of microinvasion on axillary node metastases and survival in patients with intraductal breast cancer. Arch Surg 125(10):1298-301; discussion 1301-2, 1990. PMID: 2171453.
633. Selch MT, Kopald KH, Ferreiro GA, Mirra JM, Parker RG, Eilber FR. Limb salvage therapy for soft tissue sarcomas of the foot. Int J Radiat Oncol Biol Phys 19(1):41-8, 1990. PMID: 2380094.
634. Wong JH, Cagle LA, Kopald KH, Swisher SG, Morton DL. Natural history and selective management of in transit melanoma. J Surg Oncol 44(3):146-50, 1990. PMID: 2370798.
635. Wong JH, Sterns EE, Kopald KH, Nizze JA, Morton DL. Prognostic significance of pregnancy in stage I melanoma. Arch Surg 124(10):1227-30; discussion 1230-1, 1989. PMID: 2802988.
636. Kopald KH, Layfield LJ, Mohrmann R, Foshag LJ, Giuliano AE. Clarifying the role of fine-needle aspiration cytologic evaluation and frozen section examination in the operative management of thyroid cancer. Arch Surg 124(10):1201-4; discussion 1204-5, 1989. PMID: 2802984.
637. Smith B, Hunt KK, Carr D, Blumencranz P, Hwang S, Gadd M, Stone K, Dyess D, Dodge D, Valente S, Dekhne N, Clark P, Lee MC, Samiiian L, Lesnikoski BA, Clark L, Smith KP, Chang M, Schlossberg B, Ferrer J, Wapnir I. Intraoperative Fluorescence Guidance for Breast Cancer Lumpectomy Surgery. NEJM Evidence. PMID: None.

Invited Articles

1. Hunt, KK, Balch, CM. Surgical Oncology Heroes and Legends. Annals of surgical oncology 31(2):722-723, 2024. PMID: 38062294.
2. Keung EZ, Hunt KK, Roland CL. ASO Author Reflections: A Call for Consensus, Collaboration and Data on the Role of Sentinel Lymph Node Biopsy for Soft Tissue Sarcoma. Ann Surg Oncol 30(2):968-969, 2023. e-Pub 2022. PMID: 36394686.
3. Francescatti AB, Hunt KK, Katz MHG, of Surgeons CSSPOTAC. ASO Author Reflections: Technical Standards for Cancer Surgery: From "How I Do It" to "How We Do It". Ann Surg Oncol 29(11):6559-6560, 2022. e-Pub 2022. PMID: 35288816.
4. Zheng L, Francescatti A, Deming S, Vreeland TJ, Boughey JC, Snyder RA, Hunt KK, Katz MH. Synoptic reporting for cancer surgery: Current requirements and future state. ACS Cancer Research Program Bulletin None(None):None, 2021. PMID: None.
5. Li GZ, Raut CP, Hunt KK, Feng M, Chugh R. Breast Sarcomas, Phyllodes Tumors, and Desmoid Tumors: Epidemiology, Diagnosis, Staging, and Histology-Specific Management Considerations. Am Soc Clin Oncol Educ Book 41:390-404, 2021. PMID: 34010054.
6. Francescatti AB, Roland CL, Hunt KK, Katz MH. 2020 Commission on Cancer (CoC) Operative Standards: Where are we now?. Bulletin of the American College of Surgeons 106(1):109-112, 2021. PMID: None.
7. Buchholz TA, Ali S, Hunt KK. Multidisciplinary Management of Locoregional Recurrent Breast Cancer. J Clin Oncol 38(20):2321-2328, 2020. e-Pub 2020. PMID: 32442059.
8. Fisher CS, Margenthaler JA, Hunt KK, Schwartz T. The Landmark Series: Axillary Management in Breast Cancer. Ann Surg Oncol 27(3):724-729, 2020. e-Pub 2019. PMID: 31863417.
9. Savard MF, Khan O, Hunt KK, Verma S. Redrawing the Lines: The Next Generation of Treatment in Metastatic Breast Cancer. Am Soc Clin Oncol Educ Book 39:e8-e21, 2019. e-Pub 2019. PMID: 31099662.
10. Nurudeen S, Hunt KK. Contemporary management of the axilla in breast cancer. Clin Adv Hematol Oncol 16(12):823-831, 2018. PMID: 30843891.
11. Hunt KK, Wingate HF. Satisfaction and Sustainability in a Surgical Career. Ann Surg Oncol 25(10):2785-2789, 2018. e-Pub 2018. PMID: 29992496.
12. Menen RS, Hunt KK. Considerations for the Treatment of Young Patients with Breast Cancer. Breast J 22(6):667-672, 2016. e-Pub 2016. PMID: 27542172.
13. Yi M, Hunt KK. Organizing a breast cancer database: data management. Chin Clin Oncol 5(3):45, 2016. e-Pub 2016. PMID: 27197511.
14. Leitch AM, Boughey JC, Hunt KK. Response to preoperative endocrine therapy in breast cancer patients can alter surgical and chemotherapy options. Bull Am Coll Surg 100(11):43-5, 2015. PMID: 26677537.
15. Hunt KK. Axillary surgery after chemotherapy: challenges and opportunities. Oncology (Williston Park) 29(10):741-742, 2015. PMID: 26470897.
16. Mittendorf EA, Hunt, KK. Breast cancer immunotherapy: is it ready for prime time?. American Journal of Hematology /Oncology 11(9), 2015. PMID: None.
17. Martin LW, Veeramachaneni NK, Katz MH, You YN, Boughey JC, Nelson H, Hunt KK. New manual for cancer surgery issued: Operative Standards for Cancer Surgery. Bull Am Coll Surg 100(6):43-44, 2015. PMID: 26182523.
18. Roland CL, Hunt, KK. Differences in Breast Cancer Stage at Diagnosis and Cancer-Specific Survival by Race and Ethnicity in the United States. Breast Diseases: A Year Book Quarterly 26(2):125-126, 2015. PMID: None.
19. Boughey JC, Hunt KK. Spotlight on Neoadjuvant Therapy for Breast Cancer. Ann Surg Oncol 22(5):1406-7, 2015. e-Pub 2015. PMID: 25727559.
20. Buchholz TA, Mittendorf EA, Hunt KK. Surgical considerations after neoadjuvant chemotherapy: breast conservation therapy. J Natl Cancer Inst Monogr 2015(51):11-4, 2015. PMID: 26063878.
21. Fornage BD, Hunt KK. Image-guided percutaneous ablation of small breast cancer: which technique is leading the pack?. Technol Cancer Res Treat 14(2):209-11, 2015. e-Pub 2014. PMID: 24325137.
22. Teshome M, Hunt KK. Neoadjuvant Therapy in the Treatment of Breast Cancer. Surg Oncol Clin N Am 23(3):505-523, 2014. e-Pub 2014. PMID: 24882348.
23. Hunt KK, Sahin AA. Too much, too little, or just right? Tumor margins in women undergoing breast-conserving surgery. J Clin Oncol 32(14):1401-6, 2014. e-Pub 2014. PMID: 24687821.
24. Hunt KK, Mittendorf EA. Review: Surgical considerations for breast cancer patients receiving neoadjuvant systemic therapy. Breast Cancer Management 2(5):385-395, 2013. PMID: None.
25. Black DM, Hunt KK, Mittendorf EA. Long term outcomes reporting the safety of breast conserving therapy compared to mastectomy: 20-year results of EORTC 10801. Gland Surg 2(3):120-3, 2013. PMID: 25083471.
26. Bednarski BK, Pisters PW, Hunt KK. The Role of Surgery in the Multidisciplinary Management of Patients with Localized Gastrointestinal Stromal Tumors. Expert Rev Anticancer Ther 12(8):1069-78, 2012. PMID: 23030225.
27. Chawla A, Hunt KK, Mittendorf EA. Surgical considerations in patients receiving neoadjuvant systemic therapy. Future Oncol 8(3):239-250, 2012. PMID: 22409461.
28. Buchholz TA, Hunt KK. Breast conservation therapy in the 21st century. Breast J 17(5):445-7, 2011. PMID: 21899648.
29. Caudle AS, Hunt KK. The neoadjuvant approach in breast cancer treatment: it is not just about chemotherapy anymore. Curr Opin Obstet Gynecol 23(1):31-6, 2011. PMID: 21124221.
30. Hunt KK. Axillary dissection in women in invasive breast cancer and sentinel node metastasis. Curr Breast Cancer Reports 3(2):75-8, 2011. PMID: None.
31. Rourke LL, Hunt KK, Cormier JN. Breast cancer and lymphedema: a current overview for the healthcare provider. Womens Health (Lond) 6(3):399-406, 2010. PMID: 20426606.
32. Litton JK, Hunt KK. Management of the contralateral breast in women with newly diagnosed breast cancer CME. Medscape, 2009. PMID: None.
33. Modi S, Hunt KK, Hudis CA. Preoperative chemotherapy for breast cancer: pearls and pitfalls. Medscape, 2009. PMID: None.
34. Fearmonti RM, Keyomarsi K, Hunt KK. Biomarkers in neoadjuvant trials. Cancer Treat Res 147:1-36, 2009. PMID: 21461824.
35. Boughey JC, Buzdar AU, Hunt KK. In brief. Curr Probl Surg 45(1):6-11, 2008. PMID: 18206435.
36. Boughey JC, Buzdar AU, Hunt KK. Recent advances in the hormonal treatment of breast cancer. Curr Probl Surg 45(1):13-55, 2008. PMID: 18206436.
37. Hunt KK. Invited Critique: Olsen MA et al. Hospital-associated costs due to surgical site infection after breast surgery. Arch Surg 2008;143:53-60. Arch Surg 143:61, 2008. PMID: None.
38. Mittendorf EA, Hunt KK. Significance and management of micrometastases in patients with breast cancer. Expert Rev Anticancer Ther 7(10):1451-61, 2007. PMID: 17944569.
39. Boughey JC, Hunt KK. Expanding the indications for sentinel lymph node surgery in breast cancer. Future Oncol 3(1):9-14, 2007. PMID: 17280496.
40. You YN, Hunt KK, Posner MC, Putnam JB, Nelson H, Ota DM, Pisters PW. Operative trials: the opportunity beckons-an update on the American College of Surgeons Oncology Group. Surgery 139(4):455-9, 2006. PMID: 16627052.
41. Hunt KK, Keyomarsi K. Cyclin E as a prognostic and predictive marker in breast cancer. Semin Cancer Biol 15(4):319-26, 2005. PMID: 16043362.
42. Chen AM, Meric-Bernstam F, Hunt KK, Buchholz TA. Patient selection for breast conservation-after neoadjuvant chemotherapy: Developing a prognostic index. Am J Oncol Rev 4:398-404, 2005. PMID: None.
43. Chen AM, Meric-Bernstam F, Hunt KK, Buchholz TA. Neoadjuvant chemotherapy to permit breast conservation for patients with locally advanced breast cancer. Am J Oncol Rev 3:692-6, 2004. PMID: None.
44. Buchholz TA, Hunt KK, Whitman GJ, Sahin AA, Hortobagyi GN. Multidisciplinary considerations involved in using neoadjuvant chemotherapy for breast cancer. Am J Oncol Rev 3(3):156-64, 2004. PMID: None.
45. Buchholz TA, Strom EA, McNeese MD, Hunt KK. Radiation therapy as an adjuvant treatment after sentinel lymph node surgery for breast cancer. Surg Clin North Am 83(4):911-30, 2003. PMID: 12875602.
46. Hwang RF, Hunt KK. Experimental approaches to treatment of soft tissue sarcoma. Surg Oncol Clin N Am 12(2):499-521, 2003. PMID: 12916466.
47. Meric-Bernstam F, Mirza NQ, Vlastos G, Buchholz TA, Kuerer HM, Babiera GV, Singletary SE, Ross MI, Ames FC, Feig BW, Krishnamurthy S, Perkins GH, McNeese MD, Strom EA, Valero V, Hunt KK. Impact of positive surgical margins and ipsilateral breast tumor recurrence on disease-specific survival after breast-conserving therapy. Am J Oncol Review 2(8):428-33, 2003. PMID: None.
48. Meric F, Hunt KK. Translation initiation in cancer: a novel target for therapy. Mol Cancer Ther 1(11):971-9, 2002. PMID: 12481419.
49. Hunt KK, Vorburger SA. Tech Sight. Gene therapy. Hurdles and hopes for cancer treatment. Science 297(5580):415-6, 2002. PMID: 12130788.
50. Meric F, Hung MC, Hortobagyi GN, Hunt KK. HER2/neu in the management of invasive breast cancer. J Am Coll Surg 194(4):488-501, 2002. PMID: 11949754.
51. Kuerer HM, Hunt KK. The rationale for integration of lymphatic mapping and sentinel node biopsy in the management of breast cancer patients receiving neoadjuvant chemotherapy. Semin Breast Dis 5(2):80-7, 2002. PMID: None.
52. Vorburger SA, Hunt KK. Adenoviral gene therapy. Oncologist 7(1):46-59, 2002. PMID: 11854546.
53. Hunt KK, Ross MI. Sentinel lymph node dissection in early stage breast cancer. Breast Cancer 9(4):282-8, 2002. PMID: 12459707.
54. Buchholz TA, Tucker SL, Katz A, McNeese MD, Strom EA, Perkins GH, Buzdar AU, Kuerer HM, Hunt KK, Singletary SE, Sahin AA, Thames HD, Meric F, Masullo L, Hortobagyi GN. Factors predictive for local-regional recurrence after neoadjuvant chemotherapy and mastectomy: Implications for radiation treatments. Am J Oncol Review 1(1):13-6, 2002. PMID: None.
55. Buchholz TA, Crane C, Hunt KK. 1st annual oncology update: advances and controversies. Steamboat Springs, Colorado, USA, 13-17 February 2001. Expert Rev Anticancer Ther 1(1):6-8, 2001. PMID: 12113134.
56. Newman LA, Kuerer HM, Hunt KK, Vlastos G, Ames FC, Ross MI, Singletary SE. Educational review: role of the surgeon in hereditary breast cancer. Ann Surg Oncol 8(4):368-78, 2001. PMID: 11352312.
57. Hunt KK, Feig BW. Preclinical experimental therapeutic approaches in soft tissue sarcoma. Semin Surg Oncol 17(1):78-82, 1999. PMID: 10402641.
58. Hunt KK Ross MI. The Cox et al article reviewed. Lymphatic Mapping in the Treatment of Breast Cancer. Oncology 12(9):1294-8, 1998. PMID: None.
59. Hunt KK, Ross MI. Changing trends in the diagnosis and treatment of early breast cancer. Cancer Treat Res:171-201, 1997. PMID: None.
60. Hunt KK, Ames FC, Singletary SE, Buzdar AU, Hortobagyi GN. Locally advanced noninflammatory breast cancer. Surg Clin North Am 76(2):393-410, 1996. PMID: 8610271.
61. Hunt KK, Feig B, Ames F. Ambulatory surgery for breast cancer. Cancer Bulletin 47(4):292-7, 1995. PMID: None.

Manuals, Teaching Aids, Other Teaching Publications

1. Hunt KK. "Current status of sentinel lymph node biopsy" and "Neoadjuvant chemotherapy and breast conservation". Audio-Digest General Surgery, 2006.
2. Hunt KK. Regional node management in breast cancer. M.D.Anderson Breast Medical Oncology-Clinical Issues & Therapeutic Advances, Newsletter, 2003.

Other Articles

1. Dubsky, P, Jackisch, C, Im, SA, Hunt, KK, Li, CF, Unger, S, Paluch-Shimon, S BRCA genetic testing and counseling in breast cancer. npj Breast Cancer 10(1), 2024. PMID: None.
2. Ohannesian, N, Mallick, MS, He, J, Qiao, Y, Li, N, Shaitelman, SF, Tang, C, Shinn, EH, Hofstetter, WL, Goltsov, A, Hassan, MM, Hunt, KK, Lin, SH, Shih, WC Author Correction: Plasmonic nano-aperture label-free imaging of single small extracellular vesicles for cancer detection. Communications Medicine 4(1), 2024. PMID: None.
3. Thomas, KK, Francescatti, A, Vreeland, TJ, Teshome, M, Morris, AM, Hunt, KK, Katz, MH, Villano, AM Correction to. Annals of surgical oncology 31(7):4565, 2024. PMID: 38662097.
4. Thomas, KK, Francescatti, A, Vreeland, TJ, Teshome, M, Morris, AM, Hunt, KK, Katz, MH, Villano, AM Correction to. Annals of surgical oncology 31(7):4565, 2024. PMID: 38662097.
5. Ohannesian N, Mallick MS, He J, Qiao Y, Li N, Shaitelman SF, Tang C, Shinn EH, Hofstetter WL, Goltsov A, Hassan MM, Hunt KK, Lin SH, Shih WC Author Correction: Plasmonic nano-aperture label-free imaging of single small extracellular vesicles for cancer detection. Commun Med (Lond) 4(1):126, 2024. PMID: 38942807.
6. Marques-Piubelli ML, Lyapichev KA, Fnu A, Adrada B, Stewart J, Hunt KK, Clemens MW, Iyer S, Wu Y, El Hussein S, Xu J, Ok CY, Li S, Pierson DM, Ferrufino-Schmidt MC, Nahmod KA, Yoga A, Hunsicker L, Evans MG, Resetkova E, Qiu L, Khanlari M, Garces SA, Bueso-Ramos CE, Medeiros LJ, Miranda RN The Spectrum of Non-neoplastic Changes Associated With Breast Implants: Histopathology, Imaging, and Clinical Significance. Am J Surg Pathol 48(6):e43-e64, 2024. PMID: 38451836.
7. Adesoye, T, Tripathy, D, Hunt, KK, Keyomarsi, K Exploring Novel Frontiers. Cancers 16(3), 2024. PMID: 38339245.
8. Gunther JR, Iyer SP, Hunt KK, Fang H, Wang SA, Clemens MW, Pinnix CC Beyond surgery: the proper role and delivery of radiation therapy in the local-regional management of BIA-ALCL. Case Reports Plast Surg Hand Surg 11(1):2389172, 2024. PMID: 39119029.
9. Medeiros, LJ, Marques-Piubelli, ML, Sangiorgio, VF, Ruiz-Cordero, R, Vega Vazquez, F, Feldman, AL, Chapman, JR, Clemens, MW, Hunt, KK, Evans, MG, Khoo, C, Lade, S, Silberman, M, Morkowski, JJ, Pina, EM, Mills, DC, Bates, CM, Magno, WB, Sohani, AR, Sieling, BA, O'Donoghue, JM, Bacon, CM, Patani, N, Televantou, D, Turner, SD, Johnson, LL, MacNeill, F, Wotherspoon, A, Iyer, SP, Malpica Castillo, LE, Patel, KP, Xu, J, Miranda, R Corrigendum to “Epstein–Barr-virus-positive large B-cell lymphoma associated with breast implants. Modern Pathology 36(12), 2023. PMID: 37948938.
10. Gouda MA, Janku F, Somaiah N, Hunt KK, Yedururi S, Subbiah V Multi-disciplinary management of recurrent gastrointestinal stromal tumor harboring KIT exon 11 mutation with the switch-control kinase inhibitor ripretinib and surgery. Oncoscience 10(None):38-43, 2023. PMID: 37736254.
11. Katz MHG, Francescatti AB, Hunt KK, of Surgeons CSSPOTAC Technical Standards for Cancer Surgery: Commission on Cancer Standards 5.3-5.8. Ann Surg Oncol 29(11):6549-6558, 2022. PMID: 35187620.
12. Lillemoe HA, Miranda RN, Nastoupil LJ, Clemens MW, Hunt KK Clinical Manifestations and Surgical Management of Breast Implant-Associated Anaplastic Large Cell Lymphoma: Beyond the NCCN Guidelines. Ann Surg Oncol 29(9):5722-5729, 2022. PMID: 35597841.
13. Liang DH, Black D, Yi M, Luo CK, Singh P, Sahin A, Scoggins ME, Moseley TW, Hunt KK Correction to: Clinical Outcomes Using Magnetic Seeds as a Non-wire, Non-radioactive Alternative for Localization of Non-palpable Breast Lesions. Ann Surg Oncol 29(7):4196, 2022. PMID: 35298763.
14. Yoon, EC, Ding, Q, Hunt, KK, Sahin, AA High-Grade Spindle Cell Lesions of the Breast. Surgical Pathology Clinics 15(1):77-93, 2022. PMID: 35236635.
15. Santanelli Di Pompeo, F, Clemens, MW, Atlan, M, Botti, G, Cordeiro, P, De Jong, D, DiNapoli, A, Hammond, D, Haymaker, CL, Horwitz, SM, Hunt, KK, Lennox, P, Mallucci, P, Miranda, R, Munhoz, AM, Swanson, EC, Turner, SD, Firmani, G, Sorotos, M 2022 Practice Recommendation Updates From the World Consensus Conference on BIA-ALCL. Aesthetic surgery journal 42(11):1262-1278, 2022. PMID: 35639805.
16. Newman, LA, Fejerman, L, Pal, T, Mema, E, McGinty, GB, Cheng, A, Levy, M, Momoh, AO, Troester, MA, Schneider, B, McNeil, LH, Davis, M, Babagbemi, K, Hunt, KK Breast Cancer Disparities Through the Lens of the COVID-19 Pandemic. Current Breast Cancer Reports 13(3):110-112, 2021. PMID: 34394841.
17. Hunt, KK Invited Commentary. Journal of the American College of Surgeons 232(4):378-379, 2021. PMID: 33771294.
18. Freedman RA, Minami CA, Winer EP, Morrow M, Smith AK, Walter LC, Sedrak MS, Gagnon H, Perilla-Glen A, Wildiers H, Wildes TM, Lichtman SM, Loh KP, Brain EGC, Ganschow PS, Hunt KK, Mayer DK, Ruddy KJ, Jagsi R, Lin NU, Canin B, LeStage BK, Revette AC, Schonberg MA, Keating NL Individualizing Surveillance Mammography for Older Patients After Treatment for Early-Stage Breast Cancer: Multidisciplinary Expert Panel and International Society of Geriatric Oncology Consensus Statement. JAMA Oncol 7(4):609-615, 2021. PMID: 33507222.
19. Sheu TG, Hunt KK, Middleton LP MYC and NOTCH1 positive post-radiation cutaneous angiosarcoma of the breast. Breast J 27(00):1-4, 2021. PMID: 33527629.
20. DeCoster RC, Lynch EB, Bonaroti AR, Miranda RN, Hunt KK, Clemens MW Breast Implant-Associated Anaplastic Large Cell Lymphoma: Defining Future Research Priorities. Clin Plast Surg 48(1):33-43, 2021. PMID: 33220903.
21. Park KU, Mamounas EP, Katz MHG, Unzeitig G, Carpizo D, You YN, Francescatti A, Hunt KK, Boughey JC Clinical Trials for the Surgical Oncologist: Opportunities and Hurdles. Ann Surg Oncol. PMID: 32318946.
22. Caruso JA, Duong MT, Carey JPW, Hunt KK, Keyomarsi K Low-Molecular-Weight Cyclin E in Human Cancer: Cellular Consequences and Opportunities for Targeted Therapies. Cancer Res 78(19):5481-5491, 2018. PMID: 30194068.
23. Kuerer HM, Smith BD, Chavez-MacGregor M, Albarracin C, Barcenas CH, Santiago L, Edgerton ME, Rauch GM, Giordano SH, Sahin A, Krishnamurthy S, Woodward W, Tripathy D, Yang WT, Hunt KK DCIS Margins and Breast Conservation: MD Anderson Cancer Center Multidisciplinary Practice Guidelines and Outcomes. J Cancer 8(14):2653-2662, 2017. PMID: 28928852.
24. Mittendorf EA, Boughey JC, Hunt KK SLN surgery for clinically node-positive breast cancer patients treated with neoadjuvant therapy. Bull Am Coll Surg 99(7):52-4, 2014. PMID: 25076741.
25. Mittendorf EA, Hunt KK Commentary on the Pilewskie/Morrow Article, Following the Data: Past, Present, and Future Management of the Axilla in Breast Cancer Patients. Oncology 28(5):378-382, 2014. PMID: None.
26. Hunt K, Kohman L, Nelson H Announcing the Surgical Standards Manual Project: a call for volunteers. Bull Am Coll Surg 97(9):67-68, 2012. PMID: 23002684.
27. Yi M, Hunt KK Nodal-Stage Classification in Invasive Lobular Breast Carcinoma: Influence of Different Interpretations of the pTNM Classification. Breast Diseases: A Year Book Quarterly 22(4):366-367, 2012. PMID: None.
28. Wagner JL, Hunt KK Effect of Active Resistive Exercise on Breast Cancer - Related Lymphedema: A Randomized Controlled Trial. Breast Diseases: A Year Book Quarterly 22(3):255-256, 2011. PMID: None.
29. Mittendorf EA, Keyomarsi K, Hunt KK Cyclin E amplication/overexpression is a mechanism of trastuzumab resistance in HER2 breast cancer patients. Breast Diseases 22(3):266-267, 2011. PMID: None.
30. Mittendorf EA, Hunt KK Clinical Practice Implementation of findings from the American College of Surgeons Oncology Group Z0010 and Z0011 Trials. Breast Diseases: A Year Book Quarterly 22(2):115-118, 2011. PMID: None.
31. Hsu C, Vega F, Grimes LM, Hunt KK Follicular dendritic cell sarcoma and associated myasthenia gravis: true, true, related?. J Clin Oncol 29(13):e369-71, 2011. PMID: 21321294.
32. Bloom ES, Kirsner S, Mason BE, Nelson CL, Hunt KK, Baumann DP, Gifford KA Accelerated partial breast irradiation using the strut-adjusted volume implant single-entry hybrid catheter in brachytherapy for breast cancer in the setting of breast augmentation. Brachytherapy 10(3):178-83, 2011. PMID: 20719576.
33. Ota DM, Nelson H, Ellis M, Hunt K Measuring the impact of Z1031 on clinical practice. Bulletin of the American College of Surgeons 96(5), 2011. PMID: None.
34. Mittendorf EA, Hunt KK Isolated tumor cells in sentinel lymph nodes and clinical implications for early breast cancer. Ann Surg Oncol 16(9):2661, 2009. PMID: None.
35. Kronowitz SJ, Kuerer HM, Buchholz TA, Valero V, Hunt KK A management algorithm and practical oncoplastic surgical techniques for repairing partial mastectomy defects. Plast Reconstr Surg 122(6):1631-47, 2008. PMID: 19050516.
36. Chagpar A, Middleton LP, Sahin AA, Meric-Bernstam F, Kuerer HM, Feig BW, Ross MI, Ames FC, Singletary SE, Buchholz TA, Valero V, Hunt KK Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry. Cancer 103(8):1581-6, 2005. PMID: 15747375.
37. Hunt KK Spotlight on Breast Cancer. (From the 32nd Annual Phoenix Surgical Symposium, sponsored by the Maricopa Integrated Health System and the Phoenix Surgical Society) . Audio-Digest General Surgery 52(5), 2005. PMID: None.
38. Xing Y, Cormier JN, Kuerer HM, Hunt KK Sentinel lymph node biopsy following neoadjuvant chemotherapy: review of the literature and recommendations for use in patient management. Asian J Surg 27(4):262-7, 2004. PMID: 15564176.
39. Chada S, Sutton RB, Ekmekcioglu S, Ellerhorst J, Mumm JB, Leitner WW, Yang HY, Sahin AA, Hunt KK, Fuson KL, Poìndexter N, Roth JA, Ramesh R, Grimm EA, Mhashilkar AM MDA-7/IL-24 is a unique cytokine--tumor suppressor in the IL-10 family. Int Immunopharmacol 4(5):649-67, 2004. PMID: 15120650.
40. Koh JS, Trent J, Chen L, El-Naggar A, Hunt K, Pollock R, Zhang W Gastrointestinal stromal tumors: Overview of pathologic features, molecular biology, and therapy with imatinib mesylate. Histol Histopathol 19(2):565-74, 2004. PMID: 15024716.
41. Hunt KK Spotlight on gastrointestinal tumors. (From the 32nd Annual Phoenix Surgical Symposium), jointly sponsored by the Maricopa Integrated Health System and the Phoenix Surgical Society) . Audio-Digest General Surgery 51(08), 2004. PMID: None.
42. Vorburger SA, Pataer A, Swisher SG, Hunt KK Genetically targeted cancer therapy: tumor destruction by PKR activation. Am J Pharmacogenomics 4(3):189-98, 2004. PMID: 15174900.
43. Fang B, Hunt KK Commentary for chapter, Gene Therapy and Virotherapy of Pancreatic Cancer. Pancreatic Cancer. Von Hoff DD, Evans D, Hruban RH (eds); Jones & Bartlett Publishers, Sudbury, MA, 2004. PMID: None.
44. Buchholz TA, Hunt KK, Whitman GJ, Sahin AA, Hortobagyi GN Neoadjuvant chemotherapy for breast carcinoma: multidisciplinary considerations of benefits and risks. Cancer 98(6):1150-60, 2003. PMID: 12973838.
45. Butler CE, Hunt KK, Singletary SE Management of breast carcinoma identified intraoperatively during reduction mammaplasty. Ann Plast Surg 50(2):193-7, 2003. PMID: 12567059.
46. Singletary SE, Fornage BD, Sneige N, Ross MI, Simmons R, Giuliano A, Hansen N, Kuerer HM, Newman LA, Ames FC, Babiera G, Meric F, Hunt KK, Edeiken B, Mirza AN Radiofrequency ablation of early-stage invasive breast tumors: an overview. Cancer J 8(2):177-80, 2002. PMID: 11999950.
47. Keleher AJ, Theriault RL, Gwyn KM, Hunt KK, Stelling CB, Singletary SE, Ames FC, Buchholz TA, Sahin AA, Kuerer HM Multidisciplinary management of breast cancer concurrent with pregnancy. J Am Coll Surg 194(1):54-64, 2002. PMID: 11800340.
48. Cormier JN, Patel SR, Herzog CE, Ballo MT, Burgess MA, Feig BW, Hunt KK, Raney RB, Zagars GK, Benjamin RS, Pisters PW Concurrent ifosfamide-based chemotherapy and irradiation. Analysis of treatment-related toxicity in 43 patients with sarcoma. Cancer 92(6):1550-5, 2001. PMID: 11745234.
49. Baker TP, Lenert JT, Parker J, Kemp B, Kushwaha A, Evans G, Hunt KK Lactating adenoma: a diagnosis of exclusion. Breast J 7(5):354-7, 2001. PMID: 11906446.
50. Kuerer HM, Hunt KK, Singletary SE, Ames FC Unusual aspects of breast cancer: case 3. Blue hives during lymphatic mapping for breast cancer. J Clin Oncol 19(9):2573-4, 2001. PMID: 11331339.
51. Hunt KK Comment on Jokela RM, Kangas-Saarela TA, Valanne JVI, et al. Postoperative nausea and vomiting after sevoflurane with or without ondansetron compared with propofol in female patients undergoing breast surgery. Breast Diseases. A Year Book Quarterly 12(2):201, 2001. PMID: None.
52. Kuerer HM, Hunt KK, Newman LA, Ross MI, Ames FC, Singletary SE Neoadjuvant chemotherapy in women with invasive breast carcinoma: conceptual basis and fundamental surgical issues. J Am Coll Surg 190(3):350-63, 2000. PMID: 10703863.
53. Swisher SG, Pataer A, Fang B, Yu R, Nishizaki M, Fang B, Hunt KK, Roth JA Enhancement of adenoviral mediated p53 (Adp53) tumor killing with amifostine induced CDC2 kinase activation. Surg Forum L1:312-3, 2000. PMID: None.
54. Hunt KK Comment on Winchester DJ, Fener S, Winchester DP, et al. Sentinel lymphadenectomy for breast cancer: Experience with 180 consecutive patients: Efficacy of filtered technetium 99m sulfur colloid with overnight migration time. Breast Diseases: A Year Book Quarterly 10(4):457-9, 2000. PMID: None.
55. Newman LA, Kuerer HM, Harper T, Hunt KK, Laronga C, Breslin T, Singletary SE Special considerations in breast cancer risk and survival. J Surg Oncol 71(4):250-60, 1999. PMID: 10440767.
56. Hunt KK Comment on Chan MTV, Chui PT, Ho WS, et al. Single-dose tropisetron for preventing postoperative nausea and vomiting after breast surgery. Anesth Analg 1998;87:931-5. Breast Diseases: A Year Book Quarterly 10(2):201-2, 1999. PMID: None.
57. Hunt KK Comment on Bloomston M, D'Angelo P, Galliano D, et al. One hundred consecutive advanced breast biopsy instrumentation procedures: Complications, costs, and outcome. Ann Surg Oncol 1999;6:195-9. Breast Diseases: A Year Book Quarterly 10(3):316, 1999. PMID: None.
58. Hunt KK Comment on Berardo MD, Elledge RM, de Moor C, et al. Bcl-2 and apoptosis in lymph node positive breast carcinoma. Cancer 1998;82:1296-1302. Breast Diseases: A Year Book Quarterly 9(4):354-6, 1999. PMID: None.
59. Hunt KK Comment on Seltzer MH. Preoperative prediction of open breast biopsy results. Cancer 1997;79:1822-7. Breast Diseases: A Year Book Quarterly 8(4):365, 1998. PMID: None.
60. Hunt KK Comment on Fujii Y, Tanaka H, Toyooka H. Granisetron reduces incidence of nausea and vomiting after breast surgery. Acta Anaesthesiol Scand 1997;41:746-9. Breast Diseases: A Year Book Quarterly 9(1):78, 1998. PMID: None.
61. Hunt KK Comment on Moore MM, Hargett CW III, Hanks JB, et al. Association of breast cancer with the finding of atypical ductal hyperplasia at core breast biopsy. Ann Surg 1997;225:726-33. Breast Diseases: A Year Book Quarterly 9(1):77-8, 1998. PMID: None.
62. Hunt KK Comment on Yim JH, Wick MR, Philpott GW, et al. Underlying pathology in mammary Paget's disease. Ann Surg Oncol 1997;4:287-92. Breast Diseases: A Year Book Quarterly 8(4):362-3, 1998. PMID: None.
63. Hunt KK Comment on Brain E, Garrino C, Misset J-L, et al. Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy. Br J Cancer 1997;75:1360-7. Breast Diseases: A Year Book Quarterly 8(4):343-4, 1998. PMID: None.
64. Hunt KK Comment on Frazee RC, Roberts JW, Symmonds RE, et al. Open versus stereotactic breast biopsy. Am J Surg 1996;172:491-5. Breast Diseases: A Year Book Quarterly 8(2):150, 1997. PMID: None.
65. Mansfield PF, Hunt KK Classification, staging, and management of non-Hodgkin's lymphomas. Cancer Treat Res 90:203-11, 1997. PMID: 9367084.
66. Hunt KK Comment on Curcio LD, Chu DZJ, Ahn C, et al. Local recurrence in breast cancer: implications for systemic disease. Ann Surg Oncol 1997;4:24-7. Breast Diseases: A Year Book Quarterly 8(3):242-3, 1997. PMID: None.
67. Hunt KK Comment on Salvat J, Knopf J-F, Ayoubi J-M, et al. Endoscopic exploration and lymph node sampling of the axilla: preliminary findings of a randomized pilot study comparing clinical and anatomo-pathologic results of endoscopic axillary lymph node sampling with traditional surgical treatment. Eur J Obstet Gynecol Reprod Biol 1996;70:165-73. Breast Diseases: A Year Book Quarterly 8(3):238-9, 1997. PMID: None.
68. Hunt KK Comment on Bosek V, Cox CE. Comparison of analgesic effect of locally and systemically administered keterolac in mastectomy patients. Ann Surg Oncol 1996;3:62-6. Breast Diseases: A Year Book Quarterly 8(1):52, 1997. PMID: None.
69. Hunt KK Comment on Cady B, Stone MD, Schuler JG, et al. The new era in breast cancer: invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening. Arch Surg 1996;131:301-8. Breast Diseases: A Year Book Quarterly 8(1):48-9, 1997. PMID: None.
70. Hunt KK Comment on Desai DC, Brennan EJ Jr, Carp NZ. Paget’s disease of the male breast. Am Surg 1996;12:1068-72. Breast Diseases: A Year Book Quarterly 8(2):150-1, 1997. PMID: None.
71. Hunt KK Comment on Love SM, Barsky SM. Breast-duct endoscopy to study stages of cancerous breast disease. Lancet 1996;348:997-9. Breast Diseases: A Year Book Quarterly 8(2):150, 1997. PMID: None.
72. Hunt KK Comment on Breant CM, Love SM. A hospital wide integrated database infrastructure to support a research program for a multidisciplinary breast center. Breast J 1997;2:289-298. Breast Diseases: A Year Book Quarterly 8(2):96, 1997. PMID: None.
73. Hunt KK Comment on Schoenfeld A, Luqmani Y, Sinnett HD, et al. Keratin 19 mRNA measurement to detect micrometastases in lymph nodes in breast cancer patients. Br J Cancer 1996;74:1639-42. Breast Diseases: A Year Book Quarterly 8(3):244, 1997. PMID: None.
74. Hunt KK Comment on Liberman L, LaTrenta LR, Dershaw DD, et al. Impact of core biopsy on the surgical management of impalpable breast cancer. AJR 1997;168:495-9. Breast Diseases: A Year Book Quarterly 8(3):243-4, 1997. PMID: None.
75. Hunt KK Comment on Carlson GW. Skin sparing mastectomy: anatomic and technical considerations. Am Surg-62:151-5, 1996. Breast Diseases: A Year Book Quarterly 2:283, 1996. PMID: None.
76. Swisher SG, Cates JA, Hunt KK, Robert ME, Bennion RS, Thompson JE, Roslyn JJ, Reber HA Pancreatitis associated with adult choledochal cysts. Pancreas 9(5):633-7, 1994. PMID: 7809018.
77. Miller AR, McBride WH, Hunt K, Economou JS Cytokine-mediated gene therapy for cancer. Ann Surg Oncol 1(5):436-50, 1994. PMID: 7850546.
78. Alvarez C, Hunt K, Ashley SW, Reber HA Emphysematous cholecystitis after ERCP. Dig Dis Sci 39(8):17, 19-23, 1994. PMID: 8050324.

Editorials

1. Thomas, KK, Francescatti, A, Vreeland, TJ, Teshome, M, Morris, AM, Hunt, KK, Katz, MH, Villano, AM. Standardization of Colon Resection for Cancer. Annals of surgical oncology 31(1):6-9, 2024. PMID: 37880516.
2. Zaveri S, Lillemoe HA, Teshome M, Reyna CR, Vreeland TJ, Francescatti AB, Zheng L, Hunt KK, Katz MHG, Kilgore LJ. Operative standards for sentinel lymph node biopsy and axillary lymphadenectomy for breast cancer: review of the American College of Surgeons commission on cancer standards 5.3 and 5.4. Surgery 174(3):717-721, 2023. PMID: 37202308.
3. Lillemoe HA, Williams JK, Teshome MK, Zheng L, Francescatti AB, Hieken TJ, Katz MH, Hunt KH, Vreeland TJ, Asare EA. Setting the Standard for Cutaneous Melanoma Wide Local Excision: An Overview of the American College of Surgeons Commission on Cancer Standard 5.5. J Am Coll Surg 236(2):424-428, 2023. PMID: 36648270.
4. Boughey JC, Blair SL, Subhedar PD, Edge SB, White JR, Hunt KK. The EA2108 Clinical Trial and Real-World Data: A Cautionary Tale in Stage IV Breast Cancer. Ann Surg Oncol 29(8):4663-4666, 2022. PMID: 35578060.
5. Hunt KK. Editorial on Toesca et al's "A Randomized Trial of Robotic Mastectomy Versus Open Surgery in Women With Breast Cancer or BRCA Mutation". Ann Surg 276(1):20-21, 2022. PMID: 35703454.
6. Adams AM, Vreeland TJ, Teshome M, Francescatti AB, Zheng L, Hunt KK, Katz MHG, Messick CA. American College of Surgeons Commission on Cancer Standard 5.7 for Total Mesorectal Excision for Mid-to-Low Rectal Cancer. J Am Coll Surg 234(6):1249-1253, 2022. PMID: 35703824.
7. Tamirisa N, Hunt KK. Neoadjuvant Chemotherapy, Endocrine Therapy and Targeted Therapy for Breast Cancer: ASCO Guideline. Ann Surg Oncol 29(3):1489-1492, 2022. PMID: 34989940.
8. Nissen AP, Vreeland TJ, Teshome M, Archer MA, Francescatti AB, Katz MH Hunt KK, Zheng L, Mullett TW. American College of Surgeons Commission on Cancer Standard for Curative-intent Pulmonary Resection. The Annals of Thoracic Surgery, 2022. PMID: None.
9. Nissen AP, Vreeland TJ, Teshome M, Archer MA, Francescatti AB, Katz MHG, Hunt KK, Zheng L, Mullett TW. American College of Surgeons Commission on Cancer Standard for Curative Intent Pulmonary Resection. Ann Thorac Surg 113(1):5-8, 2022. PMID: 34119494.
10. Hwang RF, Hunt KK. The Emergence of Robotic-assisted Breast Surgery: Proceed With Caution. Ann Surg 271(6):1013-1015, 2020. PMID: 32398613.
11. Howe JR, Bartlett DL, Tyler DS, Wong SL, Hunt KK, DeMatteo RP, Surgical Oncology SO. COVID-19 Guideline Modifications as CMS Announces "Opening Up America Again": Comments from the Society of Surgical Oncology. Ann Surg Oncol. PMID: 32378088.
12. Partain NS, Hunt KK. Imaging Surveillance After Definitive Treatment for Breast Cancer. Ann Surg Oncol 25(13):3790-3792, 2018. PMID: 30238244.
13. Kuerer HM, Hunt KK. Limiting Axillary Surgery for Patients with Initial Biopsy-Proven Axillary Metastases After Preoperative Chemotherapy: To Clip or Not to Clip?. Ann Surg Oncol 23(11):3432-4, 2016. PMID: 27469119.
14. Fayanju OM, Buchholz TA, Hunt KK. Postmastectomy radiation treatment rates as a quality measure: an opportunity for compliance through collaboration. Ann Surg Oncol 23(8):2377-2379, 2016. PMID: 27160527.
15. Liao N, Hunt KK, Balch CM. Management of invasive and non invasive breast cancer in the United States and China. Chin Clin Oncol 5(3):30, 2016. PMID: 27265301.
16. Yi M, Hunt KK. Optimizing Mammography Screening Intervals. JAMA 314(15):1635-6, 2015. PMID: 26501538.
17. Dixon JM, Rutgers E, Hunt KK. Intraoperative assessment of axillary lymph nodes in patients with breast cancer. BMJ 349:g6803, 2014. PMID: 25425017.
18. Mittendorf EA, Hunt KK. Following the data: past, present, and future management of the axilla in breast cancer patients. Oncology (Williston Park) 28(5):378, 380, 382, 2014. PMID: 25004649.
19. Hunt KK, Smith BD, Mittendorf EA. The controversy regarding margin width in breast cancer: enough is enough. Ann Surg Oncol 21(3):701-3, 2014. PMID: 24473644.
20. Haffty BG, Hunt KK, Harris JR, Buchholz TA. Positive sentinel nodes without axillary dissection: implications for the radiation oncologist. J Clin Oncol 29(34):4479-81, 2011. PMID: 22042942.
21. Hunt KK, Woodward WA. Have we made progress in inflammatory breast cancer? Not so fast. Oncology (Williston Park) 25(3):276, 278, 2011. PMID: 21548471.
22. Hunt KK, Cormier JN. Risky business: Identifying risk factors associated with lymphedema after breast cancer: Comment on "Risk factors for lymphedema in a prospective breast cancer survivorship stud. Arch Surg 145(11):1063-4, 2010. PMID: 21121095.
23. Rourke LL, Hunt KK. Avoiding radiation after breast-conserving surgery for ductal carcinoma in situ of the breast: beyond the margin. Ann Surg 251(4):592-4, 2010. PMID: 20224366.
24. Hunt KK, Askew R, Cormier JN. Measuring lymphedema in patients with breast cancer: Go with the flow?. Breast Cancer Res Treat 117(3):559-60, 2009. PMID: 19205875.
25. Mittendorf EA, Hunt KK. Lymphatic interrupted: Do we really understand the risks and consequences?. Ann Surg Oncol 16(7):1768-1770, 2009. PMID: 19352776.
26. Hunt KK, Buchholz TA, Hortobagyi GN. Now and later? The sticky question of lymph node management in patients receiving preoperative chemotherapy. Ann Surg Oncol 12(9):683-5, 2005. PMID: 16041472.
27. Hunt KK, Buchholz TA, Hortobagyi GN. Now and later? The sticky question of lymph node management in patients receiving pre-operative chemotherapy. Editorial. Ann Surg Oncol 12(9):1-3, 2005. PMID: None.
28. McMasters KM, Hunt KK. Neoadjuvant chemotherapy, locally advanced breast cancer, and quality of life. J Clin Oncol 17(2):441-4, 1999. PMID: 10080583.

Abstracts

1. Zaveri S, Everidge S, FitzSullivan E, Hwang R, Smith BD, Lin H, Shen Y, Lucci A, Teshome M, Sun SX, Hunt KK, Kuerer HM. ASO Visual Abstract: Extremely Low Incidence of Local-Regional Recurrences Observed among T1-2N1 (one or two Positive SLNs) Breast Cancer Patients Receiving Upfront Mastectomy without Completion Axillary Node Dissection. Ann Surg Oncol. e-Pub 2023. PMID: 37612547.
2. Witt RG, Voss RK, Chiang YJ, Nguyen S, Scally CP, Lin PP, Torres KE, Moon BS, Satcher RL, Hunt KK, Bird JE, Feig BW, Lewis VO, Roland CL, Keung EZ. ASO Visual Abstract: Practice Pattern Variability in the Management of Regional Lymph Node Metastasis in Extremity and Trunk Soft Tissue Sarcoma (ETSTS): A Survey of the Society of Surgical Oncology (SSO) and Musculoskeletal Tumor Society (MSTS) Membership. Ann Surg Oncol 30(6):3679-3680, 2023. e-Pub 2023. PMID: 36826618.
3. Hunt KK, Suman VJ, Wingate HF, Leitch AM, Unzeitig G, Boughey JC, Meric-Bernstam F, Ellis MJ, Olson JA. ASO Visual Abstract: Local-Regional Recurrence Following Neoadjuvant Endocrine Therapy - Data from ACOSOG Z1031 (Alliance), a Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clinical Stage 2-3 Breast Cancer. Ann Surg Oncol 30(4):2119-2120, 2023. PMID: 36745260.
4. Murphy BL, Yi M, Barrera AG, Tripathy D, Hunt KK, Arun BK. ASO Visual Abstract: Other Primary Malignancies in Patients with Breast Cancer Who Undergo Germline Panel Testing. Ann Surg Oncol 30(3):1669-1670, 2023. e-Pub 2022. PMID: 36210399.
5. Erstad DJ, Chiang YJ, Witt RG, Cope B, Nassif EF, Scally CP, Torres KE, Feig BW, Hunt KK, Bishop AJ, Guadagnolo BA, Roland CL, Keung EZ. ASO Visual Abstract: Clinical Impact of External Beam Radiotherapy for Surgically Resected Primary Retroperitoneal Liposarcoma. Ann Surg Oncol 30(2):941-942, 2023. e-Pub 2022. PMID: 36161369.
6. Erstad DJ, Chiang YJ, Witt RG, Cope B, Nassif EF, Scally CP, Torres KE, Feig BW, Hunt KK, Bishop AJ, Guadagnolo BA, Roland CL, Keung EZ. ASO Visual Abstract: Clinical Impact of External Beam Radiotherapy for Surgically Resected Primary Retroperitoneal Liposarcoma. Ann Surg Oncol 30(2):941-942, 2023. e-Pub 2022. PMID: 36161369.
7. Traweek RS, Martin AN, Rajkot NF, Guadagnolo BA, Bishop AJ, Lazar AJ, Keung EZ, Torres KE, Hunt KK, Feig BW, Roland CL, Scally CP. ASO Visual Abstract: Re-Excision After Unplanned Excision of Soft Tissue Sarcoma Is Associated with High Morbidity and Limited Pathologic Identification of Residual Disease. Ann Surg Oncol 30(1):492, 2023. PMID: 36245056.
8. Woodfin AA, Yam C, Teshome M, Kuerer HM, Hunt KK, Meric-Bernstam F, Barcenas C, Sun SX. Surgical Outcomes in Patients Receiving Pembrolizumab Containing Neoadjuvant Systemic Therapy Regimens for Triple Negative Breast Cancer. American Society of Breast Surgeons (ASBrS) 2023 Annual Meeting, 2023. PMID: None.
9. Murphy BL, Yi M, Barrera AG, Tripathy D, Hunt KK, Arun BK. ASO Visual Abstract: Other Primary Malignancies in Patients with Breast Cancer Who Undergo Germline Panel Testing. Ann Surg Oncol. e-Pub 2022. PMID: 36210399.
10. Alpard SK, Hunt KK, Bridges C, Jiang J, Tran J, Checka CM. Breast Surgical Oncology Innovation: Development of a Departmental Innovation Program in an Academic Institution. SSO 2022 International Conference on Surgical Cancer Care, 2022. PMID: None.
11. Alpard SK, Truskett V, Bartlett R, Boruta D, Jennings A, Price M, Romig K, Hunt KK, Lu K, Checka CM. Texas Biodesign: A Novel Cross Industry and University System Collaboration to Foster Convergent Healthcare Innovation. SSO 2022 International Conference on Surgical Cancer Care, 2022. PMID: None.
12. Carlson KA, Wang Y, Singareeka A, Yi M, Durak M, Edgerton M, Keyomarsi K, Hunt KK. Margin Status is the Only Clinical or Treatment Related Factor Significantly Associated with Breast Cancer Recurrence in Patients Diagnosed with DCIS Over Long-term Clinical Follow-Up. SSO 2022 International Conference on Surgical Cancer Care, 2022. PMID: None.
13. Hwang S, Blumencranz P, Chagpar A, Smith B, Dodg D, Carr D, Hunt KK, Gold L, Clark L, Dekhne N, Karp S, Ferrer J, Smith K, Madden S, Cohen L. The clinical impact of intraoperative margin assessment in breast cancer surgery using a novel pegulicianine fluorescence guided surgery system: A Prospective Single Arm Study. SSO 2022 International Conference on Surgical Cancer Care, 2022. PMID: None.
14. Keung EZ, Nassif EF, Lin H, Lazar AJ, Wang WL, Parra ER, Lima CF, Wistuba I, G BA, Bishop AJ, Lewis V, Torres KE, Hunt KK, Feig BW, Scally CP, Rawi AN, Crosby S, Mathew G, Ingram D, Wani K, Wargo JA, Somaiah N, Roland CL. Immune infiltrates are associated with clinical outcomes in patients with resectable soft tissue sarcoma (STS) treated with neoadjuvant immune checkpoint blockade (ICB). Society for Immunotherapy of Cancer 36th Annual Meeting, 2021. PMID: None.
15. Erstad DJ, Chiang YJ, Witt RG, Scally CP, Torres KE, Feig BW, Hunt KK, Bishop AJ, Guadagnolo BA, Roland CL, Keung EZ. Clinical Impact of External Beam Radiotherapy for Surgically Resected Primary Retroperitoneal Liposarcoma. Western Surgical Association 129th Scientific Session 2021 Annual Meeting, 2021. PMID: None.
16. Nassif EF, Roland CL, Thirasastr P, Scally CP, Zarzour A, Valenzuela R, Torres KE, Hunt KK, Feig BW, Wang WL, Lazar AJ, Somaiah N, Keung EZ. Surgical Outcomes of Patients With Well-Differentiated and Dedifferentiated Retroperitoneal Liposarcomas Treated with Palbociclib. Connective Tissue Oncology Society 2021 Virtual Annual Meeting, 2021. PMID: None.
17. Witt RG, Chiang YJ, Erstad DJ, Scally CP, Torres KE, Hunt KK, Feig BW, Roland CL, Keung EZ. Sentinel lymph node biopsy and formal lymphadenectomy for soft tissue sarcoma – a single center experience of 86 consecutive cases. Connective Tissue Oncology Society 2021 Virtual Annual Meeting, 2021. PMID: None.
18. Hunt, KK, Liang DH. Effective localization of non-palpable breast lesions using Magseed. [Abstract] Accepted for presentation, 2020 ACS Quality and Safety Virtual Conference, 2020. PMID: None.
19. Kuritzky A, Reyna C, McGuire KP, Sun W, DeSnyder SM, Aubry S, Nayyar A, Strassle P, Hunt KK, Zhou JM, Lee MC. Evaluation of 2014 margin guidelines on re-excision and recurrence rates after breast conserving surgery: A multi-institution retrospective study. Breast 51:29-33, 2020. e-Pub 2020. PMID: 32199230.
20. Piotrowski MJ, Yi M, Contreras A, Hunt KK, Hwang RF, Kuerer HM, Le-Petross HC, Teshome M, Underbrink A, DeSnyder SM. Optimization of intraoperative lumpectomy specimen labeling improves concordance between surgeon and pathology. The American Society of Breast Surgeons [ASBrS] Volume XXI, 2020. PMID: None.
21. Rajkot N, Cormier JN, Torres KE, Somaiah N, Hunt KK, Feig BW, Ikoma N, Roland CL. The impact of surveillance interval following resection of primary well differentiated liposarcoma of the retroperitoneum. Oral Presentation, 2020 South Texas ACS Annual Meeting, 2020. PMID: None.
22. Ma CX, Suman VJ, Leitch AM, Sanati S, Vij KR, Unzeitig GW, Hoog J, Watson M, Hahn OM, Guenther JM, Caudle AS, Dockter T, Korde LA, Weiss A, Hunt KK, Hudis CA, Winer EP, Partridge AH, Carey LA, Ellis MJ. Neoadjuvant endocrine treatment (NET) approaches for clinical stage II or III estrogen receptor-positive HER2-negative breast cancer (ER+ HER2- BC) in postmenopausal (PM) women: Alliance A011106. ASCO 2020 Virtual Scientific Program, 2020. PMID: None.
23. Piotrowski MJ, Yi M, Bedrosian I, Caudle AS, Hunt KK, Le-Petross C, Miggins M, Teshome M, DeSnyder SM. Optimization of intraoperative lumpectomy specimen labeling. American College of Surgeons Quality and Safety Conference, 2019. PMID: None.
24. Singh P, Scoggins ME, Sahin A, Hwang RF, Kuerer HM, Caudle AS, Mittendorf E, Thompson A, Bedrosian I, Teshome M, DeSnyder S, Meric-Bernstam F, Hunt KK. Effectiveness and Safety of Magseed-localization for Excision of Breast Lesions: A Prospective Trial. Podium Presentation, American College of Surgeons Quality and Safety Conference 2019, 2019. PMID: None.
25. Singh P, Scoggins ME, Sahin A, Hwang RF, Kuerer HM, Caudle AS, Mittendorf E, Thompson A, Bedrosian I, Teshome M, DeSnyder S, Meric-Bernstam F, Hunt KK. Effectiveness and Safety of Magseed-localization for Excision of Breast Lesions: A Prospective Trial. Poster Presentation, Society of Surgical Oncology 2019 Annual Cancer Symposium, 2019. PMID: None.
26. Nurudeen S, Yi M, Bedrosian I, Caudle A, DeSnyder S, Kuerer HM, Mittendorf EA, Hunt KK. PT16: Factors Associated with Local-Regional Recurrence Following Sentinel Lymph Node Dissection (SLND) in Clinically Node Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy. 2018 SSO's 71st Annual Cancer Symposium, 2017. PMID: None.
27. Cheung KL, Green AR, Ellis IO, Keyomarsi K, Hunt KK, Syed BM. P011 Cyclin E in early operable primary breast cancer in older women – analysis of clinical outcome and relations with biomarkers. 2017: 17th Conference of the International Society of Geriatric Oncology, 2017. PMID: None.
28. Yi M, Hunt KK, Bedrosian I, Chavez-MacGregor M. Staging for Breast Cancer Patients Receiving Neoadjuvant Chemotherapy: Utility of the 8th Edition AJCC. 2018 SSO's 71st Annual Cancer Symposium, 2017. PMID: None.
29. Brewster AM, Peterson SK, Bedrosian I, Thompson AM, Black DM, Nelson J, Cook R, DeSnyder SM, Hunt K, Cantor SB, Volk RJ, Dong W, and Parker PA. Prospective study of psychosocial outcomes of having contralateral prophylactic mastectomy among women with non-hereditary breast cancer. Journal of Clinical Oncology(15):6569-6569, 2017. PMID: None.
30. Smith BD, Jiang J, Y-CT S, Giordano SH, Huo J, Jagsi R, Caudle AS, Hunt KK, Shaitelman SF, Buchholz TA, Shirvani SM. Complication and economic burden of local therapy options for early breast cancer. Journal of the National Cancer Institute 109(1):djw178, 2016. PMID: 27678203.
31. Roland CL, May CD, Watson KL, Al Sannaa GA, Dineen SP, Feig R, Landers S, Ingram DR, Wang WL, Guadagnolo BA, Feig B, Hunt KK, Cormier JN, Lazar AJ, Torres KE. Analysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic Sarcoma. Ann Surg Oncol 23(7):2220-8, 2016. e-Pub 2016. PMID: 26847678.
32. Christina L Roland MD, Brian K Bednarski MD, Kelsey Watson BS, MD PhD KET, Janice N Cormier MD, MPH, Gary Mann MD, Wei-Lien Wang MD, MD PhD AL, Neeta Somaiah MD, Kelly K Hunt MD, Barry W Feig MD. Surgical Management of Patients with Recurrent or Intra-abdominal Metastatic GIST Following Neoadjuvant Tyrosine Kinase Inhibitor Therapy: Who is Benefiting?. None, 2016. PMID: None.
33. Simmons RM, Ballman KV, Cox C, Carp N, Sabol J, Hwang RF, Attai D, Sabel M, Nathanson D, Kenler A, Gold L, Kaufman C, Han L, Bleznak A, Stanley Smith J, Holmes D, Fornage B, Le-Petross C, Hoda S, McCall L, Hunt KK, investigators A. A Phase II Trial Exploring the Success of Cryoablation Therapy in the Treatment of Invasive Breast Carcinoma: Results from ACOSOG (Alliance) Z1072. Ann Surg Oncol. e-Pub 2016. PMID: 27221361.
34. Karakas C, Biernacka A, Bui T, Sahin A, Yi M, Akli S, Schafer J, Alexander A, Adjapong O, Hunt KK, Keyomarsi K. Cytoplasmic Cyclin E and Phospho-Cyclin-Dependent Kinase 2 Are Biomarkers of Aggressive Breast Cancer. Am J Pathol. e-Pub 2016. PMID: 27182644.
35. Lucenay KS, Doostan I, Karakas C, Bui T, Ding Z, Mills GB, Hunt KK, Keyomarsi K. Cyclin E Associates with the Lipogenic Enzyme ATP-Citrate Lyase to Enable Malignant Growth of Breast Cancer Cells. Cancer Res 76(8):2406-18, 2016. e-Pub 2016. PMID: 26928812.
36. JavanMoghadam S, Weihua Z, Hunt KK, Keyomarsi K. Estrogen receptor alpha is cell cycle-regulated and regulates the cell cycle in a ligand-dependent fashion. Cell Cycle:1-12. e-Pub 2016. PMID: 27049344.
37. Mougalian SS, Hernandez M, Lei X, Lynch S, Kuerer HM, Symmans WF, Theriault RL, Fornage BD, Hsu L, Buchholz TA, Sahin AA, Hunt KK, Yang WT, Hortobagyi GN, Valero V. Ten-Year Outcomes of Patients With Breast Cancer With Cytologically Confirmed Axillary Lymph Node Metastases and Pathologic Complete Response After Primary Systemic Chemotherapy. JAMA Oncol 2(4):508-16, 2016. PMID: 26720612.
38. Watson KL, Al Sannaa GA, Kivlin CM, Ingram DR, Landers SM, Roland CL, Cormier JN, Hunt KK, Feig BW, Ashleigh Guadagnolo B, Bishop AJ, Wang WL, Slopis JM, McCutcheon IE, Lazar AJ, Torres KE. Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors. J Neurosurg:1-11. e-Pub 2016. PMID: 27035165.
39. Caudle AS, Yang WT, Krishnamurthy S, Mittendorf EA, Black DM, Gilcrease MZ, Bedrosian I, Hobbs BP, DeSnyder SM, Hwang RF, Adrada BE, Shaitelman SF, Chavez-MacGregor M, Smith BD, Candelaria RP, Babiera GV, Dogan BE, Santiago L, Hunt KK, Kuerer HM. Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection. J Clin Oncol 34(10):1072-8, 2016. e-Pub 2016. PMID: 26811528.
40. Fayanju OM, Mayo TL, Spinks TE, Lee S, Barcenas CH, Smith BD, Giordano SH, Hwang RF, Ehlers RA, Selber JC, Walters RS, Tripathy D, Hunt KK, Buchholz TA, Feeley TW, Kuerer HM. Implementing value-based cancer care: a multidisciplinary approach to defining breast cancer outcomes. 2016 ASCO Quality Care Symposium, 2016. PMID: None.
41. Mitri ZI, Ueno NT, Yang W, Valero V, Litton JK, Murthy RK, Ibrahim NK, Arun BK, Mittendorf EA, Hunt KK, Meric-Bernstam F, Thompson A, Piwnica-Worms H, Tripathy D, Symmans F, Moulder-Thompson S. Women's triple-negative, first-line treatment: Improving outcomes in triple-negative breast cancer using molecular triaging and diagnostic imaging to guide neoadjuvant therapy. San Antonio Breast Cancer Symposium 2015, 2015. PMID: None.
42. Vila J, Bassett RL, Mittendorf EA, Bedrosian I, Shaitelman SF, Stauder MC, Gregor MC, Litton JK, Yang WT, Huo L, Kuerer HM, Hunt K, Caudle AS. A nomogram to predict axillary response to neoadjuvant chemotherapy in clinically node positive breast patients. None, 2015. PMID: None.
43. Haffty BG, Mccall LM, Ballman KV, Mclaughlin S, Jagsi R, Ollila DW, Hunt KK, Buchholz TA, Boughey JC. Patterns of Local-Regional Management Following Neoadjuvant Chemotherapy in Breast Cancer: Results From ACOSOG Z1071. International Journal of Radiation Oncology, 2015. PMID: 26867878.
44. Haffty BG, Ballman KV, Hunt KK, McCall LM, Boughey JC. Impact of radiation on Local regional control in women with node positive breast cancer treated with neoadjuvant chemotherapy (NAC) and axillary lymph node dissection (ALND. International Journal of Radiation Oncology, 2015. PMID: 26867878.
45. Dogan BE, Dryden MJ, Wei W, Fornage BD, Buchholz TA, Yang WT, Hunt KK. Value of US and US-guided needle biopsy of internal mammary (IM) nodal basin in baseline staging of breast cancer patients. 100th Radiological Society of North America Annual Meeting, 2014. PMID: None.
46. Ma CX, Suman V, Leitch AM, Sanati S, DeSchryver K, Unzeitig GW, Haluska P, Watson M, Hahn O, Zujewski JA, Hunt K, Winer EP, Hudis CA, Ellis MJ. Alliance A011106: Alternate approaches for clinical stage II or III Estrogen Receptor positive breast cancer Neoadjuvant Treatment (ALTERNATE) in postmenopausal women: A phase III study. Poster Presentation at 2014 San Antonio Breast Cancer Symposium, 2014. PMID: None.
47. Boughey JC, Ballman KV, Symmans WF, McCall LM, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, Hunt KK. Methods impacting the false negative rate of sentinel lymph node surgery in patients presenting with node positive breast cancer (T0-T4,N1-2) who receive neoadjuvant chemotherapy–results from a prospective trial–ACOSOG Z1071 (Alliance). 2014 San Antonio Breast Cancer Symposium, 2014. PMID: None.
48. Eberth JM, Xu Y, Smith GL, Jiang J, Buchholz T, Hunt KK, Black DS, Giordano SH, Whitman GH, Yang W, Shen C, Elting LS, Smith BD. Quality of breast cancer care in the US: a national analysis of Medicare beneficiaries, 2003-2007. Ann Epidemiol(9):683, 2014. PMID: None.
49. Boughey JC, McCall L, Ballman K, Mittendorf EA, Ahrendt G, Wilke L, Taback B, Leitch AM, Flippo-Morton T, Hunt KK. Tumor Subtype Impacts Surgical Approach and Pathological Response to Neoadjuvant Chemotherapy in Node-Positive Breast Cancer Patients - Findings from a Prospective Multicenter Clinical Trial (ACOSOG Z1071 [Alliance]). American Surgical Association 134th Annual Meeting, 2014. PMID: None.
50. Ikoma N, Tseng W, Torres K, Hunt K, Cormier J, Somaiah N, Feig B. Accuracy of Percutaneous Biopsy for Retroperitoneal Liposarcoma. Society of Surgical Oncology 2014 Annual Cancer Symposium, 2014. PMID: None.
51. Teshome M, Ballman K, McCall L, Cormier J, Giuliano A, Hunt K. Long-term Incidence of Lymphedema after Sentinel Lymph Node Dissection for Early Stage Breast Cancer: ACOSOG Z0010 (Alliance). Society of Surgical Oncology 2014 Annual Meeting, 2014. PMID: None.
52. Ikoma N, Chiang YJ, Cormier J, Torres K, Hunt K, You YN, Feig B. Spindle Cell Tumors of the Colon and Rectum. Society of Surgical Oncology 2014 Annual Meeting, 2014. PMID: None.
53. Shen MC, Bloom E, Shaitelman SF, Wei C, Haynes AB, Mittendorf EA, Kuerer HM, Bedrosian I, Hwang RF, Hunt KK, Tereffe W, Strom E, Babiera GV. Comparison of infectious complications between breast conserving therapy with catheter-based accelerated partial irradiation and whole breast irradiation. San Antonio Breast Cancer Symposium, 2013. PMID: None.
54. Mittendorf EA, Ballman KV, McCall LM, Hansen N, Lucci A, Gabram S, Urist M, Crow J, Hurd T, Hunt KK, Giuliano AE. Evaluation of the Stage IB Designation of the 7th Edition of the AJCC Staging System: Biologic Factors are More Important. 2012 CTRC-AACR San Antonio Breast Cancer Symposium, 2012. e-Pub 2012. PMID: None.
55. Ellis MJ, Suma V, McCall L, Luo R, Hoog J, Brink A, Watson M, Ma C, Unzeitig G, Pluard T, Whitworth P, Babiera G, Guenther M, Dayao Z, Leitch M, Ota D, Olson J, Hunt K, Allred C. Z1031B neoadjuvant aromatase inhibitor trial: A Phase 2 study of triage to chemotherapy based on 2 to 4 week Ki67 level >10%. 2012 CTRC-AACR San Antonio Breast Cancer Symposium, 2012. PMID: None.
56. Ellis MJ, Suman V, McCall L, Luo R, Hoog J, Brink A, Watson M, Ma C, Unzeitig G, Pluard T, Whitworth P, Babiera G, Guenther M, Dayao Z, Leitch M, Ota D, Olson J, Hunt K. Z1031B Neoadjuvant Aromatase Inhibitor Trial: A Phase 2 Study of Triage to Chemotherapy Based on 2 To 4 Week Ki67 Level >10%. 2012 CTRC-AACR San Antonio Breast Cancer Symposium, 2012. PMID: None.
57. Haynes AB, Bloom ES, Bedrosian I, Kuerer HM, Hwang RE, Caudle AS, Hunt KK, Graviss L, Chemaly RF, Tereffe W, Shaitelman SF, Babiera GV. Timing of Infectious Complications following Breast Conserving Therapy with Catheter-Based Accelerated Partial Breast Irradiation. 2012 CTRC-AACR San Antonio Breast Cancer Symposium, 2012. PMID: None.
58. Yi M, Huo L, Koenig KB, Mittendorf EA, Meric-Bernstam F, Kuerer HM, Bedrosian I, Symmans WF, Hortobagyi GN, Crow JR, Shah RR, Hunt KK. Estrogen Receptor Positivity: 10% or 1%?. 2012 CTRC-AACR San Antonio Breast Cancer Symposium, 2012. PMID: None.
59. Boughey JC, Suman VJ, Mittendorf EA, Ahrendt GM, Wile LG, Taback B, Leitch AM, Flippo-Morton TS, Byrd DR, Ollila DW, Julian TB, McLaughlin SA, McCallL, Symmans WF, Le-Petross HT, Haffty BG, Buchholz TA, Hunt KK. The Role of Sentinel Lymph Node Surgery in Patients Presenting with Node Positive Breast Cancer (T0-T4, N1-2) who receive Neoadjuvant Chemotherapy - Results from the ACOSOG Z1071 Trial. 2012 CTRC-AACR San Antonio Breast Cancer Symposium, 2012. PMID: None.
60. FitzSullivan E, Lari SA, Smith B, Caudle A, Krishnamurthy S, Lucci A, Mittendorf E, Barbier G, Black D, Wagner J, Bedrosian I, Woodward W, Gainer S, Hwang R, Meric-Bernstam F, Hunt KK, Kuerer HIM. Incidence and Consequence of Close Margins for Ductal Carcinoma In Situ Treated with Mastectomy. Oral Presentation at SSO's 66th Annual Cancer Symposium, March 6-9, 2013 in National Harbor, Maryland, 2012. PMID: None.
61. Bednarski B, Araujo D, Yi M, Lev D, Lazar A, Cormier J, Pisters PW, Pollock R, Feig B, Hunt KK. KIT Mutation Status and Multi-Visceral Resection Impact Outcomes of Neoadjuvant Therapy for Gastrointestinal Stromal Tumors. Oral Presentation at SSO's 66th Annual Cancer Symposium, March 6-9, 2013 in National Harbor, Maryland, 2012. PMID: None.
62. Francis AM, Grimes LM, Yi M, Mittendorf EA, Bedrosian I, Caudle A, Meric-Bernstam F, Barbier G, Krishnamurthy S, Kuerer HM, Hunt KK. Utility of Sentinel Lymph Node Dissection (SLND) in Ductal Carcinoma in Situ (DCIS). Poster Presentation at SSO's 66th Annual Cancer Symposium, March 6-9, 2013 in National Harbor, Maryland, 2012. PMID: None.
63. Caudle AS, Hunt KK, Lucci A, Tucker S, Kuerer HM, Meric-Bernstam F, Gainer S, Shah R, Babiera G, Sahin A. American College of Surgeons (ACOSOG) Z0011: Impact on Surgeon Practice Patterns. The American Society of Breast Surgeons Meeting, 2012. PMID: None.
64. Gainer S, Hunt KK, Beitsch P, Caudle AS, Mittendorf EA, Lucci A. ACOSOG Z0011 Changing Behavior: results of a Survey of The American Society of Breast Surgeons. The American Society of Breast Surgeons Meeting, 2012. PMID: None.
65. Caudle AS, Yi M, Mittendorf EA, Babiera G, Hwang R, Meric-Bernstam F, Sahin A, Hunt KK. The Identification of Internal Mammary Sentinel Lymph Node Metastasis Impacts Therapy in Breast Cancer. The American Society of Breast Surgeons Meeting, 2012. PMID: None.
66. Bloom E, Gifford, Kirsner S, Nelson C, Mason B, Bejarano M, Hoover S, Hunt KK, Bedrosian I, Babiera G. The Importance of Multidisciplinary Collaboration between Surgeon and Radiation Oncologist for Optimal Choice and Placement of Single-entry Brachytherapy Catheters for Accelerated Partial Breast Irradiation. The American Society of Breast Surgeons Meeting, 2012. PMID: None.
67. Alvarado R, Yi M, Le-Petross H, Gilcrease M, Mittendorf E, Bedrosian I, Meric-Bernstam F, Hwang R, Caudle A, Akins J, Kuerer HM, Hunt KK. Is Sentinel Lymph Node Biopsy Accurate After Neoadjuvant Chemotherapy in Patients Who Present With Node-Positive Breast Cancer?. The American Society of Breast Surgeons Meeting, 2012. PMID: None.
68. Allen LR, Gadgil PV, Bassett Jr R, Hunt KK, Mittendorf EA, Yi M, Babiera G, Kuerer HM, Ross MI, Bedrosian I, Meric-Bernstam F, Hwang RF. Nomogram to Predict Sentinel Lymph Node Involvement in Patients with Clinically Node-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy. ASCO Meeting, 2012. PMID: None.
69. Kronowitz SJ, Lam C, Terefe W, Hunt KK, Kuerer HM, Valero V, Lance S, Robb GL, Feng L, Buchholz TA. A multidisciplinary protocol for planned skin-preserving delayed breast reconstruction for patients with locally advanced breast cancer requiring postmastectomy radiation therapy: 3-year follow-up. J Clin Onc 29(15S):110s, 2011. PMID: None.
70. Gao J, et al. Mechanism of early radiographic response to imatinib in GIST. J Clin Onc 29(15S):617s, 2011. PMID: None.
71. Symmans WF, Hatzis C, Valero V, Booser DJ, Esserman L, Martin M, Vidaurre T, Holmes F, Souchon EA, Lluch A, Cotrina J, Gomez H, Hubbard R, Ferrer-Lozano J, Dyer R, Buxton M, Gong Y, Wu Y, Ibrahim N, Andreopoulou E, Ueno NT, Hunt K, Yang W, Nazario A, DeMichele A, O’Shaughnessy J, Hortobagyi GN, Pusztai L. A genomic predictor of survival following taxane-antrhacycline chemotherapy for breast cancer. Cancer Res 70(24):119s, 2010. PMID: None.
72. Hunt K, Le-Petross HT, Suman V, Haffty BG, Leitch AM, Ollila D, Byrd DR, Buchholz TA, Symmans WF, Boughey JC. A phase II study evaluating the role of sentinel lymph node surgery and axillary lymph node dissection following preoperative chemotherapy in women with node-positive breast cancer (T1-4, N1-2, M0) at initial diagnosis: ACOSOG Z1071. Amer Soc Clin Onc 28(15S), 2010. PMID: None.
73. Cote R, Giuliano AE, Hawes D, Ballman KV, Whitworth PW, Blumencranz PW, Reintgen DS, Morrow M, Leitch AM, Hunt K. ACOSOG Z0010: A multicenter prognostic study of sentinel node (SN) and bone marrow (BM) micrometastases in women with clinical T1/T2 N0 M0 breast cancer. Amer Soc Clin Onc 28(15S), 2010. PMID: None.
74. Giuliano AE, McCall LM, Beitsch PD, Whitworth PW, Morrow M, Blumencranz PW, Leitch AM, Saha S, Hunt K, Ballman KV. ACOSOG Z0011: A randomized trial of axillary node dissection in women with clinical T1-2 NO MO breast cancer who have a positive sentinel node. Amer Soc Clin Onc 28(15S), 2010. PMID: None.
75. Buzdar, A, Suman V, Meric-Bernstam F, Boughey JC, Leitch AM, Unzeitig GW, Ellis MJ, Ewer M, Hunt, K. Preliminary safety data of a randomized phase III trial comparing a preoperative regimen of FEC-75 alone followed by paclitaxel plus trastuzumab with a regimen of paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab in patients with HER2-positive operable breast cancer. Amer Soc Clin Onc 28(15S), 2010. PMID: None.
76. Hayes-Jordan AA, Green JL, Anderson PM, Xiao L, Hunt K, Mansfield PF. A phase I trial of continuous hyperthermic peritoneal perfusion using cisplatin in pediatric patients with carcinomatosis. Amer Soc Clin Onc 28(15S), 2010. PMID: None.
77. Ellis MJ, Babiera G, Unzeitig GW, Marcom PK, Guenther JM, Deshryver FK, Allred DC, Suman V, Hunt K, Olson JA. ACOSOG Z1031: A randomized phase II trial comparing exemestane, letrozole, and anastrozole in postmenopausal women with clinical stage II/III estrogen receptor-positive breast cancer. Amer Soc Clin Onc 28(18), 2010. PMID: None.
78. Liu Y, Palalon F, Keyomarsi K, Swisher SG, Hunt KK. Reduction of telomerase activity in human breast carcinoma cells by adenoviral-mediated overexpression of E2F-1. Proc Amer Assoc Cancer Res:101, 2010. PMID: None.
79. Fearmonti RM, Gayed IW, Kim E, Bedrosian I, Hunt KK, Meric-Bernstam F, Feig B, Ghonimi E, Warneke C, Babiera GV. Intra-individual comparison of lymphatic drainage patterns Using Subareolar and peritumoral isotope injection for breast cancer. Ann Surg Oncol 17(1):220-227, 2010. PMID: None.
80. Yu TK, Tereffe W, Bedrosian I, Eskambi SH, Strom EA, Litton J, Gonzalez-Angulo AM, Buchholz TA, Hunt KK, Mittendorf EA. Local-Regional Control According to Surrogate Markers of Breast Cancer Subtypes and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Undergoing Breast Conserving Therapy. Cancer Res 69(24):536s, 2009. PMID: None.
81. Caudle AS, Gonzalez-Angulo AM, Hunt KK, Kuerer HM, Pusztai L, KauS-WC, Mittendorf EA, Hortobagyi GN, Meric-Bernstam F. Impact of Progression during Neoadjuvant Chemotherapy on Operative Management of Breast Cancer. Cancer Res 69(24):567s, 2009. PMID: None.
82. Gainer SM, Lodhi AK, Krishnamurthy S, Jackson S, Hall CS, Andreopoulou E, Singh B, Bedrosian I, Meric-Bernstam F, Kuerer HM, Hunt KK, Critofanilli M, Lucci A. Predictors of persistent micrometastatic disease after neoadjuvant chemotherapy. Cancer Res 69(24):653s, 2009. PMID: None.
83. Dominici LS, Negron Gonzalez VM, Buzdar AU, Lucci A, Mittendorf EA, Pusztai L, Krishnamurthy S, Le-Petross HT, Babiera G, Bedrosian I, Meric-Bernstam F, Hunt KK, Valero V, Kuerer HM. Eradication of axillary lymph node metastases occurs in 74% of patients receiving neoadjuvant chemotherapy with concurrent trastuzumab for HER2 positive breast cancer. Cancer Res 69(24):566s, 2009. PMID: None.
84. Krishnamurthy S, Tang S, Wang X, Sahin AA, Pantoja LM, Lucci A, Kuerer HM, Babiera G, Bedrosian I, Hunt KK, Meric-Bernstam F. Utility of a One-Step Nucleic Acid Amplification (OSNA) Assay for Comprehensive Examination of Axillary Lymph Nodes in Breast Cancer. Cancer Res 69(24):541s, 2009. PMID: None.
85. Wagner JL, Warneke C, Bedrosian I, Mittendorf E, Babiera G, Kuerer H, Hunt K, Yang W, Sahin A, Meric-Bernstam F. Effect of modest delays in primary surgical treatment on progression of tumor size in breast cancer patients. J Clin Oncol 27(15s):36s, 2009. PMID: None.
86. Yi M, Hunt KK, Arun BK, Bedrosian I, Gutierrez Barrera AM, Kuerer HM, Babiera G, Mittendorf EA, Meric-Bernstam. Factors leading to the decision for contralateral prophylactic mastectomy in patients with breast cancer. J Clin Oncol 27(15s):80s, 2009. PMID: None.
87. Mittendorf EA, Tucker SL, Jeruss JS, Gonzalez-Angulo AM, Buchholz TA, Sahin AA, Cormier JN, Buzdar AU, Hortobagyi, Hunt KK. Validation of a novel staging system for breast cancer patients treated with neoadjuvant chemotherapy. J Clin Oncol 27(15s):20s, 2009. PMID: None.
88. Buzdar AU, Green MC, Broglio KR, Carter CD, Valero V, Ibrahim NK, Hunt KK, Hortobagyi GN. Prospective randomized trial evaluating weekly paclitaxel (WP) versus docetaxel in combination with capecitabine (DC) in operable breast cancer. J Clin Oncol 27(15S):16s, 2009. PMID: None.
89. Dawood S, Gonzalez-Angulo, Woodward W, Meric-Bernstam F, Hunt K, Buzdar A, Hortobagyi G, Buchholz T. Value of adjuvant radiation therapy in breast cancer patients with one to three positive lymph nodes undergoing a modified radical mastectomy and systemic therapy. J Clin Oncol 27(15S):8s, 2009. PMID: None.
90. Lester TR, Nayeemuddin KM, Davis WG, Hunt KK, Gilcrease MZ. Metaplastic sarcomatoid carcinoma of the breast: Poor overall survival is independent of the amount of sarcomatoid component. 2009 United States and Canadian Academy of Pathology (USCAP), 2009. PMID: None.
91. McAuliffe JC, Hunt KK, Lazar AJ, Choi H, Qiao W, Thall P, Pollock RE, Benjamin RS, Trent JC. A randomized, phase II study of preoperative plus postoperative imatinib in GIST: evidence of rapid radiographic response and temporal induction of tumor cell apoptosis. Journal of Surgical Research 151(2):283, 2009. PMID: 18953611.
92. Yi M, Hunt KK, Meric-Bernstam F, Kronowitz SJ, Nayeemuddin K, Feig B, Hwang RF, Symmans WF, Lucci A, Ross MI, Ames FC, Bedrosian I, Singletary E, Kuerer HM. Local-regional and distant recurrence rates in skin-sparing mastectomies compared with non-skin-sparing mastectomies. Cancer Res 69(292s), 2009. PMID: None.
93. Nagar H, Mittendorf EA, Strom EA, Perkins G, Oh JL, Terreffe W, Woodward W, Gonzalez-Angulo A, Hunt K, Buchholz T, Yu TK. Local-regional recurrence with and without radiation after neoadjuvant chemotherapy and mastectomy for T3N0 breast cancer patients. Cancer Res 69(81s), 2009. PMID: None.
94. Nguyen CV, Hunt KK, Nayeemuddin KM, Lester TR, Falcon-Escobedo R, Gilcrease MZ. Pleomorphic carcinoma of the breast: Is severe pleomorphism associated with a worse clinical outcome?. 2009 United States and Canadian Academy of Pathology (USCAP), 2009. PMID: None.
95. Shaye A, Sahin A, Hunt K, Keyomarsi K, Bedrosian I. Cyclin E overexpression in the progression of breast cancer. Breast Cancer Res Treat, 2008. PMID: None.
96. Mittendorf EA, Sahin AA, Tucker SL, Meric-Bernstam F, Yi M, Nayeemuddin KM, Babiera GV, Ross MI, Feig BW, Kuerer HM, Hunt KK. Lymphovascular invasion and lobular histology are associated with increased incidence of isolated tumor cells in sentinel lymph nodes from early-stage breast cancer patients. Ann Surg Oncol 15(12):3369-3377, 2008. e-Pub 2008. PMID: 18815841.
97. Shinde SS, Forman MR, Kuerer HM, Hunt KK, Pusztai L, Symmans WF. Association of triple-negative breast cancer phenotype with parity and breastfeeding duration. 2008 ASCO Breast Cancer Symposium, September 5-7, 2008. PMID: None.
98. Mittendorf EA, Esteva FJ, Wu Y, Meric-Bernstam F, Hunt KK, Buzdar AU, Dawood S, Hortobagyi GN, Gonzalez-Angulo A. Determination of HER2 status in patients achieving less than a pathologic complete response following neoadjuvant therapy with combination chemotherapy plus trastuzumab. 2008 ASCO Breast Cancer Symposium, September 5-7, 2008. PMID: None.
99. Yi M, Buchholz TA, Meric-Bernstam F, Bedrosian I, Hwang RF, Ross MI, Kuerer HM, Feig BW, Lucci A, Hunt KK. Ipsilateral breast tumor relapse after breast conservation therapy. 2008 ASCO Breast Cancer Symposium, September 5-7, 2008. PMID: None.
100. Blazer III DG, Lazar AJ, Xing Y, Askew RL, Lev DC, Feig BW, Pisters PW, Pollock RE, Hunt KK, Cormier JN. Improved outcomes in patients with lymph node-only stage IV disease in clear cell sarcoma: Results from a large single-institution experience and SEER database analysis. J Clin Oncol 26(15S-I):10571, 2008. PMID: None.
101. Hawes D, Patel M, Hunt KK, Guiliano AE, Cote RJ. Presence of putative breast cancer stem cells (BCSC) in lymph node occult metastases (LNOM) of patients with node negative (LN-) breast cancer (BC). J Clin Oncol 26(15S-I):1069, 2008. PMID: None.
102. Ching CD, Hunt KK, Mittendorf EA, Yi M, Feig B, Babiera GV. Impact of ultrasound and clinicopathologic factors on the accuracy of sentinel lymph node dissection in breast cancer patients following neoadjuvant chemotherapy. American Society of Breast Surgeons, New York, NY April 30 - May 4, 2008. PMID: None.
103. Wagner JL, Boughey JC, Babiera GV, Kuerer HM, Meric-Bernstam F, Singletary SE, Hunt KK, Middleton LP, Bedrosian I. Margin assessment after neoadjuvant chemotherapy in invasive lobular cancer. 2008 ASCO Breast Cancer Symposium September 5-7, 2008. PMID: None.
104. Kong A, Bedrosian I, Rao R, Meric-Bernstam F, Lee JE, Hunt KK, Ross MI. Surgical treatment for breast cancer metastasis to ipsilateral supraclavicular nodes. American Society of Breast Surgeons, New York, NY, April 30 - May 4, 2008. PMID: None.
105. Lang JE, Tereffe W, Rao R, Feng L, Meric-Bernstam F, Bedrosian I, Kuerer HM, Singletary SE, Hunt KK, Hortobagyi G, Babiera GV. Use of neoadjuvant chemotherapy (NC) prior to resection of the primary tumor in stage IV breast cancer may predict for improved survival. American Society of Breast Surgeons, New York, NY, April 30-May 4, 2008. PMID: None.
106. Boughey JC, Goravanchi F, Parris RN, Kee SS, Frenzel JC, Kowalski A, Hunt KK, Ames FC, Kuerer HM, Lucci A. A prospective randomized trial of paravertebral block for breast surgery. American Society of Breast Surgeons, New York, NY, April 30 - May 4, 2008. PMID: None.
107. Shaye AN, Shen J, Babiera GV, Ross MI, Meric-Bernstam F, Feig BW, Kuerer HM, Francis A, Ames FC, Hunt KK, Gilcrease MZ. Histologic predictors of false negative sentinel lymph nodes following preoperative chemotherapy. US and Canadian Academy of Pathology Annual Meeting, Denver, CO March 1-7, 2008. PMID: None.
108. Downs-Kelly E, Nayeemuddin KM, Wu Y, Albarracin C, Hunt KK, Gilcrease MZ. Matrix-producing carcinoma of the breast: Features associated with locoregional recurrence and survival. US and Canadian Academy of Pathology Annual Meeting, Denver, CO, March 1-7, 2008. PMID: None.
109. Mittendorf EA, Wingate H, Liu Y, Keyomarsi K, Hunt KK. HER2 regulates expression of low molecular weight cyclin E isoforms in breast cancer. J Surg Res 144:380, 2008. PMID: None.
110. Mittendorf EA, Tucker SL, Meric-Bernstam F, Gonzalez-Angulo A, Yu T, Yang W, Symmans W, Ross MI, Hortobagyi GN, Hunt KK. Relationship between extent of estrogen receptor (ER) expression and pathologic complete response rates after administration of neoadjuvant chemotherapy. 2008 ASCO Breast Cancer Symposium, September 5-7, 2008. PMID: None.
111. Moulder SL, Symmans WF, Booser DJ, Madden TL, Lipsanen C, Yuan L, Brewster AM, Cristofanilli M, Hunt KK, Buchholz TA, Zwiebel J, Valero V, Hortobagyi GN, Esteva FJ. Phase I/II study of G3139 (Bcl-2 Antisense Oligonucleotide) in combination with doxorubicin and docetaxel in breast cancer. Clin Cancer Res 14(23):7909-7916, 2008. PMID: 19047121.
112. Bedrosian I, Shaye A, Sahin A, Hao Q, Hunt K, Keyomarsi. Cyclin E deregulation is an early event in the development of breast cancer. Journal of Surgical Research 151(2):295, 2008. PMID: None.
113. Kong AL, Hunt KK, Yi M, Weatherspoon K, Bedrosian I, Tereffe W, Hwang R, Ross MI, Buchholz TA, Meric-Bernstam F. The impact of IMC nodal drainage on primary breast cancer outcome. J Clin Oncol 26(15S):534, 2008. PMID: None.
114. Boughey JC, Goravanchi F, Hunt KK, Paris RN, Kee SS, Frenzel JC, Kowalski AM, Kuerer HM, Ames FC, Lucci A. A prospective randomized controlled clinical trial of paravertebral block anesthesia for patients undergoing surgery for breast cancer. 2008 ASCO Breast Cancer Symposium, September 5-7, 2008. PMID: None.
115. Kelten C, Mittendorf EA, Broglio K, Vo T, Middleton LP, Ueno N, Hunt KK, Sahin AA. Clinical significance of occult axillary lymph node metastases in breast cancer patients without adjuvant systemic therapy: A long-term retrospective study. Breast Cancer Res Treat(December 13-16), 2007. PMID: None.
116. Boughey JC, Middleton L, Harker L, Garrett B, Fornage B, Hunt KK, Babiera GV, Dempsey PJ, Bedrosian I. Ultrasound and fine needle aspiration biopsy for preoperative nodal staging of patients with invasive lobular carcinoma of the breast. American Society of Breast Surgeons, May 2-6, 2007. PMID: None.
117. Kronowitz SJ, Buchholz TA, Hunt KK, Kuerer HM, Robb GL, Ross MI, Strom EA. Delayed-immediate breast reconstruction: 4 years later. American Association of Plastic Surgeons May 20-23, 2007. PMID: None.
118. Yi M, Hunt KK, Krishnamurthy S, Kuerer HM, Bedrosian I, Ames FC, Lucci A, Meric-Bernstam F, Ross MI. The significance of primary tumor characteristics in predicting positive sentinel lymph nodes in ductal carcinoma in situ or microinvasive breast cancer. American Society of Breast Surgeons, May 2-6, 2007. PMID: None.
119. Vo T, Xing Y, Meric-Bernstam F, Symmans F, Buchholz TA, Ames FC, Kuerer HM, Bedrosian I, Hunt KK. Long-term outcomes for mucinous, medullary, and tubular carcinomas treated with breast conservation therapy. American Society of Breast Surgeons May 2-6, 2007. PMID: None.
120. Lang JE, Rao R, Feng L, Meric-Bernstam F, Bedrosian I, Kuerer HM, Singletary SE, Hunt KK, Hortobagyi GN, Babiera GV. Impact on overall survival of primary tumor extirpation in breast cancer patients who present with stage IV disease. J Clin Oncol 25(18S):27s, 2007. PMID: None.
121. Fearmonti RM, Batista LI, Meric-Bernstam F, Hunt KK, Bedrosian I, Kuerer HM, Singletary SE, Babiera GV. Margin width correlates with residual disease at re-excision for ductal carcinoma in situ (DCIS) of the breast. 2007 ASCO Breast Cancer Symposium, Sept 7-8, 2007. PMID: None.
122. Mittendorf EA, Sahin A, Tucker SL, Meric-Bernstam F, Yi M, Ames FC, Ross MI, Feig BW, Kuerer HM, Hunt KK. Lymphovascular invasion and lobular histology are strong predictors of detecting isolated tumor cells in sentinel lymph nodes from early stage breast cancer patients. 2007 ASCO Breast Cancer Symposium, Sept 7-8, 2007. PMID: None.
123. Yi M, Hunt KK, Meric-Bernstam F, Bedrosian I, Hwang R, Kuerer HM, Lucci A, Ross MI, Akins J, Babiera GV. Sentinel lymph node biopsy in patients with multicentric invasive breast cancer. 2007 ASCO Breast Cancer Symposium Sept 7-8, 2007. PMID: None.
124. Hunt KK. Current status of sentinel lymph node biopsy for breast cancer. 2007 Congress of the World Society for Breast Disease, Tianjin, China, 2007. PMID: None.
125. Boughey JC, Goravanchi F, Parris RN, Kowalski AM, Kee S, Frenzel JC, Hunt KK, Ames FC, Kuerer HM, Lucci A. Improved post-operative pain management of breast oncologic surgeries with paravertebral block. The American Society of Regional Anesthesia, Boca Raton, FL November 14-18, 2007. PMID: None.
126. Mittendorf EA, Liu Y, McKenzie T, Keyomarsi K, Hunt KK. HER2/neu gene silencing by small-interfering RNA leads to apoptotic cell death in HER2neu-overexpressing breast cancer cells. Proc Amer Assoc Cancer Res 48:1240, 2007. PMID: None.
127. Roh V, Laemmle A, J-F D, Stroka D, Hunt KK, Candinas D, Vorburger SA. Dual induction of PKR (dsRNA activated protein kinase) by E2F-1 overexpression and interferon alpha enhances efficacy of gene therapy for hepatocellular carcinoma in-vivo. Proc Amer Assoc Cancer Res 48:1139, 2007. PMID: None.
128. Liu Y, Yokota T, Mittendorf EA, Keyomarsi K, Hunt KK. Elafin, serine protease inhibitor, is a novel tumor suppressor for breast cancer. Proc Amer Assoc Cancer Res 48:869, 2007. PMID: None.
129. Winiger IJ, Fanale M, Vorburger SA, Keyomarsi K, Hunt KK. Overexpression of E2F-1 using an hTERT promoter leads to selective cell cycle arrest and induces apoptosis in breast cancer cells. Proc Amer Assoc Cancer Res 48:783, 2007. PMID: None.
130. Anaya DA, Xing Y, Cormier JN, Tuvin D, Lahat G, Pisters PW, Hunt KK, Feig BW, Lev DC, Pollock RE. Comparison of outcomes for patients with multifocal versus unifocal recurrent retroperitoneal sarcoma. 119th Annual Meeting, Southern Surgical Association, Hot Springs, VA December 2-5, 2007. PMID: None.
131. Yokota T, Liu Y, Hunt KK, Keyomarsi K. C/EBPβ-elafin pathway is involved in generation of cyclin E low molecular weight isoforms in breast cancer. Proc Amer Assoc Cancer Res 48:101, 2007. PMID: None.
132. Fearmonti RM, Gayed IW, Kim E, Waraneke C, Bedrosian I, Hunt KK, Ghonimi E, Meric-Bernstam F, Babiera GV. In vivo comparison of lymphatic drainage patterns of subareolar and peritumoral isotope injection for breast cancer. Ann Surg Oncol 14(2):65, 2007. PMID: None.
133. Lim SJ, Cormier JN, Feig BW, Mansfield PF, Benjamin R, Griffin JR, Chase JL, Pisters PW, Pollock RE, Hunt KK. Toxicity and outcomes associated with surgical cytoreduction and intraperitoneal hyperthermic peritoneal perfusion (IPHP) for patients with sarcomatosis. Ann Surg Oncol 14(2):4, 2007. PMID: None.
134. Olson J, McCall L, Beitsch P, Whitworth P, Reintgen D, Blumencranz P, Leitch M, Saha S, Hunt K, Guiliano A. Impact of immediate vs delayed axillary node dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: Results from the American College of Surgeons Oncology Group (ACOSOG) Trials Z0010 and Z0011. Ann Surg Oncol 14(2):1, 2007. PMID: None.
135. Mittendorf EA, McKenzie-Johnson T, Liu Y, Keyomarsi K, Hunt KK. HER2 and cyclin E: A novel interaction in breast cancer. J Surg Res 137(2):193, 2007. PMID: None.
136. Lim SJ, Feig BW, Wang H, Hunt KK, Rodriguez-Bigas MA, Skibber JM, Ellis V, Cleary K, Chang GJ. Sentinel lymph node evaluation does not improve staging accuracy in colon cancer. Ann Surg Oncol 14(2):65, 2007. e-Pub 2007. PMID: 17985187.
137. Rosenkranz K, Hartmann K, Ghonimi E, Kuerer H, Singletary SE, Hunt K, Meric-Bernstam F, Lucci A, Hwang R, Bedrosian I, Feig B, Ross M, Ames F, Babiera G. Breast cancer in the very elderly: treatment patterns in a comprehensive cancer center. American Society of Breast Surgeons, 2006. PMID: None.
138. Bedi DG, Krishnamurthy R, Krishnamurthy S, Edeiken B, Le-Petross H, Hunt K, Feig BW, Singletary SE, Ross MI, Ames FC, Bedrosian I, Meric F, Kuerer HM, Fornage BD. Cortical morphology of axillary lymph nodes as a predictor of metastatic disease in breast cancer: An in vitro ultrasound study. Am J Roentgenol Supplement 186:A79, 2006. PMID: None.
139. Hird RB, Hunt KK, Cimmino VM, Sabel M, Diehl KM, Wong S, Lucas P, Degnim A, Chang AE, Newman LA. Risk of identifying metastatic nonsentinel nodes in patients with micrometastases in single versus multiple sentinel lymph nodes. Ann Surg Oncol 13(2):P111, 2006. PMID: None.
140. Lucci A, Mackie L, Beitsch P, Whitworth P, Reintgen D, Blumencranz, Leitch M, Saha S, Hunt KK, Giuliano AE. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection, versus SLND alone in the American College of Surgeons Oncology Group (ACOSOG) Trial Z0011. Ann Surg Oncol 13(2):9, 2006. PMID: None.
141. Boughey JC, Hunt KK, Ames FC, Babiera GV, Bedrosian I, Feig BW, Hwang RF, Kuerer HM, Singletary SE, Ross MI. Sentinel lymph node surgery in locally recurrent breast cancer. Ann Surg Oncol 13(2):P36, 2006. PMID: None.
142. Boughey JC, Khakpour N, Meric-Bernstam F, Ross MI, Hwang RF, Babiera GV, Lucci A, Kuerer HM, Hunt KK, Bedrosian I. Routine use of sentinel lymph node surgery in prophylactic mastectomy is not warranted. Ann Surg Oncol 13(2):P64, 2006. PMID: None.
143. Al-Refaie WB, Andtbacka RA, Ensor J, Pisters PW, Hunt KK, Cormier JN, Pollock RE, Feig BW. Should patients with isolated lymph node metastasis from extremity soft tissue sarcomas be considered to have Stage IV disease?. Ann Surg Oncol 13(2):P28, 2006. PMID: None.
144. Liu Y, Keyomarsi K, Swisher SG, Hunt KK. Small interfering (siRNA) inhibits the expression of the elafin gene and induces the low molecular weight forms of cyclin E in breast epithelial cells. AACR Special Conference - Advances in Breast Cancer Research: Genetics, Biology and Clinical Applications, 2005. PMID: None.
145. Al-Refaie W, Kuerer HM, Khuwaja A, Perry AC, Xiao L, Hunt KK, Singletary SE, Meric-Bernstam F, Ross MI, Babiera GV. Determinants of mastectomy in breast conservation therapy candidates. The 6th Annual Meeting of the American Society of Breast Surgeons, Los Angeles, CA, 2005. PMID: None.
146. Leitch AM, Beitsch PD, McCall LM, Posther KE, Newman LA, Herndon JE, Hunt KK, Giuliano AE. Patterns of participation and successful patient recruitment to ACOSOG Z0010, a phase II trial for patients with early stage breast cancer. The 6th Annual Meeting of the American Society of Breast Surgeons, Los Angeles, CA, 2005. PMID: None.
147. Khakpour N, Hunt KK, Ross MI, Kuerer HM, Yi M, Lucci A. Does negative sentinel lymph node dissection provide axillary control equal to complete axillary dissection in breast cancer patients with lobular histology?. The 6th Annual Meeting of the American Society of Breast Surgeons, Los Angeles, CA, 2005. PMID: None.
148. Khakpour N, Zager J, Yen T, Stephens T, Meric-Bernstam F, Kuerer HM, Singletary SE, Ross MI, Hunt KK, Babiera GV. The role of ultrasound in surgical management of patients diagnosed with ductal carcinoma in situ of the breast. The 6th Annual Meeting of the American Society of Breast Surgeons, Los Angeles, CA, 2005. PMID: None.
149. Suh Y, Chada S, Mckenzie T, Liu Y, Swisher S, Lucci A, Hunt KK. Synergistic tumoricidal effect between celocoxib and melanoma differentiation-associated gene 7 on human breast cancer cells. Society of University Surgeons Annual Meeting, 2005. PMID: None.
150. Kawase K, Gayed IW, Meric-Bernstam F, Ross MI, Babiera GV, Kuerer HM, Singletary SE, Akins J, Yi M, Feig BW, Ames FC, Hunt KK. Lymphatic drainage patterns from breast cancer: a large cancer center experience. Society of Nuclear Medicine, 2005. PMID: None.
151. McKenzie TS, Lui Y, Keyomarsi K, VonHolzen U, Suh YJ, Fanale M, Swisher S, Chada S, Hunt K. Adenoviral mediated delivery of the melanoma differentiation-associated gene-7 (Ad-mda7) regulates the Wnt signaling pathway in breast cancer cells. Proc Amer Assoc Cancer Res 46:3694, 2005. PMID: None.
152. Pataer A, Bocangel D, Chada S, Roth JA, Hunt KK, Swisher SG. Enhancement of Adenoviral mda-7 mediated cell killing in human lung cancer cells by geldanamycin and its 17-allylamino-17-demethoxy analogue. Proc Amer Assoc Cancer Res 46:1349, 2005. PMID: None.
153. Gilcrease MZ, Zhou X, Hunt K, Meric-Bernstam F, Welch K. α6β4 integrin-induced EGFR clustering in breast carcinoma. Proc Amer Assoc Cancer Res 46:3719, 2005. PMID: None.
154. Fanale MA, Vorburger SA, Liu Y, McKenzie TS, Swisher SG, Hunt KK. Adh TERT-E2F-1 can induce selective apoptosis of breast cancer cells through multiple mechanisms. Proc Amer Assoc Cancer Res 46:2834, 2005. PMID: None.
155. Fanale MA, Liu Y, McKenzie TS, Fokt I, Priebe W, Hunt KK. Investigation of whether expression of bcl-2 influences the apoptotic response of doxorubicin-resistant breast cancer cells to a novel anthracycline. J Clin Oncol 23:155s, 2005. PMID: None.
156. Suh Y, McKenzie T, Liu Y, Swisher SG, Lucci A, Hunt KK. Synergism between Ad-E2F1 and celecoxib results in increased rates of apoptotic cell death in breast cancer cells. J Clin Oncol 23:236s, 2005. PMID: None.
157. Suh YJ, Raju U, Chada S, McKenzie T, Liu Y, Swisher SG, Lucci A, Hunt KK. Enhanced radiosensitization of breast cancer cells in vitro by combining Adenovirus-mediated delivery of melanoma differentiation-associated gene-7 (Ad-mda7) and celecoxib. Proc Amer Assoc Cancer Res 46:2014, 2005. PMID: None.
158. Sun B, Swisher SG, Keyomarsi K, Hunt KK. Absence of pRb facilitates E2F1-induced cell death in breast cancer cells. Proc Amer Assoc Cancer Res 46:3488, 2005. PMID: None.
159. Trent JC, Choi H, Hunt K, Macapinlac H, McConkey D, Charnsangravej C, Abbruzzese J, Benjamin RS, Davis D. Apoptotic and anti-vascular activity of imatinib in GIST patients. J Clin Oncol 23:816s, 2005. PMID: None.
160. von Holzen UW, Pataer A, Bocangel D, Lu X, Barber GN, Roth JA, Hunt KK, Swisher SG. Role of the double-stranded RNA activated protein kinase PKR in AD-TNFA gene therapy. Society of University Surgeons Annual Meeting, 2005. PMID: None.
161. Bocangel DB, VonHolzen U, Chada S, Pataer A, Takada Y, Raju U, Aggarwal BB, Barber GN, Chiao P, Milas L, Hunt KK, Swisher SG. Threshold for radiation sensitization induced by adenoviral delivery of TNF-alpha: Role of the double stranded RNA activated protein kinase (PKR). Proc Amer Assoc Cancer Res 46:2016, 2005. PMID: None.
162. Lambert LA, Hunt KK, Keyomarsi K. Deregulation of cyclin E in soft tissue sarcoma. Proc Amer Assoc Cancer Res 46:5407, 2005. PMID: None.
163. Liu Y, Keyomarsi K, Lu X, Swisher SG, Hunt KK. Induction of apoptosis in human breast cancer cells following adenovirus-mediated elafin gene expression in vitro. Proc Amer Assoc Cancer Res 46:5320, 2005. PMID: None.
164. VonHolzen UW, Bocangel D, Pataer A, Takada Y, Liu Y, Aggarwal BB, Barber GN, Hunt KK, Swisher SG. Apoptosis of esophageal cancer cells following Ad-TNFα gene therapy: The role of the double-stranded RNA activated protein kinase (PKR) and the nuclear factor kappa B (NF-kB). Proc Amer Assoc Cancer Res 46:5364, 2005. PMID: None.
165. Khakpour N, Lucci A, Yi M, Meric-Bernstam E, Kuerer H, Babiera G, Feig B, Ross M, Singletary E, Ames F, Garg A, Buchholz T, Hunt KK. Sentinel node dissection provides similar local-regional control compared to axillary dissection in patients with node negative breast cancer. J Clin Oncol 23:25s, 2005. PMID: None.
166. Adepoju LJ, Symmans WF, Babiera GV, Singletary SE, Sneige N, Buchholz TA, Hunt KK, Meric-Bernstam-F, Arun B, Kuerer HM. The clinical impact of proliferative high-risk lesions presenting concurrently with ductal carcinoma in situ (DCIS) in patients (pts) treated with breast conserving therapy (BCT). J Clin Oncol 23:36s, 2005. PMID: None.
167. Lambert LA, Hunt KK, Keyomarsi K. G1 cell cycle arrest associated with up-regulation of p16 and p21 in gastrointestinal stromal tumor cells treated with procain hydrochloride. New England Surgical Society, 2005. PMID: None.
168. Swisher SG, Ajani JA, Chirieac L, Vaporciyan AA, Wu TT, Hunt KK, Correa AM, Komaki R, Rice DC, Walsh GL, Roth JA. Impact of pathologic response on pTNM esophageal cancer staging system following preoperative chemoradiation. The Southern Surgical Association Annual Meeting, 2004. PMID: None.
169. Kronowitz SJ, Kuerer H, Hunt KK, Massey PR, Robb G. The impact of sentinel node biopsy on the evolution of autologous breast reconstruction. The American Association of Plastic Surgeons 83rd Annual Meeting, 2004. PMID: None.
170. Kronowitz SJ, Hunt KK, Kuerer H, Youssef A, Robb G. The importance of timing in reconstruction of partial mastectomy defects. The American Association of Plastic Surgeons 83rd Annual Meeting, 2004. PMID: None.
171. Xing Y, Krishnamurthy S, Meric-Bernstam F, Cantor S, Ross M, Babiera G, Kuerer H, Singletary SE, Hunt KK, Cormier JN. Cost-effectiveness of intraoperative touch imprint cytology of sentinel lymph nodes in patients with breast cancer. The Pharmaceutical Services and Outcomes Research Symposium, 2004. PMID: None.
172. McKenzie T, Liu Y, Fanale M, Swisher SG, Chada S, Hunt KK. Combination therapy of Ad-MDA7 and Trastuzumab increases cell death in Her2/neu-overexpressing breast cancer cells. The Society of University Surgeons Annual Meeting, 2004. PMID: None.
173. Xing Y, Ding M, Cox D, Kuerer HM, Hunt KK, Cormier JN. Meta-analysis of sentinel lymph node biopsy following preoperative chemotherapy in patients with operable breast cancer. J Clin Oncol 23:17S, 2004. PMID: None.
174. Andtbacka R, Babiera G, Singletary E, Hunt KK, Meric-Bernstam F, Feig B, Ames F, Ross M, Dejesus Y, Kuerer H. The incidence, prophylaxis and treatment of venous thromboembolism in patients undergoing breast cancer surgery. J Clin Oncol 23:31S, 2004. PMID: None.
175. Fanale MA, Liu Y, Vorburger S, McKenzie T, Swisher S, Theriault R, Hunt KK. Utility of hTERT-driven overexpression of E2F-1 to induce selective apoptosis of human breast cancer cells. J Clin Oncol 23:233S, 2004. PMID: None.
176. Buzdar AU, Hunt KK, Smith T, Francis D, Ewer M, Booser D, Singletary E, Buchholz T, Sahin A, Hortobagyi G. Significantly higher pathological complete remission rate following neoadjuvant therapy with trastuzumab and anthracycline-containing chemotherapy: initial results of a randomized trial in operable breast cancer with HER/2 positive disease. J Clin Oncol 23:7S, 2004. PMID: None.
177. Shen J, Hunt KK, Mirza NQ, Krishnamurthy S, Singletary SE, Kuerer HM, Meric-Bernstam F, Feig B, Ross MI, Babiera G. Intramammary lymph node metastases are an independent predictor in breast cancer outcomes. . J Clin Oncol 23:31S, 2004. PMID: None.
178. Buchholz T, Woodward W, Tucker SL, Strom E, Hunt KK, Buzdar AU, Perkins GH, Schechter N, Hortobagyi G. Defining the competing risk of local-regional and distant recurrence in 1256 patients treated with mastectomy and doxorubicin-based adjuvant chemotherapy. J Clin Oncol 23:16S, 2004. PMID: None.
179. Pataer A, Chada S, Hunt KK, Roth JA, Swisher SG. Adenoviral MDA-7 induces apoptosis in p53 resistant lung cancer cells through PKR induction. The Society of University Surgeons 2004 Annual Meeting, 2004. PMID: None.
180. Chagpar A, Yen T, Sahin A, Hunt KK, Whitman G, Ames F, Ross M, Eric F, Babiera G, Singletary E, Kuerer HM. Intraoperative margin assessment reduces reexcision rates in breast conservation surgery for ductal carcinoma in situ. The American Society of Breast Surgeons Annual Meeting 5:O-8, 2003. PMID: None.
181. Yen T, Hunt KK, Mirza N, Thomas E, Meric F, Babiera G, Buchholz T, Singletary E, Feig B, Ross M, Theriault R, Ames F, Kuerer H. Physician recommendations and patient utilization of Tamoxifen following surgery for ductal carcinoma in situ at a national comprehensive cancer center. The American Society of Breast Surgeons Meeting 4:P-34, 2003. PMID: None.
182. Kuerer HM, Goldknopf IL, Fritsche H, Krishnamurthy S, Coombes KR, Clarke C, Chen J, Xiao L, Sheta EA, Hunt MC, Hunt KK. Protein expression patterns in bilateral matched-pair breast ductal fluid specimens from women with unilateral invasive breast cancer. The 3rd Annual International Symposium on the Intraductal Approach to Breast Cancer March, 2003. PMID: None.
183. Liu Y, Vorburger SA, Swisher SG, Mhashilkar A, Chada S, Feig BW, Hunt KK. Tumor growth suppressor gene mda-7 induces apoptosis and affects the pathway of APC/β-catenin in human breast cancer. Proc Am Assoc Cancer Res 44:497, 2003. PMID: None.
184. Chagpar A, Middleton LP, Sahin A, Ross MI, Ames F, Feig B, Kuerer HM, Valero V, Hunt KK. Clinical outcome of node negative breast cancer patients with micrometastic disease by immunohistochemistry. Proc Am Society Clin Oncol 22:14, 2003. PMID: None.
185. Chagpar A, Evelegh M, Fritche H, Krishnamurthy S, Hunt KK, Kuerer HM. Prospective evaluation of a novel quantitative galactose oxidase-schiff reaction in nipple aspirate fluid from women with invasive breast carcinoma. Proc Am Assoc Cancer Res 44:1449, 2003. PMID: None.
186. Kronowitz SJ, Hunt KK, et al. Delayed-immediate breast reconstruction. The American Association of Plastic Surgeons 82nd Annual Meeting, 2003. PMID: None.
187. Huang E, Tucker SL, Strom EA, McNeese MD, Kuerer HM, Hortobagyi GN, Buzdar AU, Valero V, Perkins G, Hunt KK, Sahin A, Buchholz TA. Radiation treatment reduces local-regional recurrence and improves survival in selected breast cancer patients treated with neoadjuvant chemotherapy and mastectomy. The 2003 ASTRO meeting, 2003. PMID: None.
188. Cabioglu N, Krishnamurthy S, Kuerer HM, Hunt KK, Singletary SE, Meric F, Feig BW, Ross MI, Ames FC, Babiera GV. The role of breast conserving surgery in women with breast cancer presenting with nipple discharge. Proc Am Society Clin Oncol 22:34, 2003. PMID: None.
189. Vorburger SA, Gu G, Fang B, Pataer A, Liu Y, Feig BW, Swisher SG, Hunt KK. Tumor-specific E2F-1 overexpression from the human telomerase reverse transcriptase (hTERT) promoter allows systemic treatment of colon cancer metastases. Proc Am Assoc Cancer Res 44:1448, 2003. PMID: None.
190. Lu X, Chiao PJ, Hunt KK, Vorburger SA, Ma J, Feig BW. Detection of differentially expressed genes in a series of extra-osseous osteosarcoma cell lines. . Proc Am Assoc Cancer Res 44:47, 2003. PMID: None.
191. Solorzano CC, Hunt KK, Middleton LP, Mirza NQ, Ross MI, Kuerer HM, Ames FA, Feig BW, Meric F, Singleatary SE, Babiera G. Treatment and outcome of intracystic papillary carcinoma of the breast: a contemporary series. The American Society of Breast Surgeons Annual Meeting, 2002. PMID: None.
192. Vorburger SA, Hetrakul N, Wilson-Heiner M, Liu TJ, Yu D, Pollock RE, Feig B, Pisters P, Hunt KK. Adenovirus mediated intratumoral E2F-1 gene therapy against leiomyosarcoma in vitro and in vivo. [Abstract] The Predictive Oncology and Intervention Strategies Conference, Pasteur Institute, Paris, France, 2002. PMID: None.
193. Poindexter N, Hunt KK, Grimm EA, Sahin A. Increased numbers of mature CD83+ dendritic cells found in tumor-free sentinel lymph nodes from patients with breast cancer. Proc Am Assoc Cancer Res 43:679, 2002. PMID: None.
194. Lu X, Chen Z, Chiao PJ, Hunt KK, Feig BW. Metastasis-associated differences in gene expression in a human extra-osseous osteosarcoma cell line with spontaneous lung metastasis in mice. Proc Am Assoc Cancer Res 43:903, 2002. PMID: None.
195. Liu Y, Nishikawa T, Vorburger SA, Meyn RE, Swisher SG, Chada S, Mira N, Hunt KK. Adenoviral-mediated expression of the MDA-7 gene sensitizes breast carcinoma cells to ionizing radiation. Proc Am Assoc Cancer Res 43:646, 2002. PMID: None.
196. Lin T, Gu J, Zhang L, Huand X, Yu Y, Curley SA, Hunt KK, Fang B. Selective expression of the GFP-TRAIL fusion gene delivered by an adenoviral vector induces apoptosis in human breast cancer cells and hepatocarcinoma cells. Proc Am Assoc Cancer Res 43:801, 2002. PMID: None.
197. Pataer A, Chada S, Hunt KK, Roth JA, Swisher SG. Adenoviral MDA-7 induces apoptosis in lung cancer cells through mitochondrial permeability transition independent cytochrome C release. [Abstract] AATS Annual Meeting, 2002. PMID: None.
198. Pataer A, Vorburgher SA, Barber GN, Chada S, Mhashikar AM, Yang HZ, Balachandran S, Roth JA, Hunt KK, Swisher SG. MDA-7 induces apoptisis via upregulation of the double stranded-RNA dependent protein kinase (PKR). Proc Am Assoc Cancer Res 43:1099, 2002. PMID: None.
199. Green MC, Buzdar A, Smith T, Ibrahim NK, Valero V, Rosales M, Cristofanilli M, Booser DJ, Pusztai L, Rivera E, Theriault R, Carter C, Singletary SE, Kuerer HM, Hunt KK, Strom E, Hortobagyi G. Weekly paclitaxel followed by FAC as primary systemic chemotherapy of operable breast cancer improves pathologic complete remission rates when compared to every 3-week P therapy followed by FAC- final results of a prospective phase III randomized trial. Proc Am Society Clin Oncol 21:35a, 2002. PMID: None.
200. Gilcrease MZ, Zhou X, Welch K, Jiang F, Katz R, Hunt KK, Price J, Hung MC. Alpha6BETA4 integrin-mediated signaling in breast cancer. Era of Hope Meeting, 2002. PMID: None.
201. Vorburger SA, Pataer A, Barber GN, Liu Y, Swisher SG, Hunt KK. Adenoviral gene transfer of E2F-1 induces apoptisis through upregulation of the DS-RNA activated protein kinase PKR. Proc Am Assoc Cancer Res 43:662, 2002. PMID: None.
202. Bilimoria MM, Feig B, Mansfield P, Pisters PWT, Pollock RE, Patel S, Plager A, Benjamin R, Burgess M, Chase J, Murphy A, Griffin J, Mirza N, Hunt K. A phase I trial of intraperitoneal hyperthermic chemotherapy for the treatment of sarcomatosis. [Abstract] Connective Tissue Oncology Society, Sarcoma 5(1):47-48, 2001. PMID: None.
203. Solorzano C, Hunt K, Mirza N, Meric F, Ames F, Kuerer H, Newman L, Singletary E, Delpassand E, Ross M. Utility of breast sentinel node biopsy using high dose technetium-99 sulfur colloid injection the day before surgery. 54th Annual Cancer Symposium of the Society of Surgical Oncology, 2001. PMID: None.
204. Pataer A, Nutt L, Yu R, Mhashilkar A, Bhada S, McConkey DJ, Hunt KK, Roth JASwisher SG. MDA-7 induces apoptosis by caspase activation through mitochondrial cytochrome C release. Proc Am Assoc Cancer Res 42:449, 2001. PMID: None.
205. Albo D, Wayne JD, Hunt KK, Singletary SE, Ames FC, Ross MI, Kuerer HM. Anaphylactic reaction to isosulfan blue dye during sentinel lymph node biopsy for breast cancer. [Abstract] American Society of Breast Surgeons Annual Meeting, 2001. PMID: None.
206. Wayne JD, Albo D, Hunt KK, Lee J, Myers J, Gershenwald J, Mansfield P, Ames F, Singletary SE, Ross M, Kuerer H. Anaphylactic reaction to isosulfan blue dye during sentinel lymph node biopsy is more common in breast cancer than in melanoma. Proc Am Soc Clin Oncol 20:38a, 2001. PMID: None.
207. Wayne J, Hunt K, Ngo R, Esnaola N, Bisanz A, Pisters P, Ellis L, Vauthey J, Mansfield P, Curley S, Skibber J. The rate of venous thromboembolism (VTE) is low in patients undergoing surgery for colorectal cancer on clinical pathways. 54th Annual Cancer Symposium of the Society of Surgical Oncology, 2001. PMID: None.
208. Vlastos G, Jean M, Mirza N, Kuerer H, Ames F, Hunt K, Ross M, Buchholz T, Buzdar A, Singletary E. Occult primary carcinoma presenting with axillary metastases: Is there a role for mastectomy?. 54th Annual Cancer Symposium of the Society of Surgical Oncology, 2001. PMID: None.
209. Albo D, Ames FC, Hunt KK, Ross MI, Singletary SE, Kuerer HM. Lymphatic mapping for male breast cancer. Breast Cancer Res Treat 69(3):227, 2001. PMID: None.
210. Verschraegen C, Le D, Kudelka A, Kavanagh J, Hunt KK. Cisplatin and Irinotecan (CPT-11) for peritoneal mesothelioma. Proc Am Soc Clin Oncol 20:90b, 2001. PMID: None.
211. Porter G, Cantor S, Patel S, Walsh GLeung D, DeJesus Y, Hunt KK, Feig B, Pollock R, Benjamin R, Brennan M, Pisters P. Cost-effectiveness of pulmonary resection and systemic chemotherapy in the management of metastatic soft tissue. Proc Am Soc Clin Oncol 20:291b, 2001. PMID: None.
212. Newman L, Singletary S, Kuerer H, Buzdar A, Ames F, Ross M, Hunt K. A prospective trial of preoperative chemotherapy (CTX) in resectable breast cancer: Predictors of breast conservation therapy (BCT) feasibility. . 54th Annual Cancer Symposium of the Society of Surgical Oncology, 2001. PMID: None.
213. Mirza NQ, Vlastos G, Meric F, Ames FC, Feig BW, Kuerer HM, Pollock RE, Ross MI, Singletary E, Buchholz TA, Buzdar AU, Hortobagyi GN, Hunt KK. Predictors of systemic recurrences and impact of local failure among early stage breast cancer patients treated with breast conservation therapy. . Breast Cancer Res Treat 69(3):227, 2001. PMID: None.
214. Mirza N, Vlastos G, Meric F, Singletary E, Ames F, Kuerer H, Ross M, Feig B, Pollock R, Buchholz, Hortobagyi G, Hunt K. Predictors of locoregional recurrence (LRR) among early stage breast cancer patients treated with breast conserving therapy (BCT). 54th Annual Cancer Symposium of the Society of Surgical Oncology, 2001. PMID: None.
215. Kuerer HM, Singletary SE, Buzdar AU, Ames FC, Valero V, Buchholz TA, Ross MI, Pusztai L, Hortobagyi GN, Hunt KK. Breast conservation after neoadjuvant chemotherapy: Surgical planning in women with stage II and operable stage III breast carcinoma. [Abstract] Southwestern Surgical Congress, 2001. PMID: None.
216. Kuerer H, Peoples G, Sahin A, Murray J, Singletary E, Castilleja A, Hunt K, Gershenson D, Ioannides C. Axillary lymph node (LN) cellular immune response to Her-2/Neu peptides in patients with carcinoma of the breast. The 54th Annual Cancer Symposium of the Society of Surgical Oncology, 2001. PMID: None.
217. Kuerer H, Gwyn K, Singletary E, Buchholz T, Hunt K, Ross M, Ames F, Theriault R. Conservative surgery and chemotherapy during pregnancy for breast carcinoma. 54th Annual Cancer Symposium of the Society of Surgical Oncology, 2001. PMID: None.
218. Yoshida K, Mishizaki M, Hunt KK. Combination therapy of adenovirus-mediated overexpression of E2F-1 transcription factor and chemotherapy enhances growth suppression in breast cancer cells. Proc Am Assoc Cancer Res 42:855, 2001. PMID: None.
219. Pisters PWT, Patel SR, Crane C, Feig BW, Hunt KK, Burgess MA, Papadopoulos NE, Plager C, Benjamin RS, Pollock RE, Janjan NE. Combined modality management of retroperitoneal sarcomas (RPS): Phase I trial of preoperative doxorubicin-based concurrent chemoradiation, surgical resection, and intraoperative electron-beam radiation therapy (IORT). [Abstract] 6th Annual Scientific Meeting of the Connective Tissue Oncology Society, 2000. PMID: None.
220. Jhingran A, Kim JS, Buchholz TA, Katz A, Strom E, Hunt KK, Sneige N, McNeese MD. Excellent local control following breast conserving surgery and radiation for young women with ductal carcinoma in situ of the breast. [Abstract] RSNA Meeting, 2000. PMID: None.
221. Cormier JN, Patel SR, Herzog CE, Raney RB, Plager C, Papadopoulos NE, Burgess MA, Hunt KK, Feig BW, Ballo MT, Yasko AW, Pollock RE, Benjamin RS, Zagars G, Pisters PWT. Ifosfamide-based concurrent chemoradiation: analysis of treatment-related toxicity in 43 patients with sarcoma. [Abstract] 6th Annual Scientific Meeting of the Connective Tissue Oncology Society, 2000. PMID: None.
222. Delpassand E, Hunt KK, Ross, MI. Early and delayed breast lymphoscintigraphy using TC-99M filtered sulfur colloid. EANM Paris 2000 Congress, 2000. PMID: None.
223. Wayne JD, Langstein HN, Pollack A, Hunt KK, Feig BW, Yasko AW, Smith LG, Zagars GK, Pollock RE, O'Sullivan B, Pisters PW. Preoperative radiotherapy for extremity soft tissue sarcoma (STS): Site-specific wound complication rates and the impact of reconstructive surgery. [Abstract] Proc Am Soc Clin Oncol:558, 2000. PMID: None.
224. Berman RS, Feig BW, Porter GA, Laronga C, Kumparatana M, Leroux B, Hunt KK, Pisters PW, Mansfield PF, Pollock RE. Platelet kinetics and decreased transfusion requirements after splenectomy for hematologic malignancies. [Abstract] Proc Am Soc Clin Oncol:21, 2000. PMID: None.
225. Meric F, Hess KR, Varma DGK, Hunt KK, Pisters PWT, Milas M, Patel SR, Benjamin, Plager C, Papadopoulos NEJ, Burgess MA, Pollock RE, Feig BW. Impact of neoadjuvant therapy on local control of soft tissue sarcomas. [Abstract] Proc Am Soc Clin Oncol:558, 2000. PMID: None.
226. Valero V, Esteva FJ, Rosales MF, Esparza-Guerra LT, Sahin AA, Strom EA, Ross MI, Booser DJ, Ibrahim NK, Cristofanilli M, Hunt KK, Hortobagyi GN. Phase II trial of primary chemotherapy with docetaxel and doxorubicin in locally advanced breast cancer: Clinical and pathological results. [Abstract] Proc Am Soc Clin Oncol:132, 2000. PMID: None.
227. Porter G, Ahmad S, Cantor S, Lenert J, Hunt K, Feig B, Patel S, Benjamin R, Pollock R, Pisters P. Cost-effectiveness of routine chest computed tomography in patients with T2 soft-tissue sarcoma. [Abstract] Proc Am Soc Clin Oncol:553, 2000. PMID: None.
228. Ahmad S, Patel S, Baker T, Feig B, Hunt K, Yasko A, Burgess M, Papadolopoulos N, Plager C, Benjamin R, Pollock R, Pisters P. Extraosseous osteosarcoma: Long-term results from a single institution experience. . [Abstract] Proc Am Soc Clin Oncol:560, 2000. PMID: None.
229. Pisters P, Patel S, Crane C, Feig B, Hunt K, Burgess M, Papadopoulos N, Plager C, Benjamin R, Pollock R, Janjan N. Phase I trial of preoperative doxorubicin-based concurrent chemoradiation and electron-beam intraoperative radiation therapy (IORT) for resectable retroperitoneal sarcomas. [Abstract] Proc Am Soc Clin Oncol:558, 2000. PMID: None.
230. Yared MA, Middleton LP, Ross MI, Hunt KK, Sahin AA. Recommendations for sentinel lymph node processing in breast cancer. [Abstract] Accepted for presentation, US and Canadian Academy of Pathology Annual Meeting, 2000. PMID: None.
231. Mirza NQ, Vlastos G, Meric F, Buchholz TA, Singletary SE, Ames FC, Newman LA, Kuerer HM, Feig BW, Ross MI, Pollock RE, Hortobagyi GN, Hunt KK. Incidence and survival impact of non-breast second primary malignancies (SPM) following breast-conserving therapy (BCT). Breast Cancer Res Treat 64(1):54, 2000. PMID: None.
232. Yoshida K, Nishizaki M, Hunt K. Adenovirus mediated expression of E2F-1 in combination with Paclitaxel has a synergistic effect on breast cancer cell growth inhibition. Breast Cancer Res Treat 64(1):54, 2000. PMID: None.
233. Wills DD, Meric F, Mirza NQ, Singletary SE, Ames FC, Kuerer H, Ross MI, Newman LA, Feig BW, Pollock RE, Hunt KK. Metastases to the Breast: Determinants of survival. Breast Cancer Res Treat 64(1), 2000. PMID: None.
234. Vlastos G, Mirza NQ, Meric F, Hunt KK, Newman LA, Kuerer HM, Ames FC, Ross MI, Pollock RE, Buchholz TZ, Hortobagyi GN, Singletary SE. Breast conserving therapy in the elderly: an appropriate treatment choice. Breast Cancer Res Treat 64(1):103, 2000. PMID: None.
235. Valero V, Esteva FJ, Sahin AA, Booser DJ, Strom EA, Esparza-Guerra LT, Ross MI, Rosales MF, Ibrahim NK, Cristofanilli M, Buchholz TA, Hunt KK, Hortobagyi GN. Phase II trial of neoadjuvant chemotherapy with docetaxel and doxorubicin, surgery, adjuvant CMF, and radiotherapy +/- Tamoxifen in locally advanced breast cancer. Breast Cancer Res Treat 1(64):69, 2000. PMID: None.
236. Thomas E, Buzdar A, Theriault R, Singletary S, Booser D, Valero V, Ibrahim N, Smith T, Frye D, Manuel N, S-W K, McNeese M, Strom E, Hunt KK, Ames F, Hortobagyi G. Role of paclitaxel in adjuvant therapy of operable breast cancer: Preliminary results of prospective randomized clinical trial. [Abstract] The American Society of Clinical Oncology, 2000. PMID: None.
237. Newman LA, Kuerer HM, Hunt KK, Vlastos G, Gurtner J, Ames FC, Ross MI, McNeese MD, Robb G, Singletary SE. Bilateral reduction mammoplasty (BRM) to improve breast conservation therapy (BCT) results in breast cancer patients with macromastia. Breast Cancer Res Treat 64(1):104, 2000. PMID: None.
238. Meric F, Buchholz TA, Mirza NQ, Vlastos G, Singletary SE, Ross MI, Ames FC, Pollock RE, Feig BW, Kuerer H, Newman LA, Perkins GH, Strom EA, McNeese MD, Hortobagyi GN, Hunt KK. Long-term complications associated with breast conservation surgery and radiation therapy. Breast Cancer Res Treat 64(1):54, 2000. PMID: None.
239. Lee A, Hunt K, Kuerer H, Ross M, Ames F, Singletary S, Tucker S, Sahin A, Krishnamurthy S. Predictors of non-sentinel lymph node metastasis in breast carcinoma. [Abstract] USCAP Meeting, 2000. PMID: None.
240. Krishnamurthy S, Tarco E, Hunt K, Kuerer H, Ross M, Ames F, Singletary E, Sneigt N. Utility of imprint cytology and rapid cytokeratin immunostaining for the intraoperative evaluation of axillary sentinel lymph nodes in breast cancer. [Abstract] USCAP Meeting, 2000. PMID: None.
241. Buchholz TA, Tucker SL, Mathur D, Strom EA, McNeese MD, Hortobagyi GN, Cristofanilli M, Esteva F, Newman L, Singletary SE, Buzdar, Au, Hunt KK. Impact of systemic treatment on local control for lymph-node negative breast cancer patients treated with breast conservation therapy. [Abstract] Cancer J 6:406, 2000. PMID: None.
242. Breslin, TM, Sahin, A, Kuerer, HM, Newman, LA, Delpassand ES, House R, Ames FC, Feig BW, Ross MI, Singletary SE, Buzdar AU, Hortobagyi GN, Hunt KK. Sentinel lymph node biopsy is accurate following neoadjuvant chemotherapy. . [Abstract] The Trainee Recognition Day Competition, The University of Texas M. D. Anderson Cancer Center, 2000. PMID: None.
243. Chen JH, Warneke CL, Middleton L, Singh P, Kuerer HM, Hunt KK, Martinez AL, Litton J, Oke O, Johnson HM. Low Complication Rates After Invasive Procedures on the Lactating Breast in Patients Treated for Breast Cancer During Pregnancy. American Society of Breast Surgeons None(None):None. PMID: None.
244. Boughey JC, Rosenkranz KM, Ballman K, McCall L, Haffty B, Cuttino L, Kubicky C, LePetross HC, Hunt KK, Carey LA, Partridge AH. Impact of Breast Conservation Therapy on Local Recurrence in Patients with Multiple Ipsilateral Breast Cancer – Results from Alliance Z11102. San Antonio Breast Cancer Symposium (SABCS) 2022. PMID: None.
245. Mastoraki S, Lulla AR, Schneider S, Clise-Dwyer K, Fowlkes NW, Hunt KK, Watowich SS, Keyomarsi K. LMW-E Induction and Crosstalk with Immune Cells Potentiates Local Immune Responses Leading to an Immunosuppressive Microenvironment at the Early Sstages of Breast Tumorigenesis in Mouse Models. AACR 2022 Annual Meeting. PMID: None.
246. Kettner NM, Navarro-Yepes J, Bui T, Rao X, Wang J, Meric-Bernstam F, Hunt KK, Tripathy D, Keyomarsi K. Identifying therapeutic vulnerabilities in HR-positive, HER2-negative advanced breast cancer patient-derived xenograft models refractory to CDK4/6 inhibition. AACR 2022 Annual Meeting. PMID: None.
247. Kettner NM, Bui T, Navarro-Yepes J, Eckols TK, Raghavendra AS, Tweardy DJ, Hunt KK, Tripathy D, Keyomarsi K. Circulating IL-6, an early biomarker inof HR- positive, HER-2- negative metastatic breast cancer patients progressing on CDK4/6 inhibitors. AACR 2022 Annual Meeting. PMID: None.
248. Nguyen TD, Pina M, Wang Y, Karakas C, Bui TN, Lazar A, Ingram DR, Hougton PJ, Hunt KK, Keyomarsi K. Early proliferative response via [18]FLT-PET/CT and serum TK1 activity are predictive biomarkers for synergistic effect of sequential cell cycle targeted therapy in sarcoma. AACR 2022 Annual Meeting. PMID: None.
249. Lulla AR, Akli S, Warma LD, Fowlkes NW, Hunt KK, Rao X, Wang J, Watowich SS, Keyomarsi K. Neutrophil elastase (NE)- mediated remodeling of mammary tumors facilitates lung metastasis. AACR 2022 Annual Meeting. PMID: None.
250. Navarro-Yepes J, Kettner NM, Bui T, Raghavendra AS, Rao X, Wang J, Sahin A, Damodaran S, Tripathy D, Hunt KK, Keyomarsi K. Differential mechanisms of acquired resistance to palbociclib reveals pathways of response to abemaciclib. AACR 2022 Annual Meeting. PMID: None.
251. Mastoraki S, Lin J, Rao X, Liu SR, Batra H, Raso MG, Cuentas EP, Raghavendra AS, Rasaputra KS, Yi M, Wang J, Sahin A, Tripathy D, Hunt KK, Navin NN, Keyomarsi K. Single-Cell Transcriptomic Analysis of HR+/HER2- Breast Cancer Identifies Gene Signatures That Predict Outcomes of Luminal A and B Subtypes. AACR 2022 Annual Meeting. PMID: None.
252. Akli S, Lulla AR, Saenz FR, Low KH, Wang F, Fowlkes NW, Bui T, Wang Y, Mastoraki S, Ha MJ, Hunt KK, Keyomarsi K. Aurora Kinase is an actionable target in Low Molecular Weight Cyclin E induced mammary tumors. AACR 2022 Annual Meeting. PMID: None.
253. Hunt KK, Hwang. The clinical impact of intraoperative margin assessment in breast cancer surgery using a novel fluorescence guided surgery system: A Prospective Pilot Study. JAMA Surgery. PMID: None.
254. Francis A, Alexander A, Carey JPW, Ravi V, Keyomarsi K, Hunt KK. CDK4/6 inhibitor, PD-0332991 Synchronizes Sarcoma Cells for Synergistic Demise with WEE1 Inhibitor, MK-1775. 2014 CTOS Annual Meeting, October 15-18, 2014, Berlin, Germany. PMID: None.
255. Yi M, Mittendorf EA, Yang W, Arun BK, Babiera GV, Kuerer HM, Crow JR, Lange G, Shah RR, Hunt KK. Factors Associated with Increasing Mastectomy Rates in Early Stage Breast Cancer Patients: Report from a Single Institution and Population-Based Database. 126th Annual Meeting Southern Surgical Association. PMID: None.
256. Moran, MS, Zhao, Y, Ma S, Fourquet A, Chen P, Hoffman K, Hunt, KK, Wong J, Halasz L, Freedman G, Prosnitz Jr R, Yassa M, Nguyen D, Hijal T, Haffty B, Wai E, Truong P. The Benefit of Radiation Therapy Boost for Ductal Carcinoma In Situ (DCIS) after whole Breast radiation Therapy: Analysis of Outcomes from Ten Pooled Academic Institutions. None. PMID: None.
257. Boughey JC, Ballman K, McCall L, Mittendorf EA, Julian T, Byrd D, Hunt KK. ACOSOG Z1071 (Alliance) Tumor Biology and Response to Chemotherapy Impact Breast Cancer-Specific Survival in Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy and Axillary Dissection: Long-Term Follow-Up. American Surgical Association's 137th Annual Meeting, Philadelphia, Pennsylvania. PMID: None.
258. Hronek J, Schwartz Gomez J, Stoner A, Hunt KK, Hurvitz S, Yardley D. Major Updates in the American Joint Committee on Cancer Eighth Edition Cancer. ONS 2018. PMID: None.
259. Ferrer JM, Hwang S, Hunt KK, Dodge D, Chagpar A, Grobmyer S, Karp S, Valente S, Wapnir I, Smith K, Ramirez E, Bischof T, Strasfeld D, Lee D, Smith B. Expansion into multiple institutions for training in the use of the LUM Imaging System for intraoperative detection of residual cancer in the tumor bed of female subjects with breast cancer. AACR Annual Meeting 2018(18-LB-10694-AACR). PMID: None.
260. Park KU, Kyrish K, Terrell JA, Akay CL, Bedrosian I, Black DM, Caudle AS, Checka C, Feig BW, Hunt KK, Hwang RF, Kuerer HM, Lucci A, Meric-Bernstam F, Refinetti AP, Reyna C, Ross MI, Teshome M, Thompson AM, DeSnyder SM. Opioid prescriptions after breast cancer surgery: Perception and reality. Journal of Clinical Oncology. PMID: None.
261. . Implications for Omission of Sentinel Lymph Node Biopsy (SLNB) in Patients with Early-Stage Node-Negative HR+/HER2- Breast Cancer Undergoing Mastectomy. American Society of Clinical Oncology None(None):None. PMID: None.
262. Alvarado M, Mittendorf EA, Teshome M, Thompson A, Bold R, Gittleman M, Beitsch P, Blair S, Kivilaid K, Harmer Q, Hunt KK. SentimagIC: A non-inferiority trial comparing superparamagnetic iron oxide vs. Technetium-99m and blue dye in the detection of axillary sentinel nodes in patients with early stage breast cancer. Annals of Surgical Oncology. PMID: None.
263. Park KU, DeSnyder SM, Kyrish K, Min Y, Bedrosian I, Caudle AS, Kuerer HM, Hunt KK, Miggins MV, Carson CW. Opioid Use After Breast Conserving Surgery: Identifying Risk Factors For High Opioid Use. 20th Annual Meeting of the American Society of Breast Surgeons. PMID: None.
264. Armer JM, Ballman KV, McCall L, Ostby PL, Zagar E, Kuerer HM, Hunt KK, Boughey JC. Factors Associated with Lymphedema in Women with Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy and Axillary Dissection on a Prospective Clinical Trial (ACOSOG Z1071, Alliance. JAMA Surgery. PMID: None.
265. Singh P, Hunt KK. Effectiveness and Safety of Magseed-localization for Excision of Breast Lesions: A Prospective Trial. 2019 ACS Quality and Safety Conference, Washington, DC. PMID: None.
266. Blair S, Zhao B, Tsai C, Hunt KK. Adherence to Surgical and Oncologic Standards Improves Survival in Breast Cancer Patients. None. PMID: None.
267. Armer J, Ballamn, McCall L, Ostby P, Zagar E, Kuerer H, Hunt KK, Boughey J. A Prospective Clinical Trial in Women with Node-positive Breast Cancer Treated with Neoadjuvant Chemotherapy and Axillary Dissection: Factors Associated with Lymphedema (ACOSOG Z1071: Alliance for Clinical Trials in Oncology [ALLIANCE]). 9th International Lymphoedema Framework Conference, ILF 2019. PMID: None.
268. Simons JM, Nurudeen S, Yi M, Kuerer HM, Caudle AS, DeSnyder SM, Mittendorf EA, Bedrosian I, Hunt KK. Long-term survival following sentinel lymph node biopsy in clinically node negative breast cancer patients treated with primary surgery or neoadjuvant chemotherapy. American Society of Breast Surgeons. PMID: None.
269. Lepetross C, McCall L, |Hunt KK, Ballman K, Boughey J. Central versus Local Review of Axillary Ultrasound prior to and after Neoadjuvant Chemotherapy: Results from ACOSOG Z1071 Trial [Alliance]. None. PMID: None.
270. Lee M, Kuritzky A, Reyna C, McGuire K, Sun W, DeSnyder SM, Aubry S, Nayyar A, Strassle P, Hunt KK, Zhou JM. Evaluation of 2014 Margin Guidelines on Re-Excision and Recurrence Rates after Breast Conserving Surgery: A Multi-Institution Retrospective Study. Surgery. PMID: None.
271. Blair S, Lopez N, Lee K, Bifolck KT, Y K, Dickson-Witmer D, Kelly K, Hunt KK Chang C, Caudle AS, Francescatti A. What factors influence clinical trials implementation? Results from an NAPBC Survey. SSO's 72nd Annual Cancer Symposium. PMID: None.
272. Boughey JC, Ballman K, McCall L, Hunt KK. Development of a model to predict likelihood of additional positive axillary nodes in patients with a positive sentinel node after neoadjuvant chemotherapy using ACOSOG Z1071 clinical trial (Alliance). American Surgical Association. PMID: None.
273. Chapman BV, Lei X, Patil P, Tripathi S, Nicklaus, Fingeret MC, Shaitelman SF, Hunt KK, Buchholz TA, Merchant F, Markey MK, Smith BD, Reddy JP. Quantitative 3D Assessment of Breast Cosmesis after Conventional (CF-WBI) Versus Hypofractionated Whole Breast Radiation (HF-WBI): Results of a Randomized Clinical Trial. American Radium Society. PMID: None.
274. Hunt KK, Suman V, Meric-Bernstam F, Leitch M, Ellis M, Matthew J, Boughey JC, Unzeitig G, Royce M, Buzdar A. Local-regional recurrence (LRR) data from the American College of Surgeons Oncology Group (ACOSOG) Z1041 (Alliance): a randomized neoadjuvant trial of sequential versus concurrent anthracycline with trastuzumab and paclitaxel plus trastuzumab in HER2-positive (HER2+) breast cancer (BC). Society of Surgical Oncology. PMID: None.
275. Simons JM, van Pelt M, Marinelli A, Straver ME, Zeillemaker AM, Arias-Bouda LM, van Nijnatten T, Koppert LB, Hunt KK, Smidt ML, Luiten E, van der Pol C. Experiences with axillary staging after neoadjuvant systemic therapy based on excision of both the pretreatment marked positive lymph node and sentinel lymph nodes. None. PMID: None.
276. Singh P, Scoggins M, Sahin A, Hwang R, Kuerer HM, Caudle AS, Mittendorf EA, Thompson A, Bedrosian I, Teshome M, DeSnyder SM, Meric-Bernstam F, KK <. Effectiveness and Safety of Magseed-localization for Excision of Breast Lesions: A Prospective Trial. SSO 2019. PMID: None.
277. Caudle AS, Blair S, Dickson-Witmer D, Birken S, Kelly K, Lizarraga I, Hunt KK, Lowenstein LM. Leveraging community tumor boards for oncology trial dissemination. ACS Quality & Safety Conference. PMID: None.
278. Singh P, Scoggins M, Sahin A, Hwang R, Kuerer HM, Caudle AS, Mittendorf EA, Thompson A, Bedrosian I, Teshome M, DeSnyder SM, Meric-Bernstam F, Hunt KK. Effectiveness and safety of Magseed-localization for excision of breast lesions: a prospective trial. ACS Quality and Safety Meeting. PMID: None.
279. Smith B, Hunt KK, Hwang S, Wapnir I, Smith B. Preliminary results of a multi-center feasibility trial for real-time, intraoperative detection of residual breast cancer in lumpectomy surgical margins using the LUM Imaging System. American Society of Breast Surgical Oncology. PMID: None.
280. Park KU, Kyrish K, Terrell JA, Yi M, Caudle AS, Hunt KK, Kuerer HM, Bedrosian I, Thompson AM. Surgeon Perception Versus Reality: Opioid Use After Breast Cancer Surgery. Journal of Surgical Oncology. PMID: None.
281. Kettner N, Hunt KK. Combined inhibition of STAT-3 & DNA repair in palbociclib resistant breast cancer. AACR Annual Meeting 2019. PMID: None.
282. Kim MM, Dawood S, Allen P, Sahin A, Woodward W, Strom EA, Hunt KK, Meric-Bernstam F, Gonzalez-Angulo AM, Buchholz T. Effect of Trastuzumab on Locoregional Recurrence of Breast Cancer According to HER2 and ER/PR Status. None. PMID: None.
283. Al-Refaie WB, Decker PA, Pisters PWT, Posner M, Hunt KK, Meyers B, Weinberg A, Nelson H, Newman L, Ballman KV. Variations in Attributes and Outcomes of Older Adults in Surgical Oncology Trials: Results from ACOSOG Z901101 (Alliance). 2014 American Surgical Association. PMID: None.
284. Leonard LD, Sun J, Bassett, R, Ehlers R, Refinetti A, Johnson H, Akay H, Suarez Colon J, Bedrosian I, Hunt K, Tamirisa N. Surgeon Interpretation of Margin Status Utilizing Intraoperative 3D Tomosynthesis During Breast Conserving Surgery. American Society of Breast Surgeons None(None):None. PMID: None.
285. Huynh V, Glencer A, Yi M, Wingate E, Wingate H, Allassan N, Alameddine S, Singh P, Hunt KK, Refinetti A. Impact of pathologic complete response on local-regional recurrence in patients undergoing neoadjuvant chemotherapy and breast conserving surgery. American Society of Breast Surgeons None(None):None. PMID: None.
286. Daly AE, Anderman KJ, Hunt KK, Hwang ES, Wapnir IL, Blumencranz PW, Carr D, Smith K, Schlossberg B, Chang M, Ferrer J, Smith BL. Does additional margin excision during LumiSystem pegulicianine fluorescence-guided lumpectomy surgery affect patient breast satisfaction and cancer worry. American Society of Breast Surgeons None(None):None. PMID: None.
287. Sahin A, Keyomarsi K, Hunt KK, Barbara N, Ha MJ, Guray M, Bakarau K. Pathologic Discordance of African American and West African Breast Cancer Populations. United States and Canadian Academy of Pathology's 108th Annual Meeting in National Harbor, Maryland. PMID: None.
288. Katz MH, Francescatti A, Mullett TW, Harris J, Bleznak AD, Weigel RJ, Reuter EK, Pastore BM, Funk EC, Chan K, Carpenter PJ, Burns WR, Teshome M, Vreeland TJ, Hunt K, Hieken TJ. The first national effort to standardize the performance of cancer surgery by the American College of Surgeons Commission on Cancer and Cancer Surgery Standards Program: Early results after implementation of operative standards. American Surgical Association None(None):None. PMID: None.
289. Francis AM, Kopplin N, Wang AM, Roland CL, Hunt KK, Chang EI. Keeping The Flow: Utilizing Lymphovenous Bypass (LVB) to Prevent Lymphedema in Lower Extremity Soft Tissue Sarcoma (STS) Patients. American Society for Reproductive Medicine None(None):None. PMID: None.
290. Zhao B, Tsai C, Hunt KK, Blair SL. Adhering to Surgical and Oncologic Standards Improves Survival in Breast Cancer Cohorts. Academic Surgical Congress. PMID: None.
291. Hwang R, Bedrosian I, Barcenas CH, Black DM, Caudle, AS, DeSnyder SM, FitzSullivan E, Hunt KK Kuerer HM, Lucci A, meric-Bernstam F, Park KU, Teshome M, Thompson A, Mittendorf EA. OncotypeDX score and nodal burden. Annals of Surgical Oncology. PMID: None.

Book Chapters

1. Cox SE, Hunt KK. Management of Breast Cancer in Special Presentations. In: Fischer's Mastery of Surgery. Eighth. Wolters Kluwer, 576-584, 2024.
2. Carlson KA, Liang D, Fayanju OM, Garvey PB, Karuturi MS, Bedrosian I, Hunt KK. Surgical Procedures for Advanced Local and Regional Malignancies of the Breast. In: Bland and Copeland's The Breast, Comprehensive Management of Benign and Malignant Diseases. Sixth. Elsevier, 627-640, 2024.
3. Poli EC, Sahin AA, Hunt KK. Noninvasive Breast Cancer. In: The MD Anderson Surgical Oncology Manual. 7th. Wolters Kluwer, 1-26, 2024.
4. Adesoye T, Rosso KJ, Klimberg VS, Hunt KK. General Principles of Mastectomy: From Halsted Radical Mastectomy and Modified Radical Mastectomy to Total (Simple) Mastectomy. In: Bland and Copeland's The Breast, Comprehensive Management of Benign and Malignant Diseases. Sixth. Elsevier, 368-388, 2024.
5. Yoon E, Ding Q, Hunt K, Sahin A. High-Grade Spindle Cell Lesions of the Breast: Key Pathologic and Clinical Updates. In: Surg Pathol Clin. 1st. None, 77-93, 2022.
6. Murphy, BL, Hunt, KK, DeSnyder, SM. The multidisciplinary approach to breast cancer management, 137-156, 2021.
7. Klimberg VS, Hunt KK. Diseases of the Breast. In: Sabiston Textbook of Surgery: The Biological Basis of Modern Surgical Practice. 21st. Elsevier, 2021.
8. Murphy BL, Hunt KK, DeSnyder SM. The Multidisciplinary Approach to Breast Cancer Management. In: Breast and Gynecologic Diseases. 2nd. Springer, 2021.
9. Hunt KK, Singh P, Shen Y. Trial Design: Overview of Study Designs. In: Success in Academic Surgery: Clinical Trials. 2nd. Springer, 2020.
10. Antonescu C, Thway K, Hunt KK. Classification of Breast Tumors. In: WHO Classification of Tumours: Breast Tumours. 5th. None, 2019.
11. Simons JM, Teshome M, Hunt KK. Inflammatory Breast Cancer. In: Complex General Surgical Oncology. None. Decker, 2019.
12. Fayanju OM, Sahin AA, Hunt KK. Noninvasive Breast Cancer. In: The MD Anderson Surgical Oncology Handbook. Sixth. Wolters Kluwer, 1-30, 2019.
13. Antonescu CR, Hunt KK, Rowe JJ, Thway K. Primary angiosarcoma of the breast. In: WHO Classification of Tumours: Breast Tumours. 5th. World Health Organization, 2019.
14. Parker CC, Damodaran S, Bland KI, Hunt KK. The Breast. In: Schwartz's Principles of Surgery. 11th. McGraw Hill, 2019.
15. Weiss A, King TA, Hunt KK, Mittendorf EA. Incorporating Biologic Factors into the American Joint Committee on Cancer Breast Cancer Staging System. In: Surg Clin North Am. 4th. Elsevier, 687-702, 2018.
16. Bea VJ, Black DM, Hunt KK. Percutaneous Ablation in the Treatment of Breast Cancer. In: Changing Paradigms in the Management of Breast Cancer. None. Springer, 2018.
17. Keung E, Pollock RE, Hunt KK, Torres KE. Forequarter Amputation. In: Breast Surgery. Second. Wolters Kluwer, 481-492, 2018.
18. Hunt KK, Kronowitz SJ. Mastectomy and Breast Reconstruction. In: Textbook of Complex General Surgical Oncology. None. McGraw Hill Education, 809-816, 2018.
19. Hunt KK, Newman LA, Copeland III EM, Bland KI. The Breast. In: Schwartz's Principles of Surgery. 10th. McGraw-Hill Education, 2018.
20. Fayanju OM, Garvey PB, Karuturi MS, Hunt KK, Bedrosian I. Surgical Procedures for Advanced Local and Regional Malignancies of the Breast. In: The Breast Comprehensive Management of Benign and Malignant Diseases. 5th. Elsevier, 778-801, 2018.
21. Hunt KK, Kronowitz S. Technical Issues Related to Mastectomy for Breast Cancer. In: Textbook of Complex General Surgical Oncology. 1st. McGraw Hill, 2017.
22. Bea VJ, Black D, Hunt KK. Percutaneous Ablation in the Treatment of Breast Cancer. In: Changing Paradigms in the Management of Breast Cancer. 1st. Springer, 71-84, 2017.
23. Ravi V, Antonoff M, Wingate H, Wang W, Hunt KK. Primary Sarcoma of the Lung. In: Textbook of Uncommon Cancer. 5th. John Wiley & Sons Ltd, 248-265, 2017.
24. Hunt KK, Mittendorf EA. Diseases of the Breast. In: Sabiston Textbook of Surgery, The Biological Basis of Modern Surgical Practice. 20th. Elsevier, 820-879, 2017.
25. Mathew J, Courtney CA, Hunt KK, Robertson JF. Surgical Management of Breast Cancer After Preoperative Systemic Treatment. In: Personalized Treatment of Breast Cancer. None. Springer, 263-293, 2016.
26. DeSnyder SM, Hunt KK. The Multidisciplinary Approach to Breast Cancer Management. In: Breast Cancer Screening and Diagnosis. None. Springer Science + Business Media, 393-409, 2015.
27. Buchholz TA, Hunt KK. Local-Regional Therapy following Systemic Treatment. In: Diseases of the Breast. 5th. Wolters Kluwer/Lippincott Williams & Wilkins Health, 772-783, 2014.
28. Hunt KK, Robertson JFR, Bland KI. The Breast. In: Schwartz's Principles of Surgery. 10th. McGraw Hill Professional, 565-604, 2014.
29. Buzdar AU, Buchholz TA, Taylor SH, Horotobagyi GN, Hunt KK. Breast Cancer. In: 60 Years of Survival Outcomes at The University of Texas MD Anderson Cancer Center. None. Springer, 19-34, 2013.
30. Hunt KK, Green MC, Buchholz TA. Diseases of the Breast. In: Sabiston Textbook of Surgery. 19th. Elsevier, 824-869, 2012.
31. McAuliffe PF, Andtbacka RHI, Robinson EK, Hunt KK. Noninvasive Breast Cancer. In: The M. D. Anderson Surgical Oncology Handbook. 5th. LWW, 1-26, 2012.
32. Hunt KK, Litton JK. Systemic Treatment Strategies For Early Stage Breast Cancers. In: Surgery: Evidence-Based Medicine. None. People's Medical Publishing House - USA, 604-611, 2012.
33. Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, McCall LM, Morrow M. Breast Cancer - Axillary Management. In: Year Book of Oncology 2011. 2011. Elsevier, 29-30, 2011.
34. Torres, KE, Pollock RE, Hunt KK. Forequarter Amputation. In: Master Techniques in Breast Surgery. None. None, 2010.
35. Buchholz TA, Hunt KK. Breast-Conserving Therapy: Conventional Whole Breast Irradiation. In: Diseases of the Breast. 4th. Lippincott Williams & Wilkins, 507-528, 2010.
36. Boughey JC, Hunt KK. The ACOSOG Experience. In: Kuerer’s Breast Surgical Oncology. None. McGraw Hill Medical, 517-530, 2010.
37. Fearmonti RM, Beahm EK, Pollock RE, Hunt KK. Surgical Procedures for Advanced Local and Regional Malignancies of the Breast. In: The Breast: Comprehensive Management of Benign and Malignant Diseases. 4th. Saunders (Elsevier), 1147-1173, 2009.
38. Hunt KK, Newman LA, Copeland EM, Bland KI. The Breast. In: Schwartz’s Principles of Surgery. 9th. McGraw-Hill, 2009.
39. Ching CD, Hunt KK. Percutaneous Ablation: Minimally Invasive Techniques in Breast Cancer Therapy. In: The Breast: Comprehensive Management of Benign and Malignant Diseases. 4th. Saunders (Elsevier), 1043-1050, 2009.
40. Hunt KK. Kelly K. Hunt. In: Legends and Legacies: Personal Journeys of Women Physicians and Scientists at M. D. Anderson Cancer Center. 1st. MD Anderson, 52-60, 2008.
41. Strom EA, Buzdar AU, Hunt KK. Multidisciplinary care of breast cancer patients: Overview and implementation. In: M. D. Anderson Cancer Care Series: Breast Cancer, 2nd ed. None. Springer, 197-234, 2008.
42. Boughey JC, Beahm EK, Hunt KK. Oncoplastic surgery for breast cancer. In: Textbook of Surgical Oncology. None. Informa Healthcare, 2008.
43. McKenzie-Johnson T, Sahin A, Hunt KK. Sentinel lymph node dissection: Indications, technique and results. In: Advanced Therapy in Surgical Oncology. None. BC Decker Inc, 511-22, 2008.
44. Hunt KK. American College of Surgeons Oncology Group (ACOSOG). In: BIG – An overview of recent & ongoing clinical trials for breast cancer, 4th ed. None. Cambridge University Press, 2007.
45. Chada S, Bocangel D, Pataer A, Mhashilkar AM, Inoue S, Miyahara R, Roth JA, Grimm EA, Swisher SG, Hunt KK, Ramesh R. MDA-7/IL-24 as a multi-modality therapy for cancer. In: Gene Therapy for Cancer. None. Humana Press, 413-34, 2007.
46. Andtbacka RHI, Meric-Bernstam F, Robinson EK, Hunt KK. Noninvasive breast cancer. In: The M. D. Anderson Surgical Oncology Handbook, 4th ed. None. Lippincott Williams and Wilkins, 1-22, 2006.
47. Browne TS, Chagpar A, Hunt KK, Ramirez P. Perioperative care for breast and gynecological neoplasms. In: Acute Care of the Cancer Patient. None. Taylor & Francis Group, 433-53, 2005.
48. Bedrosian I, Bland K, Hunt KK. Follow-up care of the breast cancer patient. In: The Breast: Comprehensive Management of Benign and Malignant Diseases. None. Saunders (Elsevier) and W.B. Saunders Company, 1513-32, 2004.
49. Beahm EK, Pollock R, Hunt KK. Surgical procedures for advanced local and regional malignancies of the breast. . In: The Breast: Comprehensive Management of Benign and Malignant Diseases. None. Saunders (Elsevier) and W.B. Saunders Company, 1235-54, 2004.
50. Meric F, Robinson E, Hunt KK. Noninvasive breast cancer. In: The M. D. Anderson Surgical Oncology Handbook. None. Lippincott Williams and Wilkins, 1-13, 2003.
51. Bilimoria MM, Hunt KK. Stromal tumors of the stomach and small bowel. In: The Practice of General Surgery. None. W. B. Saunders Company, 405-8, 2002.
52. Vorburger SA, Hunt KK. Experimental Approaches. In: Soft Tissue Sarcoma. None. BC Decker Inc, 375-90, 2002.
53. Hunt KK, Vorburger S, Cormier JN. Surgical approaches to extremity sarcoma. In: Soft Tissue Sarcoma. None. BC Decker Inc, 89-109, 2002.
54. Meric F, Hunt KK. Surgical options for breast cancer. In: M.D. Anderson Cancer Care Series, Breast Cancer. None. Springer, 187-222, 2001.
55. Strom EA, Buzdar AU, Hunt KK. Multidisciplinary care of the breast cancer patient: Overview and implementation. In: M.D. Anderson Cancer Care Series, Breast Cancer. None. Springer, 1-19, 2001.
56. Hunt KK, Ross MI. Paget's disease of the nipple-areolar complex. In: Breast Cancer: The M.D. Anderson Solid Tumor Oncology Series. None. Springer-Verlag, 262-72, 1999.
57. Hunt KK, Buzdar AU. Breast conservation after tumor downstaging with induction chemotherapy. In: Breast Cancer: The M.D. Anderson Solid Tumor Oncology Series. None. Springer-Verlag, 196-207, 1999.
58. Ross MI, Hunt KK. Role for lymphatic mapping and sentinel node biopsy in management of early-stage breast cancer. In: Singletary SE (ed), Breast Cancer: The M.D. Anderson Solid Tumor Oncology Series. None. Springer-Verlag, 171-83, 1999.
59. Robinson E, Hunt KK. Noninvasive breast cancer. In: The M. D. Anderson Surgical Oncology Handbook. None. Lippincott Williams and Wilkins, 1-2, 1999.
60. Hunt KK, Patel SR, Pollack A. Soft tissue sarcomas. In: Integrated Cancer Management: Surgery, Medical Oncology and Radiation Therapy. None. Marcel Dekker, Inc, 394-415, 1999.
61. Hunt KK, Singletary SE, Smith TL, Ross MI, Strom EA, McNeese MD, Ames FC. Conservation surgery and radiation: The M. D. Anderson Cancer Center experience. In: The Breast: Comprehensive Management of Benign and Malignant Diseases. None. W.B. Saunders Company, 1179-82, 1998.
62. Hunt KK, Bland KI, Ellis LM. General considerations for follow-up. In: The Breast: Comprehensive Management of Benign and Malignant Diseases. None. W.B. Saunders Company, 1460-74, 1998.
63. Hunt KK, Kroll SS, Pollock RE. Surgical procedures for advanced local and regional malignancies of the breast. In: The Breast: Comprehensive Management of Benign and Malignant Diseases,. None. W.B. Saunders Company, 1234-43, 1998.
64. Love SM, Hunt KK. Diagnostic approaches to breast masses. In: Mastery of Surgery. None. Little Brown and Company, 563-9, 1997.
65. Mansfield PF, Hunt KK. Classification, staging, and management of Non-Hodgkin's lymphomas. In: Surgical Oncology. None. Springer, 203-212, 1997.
66. Hunt KK, Ross MI. Changing trends in the diagnosis and treatment of early breast cancer. In: Surgical Oncology. None. Kluwer Academic Publishers, 171-201, 1997.
67. Hunt KK, Love S. Breast Disorders. In: McGraw-Hill Encyclopedia of Science and Technology. None. McGraw-Hill, Inc, 1996.
68. Morton DL, Hunt KK, Bauer RL, Lee JD. Immunotherapy by active immunization of the host using nonspecific agents: Clinical applications using intralesional therapy. In: Biologic Therapy of Cancer: Principles and Practice. None. J.B. Lippincott Company, 627-42, 1991.
69. Sun S, Hunt KK. Principles of Neoadjuvant Therapy for Locally Advanced Disease. In: A Practical Guide to Managing Breast Cancer for Low-Middle Income Countries. None. American College of Surgeons (ACS), None.

Books (edited and written)

1. Hunt KK, Katz MHG, Veeramachaneni N, Roland CL, Craigo A, Miller BS, Doherty GM, Kelly KJ, Kruse EJ, Shen P, Levine EA, Votanopoulos K, Siddiqui MM, Kundu S, Rocha F, Tzeng C-W, Francescatti AB, Deming S. Operative Standards for Cancer Surgery. Ed(s) None. Wolters Kluwer, 2023.
2. Hunt KK, Katz MHG, Veeramachaneni N, Grubbs EG, Wang TS, Kane JM, Fields RC, Maithel SK, Chang GJ, Halverson AL, Reddy RM, Martin LW, Francescatti AB. Operative Standards for Cancer Surgery. Ed(s) None. Wolters Kluwer, 2019.
3. Hunt KK. Integrating New Knowledge and Surgical Innovation into the Diagnosis and Management of Breast Cancer. Ed(s) 1. None, 2018.
4. Morita SY, Balch CM, Klimberg VS, Pawlik TM, Posner MC, Tanabe KK. Textbook of Complex General Surgical Oncology. Ed(s) None. McGraw Hill Education, 2018.
5. Nelson HD, Hunt KK, Veeramachaneni N, Blair S, Chang GJ, Halverson A, Katz MHG, Posner MD. Operative Standards for Cancer Surgery. Ed(s) None. Wolters Kluwer, 2015.
6. Hunt KK, Robb GL, Strom EA, Ueno NT. Breast Cancer. Ed(s) 2. Springer Science & Business Media, LLC, 2008.
7. Hunt KK, Vorburger SA, Swisher SG. Gene Therapy for Cancer. Ed(s) None. Humana Press, 2007.
8. Hunt KK, Robb GL, Strom EA, Ueno NT. Breast Cancer. Ed(s) None. Springer, 2001.

Letters to the Editor

1. Santanelli Di Pompeo, F, Clemens, MW, Atlan, M, Botti, G, Cordeiro, P, De Jong, D, DiNapoli, A, Hammond, D, Haymaker, CL, Horwitz, SM, Hunt, KK, Lennox, P, Mallucci, P, Miranda, R, Munhoz, AM, Panagiotakos, DB, Swanson, EC, Turner, SD, Firmani, G, Sorotos, M. Response to. Aesthetic surgery journal 43: NP138-NP140, 2023.
2. Alvarado MD, Mittendorf EA, Teshome M, Thompson AM, Bold RJ, Gittleman MA, Beitsch PD, Blair SL, Kivilaid K, Harmer QJ, Hunt KK. Correction to: SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer. Ann Surg Oncol 27: 979, 2020.
3. Buchholz TA, Ali S, Hunt KK. Reply to A. Thomsen et al. J Clin Oncol 38: 3577, 2020.
4. Boughey JC, Francescatti AB, Park KU, Hunt KK. ASO Author Reflections: Bridging the Gap between Clinical Trial Data and Real-World Cancer Care. Ann Surg Oncol 27: 2276-2277, 2020.
5. Rosenkranz KM, Ballman K, McCall L, Kubicky CD, Cuttino L, Le-Petross H, Hunt KK, Giuliano A, Van Zee K, Haffty B, Boughey J. Reply to "Can Patients with Multiple Breast Cancers in the Same Breast Avoid Mastectomy by Having Multiple Lumpectomies to Achieve Equivalent Rates of Local Breast Cancer Recurrence? Response to the Preliminary Alliance 11102 Trial Report". Ann Surg Oncol 26: 702, 2019.
6. Mittendorf EA, Bedrosian I, Hunt KK. Reply to L. Antolini et al. J Clin Oncol 33: 3978-9, 2015.
7. Caruso JA, Karakas C, Zhang J, Yi M, Albarracin C, Sahin A, Bondy M, Liu J, Hunt KK, Keyomarsi K. Erratum to: Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence. Breast Cancer Res 17: 87, 2015.
8. Dixon JM, Rutgers E, Hunt KK. Authors' reply to Rayter. BMJ 350: h714, 2015.
9. Yi M, Meric-Bernstam F, Kuerer HM, Mittendorf EA, Bedrosian I, Lucci A, Hwang RF, Crow JR, Hunt KK. Reply to comments by KJ Van Zee et al : Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision. J Clin Oncol 30:600-607, 2012. J Clin Oncol 30: 3144-3145, 2012.
10. Caudle AS, Hunt KK, Mittendorf EA. Response to the letter to the editor: Multidisciplinary considerations in the implementation of the findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 Study: a practice-changing trial. Ann Surg Oncol 18 Suppl 3: S283, 2011.
11. Mittendorf EA, Hunt KK. Response to letter to the Editor: Isolated Tumor Cells in Sentinel Lymph Nodes and Clinical Implications for Early Breast Cancer. Ann Surg Oncol, 2009.
12. Kronowitz SJ, Feledy JA, Hunt KK, Kuerer HM, Youssef A, Koutz CA, Robb GL. Determining the optimal approach to breast reconstruction after partial mastectomy: reply. Plast Reconstr Surg 118: 814-5, 2006.
13. Xing Y, Cormier JN, Hunt KK. Author's reply: meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer (Br J Surg 2006; 93: 539-546). Br J Surg 93: 1026, 2006.
14. Hunt KK, Keyomarsi K. Reply to comment by Tez M on Chagpar A, et al. Clinical Outcome of patients with lymph node negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry. Cancer 104: 1780, 2005.
15. Buzdar AU, Hunt KK, Berry D, Hortobagyi GN. Reply to comment by Puglisi F, et al, on Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: Results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer. J Clin Oncol 2005;23(16):3676-85. [PMID: 15738535]. J Clin Oncol 23: 6804-6805, 2005.
16. Raut C, Hunt K, Kuerer HM. Blue dye of choice for lymphatic mapping. J Clin Oncol 15: 3648-9, 2005.
17. Meric F, Mirza NQ, Vlastos G, Buchholz TA, Kuerer HM, Babiera GV, Singletary SE, Ross MI, Ames FC, Feig BW, Krishnamurthy S, Perkins G, McNeese M, Strom E, Valero V, Hunt KK. Reply to comment by Evans R on Meric F, et al. Positive surgical margins and ipsilateral breast tumor recurrence predict systemic recurrence and disease-specific survival after breast-conserving therapy. Cancer, 2005.